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shown to predisposing effect signiﬁcantly (OR, 3.08; 95% CI, 1.44-6.6; p=0.0037 and 
OR, 3.84; 95% CI, 1.73-8.5; p=0.0009, respectively), whereas the dominant model of CG 
and CGAT haplotypes indicated disease-protecting effect (OR, 0.38; 95% CI, 0.17-0.83; 
p=0.0149 and OR, 0.39; 95% CI, 0.17-0.88; p=0.024) in females.
Conclusions: This study demonstrates the association of KCNE2 gene polymorphisms 
with nonfamilial lone AF. These data suggest that KCNE2 haplotypes may contribute to the 
development of AF only in Korean females but not male as predisposing or protecting.
9:30 a.m.
1011-33 The Role of Anisotropic Conduction Velocity Restitution 
in Discordant Alternans, Conduction Block, and Re-
Entry Formation
Hye Jin Hwang, Ohad Ziv, Bum-Rak Choi, Moon-Hyoung Lee, Cardiovascular Research 
Center Rhode Island Hospital and Brown Medical School, Providence, RI
Background Conduction velocity (CV) restitution is an important factor to initiate spatially 
discordant alternans (DA). We investigated the role of anisotropic CV restitution by 
optically mapping DA and initiation of reentry.
Methods The rabbit hearts (n=4) were perfused and action potentials from the left ventricle 
were recorded using di-4-ANEPPS with a high speed CMOS camera (100×100 pixels, 
1000 f/s). Hearts were stimulated on the center of the LV free wall (A) and longitudinal 
(CVL) and transverse (CVT) restitution were calculated from the local vector.
Results We found that CVL / CVT was 2.7±0.2 and APD alternans in the rabbit started at 
longer cycle length (CL =188±12 ms; C) followed by CV alternans (CL = 155±13 ms; D), 
and DA started with CV alternans. Beat-to-beat alternation in CV was found mostly in CVL
yet CVT remained relatively stable (D). CV slowing in the longitudinal direction (B, red line) 
suggests that CVL is a major component creating heterogeneous cycle length. Nodal lines 
were aligned mostly with transverse direction (37.5%) but less frequently with longitudinal 
direction (9%), suggesting higher cell-cell coupling along longitudinal direction inﬂuences 
nodal line formation. Conduction block and reentry formation occurred equally in both 
directions (50% in transverse, 45.5% in longitudinal).
Conclusion CVL oscillation is a major cause of cycle length variation for DA formation 
but other factors such as cell-cell coupling may inﬂuence the formation and alignment of 
DA nodal lines.
9:30 a.m.
1011-34 D,l-Sotalol Reverses Atrial Electrical Remodeling 
and Prevents Atrial Fibrillation Promotion Without 
Affecting Down-Regulated L-type Ca2+ Channel mRNA 
Expression
Sakamoto Tamotsu, Fujiki Akira, Nakatani Yosuke, Kunihiro Nishida, Sakabe Masao, 
Mizumaki Koichi, Inoue Hiroshi, University of Toyama, Toyama, Japan
Introduction: Sotalol and amiodarone are equally efﬁcacious in pharmacological 
conversion of persistent atrial ﬁbrillation (AF) in the SAFE-T study. In animal experimental 
model, amiodarone reverses atrial electrical remodeling associated with improved 
expression of L-type Ca2+ channel. However, the basis of the effectiveness of sotalol for 
AF is poorly understood. Hence, we evaluated the effect of sotalol on remodeled atrium 
in a canine AF model.
Methods: Thirteen beagles were subjected to atrial tachypacing (ATP) with intact AV 
node conduction for 4 weeks. In 7 dogs, sotalol was started (2mg/kg) 1 week after ATP 
onset (Sotalol group).
Results: In the Control group, one week of ATP signiﬁcantly shortened atrial effective 
refractory period (ERP) and AF has been promoted thereafter. In contrast, the subsequent 
administration of sotalol reversed ERP shortening, and prevented AF inducibility and 
duration (Table). Ventricular rate during ATP was similar in both groups (Sotalol 160±34 
vs. Control 183±59bpm at 4 weeks of ATP). There was no difference in left ventricular 
ejection fraction in both groups (Table). Sotalol treatment did not prevent the down 
regulation of L-type Ca2+ channel mRNA expression compared with sham dogs (Sotalol 
85.5% vs. Control 86.0%).
Conclusion: Sotalol reversed atrial electrical remodeling and prevented AF perpetuation 
without affecting down-regulated L-type Ca2+ channel. These dynamic effects constitute 
a potential explanation of sotalol efﬁcacy in clinical AF.
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9:30 a.m.
1011-31 Matrix Metalloproteinase 2 and 9: Novel Biomarkers 
for Atrial and Ventricular Arrhythmias in Patients With 
Systolic Heart Failure
Shaw R. Natan, Abhijit Dasgupta, Suzanne Adams, Maura Diamond, Behzad B. 
Pavri, Arnold J. Greenspon, David J. Whellan, Thomas Jefferson University Hospital, 
Philadelphia, PA
Background: Adverse cardiac remodeling and scar formation provide an arrhythmic 
substrate in patients (pts) with systolic heart failure (SHF). Matrix Metalloproteinase 
(MMP) 2 and 9 enzymes are markers of extracellular collagen turnover, and serum levels 
correlate with the severity of LV dysfunction and prognosis. Collagen metabolism may 
serve a different role in the genesis of atrial ﬁbrillation (AF) and ventricular tachycardia or 
ﬁbrillation (VT/VF). This study examined the relationship of MMP-2 and 9 levels with AF 
and VT/VF in pts with SHF.
Methods: Pts with EF< 40% with Implantable Cardioverter Deﬁbrillators (ICDs) were 
enrolled into either event or non-event groups. Event pts were deﬁned as those receiving 
ICD therapy for spontaneous (VT/VF) within the last six months. Non-event pts had ICDs 
for at least one year without VT/VF. A detailed medical history, NYHA class, echo data, 
history of AF and blood were obtained. MMP-2 and MMP-9 levels were determined by 
ELISA according to the Amersham kit protocol.
Results: See Table. Both MMP-2 and 9 levels were higher in pts with AF (2103 vs 1789 
ng/ml p=0.05, 236 vs 192 ng/ml p=0.009).
Conclusions: MMP-2, but not MMP-9, was signiﬁcantly higher in pts without VT/VF, 
suggesting a potential role for MMP-2 in VT/VF arrhythmia stabilization. Both MMP-2 
and 9 were signiﬁcantly higher in patients with a history of AF possibly reﬂective of more 
atrial adverse remodeling. Further study of MMP 2 and 9 may reveal a mechanistic link 
between collagen metabolism and AF and VT/VF.
Event vs Nonevent Results
Event
n=28
Nonevent
n=30 P value
Age 66 74 NS
M/F (%) 24 (86) 24 (80) NS
Ischemic (%) 18 (67) 20 (69) NS
EF 0.25 0.28 NS
NYHA
I
II
III
IV
4
12
9
2
2
12
7
0
NS
NS
NS
NS
Creatinine 1.4 1.2 NS
AF (%) 13 (46) 14 (47) NS
MMP-9
(ng/mL) 178 195 NS
MMP-2
(ng/mL) 1774 2161 0.03
9:30 a.m.
1011-32 Haplotype-Based Association Study of the KCNE2 
Gene Polymorphisms in Non-familial Atrial Fibrillation
Hye Jin Hwang, Dong-Jik Shin, Jihye Han, Yangsoo Jang, Moon-Hyoung Lee, Boyoung 
Joung, Jin-Bae Kim, Namsik Chung, Sung Soon Kim, Cardiovasular center, Soul, South Korea
Background: KCNE2 protein, a B-subunit of IKr potassium channels modulate cardiac 
cellular electrophysiology, so contributing to atrial repolarization. Previous study has 
shown mutation in KCNE 2 gene to cause familial atrial ﬁbrillation (AF). However, genetic 
susceptibility of KCNE2 in patients with non-familial AF has not been well known. Thus, 
we analysed association between the KCNE2 polymorphisms and the risk of AF. 
Methods: We carried out a case-control study to investigate how genetic variations in the 
KCNE2 gene are associated with AF in Koreans. We examined a sample of 384 Koreans, 
comprising of 167 patients with AF who had no structural heart disease and preserved left 
ventricular function, and 217 controls. We analyzed 14 single nucleotide polymorphisms 
(SNPs) in the KCNE2 gene among AF patients, which were discovered using the direct 
DNA sequencing technique. All subjects were genotyped for these polymorphisms by 
single base primer extension assay using the SNaPShotTM assay. Haplotype analysis was 
performed by 4 tag SNPs.
Results: We analysed 4 tag SNPs (-7187 T/C, -6362 A/G, -72 A/T, -56C/T) among 
the discovered 14 SNPs in the KCNE2 gene. In single-locus analyses, no evidence 
for associations between SNPs and AF in overall patients was observed. After gender 
stratiﬁcation, we found that that -7187 T/C, -6362 A/G, and -56 C/T were associated with 
AF only in females, but not in males. Frequencies of the -7187 T/C, -6362 A/G, and -56 C/T 
alleles were signiﬁcantly higher in cases than in controls (p=0.013, 0.0033, and 0.0021, 
respectively). In haplotype analysis, the recessive model of TA and TAAC haplotypes was 
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RESULTS
ERP 
(ms)
AF duration 
(sec)
AF 
inducibility 
(%)
LVEF (%)
Control Sotalol Control Sotalol Control Sotalol Control Sotalol
Baseline 143±8 150±7 NA NA NA NA 57.6±11 45.6±12
1-week 
pacing 108±4† 106±5† 7±3 5±1 14±9 10±6 24.8±7.2† 21.2±4.5†
2-week 
pacing 90±4† 110±6†¶ 47±28 7±3 38±13 16±8 25.0±5.2† 20.6±8.5†
3-week 
pacing 86±3† 124±3†¶ 789±369‡ 4±1# 42±12‡ 10±8¶ 21.6±7.4† 23.8±10†
4-week 
pacing 81±3† 124±8†¶ 890±341‡ 8±2# 68±15‡ 18±7¶ 22.2±10† 26.2±7.2†
†
p<0.05 vs. 
baseline
‡ p<0.05 
vs. 
1-week 
pacing
¶ p<0.01 
vs. 
Control
# p<0.05 
vs. Control
9:30 a.m.
1011-35 Repolarisation Instability and Torsades de Pointes: 
Assessment of the Proarrhythmic Potential of Dofetilide 
and the Novel Combined Potassium/Sodium Channel 
Blocker AZD1305 in Rabbits In Vivo
Leif Carlsson, Birgit Andersson, Gunilla Linhardt, Lena Löfberg
S431 83 Molndal, Sweden
Background:AZD1305 is a combined K+/Na+ channel blocker under clinical evaluation for 
management of atrial ﬁbrillation. This study aimed to assess the proarrhythmic liability of 
AZD1305 in a rabbit model of torsades de pointes (TdP).
Methods:Anaesthetised methoxamine-sensitised rabbits were infused with dofetilide (2 
nmol/kg/min, n=17) or AZD1305 (0.33 μmol/kg/min, n=8) for 30 min maximum. ECGs were 
continuously recorded and analysed for drug-induced interval changes and appearance of 
TdP. Repolarisation instability was quantiﬁed by measuring the beat-by-beat QT variability. 
Starting 2 min before drug infusion, every ECG complex throughout the remainder of 
the experiment (until end of drug infusion or until appearance of the ﬁrst drug-induced 
extrasystole/TdP) was analysed. The QT variability was quantiﬁed as a moving average 
(of 30 consecutive beats) of the short-term variability (STV).
Results:AZD1305 increased the QT interval (from 121±7 to 159±14 ms, P<0.05) 
without inducing ventricular extrasystoles or TdP. In contrast, dofetilide prolonged the QT 
interval from 135±3 to 199±12 ms (p<0.001) and caused TdP in 12/17 rabbits (p<0.01 
vs AZD1305). During the infusions of AZD1305 and dofetilide, the QTend-peak interval 
maximally increased by 14±4 and 57±6 ms (p<0.05 vs AZD1305) and the STV from 
2±0.8 to 3±0.5 ms (NS) and from 2±0.2 to 12±2.1 ms (P<0.01). After the ﬁrst episode of 
dofetilide-induced TdP, 6 rabbits each were acutely intervened with saline or AZD1305 
(2 μmol/kg). Saline did not suppress TdP in any case whereas AZD1305 shortened the 
QT interval from 215±22.6 to 165±8.5 ms (p<0.05) and suppressed TdP in all 6 rabbits 
(p<0.01 vs saline). The QRS interval was not changed by dofetilide (from 37±2.7 ms to 
36±2.3 ms) but increased to 49±7.4 ms by AZD1305.
Conclusions:In a rabbit model of TdP combined K+/Na+ channel blockade with AZD1305 
prolongs the QT interval without increasing repolarisation instability or inducing TdP and 
suppressed TdP induced by dofetilide. In contrast, selective IKr blockade by dofetilide 
causes QT prolongation, increased transmural dispersion of repolarisation and beat-by-
beat QT variability eventually resulting in TdP.
9:30 a.m.
1011-36 Repolarisation Instability Following Sudden Cycle 
Length Changes in the Rabbit Purkinje Fibre In Vitro: 
Inﬂuence of E-4031, Lidocaine and the Novel Combined 
Potassium/Sodium Channel Blocker AZD1305
Leif Carlsson, Birgit Andersson, AstraZeneca R&D, Mölndal, Sweden
Background:Torsades de pointes is often triggered by sudden changes in heart rhythm.
Methods:The effects of IKr blockade (E-4031, 1 μM) and combined IKr/Na+ blockade by 
the antiarrhythmic AZD1305 (AZD, 3 μM) on APD after abrupt cycle length (CL) changes 
were examined in rabbit Purkinje ﬁbres (PF) .
Results:At a CL of 500 ms, AZD and E-4031 increased APD from 214±10 to 288±25 ms 
(P<0.05) and 207±7 to 387±16 ms (P<0.001). After a CL change to 1000 ms, APD of the 
beat after the change increased by 7±2 (control), 14±3 (AZD) and 149±36 ms (E-4031, 
P<0.01). Adding AZD to E-4031 shortened APD from 395±30 to 354±21 ms (P<0.05) 
and after the CL change from 185±61 to 65±15 ms. In a separate group of PF, a short 
(S2) - long (S3) - short (S4) CL sequence interrupted and was followed by steady state 
pacing (S1, CL 500 ms) in the presence of E-4031 and/or AZD and lidocaine (15 μM). 
The standard deviation of the APD of the ﬁrst 5 beats after resumption of steady state 
pacing was quantiﬁed to indicate APD stability. AZD and lidocaine attenuated the E-4031-
induced APD increase after the pause in the short-long-short CL sequence and increased 
APD stability at resumption of steady-state pacing (Table). Early afterdepolarizations were 
induced by E-4031 but never by AZD or the E-4031 combinations.
Conclusions:Interruption of regular rhythm during selective IKr blockade excessively 
prolonged APD, reduced APD stability and increased proarrhythmia liability, effects 
attenuated by combined K+ and Na+ channel blockade as in the case for AZD1305.
Cycle length (ms)
Drug 500(S1)
300
(S2)
2000
(S3)
1000
(S4)
500
(S1) APD instability (ms)
Control (15) 216±5 191±3 215±7 222±6 214±4 2±0
E-4031 (15) 378±9 303±11 558±52 428±17 312±11 32±5
AZD (6) 280±9 236±6 296±9 302±10 286±11 2±0
E-4031+AZD (8) 357±15 286±14 416±33 374±26 322±9 13±5
E-4031+lidocaine (7) 321±19 260±22 385±24 361±22 305±11 6±2
9:30 a.m.
1011-37 Lack of Cardiac Nerve Sprouting After Direct 
Intramyocardical Transplantation of Bone Marrow 
Derived Stem Cells in Chronic Ischemic Myocardium
Yuan Liu, Song-Yan Liao, Chung-Wah Siu, Wing-Hon Lai, Chu-Pak Lau, Hung-Fat Tse, 
Cardiology Division, Department of Medicine, Queen Mary Hospital, the University of 
Hong Kong, Hong Kong, Hong Kong
Background: It remains unclear whether bone marrow (BM) derived mononuclear 
cells (MNC) and endothelial progenitor cells (EPC) which are the most commonly used 
cell sources in human trials can stimulate cardiac nerve sprouting (CNS) to cause 
proarrhythmia.
Methods: We investigated the effect of direct intramyocardial transplantation of BM 
MNC (n=8) and CD31+EPC (n=8) compared with saline control (n=8) as guided by 
electroanatomical mapping (NOGA) on CNS in swine model of chronic ischemic 
myocardium. At 12 wks after transplantation, the distribution and density of CNS were 
determined by staining of tyrosine hydroxylase (TH) and growth associated protein 43 
(GAP) in the targeted ischemic and remote normal myocardium.
Results: Direct intramyocardial implantation of BM MNC (1232±69/mm) but not BM EPC 
(980±66/mm) resulted in signiﬁcantly higher number of vWF +ve capillaries in ischemic 
myocardium vs control (890±44/mm). However, there were no differences in the density of 
TH and GAP positive staining in the ischemic and normal myocardium between 3 groups 
(Fig). Furthermore, the density of TH and GAP positive staining were also similar in the 
ischemic and normal myocardium in each group of animal (P>0.05).
Conclusions: Catheter-based direct intramyocardial injection of BM MNC enhanced 
neovascularization without any signiﬁcant increase in CNS in chronic ischemic 
myocardium. This may account for the low prevalence of proarrhythmia with BM MNC or 
EPC transplantation observed in clinical trials. 
9:30 a.m.
1011-38 Oxidative Stress Promotes Ventricular Fibrillation in 
Spontaneously Hypertensive Rats: Role of Myocardial 
Fibrosis, Altered Intracellular Ca2+ Cycling and (Ca2+/
Calmodulin)-Dependent Kinase-II Signaling Pathway
Ali A. Sovari, Norishige Morita, Michael C. Fishbein, James N. Weiss, Hrayr S. 
Karagueuzian, University of California, Los Angeles, Los Angeles, CA
Background: The inﬂuence of oxidative stress on inducibility of VT / VF and the structural 
and electrophysiological abnormalities in the hearts of hypertensive subjects remain 
undeﬁned. We tested the hypothesis that adult spontaneously hypertensive rat (SHR) 
hearts are more vulnerable to H2O2-mediated VT / VF than normal adult rat hearts and 
this vulnerability is associated with altered intracellular Ca2+ handling and increased 
myocardial ﬁbrosis. We also hypothesized that CaMKII is a downstream signal for H2O2-
mediated VT / VF; therefore inhibition of this pathway prevents inducibility of VT / VF 
during oxidative stress.
Methods: SHR (N=18) and Fisher344 rat (N=16) aged 3-6 months hearts were isolated 
and studied in Langendorff-perfused setting. High-resolution dual voltage and Cai2+
optical mapping was performed using voltage and Cai2+ sensitive dyes at baseline and 
after H2O2 (100-200 μM). Then histological analysis was done by trichrome staining to 
quantify collagen deposition.
Results: 16 of 18 SHR hearts developed VT / VF within 20 min of H2O2 perfusion while 
pacing at CLs of 250-100ms. In addition, four of the SHR hearts developed spontaneous 
VF that arose suddenly during NSR. In none of the normal rat hearts either spontaneous 
or inducible VT / VF was observed at baseline or after H2O2 at all pacing CL (P < 0.001). 
Most of the VT / VF episodes were initiated by focal activities clustered at the LV base 
where histological analysis showed 4-fold greater ﬁbrosis compared to other LV sites in 
SHR hearts. The diastolic calcium level increased with decreasing pacing CL and the 
mean Cai2+ transient decline duration (Ca20-80) in SHR hearts was signiﬁcantly longer 
than in normal hearts both at baseline and after H2O2. The slope of the dynamic APD 
restitution curve was near 1 in both groups. In 4 additional SHR hearts VT / VF were 
suppressed by CaMKII inhibition with KN-93 (1 μM).
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Conclusions: Our results provide the ﬁrst experimental evidence that adult SHR hearts 
have greater susceptibility to H2O2-mediated VT / VF than normal hearts that is in part 
mediated by the CaMKII signaling pathway. Increased ﬁbrosis, altered Cai2+ handling, and 
CaMKII signaling pathway interact to promote VT / VF in the SHR hearts.
9:30 a.m.
1011-39 Increased CO2 Levels Augment Late Sodium Current 
and Cause Torsade de Pointes
Jihua Ma, Lin Wu, Hong Li, John C. Shryock, Luiz Belardinelli, CV Therapeutics, Palo 
Alto, CA, Wuhan Universiyt of Science and Technology, Wuhan, People’s Republic of 
China
Background: Increased CO2 retention (kPCO2) due to inadequate ventilation may lead 
to torsade de pointes (TdP) and sudden infant death syndrome. We hypothesized that 
increased CO2 (and intracellular acidosis), but not extracellular acidosis, may enhance 
late sodium current (INa), reduce repolarization reserve, and cause TdP.
Methods: Female rabbit isolated hearts were paced at 1 Hz and exposed to either CO2/
HCO3- or CO2-free solution. The pH values of 7.4, 7.1 and 6.8 were achieved either when 
Krebs-Henseleit solution was gassed with 5, 10 and 20 % CO2 or by use of a CO2-free
PIPES solution. Rabbit ventricular myocytes were isolated and exposed to CO2-gassed
solution. Monophasic action potential (MAP) and ion currents were recorded using MAP 
electrodes and whole-cell patch clamp, respectively.
Results: In rabbit isolated hearts, E-4031 (10 nM) prolonged MAPD90 from 188±5 
to 221±6 ms (n=9, p<0.01) without causing TdP. In the presence of 10 nM E-4031, 
increasing the CO2 level from 5 to 10 and 20 % prolonged MAPD90 to 244±7 and 277±7 
ms (n=9, compared with E-4031 alone, p<0.01), and caused TdP in 7 (70 %) and 4 
(40%) out of 10 hearts, respectively. In contrast, perfusion of CO2-free acidic solutions 
did not increase MAPD and caused no TdP (n=6). In rabbit cardiomyocytes, increases 
of CO2 from 5 to 10 and 20 % concentration-dependently increased late INa and INCX from 
-0.28±0.07 and 0.59±0.08 to -0.85±0.17 and 1.02±0.07, and - 1.66±0.08 and 1.25± 
0.10 pA/pF, respectively, (n=7, p<0.01). Increases of CO2 from 5 to 10 and 20 % also 
decreased IKr, IKs and ICaL from 2.06± 0.06, 1.89± 0.17 and -9.73± 0.46 to 1.60±0.08, 1.48± 
0.09 and -7.85± 0.59, and 0.82± 0.07, 0.78± 0.12 and -5.23± 0.84 pA/pF, respectively 
(n=7, p<0.01 in all).
Conclusions: Increased CO2 levels, but not extracellular acidosis, prolonged APD and 
caused TdP in hearts exposed to a low concentration of the IKr inhibitor E-4031. The 
proarrhythmic effect of CO2 was associated with increased late INa and decreased IKr
and IKs; these actions are expected to reduce repolarization reserve and are therefore 
proarrhythmic. The incidence of TdP was greater at 10 % CO2 (pH 7.1) that at 20 % CO2
(pH 6.8), because ICaL was reduced at the lower pH.
9:30 a.m.
1011-40 Mechanisms of Recurrent Ventricular Fibrillation in a 
Rabbit Model of Pacing-Induced Heart Failure
Masahiro Ogawa, Norishige Morita, Liang Tang, Hrayr S. Karagueuzian, James N. 
Weiss, Shien-Fong Lin, Peng-Sheng Chen, Indiana University, the Krannert Institute of 
Cardiology, Indianapolis, IN
Objectives. To determine the mechanisms of spontaneous ventricular ﬁbrillation (SVF) 
after initial successful deﬁbrillation in a rabbit model of heart failure (HF).
Background. Successful deﬁbrillation may be followed by recurrent SVF. The mechanisms 
of postshock SVF are unclear.
Methods. We performed simultaneous optical mapping of intracellular calcium (Cai) and 
membrane potential (Vm) in 12 rabbit hearts with chronic pacing-induced heart failure, in 
4 sham operated hearts and in 5 normal hearts during ﬁbrillation-deﬁbrillation episodes.
Results. We recorded 28 SVF episodes after initial successful deﬁbrillation in 4 failing 
hearts (SVF Group) but not in the remaining 8 failing hearts (no-SVF Group) or in the 
normal or sham operated hearts. The action potential duration (APD80) before pacing-
induced VF was 209±9 ms (SVF-Group) and 212±14 ms (no-SVF Group, P=NS). After 
successful deﬁbrillation, the APD80 in SVF Group shortened to 147±26 ms while in no-SVF 
Group shortened to 176±14 ms (P=0.04). However, the duration of Cai after deﬁbrillation 
was not different between these two groups (246±21 ms vs. 241±17 ms, p=NS), resulting 
in elevated Cai during late phase 3 or phase 4 of the action potential. Standard glass 
microelectrode recording in an additional 5 failing hearts conﬁrmed postshock APD 
shortening and afterdepolarizations. The APD80 of normal and sham operated hearts was 
not shortened after deﬁbrillation.
Conclusions. HF promotes acute shortening of the APD immediately after termination 
of VF in failing hearts. Persistent Cai elevation during the late phase 3 and phase 4 of the 
shortened action potential result in afterdepolarizations, triggered activity and SVF.
9:30 a.m.
1011-41 Purkinje Activation Precedes Myocardial Activation 
Following Near Threshold Deﬁbrillation Shocks 
Following Long Duration Ventricular Fibrillation
Derek J. Dosdall, Jose Osorio, Robert P. Robichaux, Jr., Jian Huang, Raymond E. 
Ideker, University of Alabama at Birmingham, Birmingham, AL
Background: While intramural reentry is the primary mechanism for short duration 
ventricular ﬁbrillation (SDVF), recent evidence indicates that the Purkinje system may 
play an important role in the maintenance of long duration ventricular ﬁbrillation (LDVF). 
The role of the Purkinje system in deﬁbrillation is unknown.
Methods: In 8 beagles (9.5 ± 0.8 kg), a 64 electrode Constellation basket was inserted 
into the LV. Ventricular ﬁbrillation (VF) was induced electrically and after episodes of 
SDVF (10 s) and LDVF (180 s), biphasic transcutaneous shocks of increasing energy 
were delivered until ﬁbrillation was terminated.
Results: The time from the shock until earliest recorded postshock activation was 
signiﬁcantly longer after LDVF than SDVF for both failed shocks (154 ± 26 vs. 65 ± 14 
ms) and successful shocks (2920 ± 3438 vs. 364 ± 550 ms). Purkinje activations were 
always recorded preceding the ﬁrst myocardial activations after LDVF for successful and 
failed shocks (8/8 and 8/8, respectively) but were rarely recorded preceding myocardial 
activations after SDVF for successful and failed shocks (2/8 and 0/8, respectively).
Conclusion: Purkinje activations commonly precede myocardial activation following near 
threshold deﬁbrillation shocks after LDVF but not SDVF. Thus, in addition to the previous 
ﬁndings of the role of the Purkinje system in the maintenance of LDVF but not SDVF, this 
study suggests the importance of the Purkinje system in the mechanism of deﬁbrillation 
for LDVF but not SDVF.
9:30 a.m.
1011-42 Cellular Mechanism Underlying Sick Sinus Syndrome in 
Intact Canine Sinoatrial Node
Boyoung Joung, Liang Tang, Seongwook Han, Mitsunori Maruyama, Peng-Sheng Chen, 
Shien-Fong Lin, Krannert Institute of Cardiology, Department of Medicine, Indiana 
University School of Medicine, Indianapolis, IN
Background: Recent studies showed that a “membrane clock” formed by voltage-
dependent ion channels and the intracellular sarcoplasmic reticulum (SR)-dependent 
“Ca clock” interactively produce sinoatrial node (SAN) rhythm. Because these two clocks 
supplement each other to provide a safe pacemaking mechanisms, we hypothesize that 
sick sinus syndrome (SSS) is caused by simultaneous impairment to both clocks.
Methods: Transmembrane potential (V
m
) and intracellular calcium (Cai) were 
simultaneously recorded with dual-camera optical mapping in 18 intact canine SAN 
preparation including right atrium. To impair “membrane clock” and “Ca clock”, ZD 7288 
and ryanodine were used.
Results: Treatment with ZD 7288 (3 μmol/L) or ryanodine (3 μmol/L) alone decreased 
heart rate to 8 % (n=3) and 16% (n=3), respectively. Although ryanodine impaired the 
regularity of sinus rhythm in 2 of 3 SAN preparations, the block of single clock mechanism 
did not produce prolonged (> 3 s) sinus pauses. Prolonged sinus pauses was produced by 
combined treatment of both ZD 7288 and ryanodine (n=4). Interestingly, tachybradycardia 
was produced by If blockade after prolonged (>1 hr) exposure of low dose (0.01 μmol/L)
isoproterenol (ISO) in 5 of 8 preparations. Low dose ISO initially increased heart rate 
by a maximum of 75 % (from 80 ± 9 to 141 ± 44 bpm, p=0.004) with late diastolic Cai
elevation (LDCAE) from superior SAN (n=8). However, after 30 min of ISO infusion, 
LDCAE disappeared and the heart rate reduced by 18%, to 127 ± 32 bpm. Because 
bolus caffeine injection (2 mM) was able to re-induce LDCAE and increase heart rate, 
the mechanism of heart rate reduction after prolonged ISO infusion was likely due to the 
desensitization of B-adrenergic receptor rather than the depletion of SR Ca.
Conclusions: Our result shows that dysfunction of either “membrane clock” or “Ca clock” 
alone does not produce signiﬁcant SSS. This ﬁnding suggests that either mechanism 
can effectively compensate for the dysfunction of the other mechanism of sinus rhythm 
generation. Tachybradycardia, a characteristic manifestation of SSS, occurs because 
of the desensitization of B-adrenergic receptor and a concomitant reduction of If, not 
because of SR Ca depletion.
9:30 a.m.
1011-43 Beat-to-Beat Effects of Rapidly Decreasing Ca2+ Inﬂux 
Through L-type Ca2+ Channels on Ca2+ Release From 
the Sarcoplasmic Reticulum
Moutaz El kadri, George Hart, Munir Hussain, University of Liverpool, Liverpool, United 
Kingdom, University of Bradford, Bradford, United Kingdom
Background: Calcium-induced calcium release (CICR) from the sarcoplasmic reticulum 
(SR) is triggered by the L-type Ca2+ current (ICa), and is proportional to ICa amplitude. In 
this study we assessed the effects of rapidly decreasing the whole cell ICa amplitude on 
SR Ca2+ release independently of changes in SR Ca2+ load.
Methods: Fura-2 loaded rat ventricular myocytes were voltage-clamped at -40 mV 
(perforated patch clamp). ICa and [Ca2+]i transients were recorded using 500 ms step 
depolarizations from a holding potential of -40 to 0 mV. To standardize SR Ca2+ load, a 
train of 5 conditioning pulses (0.5 Hz) was applied prior to each test pulse. Rapid solution 
switching permitted the solution to be exchanged within a single beat. ICa amplitude was 
decreased, either by lowering external Ca2+ to 0.2 mM [Ca2+]
o
 to decrease the driving 
force, or by decreasing channel open probability using the Ca2+ channel antagonist 
nifedipine (0.5 mM) to reduce the number of channels that permit Ca2+ inﬂux, or by using 
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a combination of 0.2 mM [Ca2+]
o
+ 0.5 mM nifedipine. 
Results: Reducing [Ca2+]
o
 from 1.0 to 0.2 mM decreased ICa amplitude by 34 ± 5%, (n=10, 
P<0.05), whereas the amplitude of the accompanying Ca2+ transient was unaffected and 
remained at 98 ± 2% of control. Decreasing Ca2+ inﬂux by using nifedipine produced a 
similar effect; ICa amplitude decreased by 38 ± 5% (P<0.05) but Ca2+ transient remained 
at 96 ± 4% of control. Consequently, the sudden, rapid decrease in macroscopic ICa
amplitude by decreasing either the unitary current, or open probability, led to an increase 
in CICR gain (62±19%, 31±12%, respectively, P<0.05). However, the combined use of 
low Ca2+ + nifedipine was synergistic and appeared to be effective in decreasing Ca2+
transient amplitude; ICa was reduced to 22 ± 4% (P<0.001) i.e. by 78% and Ca transient to 
47 ± 6% of control (P<0.001). The inhibition of both ICa and Ca2+ transient amplitudes was 
not parallel leading to a 108 ± 20% (P<0.05) increase in CICR gain.
Conclusion: Data may be indicative that ryanodine receptors could be coupled to Ca2+
channels that are redundant in triggering SR Ca2+ release. Furthermore, changes in SR 
Ca2+ release may be mediated via changes in SR load or local Ca2+ concentration.
9:30 a.m.
1011-44 Atrial Ventricular Conduction Development in Mouse 
Embryo Hearts
Fuhua Chen, Carlos De Diego, Scott John, Thomas S. Klitzner, James N. Weiss, David 
Geffen School of Medicine at UCLA, Los Angeles, CA
Background: The principal role of AV conduction delay in hearts is to separate the 
activation of the atrial chambers from that of the ventricles. However, the mechanism 
regarding how AV conduction delay is generated remains unclear.
Methods: Simultaneous optical mapping of membrane potential (Vm) and Calcium 
activation (Ca) was used to quantify changes in early stage CD-1 embryonic mouse 
hearts (n=132), embryologic day (E) 9.5, E10.5 and E11.5. Developmental expression 
patterns of connexin 43 (Cx43) and Cx30.2 were examined by immunohistochemistry.
Results: Although AV conductive distance increased, AV conduction time shortened 
signiﬁcantly during mouse embryonic development (E9.5: 373±14 ms; E10.5: 272±7 ms; 
E11.5: 210±10 ms; P<0.01). Both Vm and Ca activation analysis showed a sequential 
conduction pattern from atria to AV ring to ventricles in all E9.5 hearts (25/25), with 
the conduction speed signiﬁcantly slower (0.96±0.13 um/ms, n=14) at the AV ring area 
(180x180 um), but faster in ventricles (7.5±0.14 um/ms, n=10, p<0.001). In E10.5 hearts, 
with an AV ring area of 210x260 um, early apex activation was observed in 72% (18/25) 
hearts. In E11.5 hearts (23/23) the earliest activation of the ventricles was found in the left 
apex region, with an AV ring area of 410x280 um. Immunohistochemistry showed Cx43 
already presents in E9.5 mouse at atria and ventricles, while Cx30.2, which has slower 
conduction characteristics did not develop until E14.5 at AVR.
Conclusions: Results support the concept of the AV ring area “escaping” atrial and 
ventricular development thereby separating the fast conduction and working myocardium 
of the ventricles from the atria and generating AV conduction delay. Immmunohistological 
data suggests that Cx30.2 does not contribute to the AV conduction delay in mouse 
before E14.5.
9:30 a.m.
1011-45 Paroxysmal Atrial Fibrillation and Inﬂammatory Markers 
in Essential Hypertension
Roberto Fogari, Giuseppe Derosa, Amedeo Mugellini, Paola Preti, Annalisa Zoppi, 
Department of Internal Medicine, University of Pavia, Pavia, Italy
Background: there is emerging evidence supporting the association between 
inﬂammation and atrial ﬁbrillation (AF). Aim of this study was to investigate serum levels 
of high sensitive-C reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis 
factor-A (TNF-A) in hypertensive patients with lone paroxysmal AF (PAF).
Methods: we studied 389 consecutive mild to moderate hypertensive (SBP > 140, 
DBP > 90 a 105 mmHg) outpatients (aged 66±8 years) with a history of at least 2 
ECG documented episodes of PAF in the previous 6 months without any other evident 
comorbidity and 366 consecutive essential hypertensive patients with no evidence of PAF, 
matched for age, sex, BMI, and BP. A left atrial size q 45 mm was an exclusion criteria for 
both groups. After a 4 week wash-out placebo period during which any antihypertensive 
and/or antiarrhythmic agent was withdrawn, a standard ECG was recorded, a conventional 
echocardiographic evaluation was performed, and serum hs-CRP, IL-6, and TNF-A levels 
were measured.
Results: the 2 groups were similar regarding demographic, chimical, and 
echocardiographic characteristics. Concerning their ECG ﬁndings, hypertensive patients 
with PAF showed a longer P wave duration (119±19 vs 106±10 ms, p< 0.001) and a 
greater P wave dispersion (41.5±9.3 vs 29.1±7.1 ms, p< 0.001). Serum hs-CRP was 
higher in hypertensives with PAF than in controls (1.93±0.7 vs 0.91±0.4 mg/L, p< 0.001). 
Similarly, serum IL-6 and TNF-A were higher in hypertensives with PAF compared with 
controls (3.1±0.5 vs 1.4±0.6 pg/mL, p< 0.01, and 18.4±4.6 vs 11.9±2.9 pg/mL, p< 0.01, 
respectively).
Conclusions: hypertensive patients with lone PAF are associated with greater atrial 
electrical disomogenity and with higher hs-CRP, IL-6, and TNF-A levels than hypertensive 
patients without evidence of PAF. These ﬁndings suggest a link between the development 
of PAF and inﬂammatory process in hypertensive patients.
9:30 a.m.
1011-46 Autonomic Nerve Responses During Pulmonary 
Vein Isolation by Radiofrequency Ablation Could Be 
Associated With a Decreased Risk of AF Recurrence
Masateru Takigawa, Yukihiko Yoshida, Sumio Morita, Kenji Furusawa, Noriyoshi 
Kanemura, Ruka Yoshida, Tousei Hashimoto, Takashi Yamamoto, Yutaka Aoyama, 
Kiyotake Ishikawa, Natsuo Inoue, Yasushi Tatematsu, Mamoru Nanasato, Haruo 
Hirayama, Nagoya Daini Red Cross Hospital, Nagoya, Japan
Background: Although it is known that stimulation of intracardiac autonomic ganglionic 
plexi (AGP), which has a potential responsibility for atrial ﬁbrillation (AF), could show 
a cholinergic response such as atrioventricular block or an adrenergic response such 
as heart rate elevation, little is known about the signiﬁcance of these autonomic nerve 
responses during pulmonary vein isolation (PVI) by radiofrequency ablation (RFA) as a 
association with AF recurrence .
Methods: In consecutive 150 patients with AF (age 61.9±11.2 years, 106 men, 104 with 
paroxysmal AF, 27 with persistent AF, and 19 with chronic AF) performed PVI by RFA 
between January 2007 and March 2008 , clinical characteristics, echocardiographic 
parameters, and existence or nonexistence of autonomic nerve responses during PVI 
were examined. They were prospectively followed in outpatient clinic after PVI.
Results: During mean follow-up of 6.6±4.7 months after PVI, AF was recurred in 26/150 
(17.3%) patients. According to Cox proportional hazard regression analysis, presence 
of autonomic nerve responses during PVI by RFA was independently associated with 
decreased risk of recurrence of AF (HR 0.51, 95%CI 0.24-0.83, P=0.008). Older age was 
a boderaline predictor of AF recurrence (HR 1.05/1yrk, 95%CI 0.99-1.12. P=0.08).
Conclusions: Autonomic nerve responses during PVI by RFA, which may be a 
direct affection to AGP, could be signiﬁcantly associated with a decreased risk of AF 
recurrence.
Multivariate Analysis
Variables
Multivariate 
Analysis
P values
Hazard Ratio 95% Conﬁdential Interval
Sex NS
Age 0.08 1.05/1 yr k 1.00-1.12
Duration of AF NS
Hypertension NS
Diabetes Mellitus NS
Left Atrial Diameter NS
Ejection Fraction NS
Autonomic Nerve 
Response 0.008 0.51 0.28-0.84
9:30 a.m.
1011-47 Mortality and Guideline-Adherent Antithrombotic 
Treatment Compared With Undertreatment and 
Overtreatment in Patients With Atrial Fibrillation
Laurent Fauchier, Laurent Gorin, Bertrand Pierre, Emilie Nonin, Bruno Rauzy, Noura 
Zannad, Caroline Grimard, Jonathan Banayan, Axel de Labriolle, Dominique Babuty, 
Bernard Charbonnier, Centre Hospitalier Universitaire Trousseau, Tours, France
Background: The Euro Heart Survey showed that antithrombotic treatment in patients 
with atrial ﬁbrillation (AF) was moderately tailored to the 2001 ACC/AHA/ESC guidelines 
for the management of AF and that undertreatment of high-risk patients with AF was 
associated with a worse cardiovascular prognosis. However, the survey was declarative, 
prognosis was only studied in high risk patients and the rate of death was relatively low .
Methods: All patients with AF seen in our institution between 2000 and 2007 were 
identiﬁed and followed until December 2007. The patients were identiﬁed by a search in the 
hospital discharge records which include information on type of AF, co-existing conditions, 
performed procedures, medication at discharge and in-hospital death. Patients who died 
or were lost to follow-up within 30 days of their index event were excluded. Antithrombotic 
guideline adherence was assessed according to the 2006 ACC/AHA/ESC guidelines.
Results: Antithrombotic guideline deviance was analyzed in 3851 consecutive patients 
with AF (age 71±14 years; 2399 men [62%]), 1588 with permanent AF and 2263 with non 
permanent AF, CHADS2 score 1.5±1.1). Antithrombotic treatment was in agreement with 
the guidelines in 61% of patients, whereas 28% were undertreated and 11% overtreated. 
During a follow-up of 945±768 days, 532 deaths were recorded. Compared to guideline 
adherence, undertreatment was associated with a higher risk of mortality (odds ratio 
[OR]=2.48; 95%CI 2.09-2.96; p<0.0001). Overtreatment in the low risk patients was 
associated with a low risk of mortality compared to the whole population with guideline 
adherence (OR=0.21; 95% CI 0.12-0.39; p<0.0001). In a Cox-regression analysis, 
the factors independently associated with increased mortality were antithrombotic 
undertreatment (p<0.0001), renal failure (p<0.0001), heart failure (p<0.0001), older 
age (p<0.0001), history of stroke (p<0.0001), diabetes (p<0.001), chronic pulmonary 
disease (p=0.0009) and male sex (p=0.02).Conclusions: Antithrombotic undertreatment 
in unselected patients with AF is independently associated with a higher risk of mortality, 
whereas this is not the case for overtreatment in the low risk patients.
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9:30 a.m.
1011-48 Accuracy of Right Phrenic Nerve Image Using 64-slice 
Multidetector Computed Tomography in Patients With 
Atrial Fibrillation
Kohei Yamashiro, Mariko Ehara, Tomoya Ozawa, Koyo Satoh, Takahiko Suzuki, 
Toyohashi heart center, Toyohashi, Japan
Background: Endocardial catheter ablation at the right atrial to the superior vena cava 
junction or right pulmonary vein isolation (RPV), especially in balloon-guided procedures, 
is associated with risk for right phrenic nerve (RPN) palsy. Before the procedure of 
catheter ablation for atrial ﬁbrillation, information on the position of PN is important. 
The aim of this study was to evaluate the RPV image obtained by 64-slice multidetector 
computed tomography (CT) in comparison with that using CARTO XP system.
Methods: Thirty two consecutive patients (age 62+9 years: 4 female) who underwent 
pulmonary venography using 64-slice multidetector CT before catheter ablation for atrial 
ﬁbrillation were enrolled in this study. We measured the minimum distance between RPN 
and the ostium of the right superior pulmonary vein (RSPVos) on the axial image obtained 
by CT. Using the CARTO XP system, we deﬁned the position of RPN is the lowest pacing 
threshold point in RSPV or the superior vena cava or the right atrium of 49+11 pacing 
points on the level of RSPVos before ablation procedure. We measured the minimum 
horizontal distance between RPN on the level of the lowest pacing threshold point and 
RSPVos . We compared the minimum distance between RPN and RSPVos on the CT 
image with that obtained by the CARTO image.
Results: The RPN was identiﬁed in 31 of 32 patients (97%). The minimum distance 
between RPN and RSPVos on the CT image and obtained by CARTO image were 
16.6+5.7mm and 15.4+4.7mm respectively. The minimum distance between RPN and 
RSPVos on the CT image had signiﬁcant correlation with that by the CARTO image 
(r=0.848, p<0.001). We had no RPN palsy after RPV isolation.
Conclusions: We can detect the course of the right phrenic pericardiophrenic bundle 
using 64-slice multidetector computed tomography in patients with atrial ﬁbrillation. The 
image of phrenic nerve obtained by multidetector computed tomography is reliable in 
the setting of catheter ablation for atrial ﬁbrillation. The three dimensional image of the 
phrenic nerve may be valuable in avoiding phrenic nerve palsy.
9:30 a.m.
1011-49 Optimal Condition of Radiofrequency Catheter Ablation 
of Atrial Fibrillation: Relationship Between Left Atrial 
Thickness Under the Ablation Line and Cauterized Area
Kazuyoshi Suenari, Yukiko Nakano, Yukoh Hirai, Hiroshi Ogi, Noboru Oda, Shigeyuki 
Ueda, Yuko Makita, Kenta Kajiwara, Yasuki Kihara, Yukihiko Yoshida, Department 
of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical 
Sciences, Hiroshima, Japan
Background: Catheter ablation has become one of the primary treatments for patients 
with symptomatic, drug-refractory atrial ﬁbrillation (AF). However, left atrial myocardial 
thickness may often cause us hardship to accomplish electrical pulmonary vein isolation. 
We examined the left atrial myocardial thickness under the line of circumferential 
pulmonary vein ablation (CPVA) using 64-slice multidetector computed tomography 
(MDCT) to investigate an optimal condition of radiofrequency catheter ablation.
Methods: Forty ﬁve consecutive symptomatic patients (38 men; age 61 ± 11 years) 
with AF who underwent CPVA guided by the CartomergeTM system were enrolled. We 
measured myocardial thickness under the ablation line of all patients with using 64-slice 
MDCT. On the other hand, ablation lesions were created in freshly harvested porcine 
heart sections in a saline bath using the NavistarTM 4-mm tip ablation catheter and the 
StockertTM generator under various conditions [duration of radiofrequency energy delivery 
(15, 30, and 60 seconds), power (30 to 50 W) and temperature (55 and 60°C)]. The pieces 
were sectioned and measured each of duration of radiofrequency energy delivery.
Results: According to analysis of 64-slice MDCT, the thickest wall was left lateral ridge 
(4.6 ± 1.2 mm), while the thinnest wall was left inferior PV ostia (1.7 ± 0.3 mm). Further, 
in a result of the saline bath experience, the deepest of myocardial tissue destruction 
achieved 4.0 mm under the term of 50 W, 60°C and 60 seconds, while the shallowest 
of myocardial tissue destruction achieved 2.0 mm under the term of 30 W, 55°C and 15 
seconds.
Conclusions: This study showed that we had better change the conditions of ablation 
according to the region of left atrium during CPVA and that would lead to decrease the 
recurrence of AF.
9:30 a.m.
1011-50 Consistent Strategy of Circumferential Pulmonary Vein 
Isolation: Outcome of Patients With Paroxysmal and 
Persistent Atrial Fibrillation
Sascha Rolf, Leif-Hendrik Boldt, Abdul Parwani, Martin Huemer, Alexander Wutzler, 
Daniela Blaschke, Rainer Dietz, Wilhelm Haverkamp, Charite - Campus Virchow, 
Department of Cardiology, Berlin, Germany
Background: The application of a left atrial roof and mitral isthmus line, and ablation of 
complex fractionated atrial electrograms in addition to pulmonary vein isolation (PVI) are 
regarded as mandatory to achieve acceptable success rates for patients with chronic 
atrial ﬁbrillation (AF). Failure to accomplish complete lines, complications while attempting 
and extensive procedure durations are not uncommon even in experienced centers. 
The concept of PVI has often been evaluated albeit the knowledge that pulmonary vein 
conduction recovered in many patients with recurrences. We consistently maintained 
the PVI-strategy without additional lesion designs for patients with both, paroxysmal or 
chronic AF, and evaluated the long-term follow-up.
Methods: We consecutively performed circumferential PVI using open irrigated catheter 
ablation guided by electro-anatomic mapping (Carto or NavX) in 130 patients with 
paroxysmal (n=100) or persistent (n=30) AF. Patients were prospectively followed with 
extended Holter monitoring 3, 6, 12 months after the procedure, and on a yearly basis 
afterwards.
Results: Complete PVI was achieved in all 130 patients. Reconduction in at least one 
vein was seen in all 30 redo procedures. Cardiac tamponade did not occur in any of 
the 160 procedures. Stable sinus rhythm after 14 ± 13 months could be noted in 90% 
and 73.3% (p=0.02) of patients with paroxysmal or persistent AF, respectively. Rate of 
Redo procedures (22% and 26.7%, p=ns) and use of antiarrhythmic drugs to prevent 
recurrences of AF, atypical atrial ﬂutter, or other arrhythmias were similar in both groups 
(14.4% and 18.2%, P=ns), respectively.
Conclusions: With the PVI-strategy alone, including for redo cases, the success rate is 
higher in patients with paroxysmal vs. persistent AF. However, it is not unacceptably low. 
The higher success rate achieved with extended ablation in chronic AF patients should be 
weighed against a low complication rate in addition to short procedure duration, and may 
be reserved for patients refractory to a second PVI attempt.
9:30 a.m.
1011-51 Thromboembolic Risk Factors by Transesophageal 
Echocardiography in Patients in Sinus Rhythm After 
Pulmonary Vein Ablation for Atrial Fibrillation: A 
ROTEA Substudy
Ruvin S. Gabriel, Margaret Park, Boris S. Lowe, Ronan J. Curtin, Susan Jasper, Minerva 
Sherman, Mandeep Bhagarva, Oussama Wazni, Walid Saliba, Bruce Lindsay, Allan L. 
Klein, Cleveland Clinic, Cleveland, OH
Background: The decision to terminate long-term anticoagulation after successful 
pulmonary vein ablation (PVA) is individualized according to a patient’s risk of 
thromboembolism. Spontaneous echo contrast (SEC) and left atrium (LA) appendage 
emptying velocities <25cm/sec are markers of thrombus formation. This study evaluates 
echocardiographic predictors of thromboembolism in patients before and after PVA.
Methods: 43 patients were prospectively enrolled to undergo trans-thoracic and trans-
esophageal echocardiography (TEE) immediately prior and 3 months after PVA for atrial 
ﬁbrillation in the ROTEA study. Thirty four patients completed a TEE before ablation and 
at follow-up. 34% of patients had prior ablation attempts. Measures of LA size, function, 
LA appendage emptying and ﬁlling velocities and SEC were evaluated.
Results: Sinus rhythm was maintained in 24 (71%) patients at 3 months. Median baseline 
CHADS2 score was 1 (IQ range 0, 2). Mean LA appendage emptying and ﬁlling velocities 
increased and LA volume index decreased 3 months after PVA. 5 (15 %) patients had 
evidence of LA appendage emptying velocities <25 cm/sec and severe SEC on follow-up 
TEE. 3 of these patients were in sinus rhythm, of which 2 had a CHADS2 score of a 1.
Conclusions: Despite successful reversion to sinus rhythm after PVA, 15 % of patients 
have low LA appendage emptying velocities and SEC on follow-up TEE. TEE can identify 
patients who are at higher thromboembolic risk and may require long-term anticoagulation 
after PVA.
Variable PRE- Ablation POST- Ablation p-value
Maximum LA Volume Index (cm2/m2) 37.5 (15.2) 34.6 (18.3) 0.005
LA Ejection Fraction (%) 28.3 (10.5) 31.5 (11.3) 0.47
LA Appendage Emptying Velocity (cm/s) 39.1 (21.9) 55.7 (28.3) 0.004
LA Appendage Filling Velocity (cm/s) 35.3 (19.6) 46.9 (28.2) 0.01
LA Appendage velocity <25 cm/s (n) 12 5 0.05
9:30 a.m.
1011-52 Increasing Prevalence of Atrial Fibrillation and Flutter 
in the United States: Is it Just due to the Population 
Aging?
Gerald V. Naccarelli, Helen Varker, Jay Lin, Kathy L. Schulman, Penn State Heart and 
Vascular Institute, Hershey, PA, Healthcare Division, Thomas Reuters, Cambridge, MA
Background: Current information on the prevalence of atrial ﬁbrillation (AF) in the United 
States (US) is limited since it is based on studies from single states. Prior studies have 
indicated that the prevalence of AF is likely to increase as the population ages. We 
estimated the prevalence of AF and atrial ﬂutter (AFL) in large national databases and 
used this information to project the prevalence of these conditions to 2050.
Methods: This retrospective cohort study used data collected between July 1 2004 
and December 31 2005 from the Thomson Reuters MarketScan® research databases. 
Patients aged q 20 years with evidence of non-transient AF/AFL were identiﬁed. A control 
group without AF/AFL was matched 1:1 by age and sex to those with AF/AFL. US Census 
Bureau population estimates were used to project to national estimates using age- and 
sex-speciﬁc AF/AFL prevalence rates.
Results: Among the 20,585,927 lives in the databases, 242,903 patients (1.18%) were 
identiﬁed with non-transient AF/AFL (222,605 patients had AF only, 5,376 had AFL only, 
and 14,922 had AF and AFL). Over half of patients with AF, AFL or both AF/AFL were men 
(54.2%, 63.1% and 63.8%, respectively). Mean patient age was 72.8, 67.6 and 69.4 years 
for those with AF, AFL and both AF/AFL, respectively. Patients with AF, AFL and both AF/
AFL had a signiﬁcantly (P<0.001) higher prevalence of co-morbid conditions such as 
hypertension (62.0%, 57.0% and 61.3%, respectively), coronary artery disease (43.0%, 
44.5% and 44.7%, respectively), and valvular heart disease (30.2%, 30.3% and 33.4%, 
respectively) than age- and sex-matched controls (45.1%, 19.4% and 7.9%, respectively). 
The projected number of US individuals in 2005 with AF was 3.03 million, 0.07 million with 
AFL and 0.19 million with both AF/AFL. Prevalence increased to 7.56 million for AF, 0.15 
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million for AFL, and 0.44 million with both AF/AFL in 2050.
Conclusions:  1) Patients with AF/AFL had a greater burden of co-morbid conditions 
than age- and gender-matched controls; and 2) the prevalence of AF/AFL is high and is 
projected to increase considerably over the next 40 years. 3) These projected increases 
are greater than some earlier studies and may reﬂect more than the population aging.
9:30 a.m.
1011-53 Administration of Isoproterenol With And Without 
Defragmentation In Patients With Long Standing 
Permanent Atrial Fibrillation: Preliminary Results
Luigi Di Biase, David J. Burkhardt, Rodney Horton, Javier Sanchez, Joseph G. 
Gallinghouse, Larry Price, Dimpi Patel, Amin Al-Ahmad, Henry H. Hsia, Paul Wang, 
Steven Hao, Richard Hongo, Salwa Beheiry, Andrea Natale, Texas Cardiac Arrhythmia 
Institute, Austin, TX
Introduction: Pulmonary vein isolation (PVI) in long standing permanent atrial ﬁbrillation 
(AF) has been reported to have a lower cure rate.
In this subgroup ablation at adjunctive atrial sites (CFAE) has been shown to improve the 
success rate of atrial ﬁbrillation ablation.
In patients with long standing permanent AF we determined the effects of two different 
ablation strategies on the ability to trigger non PV ﬁring using chemical challenge with 
isoproterenol after each ablation strategy.
Methods: 58 consecutive patients with symptomatic drug refractory long standing 
permanent AF presenting for ablation were enrolled. Patients were treated either with 
isolation of the posterior wall (PVAI) (group1, 28 pts) or with PVAI and bi-atrial ablation of 
complex fractionated atrial electrograms (CFAE defragmentation) (group 2, 30 pts).
After the ablation protocol was terminated, infusion of isoproterenol up to 20 mcg/min 
was given.
During and after administration of isoproterenol the presence of extra PV triggers leading 
to spontaneous occurrence of AF were documented.
Results: There was a statistically signiﬁcant difference in the prevalence of non PV ﬁring 
resulting in AF induction in the two groups when using isoproterenol..
In group 1 39% (11 pts) of patients showed AF reinitiation from non PV triggers versus 
10% (3 pts) of group 2 patients undergoing CFAE ablation (p< 0.001).
Conclusions: Our preliminary data suggest that in patients with long standing atrial 
ﬁbrillation, part of the beneﬁcial effect achieved by defragmentation reﬂects elimination 
of non PV ﬁring sites.
9:30 a.m.
1011-54 Impact of Pulmonary Vein Anatomy Assessed by 
Multislice Computed Tomography on the Outcome After 
Radiofrequency Catheter Ablation for Atrial Fibrillation
Dennis W. den Uijl, Laurens F. Tops, Victoria Delgado, Katja Zeppenfeld, Serge A. Trines, 
Joanne D. Schuijf, Martin J. Schalij, Jeroen J. Bax, Leiden University Medical Center, 
Leiden, The Netherlands
Background: Pulmonary vein (PV) anatomy is highly variable and can pose a technical 
challenge performing radiofrequency catheter ablation (RFCA) for atrial ﬁbrillation (AF). 
The aim of this study is to investigate the relation between PV anatomy and outcome 
after RFCA for AF.
Methods: One hundred consecutive patients undergoing RFCA for AF were studied. AF 
was paroxysmal in 72 (72%) and persistent in 28 (28%). PV anatomy was assessed 
on multi-slice computed tomography (MSCT) and was classiﬁed as normal or complex. 
According to the prevalence of anatomical variants, complex anatomy of the left PVs was 
deﬁned as a common trunk of both inferior and superior PV. Complex anatomy of the right 
PVs was deﬁned as the presence of an additional PV or a common ostium of the superior 
and inferior PV. Outcome after RFCA was assessed during a 12-month follow-up: Routine 
ECG recordings were acquired on a regular basis and 24-hour Holter monitoring was 
performed at 3, 6 and 12 months.
Results: After a mean follow up of 11.4 ± 2.5 months, 41 patients (41%) had a successful 
RFCA procedure. Patients with complex anatomy of the right PVs recorded fewer 
recurrences than patients with normal anatomy of the right PVs (42% versus 65%, 
p=0.048). Similar recurrence rates were found in patients with normal and complex 
anatomy of the left PVs (54% versus 61%, p=0.453).
Conclusions: Complex anatomy of the right PVs is associated with improved outcome 
after RFCA for AF.
9:30 a.m.
1011-55 Porphyria and Atrial Fibrillation Study
Abhijeet Dhoble, Mehul B. Patel, Sahar S. Abdelmoneim, Chethan Puttarajappa, George 
S. Abela, Ranjan K. Thakur, Michigan State University, East Lansing, MI
Background: Porphyrias are a group of inherited disorders affecting enzymes in the 
heme biosynthetic pathway, leading to overproduction and/or accumulation of porphyrin 
or porphyrin precursors. These disorders have also been associated with autonomic 
dysfunction, which in turn can cause atrial ﬁbrillation (AF).
Objective: We hypothesized that tissue deposition of porphyrin or its precursors, and 
associated autonomic dysfunction may predispose these patients to AF or atrial ﬂutter 
(AFL). The purpose of this study was to characterize and compare the prevalence of AF/
AFL in patients with porphyries compared to age matched controls.
Methods: A single center retrospective cohort study was designed using data from chart 
reviews of patients who were admitted to hospital from January 2000 to December 2007. 
A total of 56 distinct cases were found with a discharge diagnosis of porphyria. Age 
and gender matched controls were identiﬁed from the same database using computer 
generated random numbers. We selected one age and gender matched control for each 
case. Electrocardiograms and echocardiograms were reviewed by two independent 
reviewers. Only patients with available 12-lead-electrocardiograms which showed AF/
AFL were labeled with that diagnosis for the purpose of this study.
Results: We included all patients with a discharge diagnosis of porphyria. Mean age of 
cases and controls in years + 2SD was 44.68 ± 16.28 and 44.86 ± 16.13 respectively. 33 
of the cases were females while control group had 30 females. The prevalence of AF/AFL 
was found to be 12.5 % in porphyria patients, compared to 1.78% in the control group (p 
= 0.028, RR 7.45, 95% CI 1.01 - 66.14).
Conclusion: This study suggests that porphyria is signiﬁcantly associated with AF/
AFL with relative risk of 7.45. Further studies are needed to conﬁrm these ﬁndings and 
elucidate possible mechanisms.
9:30 a.m.
1011-56 The Role of Transesophageal Echocardiography in 
Evaluation of Pulmonary Vein Stenosis After Ablation for 
Atrial Fibrillation. A Prospective Comparison With Multi 
Detector Computed Tomography: The ROTEA Study
Ruvin S. Gabriel, Margaret Park, Boris S. Lowe, Ronan J. Curtin, Susan Jasper, Minerva 
Sherman, Mandeep Bhargava, Oussama Wazni, Walid Saliba, Bruce Lindsay, Allan L. 
Klein, Cleveland Clinic, Cleveland, OH
Background: Currently Computed Tomography (CT) is the gold standard for assessment 
of pulmonary vein (PV) anatomy and stenosis after ablation for atrial ﬁbrillation 
(AF), however radiation exposure is a concern in some patients. Transesophageal 
Echocardiography (TEE) can provide both anatomical and functional assessment of 
pulmonary vein anatomy and stenosis, however no study has prospectively compared 
ﬁndings by TEE with CT.
Methods: 43 patients (age 56 ± 11 years, male 84%) with paroxysmal or persistent AF 
were prospectively enrolled to undergo TEE and CT assessment for PV stenosis before 
and after PV ablation. 34 patients completed both TEE and CT assessment prior to and 3 
months after PV ablation. Anatomic PV diameters were assessed by CT. Pulsed and color 
Doppler interrogation of pulmonary vein blood ﬂow was performed by TEE. Anatomic 
PV stenosis was deﬁned according to as: mild <50%, moderate 50-70%, severe >70% 
luminal reduction post PV ablation. Functional PV stenosis by TEE was deﬁned as a PV 
Doppler velocity >100 cm/sec with evidence of turbulence on color Doppler.
Results: TEE image quality was adequate to obtain anatomic and Doppler measurements 
in 97% of Left Upper, 97% of Left Lower, 100% of Right Upper and 100% of Right Lower 
PVs. A reduction in mean PV diameter was seen before and after PV ablation in each 
of the 4 veins (p<0.05) by CT and TEE. An increase in mean PV diastolic ﬂow by TEE 
was seen in each of the 4 veins (P<0.05). No moderate or severe stenosis and 7 (5%) 
mild stenoses were seen on CT. Functionally signiﬁcant PV stenosis by TEE was seen 
in 2 veins, with minimum luminal diameters of 5 and 6 mm on CT and 40% and 35% 
stenosis.
Conclusions: In the ROTEA study, TEE is able to evaluate over 97% of all pulmonary 
veins. After PV ablation, there is a reduction in the mean PV diameter after ablation. TEE 
can provide a functional and anatomical evaluation of PV stenosis and is complimentary 
to MDCT in the evaluation of PV stenosis.
9:30 a.m.
1011-57 Atrial Tachycardia After Surgical MAZE Procedure: Is 
There a Need for Postoperative Anticoagulation?
Mithilesh Kumar Das, Hillel Steiner, Raj Chakka, Patrick Antoun, Krannert Institute of 
cardiology, Indianapolis, IN
Background: The use of anticoagulation is not a routine therapy after the surgical Maze 
procedure (MAZE) for atrial ﬁbrillation (AF). Incidence of arrhythmias and the need for 
anticoagulation during the immediate postoperative and follow-up periods has not been 
well studied.
Methods: We studied 17 consecutive patients (age: 64 ± 11 years; 6 females; mean 
follow up: 134 ± 133 days) who underwent the MAZE procedure in conjunction with other 
cardiac surgery for chronic (12 patients) and paroxysmal (4 patients) AF. The surgeries 
performed included mitral valve surgery (11), aortic and mitral valve surgery (2), coronary 
artery bypass grafting (CABG) (2), and mitral valve surgery and CABG (1).
Results: Nine patients (53%) developed supraventricular arrhythmias after MAZE 
procedure. Atrial tachycardia(AT) at rate between 220 to 240 bpm with 2:1 to 3:1 AV 
block occurred in four (24%). Three of these patients developed persistent AT. One 
patient spontaneously converted to sinus rhythm (SR) 3-months post-procedure, while 
the other 2 remained in persistent AT. The fourth patient developed paroxysmal AT at 
120 bpm. Three of the four patients with AT were found to have left atrial thrombus. Two 
had persistent thrombus despite therapeutic anticoagulation for 3 months. Two patient 
with AT underwent electrophysiologic evaluation that revealed a macroreentrant left atrial 
tachycardia. The tachycardia was successfully ablated in one patient and the other patient 
had left atrial tachycardia which precluded radiofrequency ablation.
2 patients (12%) developed junctional tachycardia during the early postoperative 
period that spontaneously converted to SR. Three patients (18%) required pacemaker 
implantation for sinus node dysfunction (n=1) and for heart block (n=2). 3 patients (18%) 
remained in AF postoperatively, one of whom spontaneously converted to sinus rhythm 
after 1 week, while 2 (12%) patients remained in chronic AF at the last follow up. Twelve 
patients (71%) remained free of arrhythmia.
Conclusion: There is a signiﬁcant incidence of arrhythmias in post MAZE patients during 
long term follow-up. Aggressive anticoagulation may required in the patients with AT due 
to the risk for a left atrial thrombus.
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1011-58 Slower Atrial Fibrillation Rates Are Predictive of 
Successful Cardioversion
Christopher X. Wong, Pawel Kuklik, Anthony G. Brooks, Martin K. Stiles, Bobby John, 
Dennis H. Lau, Hany Dimitri, Ross L. Roberts-Thomson, Glenn D. Young, Prashanthan 
Sanders, Cardiovascular Research Centre, Department of Cardiology, Royal Adelaide 
Hospital, Adelaide, Australia, Disciplines of Medicine and Physiology, University of 
Adelaide, Adelaide, Australia
Background: Electrical cardioversion (CV) is a frequently used modality to achieve sinus rhythm 
from atrial ﬁbrillation (AF). However, the variables which predict the likelihood of immediate CV 
success are incompletely deﬁned. In particular, it is not known whether AF cycle length (AFCL) 
and dominant frequency (DF) during AF, both measures of AF rates, are predictive of CV 
success. We thus aimed to study the variables associated with immediate CV success.
Methods:125 patients (90 M, 55±11 y) undergoing CV during ablation of AF were studied. 
Variables evaluated in relation to CV success included: gender, age, weight, AF duration, 
left atrial size, AFCL and DF, and the presence of structural heart disease.
Results: 218 CVs were performed. Of these, 171 (78%) were successful and 47 (22%) 
were unsuccessful.
Of the variables evaluated, longer AFCL (227±67 vs 194±32 ms, p=0.004), lower DF 
(4.77±1.01 vs 5.21±0.91 Hz, p=0.009), smaller left atrial size (49±7 vs 53±7 mm, p=0.01) 
and lower weight (88±14 vs 93±9 kg, p=0.07) were associated with increased CV success. 
AFCL and left atrial size were the strongest predictive variables of CV success by multivariate 
analysis. Termination of AF was predicted by an AFCL >200 ms with a sensitivity of 56% 
and speciﬁcity of 68%. At AFCL >250 ms, speciﬁcity rises to 93% with sensitivity 28%. 
Conclusions:Successful reversion to sinus rhythm with CV can be predicted by slower 
AF rates. This is a novel ﬁnding with important clinical implications for the management 
of patients with AF.
9:30 a.m.
1011-59 Continuous Surveillance of Atrial Fibrillation 
Recurrence After Pulmonary Vein Isolation: A Novel 
Approach Using Implantable Loop Recorder.
Ashok J. Shah, John Ip, Sivakumar Ardhanari, Eric King, Chad Link, Ranjan Thakur, 
Depak Gandhi, Thoracic & Cardiovascular Institute, Lansing, MI, Michigan State 
University, Lansing, MI
Background: Recurrence of atrial ﬁbrillation (AF) after pulmonary vein isolation (PVI) is 
common. Better detection of AF is important to assess the efﬁcacy of ablation procedure 
and to guide the antiarrhythmic and anticoagulation treatment strategies.
Methods: We studied the feasibility of a novel method to continuously monitor the 
atrial rhythm post AF ablation. Extracardiac atrial electrogram (A-EGM) mapping was 
performed using implantable loop recorder (ILR) following limited thoracotomy approach 
for epicardial PVI. We tested different orientations of ILR in frontal plane to obtain the best 
vector and optimum magnitude of A-EGM during sinus rhythm (SR) and AF.
Results: A-EGM could be optimally deciphered both in SR and AF when ILR was 
positioned in the right inframammary region. Extracardiac A-EGM could discern AF 
episode satisfactorily. Diminutive ventricular electrogram did not interfere with diagnosis 
of SR or AF. (q.v.Image)
Conclusions: Robust leadless atrial electrogram recording is feasible during SR and AF. 
Incorporating atria based algorithms and extended storage capacity into contemporary 
rate-based limited-memory functional design of ILR can accurately and continuously 
reveal the AF burden for a prolonged period after AF ablation. 
9:30 a.m.
1011-60 Characterization of Anisotropic Conduction 
Abnormalities Predisposing to Atrial Arrhythmias
Christopher X. Wong, Martin K. Stiles, Bobby John, Anthony G. Brooks, Pawel Kuklik, 
Dennis H. Lau, Hany Dimitri, Han Lim, Muayad Alasady, Gautam Sharma, Narayanan 
Namboodiri, Glenn D. Young, Prashanthan Sanders, Cardiovascular Research Centre, 
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia, Disciplines of 
Medicine and Physiology, University of Adelaide, Adelaide, Australia
Background: Conduction abnormalities in the atria are critical to the initiation and 
maintenance of atrial arrhythmias. Whilst experimental studies have suggested atrial 
substrates supporting reentrant activity exhibit marked anisotropy, whether directionality 
of activation exaggerate the electrophysiological consequences of structural abnormalities 
to predispose to atrial arrhythmias in humans is unknown.
Methods: 20 patients with paroxysmal atrial ﬂutter were compared to 20 controls. 
Conduction time along linear catheters at the coronary sinus (CS) and lateral right atrium 
(RA), and conduction characteristics at the crista terminalis (CT) were assessed. RA 
electroanatomic maps were created in both sinus rhythm (SR) and CS pacing. Direction 
dependent conduction velocities, voltage properties and electrogram characteristics were 
evaluated.
Results: Patients with atrial ﬂutter demonstrated longer distal-proximal than proximal-
distal conduction times along the CS (53±19 vs 40±6ms, p<0.05) and lateral RA (73±28 
vs 53±19 ms, p<0.05). Atrial ﬂutter patients also exhibited a greater increase in double 
potentials (DP) at the CT from SR to pacing compared to controls (4.1±2.6 to 5.8±2.8 
vs 0.5±0.9 to 0.5±1.3, p=0.04). Paced maps in atrial ﬂutter patients also demonstrated 
signiﬁcant differences when compared to SR maps: slower regional conduction 
(0.78±0.19 vs 1.17±0.16 m/s, p<0.001); longer atrial activation time (127±21 vs 102±13 
ms, p=0.002); greater proportion of DP or fractionated signals (48 vs 7 %, p<0.001); 
lower regional voltage (1.4±0.3 vs 2.1±0.5 mV, p<0.005); and more contiguous lines of 
conduction block as shown by DPs (25/20 vs 14/20, p=0.03) of greater length (60±27 vs 
43±12 mm, p<0.05). No signiﬁcant changes were observed in controls.
Conclusions: Analysis of conduction properties when activity originates from the 
sinus node compared to the CS revealed signiﬁcant differences in regional conduction 
velocities, voltage and electrogram characteristics in patients with atrial ﬂutter that were 
not present in controls. This suggests anisotropic conduction that may promote reentrant 
circuits critical for the genesis and perpetuation of atrial arrhythmias.
9:30 a.m.
1011-61 Comparison of Reverse Remodeling in Paroxysmal 
Versus Persistent/Permanent Atrial Fibrillation After 
Catheter Ablation of Atrial Fibrillation
Suman S. Kuppahally, Nathan S. Burgon, Paul Anderson, Troy J. Badger, Sheldon Litwin, 
Nassir Marrouche, University of Utah, Salt Lake city, UT
Background: Atrial ﬁbrillation (AF) begets AF and structural and functional remodeling of 
atria depends on AF burden. We conducted this study to assess the degree of reverse 
remodeling after catheter ablation of AF in patients with paroxysmal and persistent/
permanent AF.
Methods: Catheter ablation was performed in 75 patients (30- paroxysmal, 45-persistent 
AF). Echocardiographic evaluation was done before and 3 months after ablation. We 
measured LA size, LA volume index by biplane area-length method, LA strain during 
maximum ﬁlling in mid-septal and mid-lateral wall by velocity vector imaging® and LV 
volumes, EF and diastolic parameters. Cardiac MRI with delayed enhancement (DE) was 
performed prior to ablation to quantify LA wall ﬁbrosis.
Results: At baseline, patients with persistent/permanent AF had more pre-ablation LA 
ﬁbrosis and larger LA diameter (p<0.005) and a trend towards lower strain. At 5.8 ± 3.2 
months after ablation, they showed a signiﬁcant improvement in strain as compared to 
those with paroxysmal AF. They also had a reduction in LA size, LA volume index and LV 
end-systolic volume index and an increase in LVEF.
Conclusion: In spite of more structural and functional remodeling of the LA in persistent/
permanent AF as compared to paroxysmal AF, there is a signiﬁcant improvement in LA 
and LV function early after catheter ablation of AF. It is reasonable to offer rhythm control 
therapies to patients even with persistent/permanent AF and assess if the beneﬁts persist 
at long term follow up. 
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1011-62 Incidence and Outcomes of Protamine Reactions 
in Patients Undergoing Catheter Ablation of Atrial 
Fibrillation
Karuna Chilukuri, Charles A. Henrikson, Darshan Dalal, Daniel Scherr, Edwin C. 
MacPherson, Alan Cheng, David Spragg, Saman Nazarian, Sunil Sinha, Ronald Berger, 
Joseph E. Marine, Hugh Calkins, Johns Hopkins Hospital, Baltimore, MD
Background: Aggressive anticoagulation with heparin to maintain an activated clotting 
time (ACT) > 300 seconds is required during catheter ablation of atrial ﬁbrillation (AF) to 
reduce the risk of systemic thromboembolism. The purpose of this study is to describe 
the incidence and outcome of protamine reactions and analyze the risk factors in patients 
undergoing catheter ablation of AF.
Methods: The patient population included 242 consecutive patients (193 men, age 
57.6±10.8 years) with drug refractory AF who underwent catheter ablation and received 
protamine immediately following catheter ablation to reverse the effects of heparin. Fifty 
eight of these patients had prior exposure to protamine.
Results: Three of the 242 patients in our study developed an adverse reaction to 
protamine (1.2%). Although each of the three protamine reaction presented in a dramatic 
fashion with profound hypotension, all three patients responded to medical treatment and 
did not experience clinical sequelae. Age, gender, type of AF, number of ablations, prior 
exposure, diabetes mellitus, and ejection fraction did not predict the occurrence of these 
reactions.
Conclusions: This study reports, for the ﬁrst time, the incidence and outcomes of 
protamine reaction in patients undergoing catheter ablation of AF. The results of this 
study reveal that protamine reactions present in a dramatic fashion often with profound 
hypotension. Although the incidence of protamine reactions in this setting is low (1.2%), 
they do occur. Electrophysiologists who use protamine need to be aware of this reaction 
and the appropriate therapeutic interventions.
9:30 a.m.
1011-63 Clinical Signiﬁcance of Serum Natriuretic Peptide Prior 
to Pulmonary Vein Isolation in Patients With Preserved 
Left Ventricular Ejection Fraction
Sarah K. Hussain, Sarinya Puwanant, Brandon Varr, Sheldon Freeberg, W. H. Wilson 
Tang, Oussama Wazni, Bruce Lindsay, Allan Klein, The Cleveland Clinic, Cleveland, OH
Background: Serum B-type natriuretic peptide (sBNP) is a biomarker for various 
cardiovascular diseases including impaired left ventricular (LV) dysfunction and recurrence 
of atrial ﬁbrillation (AF). Little is known about the signiﬁcance of sBNP prior to pulmonary 
vein isolation (PVI) in patients (pts) with preserved LVEF.
Methods and Results: Of 1058 pts undergoing transesophageal echocardiography 
(TEE) prior to PVI, 665 (58 ± 11y, 79% M) had sBNP drawn within 3 days prior to PVI, 
80% within 24 hours. Of those, 445 pts had LVEF>50%. Pre-procedural sBNP in those 
increased with increasing CHADS2 score (Fig1A). Pts with left atrial appendage (LAA) 
sludge & thrombus had signiﬁcantly higher pre-PVI sBNP (Fig1B). Of 445 pts, 3 died 
(518±411 days post PVI) and 5 developed stroke. The causes of death include heart 
failure, pneumonia, and sudden death. Pre-procedural sBNP in pts with death tended to 
be higher (195±93 vs.114±109 pg/ml, p=0.09)(Fig1C). sBNP was not different between 
those with and without stroke (254±152 vs.143±126, p=NS).
Conclusions: (1) Pre-PVI sBNP signiﬁcantly increased with increased clinical risk 
factor(s) assessed by CHADS2 score. (2) PrePVI sBNP can be used as a biomarker 
associated with LAA sludge &thrombus. This suggests LAA thrombogenic milieu are 
directly or indirectly associated with increased BNP secretion. (3) Pts with a higher pre-
PVI BNP had a trend of higher post-procedural mortality; however, further large scale 
studies are necessary to assess the mortality endpoint.
9:30 a.m.
1011-64 Occurrence of Stroke After Successful Ablation of 
Atrial Flutter
Ghassan Moubarak, Dominique Pavin, Erwan Donal, Bruno Laviolle, Aude Solnon, 
Jean-Claude Daubert, Philippe Mabo, Centre Hospitalo-Universitaire de Rennes, 
Rennes, France
BACKGROUND. Chronic atrial ﬂutter (AFL) is associated with an increased risk of 
thromboembolism. Radiofrequency catheter ablation is an effective treatment for typical 
AFL with few relapses but the incidence and determinants of stroke during long-term 
follow-up after successful AFL ablation are unknown.
METHODS. All patients who underwent successful AFL ablation at our institution 
between November 1998 and December 2000 were prospectively followed. Clinic visits 
were scheduled at 1, 3, 6, and 12 months then yearly. Diagnosis and classiﬁcation of 
stroke was based on clinical and radiological ﬁndings.
RESULTS. There were 135 patients with a mean age of 62 ± 11 years. Structural heart 
disease was present in 69 (51%) patients, hypertension in 56 (41%), diabetes in 15 (11%), 
history of atrial ﬁbrillation (AF) in 64 (47%) and history of stroke or transient ischemic 
attack in 11 (8%). Mean CHADS2 score was 1.1 ± 1.1 at baseline. During a mean follow-
up of 7.1 ± 2.1 years, AF was documented in 99 (73%) patients and AFL in 11 (8%). Three 
patients developed intracerebral hemorrhage under antithrombotic therapy. Nine patients 
(7%) developed ischemic stroke at a mean of 5.4 ± 1.5 years after AFL ablation (range 
3.3-7.8). Seven of these patients had at least one episode of AF before the occurrence 
of stroke but only 2 were receiving anticoagulants and 4 were receiving aspirin. Age was 
the only signiﬁcant predictor of ischemic stroke in univariate analysis (at baseline, 72 ± 5 
years vs 61 ± 11 years, p=0.001).
CONCLUSION. Ischemic stroke may occur late after successful catheter ablation of 
typical AFL, especially in elderly patients with AF. Risk of stroke is identical to that in the 
general AF population and adherence with anticoagulation guidelines is mandatory.
9:30 a.m.
1011-65 Locating the Right Phrenic Nerve by Imaging the 
Right Percardiophrenic Artery With Computerized 
Tomographic Angiography
Rodney Horton, Javier Sanchez, Eric Hepler, Joseph Gallinghouse, Robert Canby, 
Jason Zagrodzky, Larry Price, Shane Bailey, David Burkhardt, Mathew Dare, Andrea 
Natale, Texas Cardiac Arrhythmia Institute, Austin, TX, St. Davids Hospital, Austin, TX
Background: Phrenic nerve (PN) injury, a known complication from radiofrequency 
ablation, has been commonly reported with ablation of atrial ﬁbrillation (AF). Balloon 
based ablations may pose a greater risk of PN injury due to greater lesion depth. We 
present a method of locating the right pericardiophrenic artery (RPA) to approximate the 
PN and predicting patients at higher risk of PN injury.
Methods: 20 patients underwent computerized tomographic angiography (CTA) with 3-D 
segmentation of the left atrium (LA) prior to an AF ablation. The location of the RPA 
was identiﬁed on the coronal CTA images and the RPA to right superior pulmonary vein 
(RSPV) was measured in the 3-D image. During ablation, location of the right PN was 
identiﬁed by pacing, the PN-RSPV distance measured by venography and compared to 
the RPA-RSPV measurement. Using this same technique, CTA images were obtained 
from subjects enrolled in 2 balloon ablation trials and compared to clinical evidence of 
PN injury.
Results: The mean RPA-RSPV ostial distance was 20 (6-42) mm with a measurement 
difference between PN capture and imaged RPA of 0.8 mm. In the 5 cases balloon 
ablation PN injuries seen, the RPA location was <10 mm from the RSPV ostium. This 
PN proximity occurred in 22 % of patients studied posing a higher risk of PN injury using 
these balloon ablation techniques.
Conclusions: Imaging the RPA can reliably locate the right PN. This technique could 
identify more vulnerable PN anatomy and guide the most appropriate ablation approach. 
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1011-66 Multiple Scar-Related Macroreentrant Atrial 
Tachycardias Are Common in Patients Presenting With 
Cavo-Tricuspid Isthmus Dependent Atrial Flutter After 
Prior Cardiac Surgery
Diego F. Belardi, Jeffery Sanders, Joseph Schuller, Royce Bargas, Christopher Stees, 
Laurent Lewkowiez, Michelle Khoo, Christopher M. Lowery, William H. Sauer, University 
of Colorado, Denver, CO
Introduction: Cavo-Tricuspid Isthmus (CTI) dependent atrial ﬂutter (AFl) can occur years 
after prior cardiac surgery and can be reliably treated with catheter ablation. It is known 
that previous atriotomy scar is a risk factor for development of scar-related macroreentrant 
atrial tachycardia (AT). We sought to deﬁne the incidence of scar-related AT in patients 
referred for CTI AFl with history of previous atriotomy.
Methods: 28 consecutive patients with a prior history of right atriotomy from previous 
cardiac surgery undergoing ablation of CTI AFl were included in the cohort. CTI AFl was 
deﬁned by surface electrogram criteria, entrainment mapping, and successful termination 
during delivery of RF at the CTI. Initiation of CTI-dependent ﬂutter and atypical AFl was 
attempted with programmed stimulation (up to triple atrial extra stimuli) in all patients. 
All subjects underwent electroanatomic mapping and identiﬁcation of AT was identiﬁed 
prospectively.
Results: Scar-related AT was discovered in 22 (79%) of the 28 subjects identiﬁed. There 
were 7 patients (21%) with previous atriotomy scar who did not have AT post CTI ablation. 
Patients presenting with AT post CTI ablation had a mean of 2.3 morphologically distinct 
AT variants (range 1 - 4). Of these, all were related to a region of low voltage in the 
posterolateral right atrial wall at the site of prior atriotomy. After a mean follow-up of 9.2 +/- 
3.4 months, 25 of 28 subjects with identiﬁed macroreentrant AT were free of arrhythmias 
(91%) after the initial procedure. Of the 3 that required an additional ablation attempt, 2 
had developed AT not identiﬁed at the time of the initial procedure and 1 was a recurrence 
of a previously identiﬁed AT.
Conclusions: Scar-related macroreentrant AT identiﬁed after ablation of CTI AFl is 
common in patients with previous right atriotomy scar. Therefore, these ATs should be 
mapped and ablated after successful ablation of the presenting arrhythmia.
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1020-31 Atrial Fibrillation: Differences in Patient Characteristics 
and Management Between the United States and the 
Rest of the World in the RecordAF Registry
Peter J. J. Schwartz, Jean-Yves Le Heuzey, Günter Breithardt, John Camm, Harry 
Crijns, Paul Dorian, Peter Kowey, Eric N. Prystowsky, Christian Torp-Pedersen, William 
Weintraub, University of Pavia and IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy, 
Hôpital Georges Pompidou - APHP, Paris, France
Background: The ongoing RecordAF study is the ﬁrst worldwide, prospective, 
observational survey of real-life management of recently diagnosed atrial ﬁbrillation (AF) 
patients with a 1-year follow-up. We compared patient characteristics at baseline and the 
physicians’ choice of rhythm- or rate-control approaches to pharmacologic AF therapy in 
the United States (US) and in the rest of the world (RoW).
Methods: Consecutive eligible patients aged q18 yrs presenting with or treated for AF 
(a1 yr from diagnosis) were recruited from randomly selected ofﬁce- or hospital-based 
cardiologists
Results: Of 5814 patients recruited from 21 countries, 5604 were eligible for evaluation. 
The Table shows the main characteristics and treatment strategies that differed between 
the US and RoW. US patients were older, more obese, and had more comorbidities 
(except heart failure). More US patients had paroxysmal AF; persistent AF was more 
frequent in RoW. Rate-control strategy was preferred in US, with higher uses of beta-
blockers and calcium-channel blockers; rhythm-control strategy was preferred in RoW. 
Oral anticoagulants were less prescribed in RoW patients. 
US Rest of the World* P-value(Test)
N 955† 4649†
Age, years, mean (SD) 68.9 (12.5) 64.9 (11.7) < 0.001 (A)
BMI >30 kg/m² 370 (39.2%) 1408 (30.5%) < 0.001 (C)
History of MI or coronary artery disease 225 (23.6%) 813 (17.5%) < 0.001 (C)
History of heart failure 140 (14.7%) 1312 (28.2%) < 0.001 (C)
History of dyslipidemia 530 (55.7%) 1842 (39.7%) < 0.001 (C)
History of diabetes 187 (19.6%) 692 (14.9%) < 0.001 (C)
History of hypertension 669 (70.2%) 3164 (68.1%) 0.198 (C)
AF Classiﬁcation < 0.001 (C)
Paroxysmal AF 632 (69.0%) 2116 (48.8%)
Persistent AF 284 (31.0%) 2222 (51.2%)
Choice of treatment strategy at inclusion < 0.001 (C)
Rhythm-control strategy at inclusion 386 (40.4%) 2690 (57.9%)
Rate-control strategy at inclusion 569 (59.6%) 1959 (42.1%)
Vaughan Williams Class Ic AAD 54 (6.0%) 513 (11.3%) < 0.001 (F)
Vaughan Williams Class III 196 (21.8%) 1366 (30.1%) < 0.001 (F)
Beta blockers (except sotalol) 612 (68.2%) 2682 (59.1%) < 0.001 (F)
Heart-rate lowering calcium channel 
blockers 214 (23.8%) 316 (7%) < 0.001 (F)
Vitamin K antagonists 590 (61.8%) 2320 (49.9%) < 0.001 (C)
Lipid lowering drugs 466 (48.8%) 1636 (35.2%) < 0.001 (C)
*Countries: Austria, Belarus, Brazil, Colombia, Denmark, France, Germany, Greece, 
Hungary, Italy, Korea, Mexico, Philippines, Poland, Portugal, Russia, Spain, Sweden, 
Thailand, United Kingdom
†Number of patients evaluable for different parameters varies.
A, analysis of variance; C, chi-square test; F, Fisher’s exact test; W, Wilcoxon test.
Conclusions: Patients presenting with a recent history of AF have a different 
cardiovascular proﬁle and are managed differently in the US compared to the rest of the 
world. These differences are likely to impact on patient outcomes.
3:30 p.m.
1020-32 Intravenous Magnesium Sulfate Enhances the Ability of 
Dofetilide to Successfully Convert Atrial Fibrillation
Dhruva Chawla, Abhijit Ghatak, Nitesh Sood, Ripple Talati, Craig I. Coleman, Jeffrey 
Kluger, Hartford Hospital, Hartford, CT
Background: A previous study found that the adjunctive use of intravenous magnesium 
sulfate with ibutilide could increase the odds of a patient chemically converting from 
atrial ﬁbrillation (AF) to normal sinus rhythm (NSR) by 78%. Whether or not, intravenous 
magnesium has the same effect on dofetilide’s ability to chemically convert patients from 
AF to NSR is not known.
Methods: This was a retrospective cohort evaluation of consecutive eligible patients 
receiving dofetilide for chemical conversion of AF at a single institution. All patients 
received dofetilide according to the institution’s standard protocol, which required 
patients to remain as an inpatient for a minimum of 3 days or 6 doses after initiation of 
dofetilide therapy. Patients receiving intravenous magnesium starting on the same day as 
dofetilide constituted the treatment group. Controls received dofetilide, but no intravenous 
magnesium any time prior to chemical conversion. Patients underwent continuous 
electrocardiographic monitoring throughout their hospital admission. Multivariate logistic 
regression analysis was used to determine the impact of intravenous magnesium on 
dofetilide’s efﬁcacy.
Results: A total of 159 patients in AF (mean age 66.6 ± 11.0 years, 72.3% male, 29.6% 
in AF>15 days, 54.7% hypertension, 37.1% heart failure, 16.4% valvular disease, 15.7% 
previous myocardial infarction, baseline serum magnesium levels 2.1 ± 0.26 mg/dL) and 
receiving dofetilide (mean dose 428±118 mcg/dose) were included in this analysis. The 
average ﬁrst dose of magnesium was 3± 2 gm and the total dose during the hospital 
course was 6±5 gm. The overall chemical conversion rate with dofetilide irrespective 
of intravenous magnesium was 41.5%. The concurrent administration of intravenous 
magnesium (n=50) was associated with a 115% increased odds of successful chemical 
conversion (adjusted odds ratio; 2.15 [95% conﬁdence intervals, 1.01-4.60]) compared to 
those who did not receive magnesium (n=109). No cases of Torsade de Pointes occurred 
in either group during the index hospital admission.
Conclusions: Concurrent use of intravenous magnesium is associated with an enhanced 
ability of dofetilide to successfully convert AF.
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3:30 p.m.
1020-33 Suitable Premedication Treatment to Avoid Critical 
Hemorrhagic Complications Occurred During 
Pulmonary Vein Isolation
Yasuhiko Hori, Shigeto Naito, Chizuru Sato, Koki Nakamura, Koji Goto, Yasuaki Tanaka, 
Jotaro Iwamoto, Miki Yokokawa, Koji Kumagai, Shigeru Oshima, Koichi Taniguchi, 
Nobusada Funabashi, Issei Komuro, Gunma Prefectural Cardiovascular Center, 
Maebashi, Japan, Chiba University, Chiba, Japan
Background: Pulmonary vein isolation (PVI) a is useful procedure for treatment 
of paroxysmal to chronic atrial ﬁbrillation (Af), but requires needling of the inter-atrial 
septum and an indwelling catheter, and complications such cardiac tamponade (CT) and 
thromboembolism (TE) may occur. To avoid these complications, we sought to qunatitate 
suitable premedication, including anticoagulant therapy with a suitable limit of international 
ratio (INR) of prothrombin time (PT).
Methods: 262 consecutive subjects (184 males, 19-79 years old) who underwent PVI for 
paroxysmal or chronic Af were divided into the following three premedication treatment 
groups: 1) with anticoagulant therapy (n=149), 2) with antiplatelet therapy (n=63), and 3) 
with neither (n=50) 48 hours before the PVI procedure. Incidence of critical hemorrhagic 
complications, such as de novo pericardial effusion (DNPE), including CT, cerebral 
hemorrhage, and critical TE complications such as cerebral infarction, or left to right 
shunt due to Brockenbrough procedure were evaluated. Furthermore, in Group 1, a 
suitable limit of INR determined just before PVI was estimated to distinguish high and low 
incidence of critical complications.
Results: Critical hemorrhagic complications were detected in 32 subjects (32 DNPE 
including 1 CT) and TE was detected in 2 subjects (2 cerebral infarction). Among the three 
premedication treatment groups, the 21 DNPE and 2 cerebral infarctions occurred in the 
anticoagulants group (14.1%,1.3%, respectively), and the incidence of DNPE was higher 
than the other two groups (4.8% and 0% with antiplatelet therapy, and 16% and 0% with 
neither, respectively all P=NS). Among anti coagulant groups, if PT INR was >2.0, there 
were no cerebral infarctions, but incidence of DNPE (22.2%) was signiﬁcantly higher than 
those whose PT INR was < 2.0 (10.6%, P=0.001).
Conclusions: The incidence of critical hemorrhagic complications in PVI was higher 
with anticoagulant premediation therapy than with antiplatelet treatment or neither. 
Excessive control of anticoaglants in this study (suitable limit of PT INR was estimated 
to be approximately 2.0) may have been a cause of critical hemorrhagic complications 
even without TE.
3:30 p.m.
1020-34 D-Dimer Levels Predict Subsequent Thromboembolic 
and Cardiovascular Events in Patients With Atrial 
Fibrillation During Oral Anticoagulant Therapy
Tsuneaki Sadanaga, Motoaki Sadanaga, Yatsushiro General Hospital, Yatsushiro, 
Japan, Sadanaga Clinic, Yatsushiro, Japan
Background: Atrial ﬁbrillation (AF) is associated with hemostatic abnormality even 
during oral anticoagulant therapy. We assessed whether elevated D-dimer levels predict 
subsequent thromboembolic and cardiovascular events in patients with AF. Subject and 
method: This study included 269 patients with AF (age 74±9 years, 118 female, 175 
paroxysmal AF, 110 congestive heart failure, 30 history of stroke, CHADS2 score: 1.8±1.3) 
treated with warfarin. Does of warfarin was adjusted according to the Japanese guideline 
of AF (PT-INR, 1.5-3.0). Results: PT-INR levels (mean: 2.0 ± 0.7) were within therapeutic 
range in 228 (85%) patients. D-dimer levels (mean: 0.5±1.0 μg/dl) were higher than 0.5 
μg/dl in 67 (25%) patients. During an average follow-up period of 619±198 days, 6(2.2%) 
thromboembolic events (5 cerebral infarction) and 25 (9.3%) combined cardiovascular 
events (10 death from heart failure, 6 thromboembolism, 3 sudden death) occurred (ﬁgure). 
Cox proportional hazard model revealed that elevated D-dimer levels (Hazard ratio22.8; 
CI 2.3-220) and history of stroke were associated with thromboembolic events and it also 
revealed that elevated D-dimer levels (Hazard ratio 3.7; CI 1.4-10.2), history of stroke, 
congestive heart failure, and diabetes mellitus were signiﬁcantly associated with combined 
cardiovascular events. Conclusion: D-dimer might be a useful additional marker of both 
embolic and cardiovascular risk in AF patients during oral anticoagulant therapy. 
3:30 p.m.
1020-35 The Impact of Alcohol Consumption on Pulmonary Vein 
Success Rates
Dimpi Patel, Mazeen Shaheen, Preeti Venkatraman, Luciana Armanagijian, Luigi 
DiBiase, Rodney Horton, J David Burkhardt, Robert Canby, Jason Zagrodzy, Javier 
Sanchez, joesph gallinghouse, Larry Price, Dhanunjaya Lakkireddy, Andrea Natale, St. 
David’s Medical Center, Austin, TX
Background: Whether resuming alcohol consumption following pulmonary vein isolation 
(PVI) is associated with recurrences of AF is unknown.
Objective: To assess if alcohol intake following PVI affects recurrence.
Methods: We screened 700 consecutive PVI patients from 2006 to 2007 for amount 
of alcohol consumption. Group 1: no alcohol +PVI, Group 2: alcohol consumption (1-7 
drinks a week) +PVI, Group 3 PVI + (8 or more drinks a week). Alcohol consumption 
was self reported
Results: Baseline demographics and success rates are given in table.
Conclusion: The quantity of alcohol intake after PVI does not signiﬁcantly affect 
recurrence. 
N=700 No ETOH 1-7 drinks ETOH 8 or more drinks a week
Number of Patients 376 220 156
Male 203 145 92
Age 56+/-10 45+/-7 44+/-11
Paroxysmal AF 193 (51.3%) 115 (52.2%) 86 (55.1%)
Persistent AF 97 (25.7%) 72 (32.7%) 46 (29.4%)
Chronic AF 86 (22.8%) 33 (15%) 24 (15.3%)
Success Rates
PVI in PAF 148 (77%) 91 (79%) 61 (71%)
PVI in Persistent AF 73 (75.2%) 55 (77%) 30 (65%)
PVI in Chronic AF 59 (69%) 22 (68%) 14 (60%)
3:30 p.m.
1020-36 Multicenter Results of Minimally Invasive Surgical 
Ablation of Lone Atrial Fibrillation by Bipolar 
Radiofrequency 
Buu-Khanh Lam, Xu Meng, Erik Beyer, Richard Lee, University of Ottawa Heart 
Institute, Ottawa, Canada, Anzhen Hospital, Beijing, People’s Republic of China
Background: By combining new ablation technology such as bipolar radiofrequency 
energy with minimally invasive surgical techniques, we are now able to treat patients with 
lone atrial ﬁbrillation (AF) in a better manner. The objectives of this study were to report 
on the safety and efﬁcacy of this novel therapeutic modality.
Methods: At four institutions from the USA, Canada and China, between February 2005 
and May 2008, 203 patients underwent thoracospic- assisted bilateral pulmonary vein 
isolation, autonomic denervation and left atrial appendage resection via bilateral mini-
thoracotomies. The mean age was 61+/-11 years with 66% being male. Mean duration 
of AF was 75+/-65 months; AF was paroxysmal in 102 (50%) patients, persistent in 47 
(23 %) and longstanding persistent in 54 (27%). Main indications for surgery were failure 
of medical therapy or percutaneous ablation and severe symptoms. Mean follow-up was 
10+/-7.5 months and complete; all patients had at least a 24-hour Holter monitor following 
a blanking period.
Results: The mean operative time was 198 + 58 minutes and mean hospital length of stay 
was 7.5+/-4 days. There were no intra-operative conversions. Postoperative complications 
included pacemaker requirement in 3 (1.5%) patients, phrenic nerve palsy in 3 (1.5%), 
hemothorax in 2 (1%), TIA in 1 (0.5%), PE in 1 (0.5%) and DVT in 1(0.5%). There has 
been no mortality at any time point. At time of follow-up, 83% of patients were in normal 
sinus rhythm (paroxysmal 88%, persistent 89%, longstanding persistent 71%; P<.05); anti-
arrhythmic and anticoagulation therapy was discontinued in 67% of patients respectively.
Conclusion: Minimally invasive surgical ablation of lone AF using bipolar radiofrequency 
is a safe and efﬁcacious therapeutic option in selected patients. These initial results on 
the largest series to be reported to date with this technique are encouraging but further 
long-term prospective results are required to validate this modality as a therapeutic option 
to treat lone AF.
3:30 p.m.
1020-37 Timing and Role of Electrical Cardioversion for 
Recurrence of Atrial Arrhythmias After Catheter 
Ablation for Atrial Fibrillation
Timir S. Baman, Sanjaya K. Gupta, Sree Billakanty, Eric Good, Thomas Crawford, Jean 
F. Sarrazin, Michael Kuhne, Nagib Chalfoun, Krit Jongnarangsin, Frank Pelosi, Jr., Frank 
Bogun, Aman Chugh, Fred Morady, Hakan Oral, University of Michigan Hospitals, Ann 
Arbor, MI
Background: It is not clear whether early restoration of sinus rhythm for recurrent atrial 
arrhythmias (RAA) after catheter ablation for atrial ﬁbrillation (AF) facilitates reverse atrial 
remodeling and promotes maintenance of sinus rhythm.
Methods and Results: Radiofrequency catheter ablation was performed in 384 
consecutive patients (age= 60±9 years) with paroxysmal (215) or chronic AF (169). 
Transthoracic cardioversion was performed in 93 patients (24%) for recurrent AF (n=74) 
or atrial ﬂutter (n=19) at a mean of 51±53 days from the recurrence of atrial arrhythmia 
and 88±72 days from the ablation procedure. Atrial arrhythmias ﬁrst recurred at a mean 
of 37±49 days after the ablation procedure. Among the 93 patients, 50 were being treated 
with an antiarrhythmic drug post-procedure which was discontinued within 3 months of 
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3:30 p.m.
1020-40 Anatomic Study of the Human Atrial Coronary Arteries 
in Areas Involved in Atrial Fibrillation Catheter Ablation
Januário Pardo Mêo, Aristides Correia, Carina Hardy, Sissy Lara, Denise Hachul, 
Francisco Darrieux, Marcelo Jatene, Fabio Jatene, Eduardo Sosa, Maurício 
Scanavacca, Heart Institute (InCor) - University of São Paulo Medical School, São 
Paulo, Brazil
Background: Atrial ﬁbrillation (AF) is the most common arrhythmia in clinical practice, and 
its nonpharmacological therapy is still evolving. During the development of the surgical 
approaches for AF ablation, the knowledge of the atrial coronary arteries anatomy has 
lead to important technical modiﬁcations. However, little or no attention has been given to 
the atrial arterial circulation during the development of the catheter ablation techniques.
Objectives
To analyze the atrial coronary arteries anatomy in areas involved in AF catheter ablation.
Methods: Twenty four human hearts were obtained from cadavers with age at death 
23- 82 years (mean 47.2). Coronary ostium were dissected, cannulated and injected with 
colored resin. The hearts were ﬁxed, bleached, carefully dissected, photographed and 
analyzed with the software Image Tool 3.0 (UTHSCSA).
Results: The sinus node artery (SNA) arose from the circumﬂex artery in 10/24 (42%) of 
cases. In 7 (29%) of these cases, its origin was proximal to the left atrial apendage (LAA), 
crossing the left atrium (LA) through the anterior wall (mean diameter 1.31+-0.34 mm). In 
the remaining 3 cases (13%) its origin was after the LAA, crossing the mitral isthmus with 
a mean diameter 3.14+-0.60 mm, passing close to the left inferior pulmonary vein (PV) 
(mean diameter 2.58+-0.20mm), the left superior PV (2.45+-0.28mm), the left atrial roof 
(2.27+-0.26mm) and right superior PV (2.10+-0.60mm). In 14/10 cases (58%) the SNA 
arose from the right coronary artery.
Arteries q1mm in diameter were found in the mitral isthmus in 13 pts (54%), close to the 
left inferior PV in 9 (37%), the left superior PV in 6 (25%), the LA roof in 13 (54%), the right 
superior PV in 11 (46%) and in the LA anterior wall in 7 (29%).
LAA irrigation was always accomplished through its base, by small branches arising from 
the circumﬂex artery.
Conclusions: Atrial coronary arteries, including the SNA, were commonly found in the 
areas involved in AF ablation. This could cause difﬁculties in obtaining transmural lesions 
and electric isolation, due to blood ﬂow cooling, or even lead to ischemic sinus node or 
atrial dysfunction.
3:30 p.m.
1020-41 Reduction of Cardiovascular Events Associated With 
Atrial Fibrillation by Hybrid Therapy in Patients With 
Hypertrophic Cardiomyopathy
Koki Nakamura, Shigeto Naito, Naoki Takemura, Chizuru Sato, Yasuhiko Hori, Koji Goto, 
Yasuaki Tanaka, Jyotaro Iwamoto, Rie Tsuru, Miki Yokokawa, Koj Kumagai, Shigeru 
Oshima, Koichi Taniguchi, Marehiko Ueda, Nobusada Funabashi, Issei Komuro, Gunma 
Prefectural Cardiovascular Center, Maebashi, Japan, Chiba University Graduate School 
of Medicine, Chiba, Japan
Background:Patients with hypertrophic cardiomyopathy (HCM) often have cardiovascular 
events caused by atrial ﬁbrillation (AF), such as heart failure (HF), ventricular arrhythmia 
(VA), thromboembolism (TE) and severe symptom. The aim of this study was to examine 
the feasibility of hybrid therapy with antiarrhythmic drugs (AAD) and radiofrequency 
catheter ablation (RFCA) for AF accompanied by HCM.
Methods:A total of 104 hospitalizations in 59 consecutive patients at our institute 
between February 2004 to August 2008 were included, and 37 (35.6%) were due to 
HF, 15 (14.4%) were VA, 6 (5.8%) were TE, and 46 (44.2%) were intolerable palpitation 
or chest pain. Twenty-three of the 59 patients (39%) had cardiovascular events due to 
paroxysmal or persistent AF. Of the 23 patients, 10 patients had antiarrhythmic therapy 
(AAT group) and 13 patients had both RFCA and antiarrhythmic therapy (RFCA group). 
Extensive encircling pulmonary vein isolation with (n = 6) or without (n = 7) additional left 
atrial ablation was performed in RFCA group.
Results:Patients in RFCA group had experienced persistent AF for 3.2 ± 2.9 years prior to 
RFCA, refractory to 2.4 ± 1.0 AAD. Amiodarone was administered to 8 patients (61.5%), but 
7of the 8 patients had recurrent AF events and the 1 remainder discontinued administration 
of Amiodarone due to side effect. Over a mean follow-up of 1.3 ± 1.2 years after RFCA, 8 
of the 13 patients (61.5%) were free from an AF recurrence with AAD and persistent AF 
transitioned to paroxysmal AF in 3 patients. The frequency of cardiovascular events with AF 
decreased in 12 patients (92.3%) (p <0.0001), and the risk of events decreased from 0.87 to 
0.17 per person-year after RFCA. In AAT group, Amiodarone was administered to 5 patients 
(50%). The LVEF was lower and the LAD was larger in AAT group than those in RFCA group 
(LVEF 57.0 ± 14.1% vs. 63.8 ± 13.8%, LAD 48.3 ± 8.4 mm vs. 44.4 ± 5.4 mm). Over a mean 
follow-up of 3.3 +/- 2.9 years, the risk of cardiovascular events with AF was 1.02 per person-
year and persistent AF transitioned to permanent AF in 2 patients (20%).
Conclusions:Hybrid therapy with AAD and RFCA reduces cardiovascular events due to 
AF and improves quality of life in patients with HCM.
3:30 p.m.
1020-42 Ablation of Atrial Fibrillation at the Time of 
Cavotricuspid Isthmus Ablation in Patients With Lone 
Atrial Flutter Derives a Better Long-Term Beneﬁt
Antonio J. Navarrete Casas, Frank Conte, Nathan Milikan, Michael Moran, Ali Ishti, Ball 
Memorial Hospital, Muncie, IN, Medical Consultants, Muncie, IN
Background: A clinical interrelationship between atrial ﬁbrillation (AF) and atrial ﬂutter (AFL) 
has long been appreciated. Combining AF and the cavotricuspid isthmus (CTI) ablation 
successful maintenance of sinus rhythm. At a mean follow-up of 16±10 months after 
the index procedure, 25/93 patients (27%) who underwent cardioversion were in sinus 
rhythm without antiarrhythmic drug therapy. Of those who were underwent cardioversion 
within 30 days of RAA, 23/46 patients (50%) had freedom from atrial ﬁbrillation 
without antiarrhythmic therapy. There was a signiﬁcant association between long-term 
maintenance of sinus rhythm and the time to cardioversion after the onset of RAA (OR 
22.5; 95% CI 4.87 to 103.88) if performed within 30 days. Time to arrhythmia recurrence 
from index procedure was not a signiﬁcant predictor of long term success. On multivariate 
analysis that included clinical variables of age, gender, left atrial size, whether AF was 
paroxysmal or chronic, ejection fraction, duration of AF, and concomitant antiarrhythmic 
drug therapy post procedure, no clinical predictors were predictive of freedom from atrial 
arrhythmias.
Conclusion: Sinus rhythm can still be maintained in ~50% of patients who undergo 
cardioversion for recurrent atrial arrhythmias after catheter ablation of AF if promptly 
performed within 30 days.
3:30 p.m.
1020-38 Circumferential Pulmonary Vein Ablation Using a Remote 
Irrigated Tip Magnetic Catheter: Long-Term Outcome
Vincenzo Santinelli, Andrea Radinovic, Gabriele Vicedomini, Patrizio Mazzone, 
Giuseppe Ciconte, Giuseppe Augello, Stefania Sacchi, Gabriele Paglino, Simone 
Gulletta, Simone Sala, Cristiano Ciaccio, Nicoletta Sora, Andreina Santagostino, Carlo 
Pappone, San Raffaele University Hospital, Milan, Italy
Background: To report the ﬁrst human experience on magnetic irrigated-tip catheter 
ablation and the long-term outcome.
Methods: CPVA was performed using an irrigated-tip magnetic catheter (ThermoCool 
NaviStar-RMT, Biosense Webster) in 29 patients (mean age 58.8±11.8 years) with 
symptomatic drug-refractory atrial ﬁbrillation (AF). The RF generator was set to power-
control mode with a ﬁxed power of 30 W. Patients were assesses at 1, 3, 6 and 12 months 
after ablation. Primary endpoints were feasibility, safety and long-term efﬁcacy of the 
catheter. Temperature tip, impedance and power were monitored from the onset to the 
end of RF applications.
Results: Procedural endpoints were safely and successfully achieved in 27/29 patients 
while crossover to manual catheters was required in 2 patients to achieve completeness 
of mitral isthmus line. The total procedure time including lesions validation was 80.5±7.4 
min. Impedance values signiﬁcantly decreased during RF applications (p<0.0001) and 
the maximum temperature on the catheter tip was 36.4 ±0.8 °C. No acute complications 
occurred during and after the procedure. Freedom from AF without antiarrhythmic drug 
therapy was achieved in 82% of study patients after a follow-up period of 12±2 months.
Conclusions: Remote ablation with irrigated-tip magnetic catheters is safe, feasible and 
effective in the long-term resulting in PV isolation in 100% of the PVs. Conﬁrmation of 
PVs isolation and completeness of linear lesions conduction block can be achieved in 
almost all patients.
3:30 p.m.
1020-39 Safety and Efﬁcacy in Females Undergoing Pulmonary 
Vein Isolation
Dimpi Patel, Mazeen Shaheen, Preeti Venkatraman, Mohamed Basoni, Luciana 
Armanijan, Luigi DiBiase, Shane Bailey, Rodney P. Horton, Javier Sanchez, Oussama 
Wazni, Larry Price, Joesph Gallinghouse, Dhanunjaya Lakkireddy, Marketa Kozeluhova, 
J David Burkhardt, Robert Canby, Jason Zagrodzky, Andrea Natale, St. David’s Medical 
Center, Austin, TX
Background: Fewer females have pulmonary vein ablation than males. A paucity of 
information exists on the safety and efﬁcacy of females having pulmonary vein isolation 
(PVI). Our study assesses safety and efﬁcacy in females undergoing PVI.
Methods: We screened 2,749 patients who underwent PVI from 2004-2007. Group 1: 
Males + PVI . Group 2: Females +PVI .
Results: Baseline demographics, safety and success rates are in given in the table. 
Incidence of postablation stroke in females and males (2.4% versus .8%). The incidence 
of severe PV stenosis in females and males (4.1% versus .04% p=.001). The incidence of 
major hematoma in females and males (5.3% versus .7% p=.001).
Conclusion: Females have signiﬁcantly more recurrences and complications such as 
postoperative stroke, severe PV stenosis, and major hematoma after PVI. 
N=2,749
Males Females p-value
Number of Patients 2,265 (82.3%) 484 (17.6%)
Mean Age 56 +/-9.1 59.4+/-11 ns
HTN 1,360 (63%) 21(60%) ns
CVA prior to PVI 35 (1.7%) 52 (10.7%) <0.001
DM 168 (7.4%) 112 (23.1%) <0.001
CAD 73 (3.2%) 26 (5.3%) ns
CHF 126 (5.5%) 35 (7.2%) ns
Paroxysmal AF 1,403 (61%) 203 (41%) <0.001
Recurrent AF 616 (27.1%) 140 (28.9%) ns
Chronic AF 246 (10.8%) 141 (29.1%) <0.001
Success Rates 
In Paroxysmal AF patients 1,206 (86%) 131 (65%) <0.001
In Persistent AF patients 474 (77%) 77 (55%) <0.001
In Chronic AF patients 165 (67%) 72(51%) <.01
Complications 126 (6%) 131 (27.1%) <0.001
JACC March 10, 2009 ABSTRACTS - Cardiac Arrhythmias  A111
C
ardiac A
rrhythm
ias
in patients presenting with both arrhythmias is known to be beneﬁcial. However, whether 
ablation of AF may be beneﬁcial at the time of AFL in patients without documentation of 
AF is still unknown. Methods: 47 patients (pts) with paroxysmal and or persistent typical 
AFL, left atrial size <4.5mm and no prior history of AF were randomized to CTI ablation 
(group A, n=25) or to Pulmonary veins isolation (PVI) (Group B, n=23) plus CTI ablation. In 
addition to PVI, complex fractionated electrograms, roof and mitral isthmus ablation line, 
in a step wise approach was performed in pts of group B when AF was induced by atrial 
burst pacing and sustained for 2 min. (12 pts). The procedure endpoints were bidirectional 
block at the CTI in group A and isolation of all pulmonary veins plus AF termination or 
non inducibility in group B when AF was induced. Patients were followed up every two 
months for one year with placement of a 48 hours holter on each visit. Results: There was 
no signiﬁcant difference between the groups in age (55±4 Versus 57±5), Chad score (1 
Versus 1.2), left atrial size (4.2± 0.2 Versus 4.1±0.2mm) and duration of arrhythmia (12±3 
Versus 12±2 months). Eleven pts were in AFL at the time of ablation (group A=5, group 
B=6). Eleven pts (52%) in-group A had AF within 8 months after the ablation; 8 pts had 
paroxysmal AF and 5 had persistent AF that required cardioversion. Four pts in group B 
had short self-terminated episodes of AF within the ﬁrst month post-ablation and 2 pts 
had recurrence of AF after 6 months post ablation. Nineteen pts in group B (86%) were 
free of arrhythmia without medications 4 months post ablation. Two pts developed mild 
groin hematomas after AF ablation, NS. Fluoroscopy time was signiﬁcantly longer in group 
B (19±3min Versus 7±3min). Mild pericardial effusion was observed in 2 pts in group B, 
(NS). Conclusions: Patients with lone atrial ﬂutter have a high and early incidence of AF 
after CTI ablation. Ablation of AFIB at the time of CTI appears to be beneﬁcial in this set 
of patients without an increase in major complications.
3:30 p.m.
1020-43 Properties of Atrioventricular Accessory Pathways - 
Are Concealed Pathways Safer in a Population With 
High Occupational Risk?
Gregg Gerasimon, Philip J. Gentlesk, Mark E. Peele, Robert E. Eckart, Brooke Army 
Medical Center, San Antonio, TX
Background: Management of Wolff-Parkinson-White is based on risk of sudden death 
and control of symptoms. Military personnel may be limited in the use of medications, and 
are frequently in positions where incapacitating tachyarrhythmias may risk the lives of the 
subject or others around them. We sought to determine if there are objective differences 
in inducibility for arrhythmia in those with no risk of pre-excited atrial ﬁbrillation, those with 
retrograde only conduction.
Methods: Electrophysiologic studies were reviewed to identify those patients with ﬁnding 
of an atrioventricular AP. We identiﬁed clinical characteristics patients presenting with 
suspected arrhythmia, location and properties of AP, to include inducible arrhythmia.
Results: We identiﬁed 64 patients with a mean age of 33±13 years. Conduction over the AP 
had retrograde only conduction in 22 (34.4%) of patients. Although there was no difference 
in the reporting of palpitations (84.2%), there was a higher incidence of documented SVT 
in those with retrograde only conduction compared to those with antegrade conduction 
(77.3% vs. 38.1%, p=0.004). The frequency of either septal or left-sided APs was not 
different based on conduction properties. AVRT was more likely to be induced in those 
with retrograde only conduction compared to those with antegrade conduction (95.5% vs. 
73.8%, p=0.045) and those with retrograde only conduction appeared to be less likely to 
require the use of isoproterenol for arrhythmia induction (22.7% vs. 47.5%, p=0.064). There 
was no difference in the tachycardia cycle length for retrograde only versus antegrade 
capable conduction (357±52 vs. 331±84msec, p=0.192).
Conclusion: There were no differences in properties of retrograde only conducting 
AP compared to those with antegrade conduction. Ease of inducibility and identical 
tachycardia cycle length suggest the potential for similar risk of incapacitation for 
concealed and manifest AP.
3:30 p.m.
1020-44 Duty Cycled, Unipolar-Bipolar RF Ablation via Multi-
Electrode Catheter in Patients With Paroxysmal Atrial 
Fibrillation
Ole Kongstad, Shiwen Yuan, University Hospital, Lund, Sweden
Background: Techniques for catheter ablation of atrial ﬁbrillation (AF) continue to improve, 
but often require complex equipment, high level of operator skill, and a long learning curve. 
Methods: To simplify AF ablation, we investigated a system featuring a multi-channel 
radiofrequency (RF) generator that can simultaneously delivers duty-cycled, bipolar-
unipolar energy to operator selectable electrodes of a decapolar circular catheter (PVAC, 
Ablation Frontiers) for achieving pulmonary vein (PV) isolation via antrum ablation. RF was 
delivered in a temperature-controlled manner to achieve a target of 55-60 C° with power 
limited to 10W per electrode. PV angiography was performed to facilitate identiﬁcation of the 
PV ostium. End-point is disappearance of all PV potentials as conﬁrmed by use of a circular 
mapping catheter. Results: Since Sept. 2007 we have treated 37 patients with paroxysmal 
AF, aged 60±9 years, using this technique. Average number of RF applications per PV was 
7±3. Procedure time was 92±16 min and ﬂuoroscopy time was 19±9 min. No complications 
were observed. CT/MRI performed pre-procedure and at 2-4 months follow up ruled out 
asymptomatic PV stenosis. Holter monitoring demonstrated freedom of AF in 15/18 (83%) 
patients at q 6 months follow up. Conclusion: This proposed single-catheter method is 
safe, efﬁcient, and feasible for AF ablation and has early results comparable to those of 
widely reported techniques. In addition, simpliﬁed catheter manipulation, shorter learning 
curve, shorter procedure time and independence from 3D-mapping system may make the 
method available to a larger number of centers.
3:30 p.m.
1020-45 Role of CHADS2 Score in Evaluation of Thromboembolic 
Risk and Mortality in Patients With Atrial Fibrillation 
Undergoing Direct Current Cardioversion: An ACUTE 
Substudy
Brandon Varr, Sarinya Puwanant, Elizabeth Lieber, Sarah J. Williams, Susan E. Jasper, 
Christine Whitman, Allan L. Klein, Cleveland Clinic, Cleveland, OH, Case Western 
Reserve University School of Medicine, Cleveland, OH
Background: The CHADS2 scoring scheme was found to be a good predictor of stroke risk 
in patients with non-valvular atrial ﬁbrillation (AF). The utility of a CHADS2 score in the risk 
stratiﬁcation of these patients prior to direct current cardioversion (DCC) is unknown.
Methods: The study population consisted of a subgroup of 541 patients from the ACUTE 
study with AF > 48 hours planned for DCC undergoing transesophageal echocardiography 
(TEE) who had a completed CHADS2 score (congestive heart failure, hypertension, 
age>75, diabetes, stroke [double]).
Results: Fourteen patients (10%) with a CHADS2 score of 0 had left atrial appendage 
(LAA) thrombus identiﬁed by TEE, but the rate of stroke (1%) and death (0%) at 6 months 
remained low (Table 1). In patients with a CHADS2 score of 4-6, the prevalence of LAA 
thrombus and stroke were similar to those with lower CHADS2 scores. However, the 
mortality in this group was signiﬁcantly higher compared to those with lower CHADS2
scores (14% vs <1%, p<0.05).
Conclusions: In this ACUTE substudy, a higher CHADS2 score predicted an increased 
mortality rate in patients with AF undergoing DCC. The prevalence of LAA thrombus was 
not nominal in patients with a low CHADS2 score. This suggests that CHADS2 score is a 
useful predictor of mortality but may be limited in differentiating the thromboembolic risk 
of patients undergoing DCC. 
3:30 p.m.
1020-46 Low Incidence of Macro-reentrant Left Atrial 
Tachycardia After Atrial Fibrillation Ablation Using an 
Electrogram Guided Approach
Javier E. Banchs, Omer Shedd, Jaime Rivera, Knut S. Erga, Erica Penny-Peterson, 
Robert Stevenson, Parag Patel, Nehal Patel, Soraya Samii, Deborah L. Wolbrette, 
Gerald V. Naccarelli, Mario D. Gonzalez, Penn State Hershey Heart & Vascular Institute, 
Hershey, PA, University of Florida, Gainesville, FL
Background: Wide area circumferential ablation of atrial ﬁbrillation (AF) results in macro-
reentrant left atrial tachycardias (MLAT) in up to 1/3 of these patients. MLAT is often 
incessant, symptomatic and secondary to gaps created by incomplete ablation lines. We 
speculated that an electrogram guided approach not intended to create lines of block 
would result in a lower incidence of MLAT.
Methods: The study included 300 patients with AF (218 paroxysmal; 82 persistent) 
followed for at least 1 year. Radiofrequency (RF) energy (10-30 watts) was delivered 
through a 3.5 mm externally irrigated electrode. Following segmental pulmonary vein 
isolation using a circular mapping catheter, cardioversion and/or ibutilide were used when 
needed to restore sinus rhythm. Ablation in the left atrium targeted sites with fractionated, 
low amplitude potentials.
Results: Fractionated potentials (ﬁgure) were of longer duration and lower voltage than 
nearby potentials (97.2±23.4 vs 42.1±17.3 ms; and 0.83 vs 2.75±1.3 mV, both p<0.001). A 
mean of 7.3±4.5 RF applications were required to isolate each pulmonary vein and 18.2±12.1 
to eliminate atrial fractionated potentials. A second ablation was required in 87 patients (29%). 
After a follow-up of 19±5 months, 234 patients (78%) were in sinus rhythm and 4 (1.3%) 
developed MLAT. Groin hematoma (4%) was the only signiﬁcant complication.
Conclusions: Electrogram guided AF ablation results in a low incidence of MLAT with a 
comparable success rate to more extensive procedures. 
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Treatment results
Treatment arm AF episodes (n): before (1 year time)
AF episodes (n): after 1 
year of therapy p value
A: SPIR+ACEI+BB 9.4±2.1 2.7±0.8 p<0.005
B: SPIR+BB 8.4±1.6 3.4±1.1 p<0.001
C: ACEI+BB 8.2±2.0 8.1±2.0 p=0.85
D. BB 8.8±2.9 11.4±2.8 p=0.33
3:30 p.m.
1020-49 Effect of General Anesthesia and Conscious Sedation 
on Arrhythmogenic Targets During Atrial Fibrillation 
Ablation
Matthew Forcina, Matthew Klein, E. Matthew Quin, Brent Lawhon, Barbara Knick, J. 
Lacy Sturdivant, Robert B. Leman, Michael R. Gold, Orin F. Guidry, James H. Abernathy, 
J. Marcus Wharton, Medical University of South Carolina, Charleston, SC
Background Type and depth of sedation may affect atrial ﬁbrillation (AF) initiators and 
substrate targeted during wide area circumferential ablation (WACA). This study compares 
the effects of general anesthesia (GA) and conscious sedation (CS) on ablation targets 
after WACA.
Methods In 100 patients undergoing WACA, 47 received GA with remifentanyl and propafol 
and 53 received CS with fentanyl and midazolam. The incidence of non-pulmonary vein 
(NPV) initiators, concealed extrasystoles (CEs), premature atrial contractions (PACs), 
and continuous fractionated atrial electrograms (CFAEs) were compared, as were patient 
characteristics and procedural factors. Groups were compared using Fisher’s exact test 
and t test.
Results There were no differences between GA and CS groups in baseline characteristics 
or comorbidities except LA size. Isoproterenol dose to achieve a pulse of 120 bpm was 
higher with GA. NPV AF initiators were twice as common with GA, but there were no 
differences between groups in other targets. 
GA (n=47) CS (n=53) p
Age (y) 60±12 58±9 0.56
Male (%) 68 74 0.35
Paroxysmal (%) 49 43 0.69
LA size (cm) 4.8±0.9 4.5±0.8 0.03
EF (%) 58±11 61±9 0.18
NPV (%) 46.8 20.7 0.01
CE (%) 6.4 1.9 0.33
PAC (%) 46.8 34.0 0.22
CFAE (%) 25.5 20.8 0.64
Pulmonary vein isolation (%) 100 100 NS
Isoproterenol (mcg/min) 5.8±4.3 4.2±2.9 0.03
Fluoroscopy time (min) 60±14 55±10 0.03
Procedure time (h) 5.8±0.9 5.6±0.9 0.29
Conclusions Although deeper sedation with GA was anticipated to decrease the 
incidence of NPV initiators, the opposite was found in the present study, despite the need 
for higher dosages of isoproterenol to achieve the same degree of sympathetic stimulation. 
Although the mechanism for this effect is unclear, alterations in parasympathetic tone or 
hemodynamic changes may play a role.
3:30 p.m.
1020-50 Atrial Fibrillation Ablation Improves Cardiac Structure 
and Function: A Long-Term Cardiac Magnetic 
Resonance Study
Payman Molaee, Karen S.L Teo, Pawel Kuklik, Stephen G. Worthley, Prashanthan 
Sanders, Cardiovascular Research Centre, Royal Adelaide Hospital and The University 
of Adelaide, Adelaide, Australia
Background: Atrial ﬁbrillation (AF) is associated with tachycardia mediated remodelling of 
both the atria and ventricles. The long term effects of AF ablation on the cardiac chambers 
have not been fully established.
Methods: 27 patients (21M, age 58.7 ± 8.2 y; 20 paroxysmal) undergoing AF ablation had 
Cardiac Magnetic Resonance (CMR) imaging (1.5 T Siemens Avanto) at baseline and 
12 months post ablation, in sinus rhythm. Ablation comprised circumferential pulmonary 
vein isolation in all with substrate modiﬁcation (linear ± complex fractionated atrial 
electrogram ablation) in patients with AF episodes >48 h, largest left atrial (LA) size >57 
mm or structural heart disease. Steady state free precession cine images of the atria and 
ventricles were acquired in short and horizontal long axis planes. Chamber volumes were 
calculated by manually tracing endocardial contours and applying Simpson’s rule.
Results: 81% of this cohort was in sinus rhythm without the use of antiarrhythmic drugs 
at 12 months post procedure. The table presents changes in cardiac chamber size and 
function at baseline and 12 months. 
3:30 p.m.
1020-47 The Relationship Between Left Atrial Tissue Scar 
Formation and Procedural Success Following Catheter 
Ablation for Atrial Fibrillation
Nathan S. Burgon, Troy J. Badger, Nazem Akoum, Yaw A. Adjei-Poku, Saul Kalvaitis, Ryan 
Broderick, Eugene Kholmovski, Edward V. R. DiBella, Rob S. MacLeod, Nassir F. Marrouche, 
Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT
Background. Substrate modiﬁcation of the left atrium (LA) has been proposed as a 
curative approach to atrial ﬁbrillation (AF). Posterior wall (PW) debulking reduces the 
amount of LA tissue available to form re-entry AF circuits. We report the relationship 
between the degree of PW scar formation and AF recurrence following AF ablation using 
delayed enhancement MRI (DE-MRI).
Methods. Eighty-six patients presented for AF ablation. DE-MRI was obtained at three 
months follow up. PW scar was measured as percent enhancement using a threshold 
based lesion algorithm. In all images, the epicardial and endocardial borders were 
manually contoured using custom software. The extent of injured LA tissue was then 
chosen for each image at 3 standard deviations above the mean normal tissue intensity.
Results. Overall scarring for the cohort was 28.7% ± 15.7% of the LA wall. Signiﬁcant 
differences were seen in the degree of scarring between patients who returned to normal 
sinus rhythm (LA scar = 31.4% ± 16.1%) and those who suffered a recurrence of AF 
(22.2% ± 12.4%; p = 0.013). Scar in the posterior wall and septum were also strong 
predictors of procedural response (p = 0.019 and p = 0.009, respectively). The ﬁgure 
shows two patients, one with mild scar formation (top left) and the second with extensive 
scar formation (top right). Kaplan Meier analysis noted signiﬁcant differences in procedure 
response. Cutoffs were Quartile 1: Scar = 7.2%, Quartile 2: Scar = 15.1%, Quartile 3: Scar 
= 29.2%, Quartile 4: Scar = 40.9%.
Conclusion. Extent of substrate modiﬁcation based on the degree of overall scar 
formation appears to favorably inﬂuence patient response to AF ablation.
3:30 p.m.
1020-48 Combined Spironolactone - Beta-Blocker Treatment 
Reduces the Occurrence of Atrial Fibrillation Episodes 
in One-Year Prospective Evaluation: Randomized, Pilot 
Study in Patients With Paroxysmal/Persistent Atrial 
Fibrillation (SPIR-AF Study)
Rafal Dabrowski, Anna Borowiec, Edyta Smolis - Bak, Alicja Kraska, Ilona Kowalik, 
Jacek Wozniak, Cezary Sosnowski, Barbara Kazimierska, Tomasz Chwyczko, Hanna 
Szwed, Institute of Cardiology, Warsaw, Poland
Background:Atrial ﬁbrillation [AF] itself perpetuates the development of structural atrial 
and ventricle alterations also by increased expression of ACE and aldosterone. RAA 
system plays a decisive part in every stage of AF occurrence. The aim of the study was a 
direct comparison of 4 treatment regimens to evalute the effect of spironolactone [SPIR] 
and ACEI on prevention of AF episodes.
Methods: randomized, open study was conducted between Jan 05 and Sep 08 in 122 
patients [pts] (54% men, mean age: 66±9), with paroxysmal (51%) or persistent (49%) 
AF, with no consent for ablation therapy and resistant to AA drugs. Documented history 
of arrhythmia was median 4.0 yrs. Pts were randomized to 4 treatment arms, A: SPIR 25 
mg + ACEI + beta-blocker [BB], 25%; B: SPIR 25 mg + BB, 23%; C: ACEI + BB, 32%, D: 
BB only, 20%; visits every 3 months. Other pts drugs were: coumarin: 60%, aspirin: 39%, 
statins: 58%: with no signiﬁcant differences between 4 arms. The primary end-point was 
evaluation of occurrence of AF episodes (>60 min) documented by ECG and/or patient 
self-monitoring in comparison with last year record of AF episodes.
Results: both treatment regimens including SPIR reduced number of signiﬁcant AF 
episodes after each period of 3 month therapy and after 1 year vs last year record of 
AF episodes.
Conclusions: this is the ﬁrst clinical trial to show that aldosterone blocking therapy may 
be a valuable additional therapeutic option or supplementing factor in prevention of AF 
episodes occurrence in longer period.
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1020-53 Limited Thoracotomy Approach for Pulmonary Vein 
Isolation in Patients With Symptomatic Refractory 
Atrial Fibrillation: Clinical Outcomes
Ashok J. Shah, John Ip, Sivakumar Ardhanari, Eric King, Chad Link, Ranjan Thakur, 
Depak Gandhi, Thoracic & Cardiovascular Institute, Lansing, MI, Michigan State 
University, Lansing, MI
Background: Limited thoracotomy approach for epicardial pulmonary vein isolation (PVI) 
is feasible in patients with atrial ﬁbrillation (AF).
Methods: We prospectively evaluated the clinical outcomes (hospitalization, electrical 
cardioversion, need for antiarrhythmic agent and recurrence of symptomatic AF) in 36 
patients following limited thoracotomy, video assisted epicardial AF ablation using bipolar 
radiofrequency clamp. All patients underwent PVI with comprehensive electrical mapping 
of PV potentials and evaluation of ganglionic plexii & pulmonary vein conduction. All 
patients were symptomatic and had failed q2 antiarrhythmic drugs. More than a quarter 
patients had failed q1 endocardial ablation procedure. Patients were followed-up at 1st
month and then every 3 months.
Results: Eight patients had persistent and 28 had paroxysmal AF, age 56 ± 4.6y. The need 
for hospitalization and cardioversion reduced by >90% each. At 3 months post ablation, 
discontinuation of antiarrhythmic agents and oral anticoagulation was undertaken in 38% 
patients in view of no AF. At the median follow up of 8 months (range 1-16 months), all 
patients were in sinus rhythm. 
Clinical Parameter Pre Ablation Post Ablation(8 months) Absolute Reduction
Hospitalization (days) 86 05 94%
Cardioversions 28 01 96%
Oral anticoagulation
(patients) 36 22 38%
Antiarrhythmic agents
(patients) 36 22 38%
Documented symptomatic
AF (patients) 36 02 94%
Conclusions: Limited thoracotomy approach for PVI in patients with symptomatic AF 
reduces clinical events including requirement for recurrent hospitalization, electrical 
cardioversion, antiarrhythmic agents and oral anticoagulation. More number of patients 
and longer follow-up are necessary to validate this procedure.
3:30 p.m.
1020-54 Effect of Dronedarone on Cardiovascular Outcomes: 
A Meta-analysis of Five Randomized Controlled Trials 
in 6157 Patients With Atrial Fibrillation/Flutter
Stefan H. Hohnloser, Stuart J. Connolly, Martin van Eickels, David Radzik, Jean-Marc 
Davy, Bramah N. Singh, J. W. Goethe University, Frankfurt, Germany, McMaster 
University, Hamilton, Canada
Background: Dronedarone 400 mg twice daily (D), a new multichannel-blocking 
antiarrhythmic drug, was investigated in 5 randomized placebo (P)-controlled trials 
(DAFNE, EURIDIS, ADONIS, ERATO, ATHENA) in 6157 patients with atrial ﬁbrillation 
(AF) or ﬂutter.
Methods: Individual patient data from all trials, including all types of atrial fribrillation, 
were entered in a central database, and the effects of D compared to P on clinically 
relevant outcomes were determined.
Results: Mean age was 70 years, 43% were female patients, 79% had hypertension. 
A history of heart failure was present in 27%. Patients were on standard background 
medications. 
Outcome Measure Placebo# of events
Dronedarone
# of events HR 95% CI p-value
Time to ﬁrst CV hospitalization 
or death 987 850 0.76 0.69-0.84 <0.001
All-cause death* 145 128 0.85 0.67-1.08 0.111
CV death* 98 73 0.71 0.52-0.96 0.017
Sudden death* 36 19 0.49 0.28-0.86 0.011
Pre ablation Post ablation P value
Maximum LA volume (mL) 101.4 ± 35.0 91.4 ± 29.3 0.002
LA ejection fraction (%) 42.6 ± 15.4 39.0 ± 8.6 0.02
Maximum right atrial volume (mL) 96.8 ± 35.6 85.7 ± 26.2 0.009
LV end-diastolic volume (mL) 151.6 ± 44.5 137.3± 40.1 0.002
LV ejection fraction (%) 71.5 ± 11.1 75.5 ± 7.8 0.3
LV mass (g) 132.2 ± 35.9 126.6 ± 36.9 0.16
Right ventricular end-diastolic volume (mL) 185.3 ± 57.1 164.2 ± 43.7 0.001
Right ventricular ejection fraction (%) 48.9 ± 15.1 55.5 ± 10.2 0.03
CONCLUSION
AF ablation results in a signiﬁcant reduction in left and right atrial size, ventricular volumes 
and resultant increase in ventricular function at long term follow up. Interestingly, the 
reduction in size of the right atrium, where ablation had not been performed, implicates a 
possible role for reverse remodelling in the success of AF ablation.
3:30 p.m.
1020-51 Prominent Effects of Activating Autoantibodies to Beta 
Adrenergic and M2 Muscarinic Receptors in Atrial 
Fibrillation Compared to Heart Failure
Stavros Stavrakis, Xichun Yu, Shijun Huang, Reji Pappy, Sean Hamlett, Eugene 
Patterson, Madeleine W. Cunningham, David C. Kem, University of Oklahoma Health 
Sciences Center, Oklahoma City, OK
Background: Activating autoantibodies to beta1 adrenergic (AAB1!R) and M2 muscarinic 
(AAM2R) receptors coexist in some patients with heart failure (HF) and atrial ﬁbrillation 
(AF). We have investigated the functional properties of these autoantibodies in subjects 
with HF without AF and in others having AF without HF using an isolated canine Purkinje 
ﬁber contractility assay.
Methods: IgG was obtained from 26 patients: 16 with HF (ischemic or dilated 
cardiomyopathy, group A) and 10 with AF (lone or associated with hyperthyroidism, group 
B) and 10 healthy controls (HC). The contractile response of isolated perfused canine 
Purkinje ﬁbers (deﬁned as shortening of the Purkinje ﬁber during a loaded contraction, 
measured with a video-edge detector) paced at 120/min was examined before and after 
addition of either buffer or puriﬁed IgG from each subject. Atropine was used to block the 
AAM2R component of IgG. An increase in contractility over baseline with IgG plus atropine 
represented the AAB1AR effect. The difference in IgG effect on contractility between the 
presence and absence of atropine was a surrogate marker of the AAM2R effect.
Results: All patients in groups A and B demonstrated evidence for either or both 
autoantibodies. IgG from 14/16 patients in group A, 9/10 patients in group B and 0/10 HC 
demonstrated evidence for AAB1AR by the Purkinje ﬁber assay. IgG from 10/16 patients 
in group A, 9/10 patients in group B and 0/10 HC demonstrated evidence for AAM2R 
(p<0.001 by x2 test for both AAB1AR and AAM2R). When only the IgG samples that 
demonstrated evidence for AAB1AR and AAM2R effects were included in the analysis, 
the AAB1AR effect (% over baseline) was similar in groups A and B (22.2±2.0%, n=14 
vs 24.8±2.9%, n=9, p=0.451). However, the inhibitory AAM2R effect (% change from 
baseline) was signiﬁcantly more prominent (p=0.020) in group B (31.9±4.6%, n=9) vs. 
group A (17.1±3.6%, n=10).
Conclusions: Our results demonstrate prominent AAB1!R and AAM2R effects in AF 
compared to prominent AAB1!R and lesser AAM2R effects in HF. These ﬁndings support 
a role for combined M2 muscarinic and beta1 adrenergic receptor activation in AF, while 
beta1 adrenergic receptor activation was preeminent in HF.
3:30 p.m.
1020-52 Obesity and Recurrence of Atrial Fibrillation After 
Cardioversion
Tania Babar, Sara Mekuria, Priya Malik, Mina K. Chung, Cleveland Clinic Foundation, 
Cleveland, OH
Background: Although obesity is associated with increased incident risk of atrial 
ﬁbrillation (AF), it is unknown if obesity contributes to AF recurrence or whether targeting 
weight loss is a rational approach to improving cardioversion (CV) outcomes.
Methods: Consecutive patients undergoing CV and who had baseline and follow-up 
echocardiograms were included for study. Demographic, clinical and echo data, body 
mass index (BMI) and AF recurrence at follow-up echo were collected. Groups were 
deﬁned as normal weight (BMI<25), overweight (25-29.9), obese (30-34.9) and morbidly 
obese (>35). Univariate and multivariate logistic regression analyses were performed.
Results: Of 2030 patients who underwent CV, 1063 had BMI data (mean 28.7±6.1). 
Mean age was 66±12yrs and 372 (35%) were in AF at follow-up (mean follow-up time 
11.1±14.0 mos). Patients with recurrent AF had signiﬁcantly higher BMI (29.7±6.7 vs 
28.2±5.7, p=0.002). BMI groups were signiﬁcantly associated with AF recurrence (Figure, 
p = 0.002) with recurrence rates of 31% in normal, 32% in overweight, 38% in obese and 
49% in morbidly obese groups. Hypertension, sleep apnea, diabetes and hyperlipidemia 
did not predict AF recurrence. After adjustment for age and comorbidites, BMI remained 
a signiﬁcant predictor of AF recurrence.
Conclusion
Elevated BMI, a potential therapeutic target, is a signiﬁcant risk factor for AF recurrence 
after CV. These data suggest that targeting weight loss may promote maintenance of 
sinus rhythm after CV.
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3:30 p.m.
1020-57 Do Bisphosphonates for Osteoporosis Really Increase 
the Risk of Developing Atrial Fibrillation? Long-Term 
Results From Two Large Databases
T. Jared Bunch, Jeffrey L. Anderson, Heidi T. May, Joseph B. Muhlestein, Benjamin D. 
Horne, Brian G. Crandall, J. Peter Weiss, Donald L. Lappe, Jeffrey S. Osborn, John D. 
Day, Intermountain Medical Center, Murray, UT
Background: Bisphosphonates comprise the most common treatment for patients with 
osteoporosis and fracture risk. Large randomized trials have shown that these therapies 
may increase risk of atrial ﬁbrillation. Controversy over the arrhythmia risk prompted 
the Federal Drug Administration (FDA) to recently pursue an ongoing safety review to 
determine the cardiac risk across the entire drug class.
Methods: Study patients came from two large prospective databases (ongoing registry 
of consecutive patients who underwent coronary angiography and the Intermountain 
Healthcare health plans database). Medical details regarding bisphosphonate use and 
cardiovascular risk factors were abstracted from the records. Endpoints included atrial 
ﬁbrillation, myocardial infarction, and death.
Results: In the angiography database (n=9623), patients treated with bisphosphonates 
were older and more likely to have hypertension, a prior myocardial infarction, heart failure, 
and osteoporosis. Over 1481±1024 days we found no increased risk of atrial ﬁbrillation 
in the drug-treated group (HR 0.90, 95% CI: 0.48-1.68, p=0.74). In the Intermountain 
Healthcare health plans database (n=37,485), patients treated with bisphosphonates 
were older and were more likely to have hyperlipidemia and osteoporosis. Over 
1667.5±557.0 days, there was no increased risk of atrial ﬁbrillation (HR 0.82, 95% CI: 
0.66-1.01, p=0.63). In both databases there was no statistical difference in long-term 
rates of myocardial infarction or mortality.
Conclusion: In a long-term study comprising over 47,000 people we were unable to ﬁnd 
an association between bisphosphonate therapy and atrial ﬁbrillation. However, patients 
that received bisphosphonates were older and had more cardiovascular disease that we 
suspect accounts for the increased arrhythmia risk reported in other trials. 
3:30 p.m.
1020-58 Suppressed Inducibility of Atrial ﬁbrillation by a 
Novel Pacing Mode With Atrial Resynchronization 
Depolarization
Kun-Tai Lee, Wen-Ter Lai, Kaohsiung Medical University, Kaohsiung, Taiwan,ROC
Background: Homogenous atrial depolarization by multiple sites of atrial pacing may 
prevent the occurrence of AF. Sequential biatrial pacing from coronary sinus (CS) and 
right atrial appendage (RAA) may suppress AF occurrence by resynchronizing atrial 
depolarization.
Methods: 20 patients (11F, mean age: 45±12 yrs) were enrolled. Three quadripolar 
and a decapolar electrode catheters were placed to high right atrium (HRA), RAA, right 
middle interatrial septum (RMS) and CS. Different pacing modes were performed: (1) 
simultaneous pacing from RAA and distal CS (DCS). (2) simultaneous pacing from 
RAA and DCS with RAA pacing earlier than DCS by 20, 40 and 60 ms, respectively. (3) 
simultaneous pacing from RAA and DCS with DCS pacing earlier by 20 , 40 and 60 ms, 
respectively. The following parameters were calculated at different pacing modes: (1) P 
wave duration in lead II;(2) the ERP of HRA, RAA, RMS, proximal CS (PCS) and DCS; 
(3) the intraatrial (HRA to PCS) and interatrial (HRA to DCS) conduction times (CT). The 
inducibility of AF was performed by program stimulation compared at different pacing 
modes.
Results:The mean P wave duration at pacing modes with simultaneous pacing from 
RAA and DCS (96±12 ms) and from DCS earlier than RAA by 20ms (99±16 ms) were 
signiﬁcantly shorter than baseline and those of other pacing modes (P<0.05). Compared 
with baseline data, the ERP of each representative site, the intra and inter-atrial CT 
were not signiﬁcantly changed at all different pacing modes. The inducibility of AF was 
signiﬁcantly decreased at pacing modes with DCS earlier than RAA by 20 ms.
Conclusions:The inducibility of AF could be signiﬁcantly decreased by pacing mode with 
DCS pacing earlier than RAA by 20 ms.
3:30 p.m.
1020-59 A Wolff in Sheep’s Clothing: Unmasking Sudden Death 
Risk in Catecholamine Sensitive Accessory Pathways
Diego F. Belardi, Joseph Schuller, Royce Bargas, Christopher Stees, Laurent 
Lewkowiez, Michelle Khoo, Christopher M. Lowery, William H. Sauer, University of 
Colorado, Denver, CO
Introduction: Accessory pathways (APs) have the potential to result in sudden cardiac 
death (SCD) when atrial ﬁbrillation results in rapid ventricular activation degrading into 
ventricular ﬁbrillation. APs with an effective refractory period (ERP) greater than 250 
msec are not associated with this risk of SCD; however, some of these APs that are 
apparently low-risk for SCD may be catecholamine sensitive and demonstrate shorter 
refractory periods during exercise or in the setting of high circulating catecholamines. We 
sought to determine the incidence of catecholamine sensitivity among manifest APs with 
an ERP > 250 msec that would otherwise not have an indication for RF ablation.
Methods: Patients undergoing electrophysiologic study (EPS) with manifest preexcitation 
and an anterograde AP ERP of >250msec were included in the cohort. Those with 
inducible atrioventricular reciprocating tachycardia or baseline anterograde AP ERP < 
250 msec were excluded from the analysis. All patients underwent a graded infusion of 
isoproterenol up to 20 mcg/min with serial measurements of anterograde AP ERP.
Results: A total of 14 subjects with AP ERP > 250 msec were identiﬁed. Nine (64%) of 
the 14 demonstrated a reduction in AP anterograde ERP to less than 250 msec during 
CV = cardiovascular; HR = hazard ratio; CI = conﬁdence interval; *randomized and 
treated patients.
Relative risk estimates for important patient subgroups regarding all outcome measures 
showed consistency of the beneﬁcial effects of D across all subgroups tested. Relative 
risk analyses on safety events indicated that differences between D and P were mainly 
related to increased blood creatinine, rash, GI symptoms and fatigue. As expected from 
the pharmacological proﬁle prolonged QT interval and bradycardia were more frequent in 
the D group. Only a single case of Torsade de Pointes was reported in one patient, with 
multiple risk factors for Torsades, who received D.
Conclusion: Dronedarone improves relevant clinical outcomes across a wide range of 
patients with atrial ﬁbrillation in addition to its rate and rhythm controlling effects.
3:30 p.m.
1020-55 Initial Experience With Robotic Magnetic Navigation: A 
Prospective Evaluation of Clinical Utility and Outcome 
in a Community Hospital
Karthik Ramaswamy, Joon Ahn, Northeast Georgia Medical Center, Gainesville, GA
Background: Magnetic Navigation (MN) for mapping and ablation has been demonstrated 
to have advantages to conventional manual catheter manipulation (CONV), such as 
improved ﬂuoroscopy times, precision and stability, integration with electroanatomic 
mapping, and remote catheter control. Studies regarding the implementation of this 
sophisticated technology in clinical practice are limited, and the extent to which MN can 
replace CONV is not known. The purpose of this study was to determine the degree of 
utilization, performance, and outcomes of MN in a community hospital environment.
Method: From Jan 2006-Dec 2007 all patients presenting for mapping/ablation of SVT 
(AV junction (AVJ), AVNRT, accessory pathway (AP), and non-isthmus-dependent focal 
or macroreentrant atrial tachycardia (AT)) were considered for MN with the Stereotaxis 
system. A 4mm tip magnetic catheter (Biosense-Webster RMT) was used for all MN 
cases. 3D mapping was used except in AVJ ablation. A prospective, consecutive cohort 
of patients was analyzed. Reasons for non-utilization of MN, arrhythmia type, ablation 
success, crossover to CONV, and complications were recorded.
Results: 147 mapping/ablation procedures were performed over 24 mo. The MN system 
was used in 127 cases (86%). Reasons for non-utilization were: 1. need for an alternative, 
non-magnetic, ablation source (ALTABL) (cryo, irrigated, or 8mm electrode):10 (7%) 2. 
technical problems with MN: 3 (2%) 3. patient size: 2 (1%) or 4. other: 5 (3%). MN cases 
included 21 AVJ (17%), 63 AVNRT (50%), 23 AP (18%), and 20 AT (16%) . Success 
rate without need for CONV was 82% (AVJ 16/21 (76%), AVNRT: 54/63(86%), AP 18/23 
(78%), AT 16/20 (80%)). If patients requiring ALTABL for success are excluded, success 
rate for MN ablation is 90% (AVJ: 16/17(94%), AVNRT: 54/57 (95%), AP: 18/21 (86%), 
AT: 16/20 (80%). There were 3 (2%) complications in the entire cohort (2 in MN group 
and 1 in CONV).
Conclusions: Magnetic navigation can be implemented as a primary method for mapping 
and ablation for SVT and can replace conventional catheter manipulation for the majority 
of procedures. Newer magnetic catheters with large- and irrigated- tip electrodes may 
enhance implementation of magnetic navigation.
3:30 p.m.
1020-56 Activation Mapping of Dominant Frequency Sites in 
Patients With Permanent Atrial Fibrillation
Paolo De Sciscio, Pawel Kuklik, Anthony G. Brooks, Martin K. Stiles, Bobby John, 
Dennis H. Lau, Hany Dimitri, Gautham Sharma, Narayanan Namboodiri, Lauren 
Wilson, Glenn D. Young, Prashanthan Sanders, Cardiovascular Research Centre, Royal 
Adelaide Hospital and the University of Adelaide, Adelaide, Australia
Background: Frequency mapping has identiﬁed localised sites of dominant frequency 
(DF) during atrial ﬁbrillation (AF) as possible sites maintaining AF. Experimental studies 
have demonstrated temporal and spatial stability of these sites. Whether these sites can 
be identiﬁed by conventional activation mapping is unknown.
Methods: Bi-atrial high-density contact mapping (507±150 points/patient) was performed 
in 20 patients during AF using a 5-spline PentaRay catheter. Data was collected by 
sequentially acquiring 15 simultaneous electrograms for 8 secs. DF was calculated by 
FFT, ﬁltered by RI > 0.2 and ranked in descending order (highest-to-lowest). At sites of 
high DF (95th percentile) and median DF (50th percentile ± 2.5%), local activation time 
(LAT) maps were generated for 5 consecutive beats when local activity was organised. 
Comparisons were made between high and median DF sites for the following: type 
of activation, activation consistency and fractionation (CFE-mean). Blinded visual 
interpretation was used to determine the pattern and consistency of activation. 
Results: 46 high DF sites (6.2±0.7Hz) were compared to 70 median DF sites (5.5±0.8Hz). 
At high DF sites there were 34 circumferential rotor type activation, 7 passive activation, 
and 5 focal activation with bracketing of the earliest activity; compared to 14, 44 and 12 
at median DF sites respectively. Importantly, high DF sites had a greater percentage of 
rotor-like activation (73% vs. 19%, p=0.001) and more consistent beat-to-beat activation 
over 5 ﬁbrillatory cycles (73% vs. 50%) compared to median DF sites. Signiﬁcantly less 
fractionation was present at high DF compared to median DF sites (CFE-mean: 166.4 ± 
88.7 vs. 132.1 ± 58.9, p=0.02).
Conclusions: High DF sites more frequently displayed circumferential rotor type 
activation that demonstrated beat-by-beat consistency, suggesting these sites are 
involved in maintaining AF. The changing activation pattern at median DF sites may be 
indicative of passive activation and/or wave-front integration rather than sites driving AF. 
Activation mapping may be able to identify sources maintaining AF.
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236±64) (p <0.001); AVRT was induced more frequently in group III than in group I (41 
% vs 10 %, p < 0.001), but less frequently than in group II (41% vs 93 %, p< 0.001). AF 
induction was more frequent in group IIII than in groups I and II (73 % vs 18.5 %, and 16 
%, p < 0.001). Malignant forms of WPW were more frequent in group III than in group I 
and II (58 % vs 8 and 7.5 %) p<0.001). Male sex was more frequent in group III (68 %) 
than in group II (55 %) (< 0.05) but was not different from group I (65%). Other clinical 
data were similar: AP was generally left sided (64 % in group III, 46.5 % in group I, 68 
% in group II) (NS). Associated heart disease was as frequent in group III (10 %) as in 
groups I (8 %) and II (8 %).
Ablation of AP, performed in 29 group III pts suppressed the recurrence of AF in 23 pts; 
recurrence was noted in a pt 44 years old with valvular disease and 5 pts aged 56, 59, 
66, 66 and 74 years.
Conclusions: Spontaneous AF was a rare event in WPW sydrome. Identiﬁed risk factors 
for AF were an older age and a shorter accessory pathway refractory period than in 
other pts. AP catheter ablation prevented AF recurrence in pts less than 55 years old and 
without associated heart disease.
3:30 p.m.
1020-62 Right Atrial and Septal Triggers in Atrial Fibrillation: 
Analyses Based on Three-Dimensional and Biatrial 
Mapping in Paroxysmal and Persistent Atrial Fibrillation
Sanjeev Saksena, Rangadham Nagarakanti, Nicholas Skadsberg, Electrophysiology 
Research Foundation, Warren, NJ, Medtronic Inc., Minneapolis, MN
Background:Anatomic approaches to ablation in paroxysmal and persistent atrial 
ﬁbrillation (AF) concentrate on pulmonary vein and LA ablation but recurrent AF often 
requires staged or sequential procedures.
Objectives: To map and evaluate spontaneous atrial premature beats (APB) & atrial 
tachyarrhythmias (ATs) to identify all ATs in RA & LA that could be potential ablation targets.
Methods: Spontaneous APBs & ATs were mapped during simultaneous biatrial catheter 
& 3 D non contact mapping (NCM) in pts with drug-refractory AF with or without heart 
disease.
Results: 76 pts with AF (Paroxysmal = Gp.1, n=20; Persistent = Gp.2, n= 56) were 
studied. APB frequency in the two pt cohorts was comparable for septal origin, but was 
more common and diffusely distributed in the other RA regions in Gp.2 pts. Isthmus and 
non-isthmus dependent RA ﬂutter was observed in 83% of Gp.1 pts and 76% of Gp.2 pts, 
respectively (Figure 1). Focal and macroreentrant ATs were only seen in the LA in Gp.1 
pts (33%), whereas they were observed in both RA (7%) and LA (20%) in Gp.2 pts.
Conclusions:(1) RA and Septal ATs and RA ﬂutter are commonly observed in both 
paroxysmal and persistent AF pts. (2) Septal and RA linear ablation performed at the 
initial ablation procedure could potentially reduce ATs &/or APBs and enhance the 
efﬁcacy of catheter ablation of AF in both pt groups. 
3:30 p.m.
1020-63 Global Registry on Atrial Fibrillation Management: 
Regional Differences in Standard of Care
Peter R. Kowey, Günter Breithardt, John Camm, Harry Crijns, Paul Dorian, Jean-Yves 
Le Heuzey, Eric N. Prystowsky, Peter J. Schwartz, Christian Torp-Pedersen, William 
Weintraub, Lankenau Hospital, Wynnewood, PA, University of Muenster, Muenster, 
Germany
Background: The ongoing RecordAF registry is the ﬁrst worldwide, prospective, 
observational survey of the real-life management of atrial ﬁbrillation (AF) in recently 
diagnosed patients with a 1-year follow-up. We present the results of a pre-study 
questionnaire on physicians’ attitudes towards rhythm and rate control.
Methods: Investigators were randomly selected from lists of ofﬁce- or hospital-based 
cardiologists in ratios reﬂecting cardiology practice in each country. From June 2007 to 
February 2008 one physician from each of 583 sites from 21 countries in 12 regions 
completed a questionnaire on their practice, preferred ﬁrst- and second-line agents for 
rhythm and rate control in AF patients, and factors involved in altering strategy.
Results: The most frequent choices of ﬁrst-line rhythm-control agents were: for patients with 
structural heart disease (SHD), amiodarone (66% of physicians) (range 26% [Northern Europe] 
to 85% [Belarus]); congestive heart failure (CHF), amiodarone (82%) (52% [Northern Europe] 
to 96% [Other Southern Europe]); lone AF, propafenone 31% (7% [France and UK] to 67% 
[Greece]), although amiodarone was ﬁrst choice in some regions (despite being recommended 
as second choice in the AF guidelines). Overall, 82% said they would coprescribe a rate-
controlling agent to patients receiving a rhythm-control strategy, most commonly a B-blocker 
(88%). They would try a median of 2 antiarrhythmic drugs before switching to a rate-control 
strategy (exceptions in individual regions were 3 and 3.5 in Belarus and Russia, respectively). 
First-line treatments for rate control were: in SHD patients, B-blockers (85%) (56% [Asia] to 
isoproterenol infusion. The mean anterograde ERP measured at baseline was 536 msec 
(median 430 msec; range 310-1000 msec). Two of these 14 APs did not demonstrate 
retrograde conduction at baseline or with isoproterenol.
Conclusions: Catacholamine sensitive APs are common in patients with apparently long 
anterograde AP ERP. Patients with APs that appear to have a long ERP at baseline may 
be at risk for SCD due to this phenomenon. These data suggest that all patients with 
manifest preexcitation undergoing EPS for risk stratiﬁcation should have isoproterenol 
infusion to evaluate accurate AP ERP and possible ablation for reduction of SCD risk.
3:30 p.m.
1020-60 Differences in Patient Proﬁles and Management of 
Paroxysmal Atrial Fibrillation Compared to Persistent 
Atrial Fibrillation in the RecordAF Registry
Guenter Breithardt, Jean-Yves Le Heuzey, John Camm, Harry Crijns, Paul Dorian, 
Peter Kowey, Eric N. Prystowsky, Peter J. Schwartz, Christian Torp-Pedersen, William 
Weintraub, University of Muenster, Muenster, Germany
Background: RecordAF study is the ﬁrst worldwide, prospective, observational survey 
of real-life management of atrial ﬁbrillation (AF) in recently diagnosed patients (pts). We 
compared the proﬁles and management by physicians of pts with paroxysmal or persistent 
AF at baseline. Methods: Consecutive eligible pts q18 years presenting with or treated for 
AF (ﬁrst diagnosis or a1 yr from diagnosis), whatever the purpose of their visit to randomly 
selected ofﬁce- or hospital-based cardiologists, were recruited in 21 countries. Results: Of
5814 pts enrolled, 5254 presented with paroxysmal or persistent AF. Characteristics and 
treatment strategies at baseline that differed between AF groups are presented (Table). 
Persistent AF pts were slightly older, more often male, more obese, and more often had 
a history of heart failure. In paroxysmal pts, lone AF was more frequent, AF was more 
often symptomatic and associated with other arrhythmias, sinus rhythm at baseline was 
more frequent, and more pts had dyslipidemia. Rhythm-control strategy was preferred 
for paroxysmal AF. Antithrombotic management differed with more antiplatelet agents 
in paroxysmal AF and more oral anticoagulants in persistent AF pts who also received 
more antihypertensive drugs. Conclusions: Patients with persistent AF appear more at 
cardiovascular risk and are preferentially treated with rate-control strategy compared with 
paroxysmal AF pts, although marked overlap exists between both groups. 
Paroxysmal AF Persistent AF P-value(test)
N 2748* 2506*
Age, years, mean (SD) 65.0 (12.2) 66.3 (11.4) < 0.001 (A)
Male 1482 (53.9%) 1508 (60.2%) < 0.001 (C)
BMI >30 kg/m² 834 (30.5%) 840 (33.8%) 0.012 (C)
Lone AF 573 (20.9%) 374 (14.9%) < 0.001 (C)
History of heart failure 532 (19.4%) 850 (33.9%) < 0.001 (C)
- NYHA Class I+II 464 (87.5%) 696 (82.1%) 0.007 (C)
- NYHA Class III+IV 66 (12.5%) 152 (17.9%) 0.007 (C)
History of dyslipidemia 1240 (45.3%) 988 (39.5%) < 0.001 (C)
AF at inclusion 784 (29.1%) 2115 (84.8%) < 0.001 (C)
Symptoms 2405 (87.6%) 1924 (76.9%) < 0.001 (C)
Choice of treatment strategy at inclusion < 0.001 (C)
- Rhythm-control strategy 1938 (70.5%) 925 (36.9%)
- Rate-control strategy 810 (29.5%) 1581 (63.1%)
Vaughan Williams Class Ic 
antiarrhythmics 375 (14.0%) 152 (6.3%) < 0.001 (F)
Vaughan Williams Class III 816 (30.5%) 628 (25.9%) < 0.001 (F)
- Sotalol 209 (25.8%) 82 (13.1%) < 0.001 (C)
- Other class III 602 (74.2%) 543 (86.9%) < 0.001 (C)
Beta blockers (except sotalol) 1588 (59.4%) 1536 (63.3%) 0.004 (F)
Cardiac glycosides 276 (10.3%) 756 (31.2%) < 0.001 (F)
Antihypertensive drugs 1894 (68.9%) 1967 (78.5%) < 0.001 (C)
Antiplatelet agents 1376 (50.1%) 811 (32.4%) < 0.001 (C)
Vitamin K antagonists 1078 (39.2%) 1676 (66.9%) < 0.001 (C)
Lipid lowering drugs 1100 (40.0%) 883 (35.2%) < 0.001 (C)
*Number of patients evaluable for different parameters varies.
A, analysis of variance; C, chi-square test; F, Fisher’s exact test; W, Wilcoxon test.
3:30 p.m.
1020-61 Spontaneous Atrial Fibrillation in Wolff-Parkinson-White 
Syndrome: Clinical and Electrophysiological Risk 
Factors
Béatrice Brembilla-Perrot, Irina Popescu, Etienne Aliot, Cardiology, CHU of Brabois, 
Vandoeuvre Les Nancy, France
Background: Wolff-Parkinson-White syndrome (WPW) can be asymptomatic or revealed 
by atrioventricular reentrant tachycardia (AVRT). Atrial ﬁbrillation (AF) might be also the 
ﬁrst event, but its incidence and the risk factors are unknown. The purpose of the study 
was to determine the clinical and electrophysiological data of patients (pts) with a WPW 
presenting spontaneous AF.
Methods: 580 patients (pts) aged from 6 to 93 years were consecutively recruited for 
a WPW: 79 had unexplained syncope and were excluded from the study; 196 pts were 
asymptomatic (group I); 270 pts had AVRT (group II) and in 36 remaining pts (6 %), the 
ﬁrst event was documented AF (group III). Clinical and electrophysiological data of groups 
I, II and III were compared.
Results: Group III pts differed from groups I and II by the following data: they were 
older (47±17 vs 36±17 years and 30±16) (p< 0.001); maximal rate conducted through 
accessory pathway (AP) was higher in group III than in groups I and II in control state 
(222±67 b/min vs 193±63 and 186±57), and after isoproterenol (278±72 vs 222±67 and 
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3:30 p.m.
1020-66 Successful Ligation of the Left Atrial Appendage by a 
Novel Percutaneous Epicardial Technique
Charles Dalegrave, Charles Bruce, Samuel Asirvatham, Andrew Danielsen, Masayoshi 
Kinoshita, Susan Johnson, Douglas Packer, Paul Friedman, Mayo Clinic, Rochester, MN
Background: The left atrial appendage (LAA) is considered to be the primary source 
of thrombi in patients with atrial ﬁbrillation (AF) and resulting stroke. The LAA may also 
serve as an important substrate in the initiation and maintance of AF. Present techniques 
to mitigate stroke risk involve either invasive surgical procedures or the placement of an 
intravascular foreign body in the LAA. We sought to evaluate the efﬁcacy and safety of 
a novel epicardial based percutaneous system to ligate the LAA. We also observed the 
effects of ligation on LAA electrical function
Method: Four mongrel dogs were studied under general anesthesia. Subxiphoid 
percutaneous epicardial access was obtained in a standard fashion. The ligation system 
consisted of two parts; 1) a grabber that utilized a novel electrogram based navigation 
system to identify the LAA and 2) a unique hollow suture preloaded with a central wire 
to provide mechanical support and allow placement of the ligature at the base of the 
LAA subsequently tightened remotely. LAA size, ﬂow and adequacy of the ligature were 
assessed by intracardiac echocardiography (ICE) and at necropsy.
Results: Successful navigation, capture and ligation of the LAA using the novel system 
was performed in all dogs. ICE conﬁrmation of closure conﬁrmed at necropsy occurred 
in each case. There was loss of electrical activity in the LAA following ligation and no 
evidence of residual ﬂow on ﬁnal evaluation. In addition, there was a signiﬁcant decrease 
in P wave duration (P < 0.001) following LAA ligation and PQ segment elevation.
Conclusion: Percutaneous epicardial LAA ligation was successfully performed using 
a new electrical navigation and remotely tightened hollow suture within the conﬁne of 
the pericardial space. This technique may allow decreasing risk of stroke in AF patients 
without the need for thoracotomy or endocardially placed prosthetic device. It may also 
exclude the LAA electrically.
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0903-3 Long-Term Success and Side Effects of Antral Isolation 
of Pulmonary Veins With Cryoballoon Technique in a 
Large Patient Cohort With Atrial Fibrillation
Juergen Vogt, Johannes Heintze, Bogdan G. Muntean, Ursula Scholz, Lam Luong 
Thanh, Dieter Horstkotte, Department of Cardiology, Heart and Diabetes Center North 
Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
Background: In treatment of paroxysmal atrial ﬁbrillation (af) circumferential substrate 
modiﬁcation of the antrum of pulmonary veins with radiofrequency energy includes 
risks of pv stenoses and esophago - left atrial ﬁstula.This study reports on long term 
experience in antral isolation of pv with cryoballoon technique.
Methods: After pv angiography isolation was performed with best ﬁtting 28/23mm balloon 
(Arctic Front, Cryocath, Canada).The inﬂated over the wire balloon occludes the venous 
antrum freezing down to - 75 ° C 6 minutes two times per vein with nitrous oxide.Lasso 
mapped rest potentials were eliminated with additional balloon freezes or due to touch 
up with a 9 french Freezor Max catheter. To avoid phrenic nerve palsy pacing of phrenic 
nerve was monitored. Patients (p) were followed three monthly with 7 day holter.
Results: We analysed the ﬁrst 251 p (79 women, mean age 59±10 years, 233 with 
paroxysmal,18 persistent af, left atrium 43±5 mm, 118 p with lone af, 93 hypertension, 
40 mild structural heart disease, history of af 77±67 months). With 2.4±1.2 impulses we 
isolated in 201 p (80%) all pv with balloon only, in 20 % with additional touchup. In the 
last 145 p all pv could be isolated with balloon only. In 44% we combined two balloon 
sizes. Mean procedure time decreased to 164±31 min and x ray burden to 26±7 min. 
Phrenic nerve palsy in 8 p (3%, 7 with 23 mm balloon) recovered within 3 to 9 months.
With pacing technique damage of phrenic nerve could be avoided completely.During 
follow up of 8.5±6 months and 1.1 procedures per p of 168 p after blanking time of 3 
months 81 % (136 p) were free of af, with one procedure 72%, in p with left common 
ostia (11 of 13) 85%. No pv stenoses, no ﬁstulas were observed.Other side effects were 
3 groin hematomas, 2 aditional substrate modiﬁcations of left atrium and 7 later ablations 
of typical atrial ﬂutter.
Conclusions: Antral cryoisolation of the pv with cryoballoon technique is safe. With 
pacing technique persistent phrenic nerve palsy can be avoided completely. Success rate 
is comparable to risks of side effects are superior to encircling techniques of pv antrum 
with RF energy. Early cryoballoon therapy may prevent progression to persistent af.
98% [Russia]); in CHF, B-blockers (64%) (27% [Asia] to 91% [Northern Europe]); for lone AF, 
B-blockers (85%) (67% [East USA] to 98% [Other Eastern Europe]).
Conclusions: Although a substantial proportion of centers would manage AF in 
accordance with treatment guidelines, stated practice patterns are widely variable 
and sometimes counter to guidelines. This survey will allow a comparison of declared 
theoretical treatment practices versus actual practices.
3:30 p.m.
1020-64 Steerable Sheath Catheter Navigation for Ablation 
of Atrial Fibrillation: Long-Term Results and the 
Predictors of Successful Ablation After Single 
Procedure in 674 Patients
Arash Arya, Gerhard Hinrdircks, Yan Hou, Philipp Sommer, Andreas Bollmann, Kerstin 
Bode, Christopher Piorkowski, Christopher Piorkowski, Heart Center University of 
Leipzig, Leipzig, Germany
Background: Identifying suitable candidates for circumferential left atrial pulmonary 
vein ablation (CPVA). CPVA is widely used as an ablation strategy in patients with atrial 
ﬁbrillation (AF). Understanding the predictors of long term success of single catheter 
ablation procedure of AF based on CPVA can help to identify those patients who have a 
high risk of recurrence based on this approach.
Methods: In this retrospective analysis 674 consecutive patients (464 male, mean age 
57.3±10.8 years) with AF (84.8%, paroxysmal) treated with CPVA ablation between May 
2005 and August 2007 using a manually controlled steerable sheath, were included. The 
endpoint of the ablation was the completion of predeﬁned lesions (CPVA for paroxysmal, 
and CPVA + mitral isthmus and roof line ablation for persistent AF). Seven day Holter 
recordings were done immediately, 3, 6, and 12 month after ablation. AF longer than 30 
seconds was considered as recurrence. The success was deﬁned as lack of recurrence 
during 7-day Holter recordings after ablation. Early recurrence was deﬁned as recurrence 
during the ﬁrst 7-day Holter recording immediately after ablation.
Results: During the ﬁnal data gathering (January 2008) 674, 604, and 410 patients completed 
the 3, 6, and 12 months follow up, respectively. 51.5% experienced early recurrence. Twelve 
months success rate was 75.7% (paroxysmal: 75.7%, persistent: 75.0%, P=1.0). Using 
multivariate analysis left atrial (LA) diameter q 50 mm was the predictor of early recurrence 
(Hazard Ratio [HR] (95% conﬁdence interval [CI])= 5.1 (2.0 - 12.9)). LA Diameter q 50 mm 
(HR [95%CI]= 4.6 [2.6 - 9.1]); early recurrence (HR[95%CI]= 4.3 [2.0 - 9.1]); and arterial 
hypertension (HR[95%CI]= 4.6 [2.6 - 9.1]) were predictors of late recurrence.
Conclusions: In our patients’ cohort, a single catheter ablation procedure based on 
CPVA resulted in a one year success rate of 75.7% (without [91.0%] and with [58.6%] 
early recurrence, respectively P=0.0001). Among those patients who are at high risk for 
recurrence after CPVA other ablation endpoints rather than completion of predeﬁned 
lesions might be necessary to increase the success rate.
3:30 p.m.
1020-65 New Delayed Enhancement Magnetic Resonance 
Imaging Based Method Predicts Early Recurrence 
of Atrial Fibrillation after Ablation: A Guide for Early 
Initiation of a Short Trial Anti-Arrhythmic Drugs After 
Ablation of Atrial Fibrillation
Saul Kalvaitis, Marcos Daccarett, Troy J. Badger, Swati N. Rao, Nathan S. Burgon, 
Nazem Akoum, Ryan Broderick, Rob S. MacLeod, Nassir F. Marrouche, Division of 
Cardiology, University of Utah School of Medicine, Salt Lake City, UT
Background: Early recurrence of atrial ﬁbrillation (ERAF) remains common post 
procedural issue after ablation of atrial ﬁbrillation (AF). A clear guidance for initiation of 
anti-arrhythmic drugs (AAD) is still lacking. We describe novel delayed enhancement 
magnetic resonance imaging (DE-MRI) based method to deﬁne patients with high risk 
of ERAF after ablation of AF.
Methods and results: Fifty seven patients presenting for AF ablation underwent pre-
procedural DE-MRI of the left atrium (LA). DE-MRI images were segmented to isolate 
the LA and custom software was implemented to detect regions of low voltage tissue by 
quantifying delayed enhancement (Figure 1). Patients were assessed for ERAF following 
ablation. Eighteen patients (31.6%) experienced ERAF. There was correlation (p=0.017) 
between amount of ﬁbrosis and ERAF, with amount of ﬁbrosis in group with no recurrence 
being 14.8+/-9.4%, and in group with recurrence 23.2+/-16.4%.
Conclusion: From our preliminary data DE-MRI seems to predict ERAF after ablation of 
AF. This novel method would facilitate deﬁning patients at a high risk of ERAF and guide 
early initiation of short trial AAD to suppress the arrhythmia. 
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Results:After a mean follow-up of 220 +/- 204 days, 78.6% (213/271) of patients were 
free from AF. In patients treated with RAS blockers, AF recurrence was signiﬁcantly 
lower than those without (HR = 0.49 [95% CI: 0.29-0.83] p = 0.006) assessed by Cox 
regression analysis. In addition, after multivariate adjustment for potential confounders, 
RAS blockers use (HR = 0.50 [95% CI: 0.27-0.93] p = 0.028) and anti-arrhythmic drugs 
use (HR = 0.39 [95% CI: 0.21-0.72] p = 0.002) were the only independent predictors 
for AF non-recurrence. When limited to late AF recurrence; more than 1month after the 
ablation (n=243), RAS blockers use was the strongest predictor for non-recurrence (HR = 
0.28 [95% CI: 0.14-0.58] p = 0.001).
Conclusions:Treatment with (RAS) blockers markedly reduces the risk of AF recurrence 
after catheter ablation. This beneﬁt is more efﬁcient for late AF recurrence.
9:00 a.m.
0903-7 Effect of Acute Volume Loading Stretch on Pulmonary 
Vein Electrophysiology in Humans
Paolo De Sciscio, Fréderic Sacher, Pierre Jaïs, Anthony Brooks, Pawel Kuklik, Li-Fern 
Hsu, Mélèze Hocini, Michel Haïssaguerre, Prashanthan Sanders, Cardiovascular 
Research Centre, Royal Adelaide Hospital and the University of Adelaide, Adelaide, 
Australia, Hôpital Cardiologique du Haut-Lévêque and the Université Victor Segalen 
Bordeaux, Bordeaux, France
Background: Atrial stretch is a characteristic of many clinical conditions that predispose 
to the development of atrial ﬁbrillation (AF). Atrial stretch has been demonstrated to result 
in atrial electrical remodeling; however, the electrophysiological effects of stretch on the 
pulmonary veins (PVs) remains unknown.
Methods: 20 patients (9m, 36 ± 14 yrs) with structurally normal hearts undergoing ablation 
of left accessory pathways were studied. In 13 patients, atrial stretch was achieved by 
acute volume loading (of 0.9% saline) to increase the left atria (LA) pressure q 2-fold. 
The remaining 7 patients underwent the same protocol without induction of stretch. 
Electrophysiological evaluation of the PVs was performed in all patients before and after 
volume loading by sequentially positioning a 10-pole Lasso catheter at the PV ostium and 
stimulating a 4-pole mapping catheter positioned distally. The following variables were 
assessed at baseline and after volume loading: PV effective refractoriness (ERP); PV-LA 
functional refractoriness (FRP); PV conduction time (CT); PV-LA CT; LA ERP, FRP, and 
CT. ERP was determined at the superior and inferior aspects of each PV as well as the 
LA roof and appendage.
Results: In patients undergoing atrial stretch, LA pressure increased from 6±2 to 14±4 
mmHg (p<0.02). This was associated with a signiﬁcant increase in the ERP of the PVs 
(287±29 vs. 310±37 ms, p<0.001) and LA (269±45 vs. 282±45 ms, p<0.001). In addition, 
there was a signiﬁcant increase in the FRP of the PV-LA junction at the PVs (317±27 vs. 
345±40 ms, p<0.001). Atrial stretch prolonged the CT within the PVs (24±7 vs. 29±7 ms, 
p<0.001) and at the PV-LA junction (68±19 vs. 79±17 ms, p<0.001) and was associated 
with prolonged and more complex PV potentials at the ostia. No signiﬁcant change was 
observed in variables measured in control patients.
Conclusions: Acute PV stretch by volume loading results in an increase in refractoriness 
and slowing of conduction at the PV and PV-LA junction. This was associated with 
prolonged and more complex potentials at the PV-LA junction. These factors may 
contribute to PV arrhythmogenesis.
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9:30 a.m.
1029-31 Right Ventricular Dysfunction Is a Strong Predictor 
for Developing Atrial Fibrillation in Acutely 
Decompensated Systolic Heart Failure Patients
Emad F. Aziz, Marrick Kukin, Amjad Nader, Ajay Shah, Anshu Alok, Omar Wever-
Pinzon, Maria Elena De Bendetti, Carlos Leon Alviar, Rishi Malhan, Rajan Garg, 
Deborah Tormey, Raja Singh, Farooq A. Chaudhry, Eyal Herzog, St. Luke’s-Roosevelt 
Hospital Center, New York City, NY
Background: Heart failure is often complicated by atrial ﬁbrillation (AFib), and AFib can 
exacerbate and in some cases cause heart failure. However the role of RV dysfunction in 
developing AFib in acute decompensated heart failure (ADHF) is unknown.
Methods: 904 patients admitted with ADHF were studied. Incidence of AFib on admission 
were recorded. Echocardiographic parameters; including RV dysfunction, LA diameter 
(LAD), LV end-systolic (LVES) and end-diastolic (LVED) diameters as well as patient 
demographics used to identify the predictors of AFib in this cohort.
Results: In 904 ADHF patients (57% male, mean age of 69 ± 14 years), 81% had 
hypertension, 40% were diabetics and 51% were smokers. 63% had known CHF with mean 
EF of 34 ± 21% and 33% had ischemic cardiomyopathy. Echocardiographic Parameters 
were; LAD 4.5 ± 0.8 cm, LVES 4.1 ± 1.3 cm, LVED 5.3 ± 1.1 cm, RV dysfunction was 
present in 31% of the patients. AFib incidence was seen 160 (31%) patients. Using the 
Univariate analysis, older age (OR 1.02; p=0.0001), LA dilation (OR 1.8; p=0.0001), the 
8:15 a.m.
0903-4 Outcomes in Patients Requiring Cardioversion 
Following Catheter Ablation of Atrial Fibrillation
Jonathan Dukes, Karuna Chilukuri, Daniel Scherr, Charles Henrikson, Joseph Marine, 
Ronald Berger, Saman Nazarian, Alan Cheng, David Spragg, Hugh Calkins, The Johns 
Hopkins Hospital, Baltimore, MD
Background: Recurrence of atrial ﬁbrillation (AF) after catheter ablation is common during the 
ﬁrst 3 months post procedure and may result from myocardial irritation rather than procedural 
failure. The role and efﬁcacy of cardioversion (CV) during this time period is unknown. The 
purpose of this study is to evaluate the outcomes of patients who require CV early (within 3 
months) or late (3 - 6 months) following catheter ablation of AF. We also sought to test the 
hypothesis that since early recurrence is likely to be inﬂammatory mediated, patients who 
defer CV for at least 3 months will have a lower rate of recurrent AF.
Methods: The patient population consists of 335 consecutive patients who underwent 
catheter ablation of AF at our center. Of these, 44 patients (16% female, 25% paroxysmal 
AF, 75% persistent AF, mean age 57 ± 10 years at ablation) underwent CV in the ﬁrst 6 
months post ablation because of persistent AF. This cohort was divided into two groups: 
CV in the ﬁrst 90 days (early CV) and CV 91 to 180 days post (late CV). Minimum follow-
up was 1 year.
Results: 25 patients required early CV, of which 24 patients (96%) developed recurrent 
AF after CV with an average time to recurrence of 27 days (range 0 to 365 days, 6 
acute failures). The recurrent AF was persistent at the time of recurrence in 54% of these 
patients. The other 19 patients required late CV, of which 16 patients (84%) developed 
recurrent AF with an average time to recurrence of 42 days (range 0 to 334 days, 2 
acute failures). The AF was persistent at the time of recurrence in 75% of these patients. 
No signiﬁcant difference was observed in the incidence of recurrent AF, the time to 
recurrence, nor the type of recurrent AF, when comparing early or late CV (p = 0.3, 0.23, 
and 0.23 respectively).
Conclusion
In our cohort, a patient had a >80% chance of recurrent AF following a post ablation CV. 
There was no statistical difference in AF recurrence rates comparing early and late CV. 
These rather sobering ﬁndings are of importance as they allow clinicians to provide their 
patients who require CV realistic expectations regarding their long-term outcome and/or 
requirement for a second ablation procedure.
8:30 a.m.
0903-5 Prediction and Prevention of Esophageal Injury During 
Atrial Fibrillation Ablation
Martin Martinek, Gabor Bencsik, Josef Aichinger, Said Hassanein, Rainer Schoeﬂ, Petra 
Kuchinka, Hans-Joachim Nesser, Helmut Pürerfellner, Elisabethinen University Teaching 
Hospital, Linz, Austria
Background: Atrio-esophageal ﬁstula is an uncommon but often lethal complication of 
atrial ﬁbrillation (AF) ablation. The purpose of our study was the development of a risk 
score for esophageal ulcerations (ESUL).
Methods: 175pts, 57.1% paroxysmal AF; 78.5% male, underwent AF ablation and 
esophagoscopy 24 hours thereafter. We performed a 2:1:1-randomization as follows: 
Control group: Ablation without visualization of the esophagus using 25W power limit on 
the posterior wall, n=70.
Visualization and 15W maximum: Ablation guided by barium visualisation of the 
esophageal course using a limit of 15W, n=35.
Visualization and 25W “short burns”: Ablation guided by barium visualization using 25W 
and “short burns” (max. 5sec), n=35.
Pts performed under general anesthesia (n=35) were separated as a nasogastric tube for 
visualisation of the esophagus was used.
Results: In total we found 2.9% of pts (5/175) presenting ESUL. Visualization of the 
esophagus could not prevent ESUL. Parameters discriminating the development of 
ESUL in a speciﬁc patient were maximum energy delivered on posterior wall, usage of a 
nasogastric tube, and additional left atrial lines. Discriminant analysis reached sensitivity 
as high as 88.0% to predict ESUL creation. Pts with a score higher than 6 were at 
increased risk for ESUL.
Conclusions: With a power limitation to 25W on posterior wall we discovered a much 
lower rate of ESUL than reported in other studies. We were able to develop a scoring 
system to predict and prevent esophageal injury.
8:45 a.m.
0903-6 The Effects of Renin-Angiotensin System Blockers on 
Atrial Fibrillation Recurrence Following Pulmonary Vein 
Isolation
Kiyotake Ishikawa, Yukihiko Yoshida, Noriyoshi Kanemura, Luke Yoshida, Takashi 
Yamamoto, Tousei Hashimoto, Yutaka Aoyama, Masateru Takigawa, Natsuo Inoue, 
Yasushi Tatematsu, Mamoru Nanasato, Haruo Hirayama, Nagoya Daini Red Cross 
Hospital, Nagoya, Japan
Background:Ablation has emerged as a major treatment option for atrial ﬁbrillation (AF). 
However, this procedure is limited by a certain degree of AF recurrence. We aimed to 
examine the effects of renin angiotensin system (RAS) blockers on the recurrence of AF 
following ablation.
Methods:We conducted a retrospective study of consecutive 271 patients (mean age; 61 
+/- 11 yrs, 74.2% males) who underwent ablation for paroxysmal (n = 180) or persistent 
AF (n = 91). One hundred and ﬁfty patients (55.4%) were treated with RAS blockers after 
the ablation and for the duration of follow-up (angiotensin-converting enzyme inhibitors; 
n=16, angiotensin receptor blockers; n=131, both; n=3).
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fully reported AAD use, there was no evidence of improved survival free from AF and AAD 
therapy (OR 1.78, 95% CI 0.73-4.34). These procedures were not signiﬁcantly associated 
with increased length of hospital stay, perioperative complications, or all-cause mortality. 
Conclusions: Among patients with valvular AF, the surgical or modiﬁed Maze procedures 
are associated with a decrease in AF within 1 year post-procedure without signiﬁcant 
increase in mortality.
9:30 a.m.
1029-34 Beneﬁcial Effects of Successful Ablation on Left 
Ventricle and Right Ventricle Function in Patients With 
Frequent PVC and Preserved Ejection Fraction
Adrianus P. Wijnmaalen, Victoria Delgado, Martin J. Schalij, Eduard R. Holman, Jeroen 
J. Bax, Katja Zeppenfeld, Leiden University Medical Center, Leiden, The Netherlands
Background: Successful radiofrequency catheter ablation (RFCA) of frequent 
monomorphic premature ventricular contractions (PVC) can result in dramatic 
improvement of left ventricular (LV) function in selected patients (pts). Subtle and early 
forms of PVC induced LV impairment may not be detected by standard echo techniques.
Methods: Twenty-seven pts (15 Male, 44±15y) who underwent RFCA of frequent 
PVC were studied. PVC burden decreased from a mean 28±13% to <1% in all pts. 
Pts underwent 2-dimensional (2-D) echocardiography prior to ablation and at follow-up 
(median 9, range 3 - 53 months). LV volumes and ejection fraction (EF) were calculated 
by Simpson’s rule. Tricuspid annulus plane systolic excursion (TAPSE) and fractional area 
change (FAC) were calculated to assess right ventricular (RV) function. Multidirectional 
LV strain (radial, circumferential and longitudinal) and RV free wall longitudinal strain were 
calculated by 2-D speckle tracking imaging (STI).
Results: At baseline and at follow-up LVEF and volumes were normal (Table). Despite 
preserved LVEF, 2-D STI demonstrated a subtle reduction in LV and RV strain. At 9 
months after RFCA, a signiﬁcant improvement in radial, circumferential and longitudinal 
strain was observed, whereas LVEF and RV systolic function remained unchanged.
Conclusions: Frequent PVCs can induce cardiac dysfunction detected by STI analysis 
in pts without apparent cardiomyopathy. RFCA can successfully eliminate PVC’s and 
improve cardiac function.
2D echocardiographic analysis
Baseline Follow-up p=
LV end diastolic volume (ml) 133±39 127±32 0.260
LV end systolic volume (ml) 60±21 53±15 0.034
LVEF(%) 56±7 58±5 0.086
LV radial strain 31.2±15.3 45.3±19.7 0.003
LV circumferential strain -16.4±3.7 -19.8±4.4 0.006
LV longitudinal strain -18.1±2.4 -19.7±2.2 0.011
RV FAC (%) 41 ± 8 42 ± 8 0.580
RV longitudinal stain -24.8±8.1 -29.3±5.8 0.027
9:30 a.m.
1029-35 Independent Predictors of Sudden Cardiac Death in 
Patients With Nonischemic Cardiomyopathy
Brett D. Atwater, Erik Iverson, Mauricio Velez, David L. DeMets, Nancy K. Sweitzer, Duke 
University Medical Center, Durham, NC, University of Wisconsin, Madison, WI
Background: Most patients with non-ischemic cardiomyopathy (NICM) die of sudden 
cardiac death (SCD) or progressive heart failure (HF). Little is known about the impact of 
patient characteristics and therapeutic strategies on the risks of death from SCD versus 
other causes.
Methods: Data were collected from patients with NICM enrolled in the PRAISE 1, PRAISE 
2, and VeST trials and entered into a single registry. Separate univariable and multivariable 
Cox-regression models were created for SCD and all-cause mortality (ACM). SCD was 
deﬁned as witnessed unexpected death occurring within 60 minutes of symptom onset. The 
discriminative capacities of the multivariable models were assessed using the area under 
the receiver operating characteristic curve as an index of model performance (c-index).
Results: 3,583 patients with NICM were followed for an average of 19.8 months. SCD 
occurred in 502 patients and 425 patients died of other causes. Ejection fraction, gender, 
NYHA class, systolic and diastolic blood pressure, and antiarrhythmic or digoxin use 
presence of LVH (OR 4.9, P=0.001) and RV dysfunction (OR 2.0; P=0.0001) were the 
strongest predictors for AFib. Controlling for LA size and LVH using a forward stepwise 
regression, RV dysfunction remained the strongest predictor (p=0.008). Presence of RV 
dysfunction carried worse outcome in ADHF and AFib (p=0.015). see graph.
Conclusion: RV dysfunction is a strong predictor for developing AFib in acutely 
decompensated systolic failure patients, with worse outcome. 
9:30 a.m.
1029-32 The Effects of Bidirectional Cavo-Tricuspid Isthmus 
Block in Persistant Atrial Fibrillation
Jin-Bae Kim, Min-Soo Ahn, Byoung-Ho Lee, Sang-Hee Lee, Boyoung Joung, Moon-
Hyoung Lee, Sung-Soon Kim, Yonsei Cardiovascular Center and Cardiovascular 
Research Institute, Yonsei University College of Med, Seoul, South Korea
Background: The catheter ablation is considered standard therapy for patients who have 
symptomatic paroxysmal atrial ﬁbrillation(AF) after having had no response to a single 
antiarrhythmic drug. However, the effectiveness of catheter ablation was much lower in 
patients with persistant AF despite prolonged procedure. The hybrid therapy with catheter 
ablation of the cavo-tricuspid isthmus(CTI) and continuation of anti-arrhythmic drugs 
(AAD) or electrical cardioversion with AADs might be alternatives for the treatment of 
these patients. This study was aimed at verifying long term results, and determining the 
risk factors for the recurrence of persistant AF in patients undergoing the hybrid therapy 
for anti-arrhythmic drug-induced AFL. Method: A total of 33 patients (age 57.1 ± 10.8, 
males 27) who developed AFL after the administration of Class Ic/III anti-arrhythmic drug 
was enrolled and follow up. This group was compared with cardioversion group(n=34) 
who received DC cardioversion with AADs. Baseline clinical and electrocardiographic, 
echocardiographic data were collected and regular ECG & symptom driven Holter 
monitoring were performed at every 2-4months. Results: there was no signiﬁcant 
difference in baseline characteristics between the groups. 12 month AF free survival 
was better in hybrid group. (49.0% vs 33.1%, p= 0.048). However, during 55.7 ± 43.0 
month follow up, this better surivival rate was regressed (p=0.25). The risk factors for 
the recurrence was pre-ablative LA size (odds ratio 2.5, CI of 95% 1.494 - 3.66, p=0.02). 
The larger LA size (<44mm) was independent risk factor in recurrence of AF after 
adjusting age, sex, hypertension, diabetes, treatment strategy, LV EF. Conclusion: The 
CTI ablation with AADs showed comparable outcome to prolonged LA ablation with PV 
isolation and multiple linear lesions in 12 month follow up. Minimal substrate modiﬁcation 
with AADs can be alternative to patients with persistant AF accompaing minimal atrial 
remodeling. In patients with persistant AF and severe atrial remodeling, rhythm control 
could not be maintained, therefore, rate control without AAD is more reasonable for long 
term treatment strategy.
9:30 a.m.
1029-33 Surgical Maze Procedure as a Treatment for Atrial 
Fibrillation: A Meta-Analysis of Randomized Controlled 
Trials
Melissa H. Kong, Renato D. Lopes, Jonathan P. Piccini, Vic Hasselblad, Tristram D. 
Bahnson, Sana M. Al-Khatib, Duke University Medical Center, Durham, NC
Background: Surgical or modiﬁed Maze procedures have been promoted to treat 
atrial ﬁbrillation (AF). We evaluated the efﬁcacy of surgical Maze procedures performed 
concomitantly with other cardiac surgery compared with pharmacologic therapy for 
treatment of AF.
Methods: We searched MEDLINE, the Cochrane database, the FDA web-portal, 
clinicaltrials.gov, and EMBASE for all randomized trials comparing surgical Maze 
procedures with medical therapy for maintenance of sinus rhythm. Primary outcomes 
were freedom from AF within 1 year post-procedure off antiarrhythmic drug (AAD), or 
freedom from AF while taking an AAD. Both ﬁxed- and random-effects models were used 
for a meta-analysis of 9 randomized trials (n = 472; 249 underwent a Maze procedure and 
213 underwent referral surgery alone).
Results: The surgical Maze procedure signiﬁcantly increased the odds of freedom from 
AF within 1 year compared with cardiac surgery alone (OR 5.22, 95% CI 1.71-15.88) 
(ﬁgure). There was signiﬁcant heterogeneity among the trials. Among the 2 studies that 
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1029-38 Identiﬁcation of an Initial Far Field Component of the 
Earliest Endocardial Electrogram Predicts Epicardial 
Origin of Ventricular Tachycardia
Diego F. Belardi, Joseph L. Schuller, Royce Bargas, Christopher Stees, Laurent 
Lewkowiez, Michelle Khoo, Christopher M. Lowery, William H. Sauer, University of 
Colorado, Denver, CO
Background: Different schemas have been developed to predict an epicardial source of 
VT, but algorithms using the endocardial electrogram (EGM) have not been developed.
Methods: We evaluated 28 consecutive patients with incessant or inducible sustained 
VT. Activation, entrainment, and CARTO electroanatomic mapping were performed. 
EGM characteristics at the earliest endocardial activation were analyzed. Far ﬁeld EGM 
components were deﬁned as low frequency bipolar signals (discrete monophasic EGM > 
10 msec in duration) observed in the setting of high frequency signals (multiphasic EGM 
occurring within 10 msec in duration).
Results: Of the 28 patients included in the analysis, 5 (18%) were found to have an epicardial 
origin of VT. The earliest endocardial activation was initially recorded in the 5 epicardial 
cases, demonstrating a far-ﬁeld early component followed by a sharp near-ﬁeld component 
(Figure). Ablation lesions at these sites resulted in suppression or delayed termination of the 
tachycardia. In these cases, the earliest ventricular activation was identiﬁed in the epicardium 
showing a near-ﬁeld electrogram followed by a far-ﬁeld signal (Figure).
Conclusion: A characteristic endocardial EGM with an early far-ﬁeld signal predicts 
an epicardial origin of VT. When performing endocardial activation mapping of VT, this 
characteristic EGM may predict the necessity of epicardial mapping and ablation.
9:30 a.m.
1029-39 Limited Linear Ablation of Postmyocardial Infarction 
Ventricular Tachycardia Using a Standardized Approach 
Based on Sinus Rhythm Mapping
Thomas Deneke, Thomas Lawo, Bernd Lemke, Leif Bösche, Marc Horlitz, Andreas 
Mügge, University Heart Center Bochum, Bochum, Germany, Academic Heart Center 
Cologne, Cologne, Germany
Background:Ventricular tachycardias (VTs) in patients with remote myocardial infarction 
are often electrically and hemodynamically instable. We attempted to evaluate the 
efﬁcacy of limited linear ablation in VT exit regions identiﬁed during sinus rhythm (SR) 
mapping alone.
Methods:115 consecutive patients presenting for ablation of post-myocardial VT were 
included. Invasive electrophysiology was performed. Left ventricular substrate mapping 
during SR differentiating normal, scar border zone and scar tissue based on endocardial 
bipolar voltage was performed. In a second step the exit site of the target VT was 
regionalized by a simpliﬁed pace-mapping approach. Regional linear ablation along the 
scar border in the approximated exit region to target all inducible VTs was performed.
Results:The clinical VT was successfully ablated in 97% (112/115) of patients (77% of all 
inducible VTs). In 62% (71) no sustained VT was inducible at the end of ablation procedure 
(complete success). During a median follow-up of 15±10months 89 patients (77%) had 
no sustained ventricular arrhythmia documented. 7 patients (2%) had recurrences of 
the initially ablated VT and 16 had new-onset VT. Patients with complete success had a 
signiﬁcantly lower number of ventricular arrhythmia re-occurrences compared to patients 
with incomplete ablation success (11% versus 37%, p=0.002).
Conclusions:Post-infarct VT can effectively be ablated in 97% of clinical VTs without 
mapping during ongoing VT using a simpliﬁed regional linear ablation approach targeting 
the scar border zone. Freedom from any ventricular arrhythmia can be achieved in 77% 
of patients during mid-term follow-up. Arrhythmia re-occurrences depend upon mode of 
ablation success.
were independently associated with SCD and ACM in multivariable analyses. Digoxin 
use disproportionately increased the risk of SCD compared to other causes of death. 
The Chi-square for predicting SCD was 115 and the c-index was 0.63. The Chi-square for 
predicting ACM was 310 and the c-index was 0.66.
Conclusions: Clinical variables predict mortality among patients with NICM but do not 
adequately discriminate mode of death.
Variable SCD Hazard Ratio (95% CI)
SCD
P-Value
ACM Hazard Ratio 
(95% CI)
ACM 
P-Value
Ejection Fraction (per 
10% increase) 0.691 (0.596-0.801) <0.001 0.695 (0.624-0.774) <0.001
Female Gender 0.734 (0.601-0.895) 0.0023 0.765 (0.661-0.884) <0.001
NYHA Functional 
Class (1-4) 1.626 (1.320-2.002) <0.001 1.822 (1.570-2.115) <0.001
Systolic BP (per 10 
mmHg increase) 0.924 (0.864-0.988) 0.02 0.889 (0.845-0.934) <0.001
Diastolic BP (per 10 
mmHg increase) 0.879 (0.791-0.976) 0.016 0.836 (0.773-0.904) <0.001
Antiarrhythmic Use 1.292 (1.021-1.636) 0.033 1.595 (1.354-1.879) <0.001
Digoxin Use 2.717 (1.118-6.599) 0.027 2.092 (1.178-3.715) 0.012
9:30 a.m.
1029-36 Integration of MRI Derived 3D Scar Maps With 
Electroanatomical Mapping During Catheter Ablation of 
Scar-Related Ventricular Tachycardia
Adrianus P. Wijnmaalen, Rob J. van der Geest, Hans-Mark J. Siebelink, Lucia J. Kroft, 
Jeroen J. Bax, Johan H. Reiber, Martin J. Schalij, Katja Zeppenfeld, Leiden University 
Medical Center, Leiden, The Netherlands
Background: The current used gold standard to guide substrate based ablation of 
scar-related ventricular tachycardia (VT) relies on electroanatomical endocardial and 
epicardial voltage mapping (EAM). Integration of the complex 3-dimensional (3D) scar 
geometry derived from contrast enhanced magnetic resonance imaging (CE-MRI) with 
EAM may provide supplementary substrate information. This study aimed to assess the 
feasibility of integrating CE-MRI derived data with EAM during radiofrequency catheter 
ablation (RFCA) of scar-related VT.
Methods: Seventeen patients (15 male, 60±13yr) referred for RFCA of scar-related VT (12 
post-myocardial infarction, 5 dilated cardiomyopathy) underwent CE-MRI using a 1.5 T MRI 
system. Endocardial and epicardial contours of the CE-MRI were used to create 3D surface 
meshes of the left ventricle (LV), the aortic cusps and the left main (LM) origin. The vertices 
of the meshes were color coded based on the transmural extend of scar at a particular 
intramural location. Prior to ablation the MRI derived scar maps were imported into the 
CARTO-merge system. Bipolar endocardial EAM of the LV and aortic cusps were obtained 
and the LM location was marked. Areas with bipolar electrograms <1.5mV were deﬁned as 
scar. Registration of the MRI derived scar maps and electroanatomical voltage maps was 
performed using the LM as landmark and the CARTO surface registration algorithm.
Results: The average number of LV EAM points was 235±56. Merging of MRI derived scar 
data with voltage maps was successful in all patients with an average registration error of 
4.02±0.78mm. There was a good agreement between regions of transmural scar deﬁned by 
MRI and low voltage areas. In 4 (33%) patients after myocardial infarction the subendocardial 
scar area deﬁned by CE-MRI was larger than the scar area deﬁned by EAM.
Conclusions: Integration of MRI derived scar maps with EAM during VT ablation is 
feasible and accurate. CE-MRI derived scar maps identify intramural scar undetected by 
EAM and may provide important supplementary substrate information.
9:30 a.m.
1029-37 Alterations in KCNQ1 Tau Activation Time Is Associated 
With Risk of Cardiac Events in LQT1 Patients
Christian Jons, Coeli M. Lopes, Arthur J. Moss, Arthur A M Wilde, Wataru Shimizu, Ilan 
Goldenberg, Wojciech Zareba, Judy Liu, Scott McNitt, Jennifer L. Robinson, University 
of Rochester Medical Center, Rochester, NY
Background: Risk differs signiﬁcantly among LQT1 patients with different missense 
mutations in the KCNQ1 gene. No correlation has been established to date between 
basic channel function and clinical phenotype. The purpose of this study was to determine 
whether changes from wild type in current ($I) and activation time ($Tact) caused by 
KCNQ1 mutations correlate with QTc and risk of cardiac events in LQT1 patients.
Methods: 381 genotyped LQT1 patients with 17 different mutations in the KCNQ1 gene 
were drawn from 4 LQTS registries. All mutations were present in at least 10 patients 
to allow for estimation of the risk of cardiac events. Conventional methods were used 
to express and measure current and activation time for all mutant channels. Linear 
regression and Cox proportional hazards were used to measure correlation between 
QTc, $I and $Tact and the risk of cardiac events.
Results: QTc interval varied considerably within patients carrying the same mutation. In 
a multivariate regression model with QTc as the response variable, both $Tact and $IKs
were signiﬁcantly predictive. $Tact was predictive of time to 1st cardiac event (HR=4.50 
per unit change in $Tact, p<0.001) while IKs was not (HR=0.95, p=0.899), after adjusting 
for QTc, gender and beta blocker therapy.
Conclusions: KCNQ1 channel $Tact is highly predictive of risk of cardiac events in LQT1 
patients, whereas channel $I is not. Measuring $Tact should help predict risk of cardiac 
events in newly detected KCNQ1 mutations. 
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data on SCD risk prediction for either marker in a general population of women.
Methods: We conducted a prospective, nested case-control analysis within the 121,700 
participant Nurses’ Health Study. We identiﬁed 99 cases of deﬁnite or probable SCD and 
matched to 294 controls. Baseline plasma biomarker levels were measured.
Results: Plasma NT-proBNP levels, but not hsCRP or lipid levels, were signiﬁcantly 
associated with SCD across quartiles after adjustment for CHD risk factors and other 
biomarkers (RR 2.45 for comparison of the highest versus lowest quartile; P for trend 
0.04). When examined continuously, NT-proBNP and hsCRP were signiﬁcantly associated 
with SCD (P for linear trend 0.04 and 0.03). Adjustment for CHD risk factors and other 
biomarkers strengthened the relationship with NT-proBNP and SCD (RR for 1 SD increment 
1.50; 95% CI, 1.11-2.18; P =0.01), but eliminated the relationship with hsCRP (P =0.34). 
Women with NT-proBNP levels above the prespeciﬁed cut-point of 389 pg/mL were at a 
markedly increased risk of SCD in both models (RR 5.32; 95% CI, 1.70-16.7; P =0.004).
Conclusions: In this study of apparently-well women, baseline levels of NT-proBNP but 
not hsCRP were independently associated with the subsequent development of SCD.
Relative Risks of Sudden Death According to Quartile of Baseline 
Plasma Biomarker Levels
Quartile 1 Quartile 2 Quartile 3 Quartile 4 P for trend
NT-proBNP
Median (pg/mL) 32.5 61 102.5 235
NT-proBNP
Quartile Range (pg/mL) 6-44 45-78 79-146 148-3126
Relative Risk of SCD
Adjusted for age, fasting 1.0
1.08 (0.53 
-2.19)
1.33 (0.65 
-2.74)
1.66 (0.79 
-3.47) 0.15
Relative Risk of SCD
Multivariate Model (cardiac risk 
factors, biomarkers)
1.0 1.34 (0.59 - 3.04)
1.33 (0.57 - 
3.09)
2.45 (1.00 - 
6.00) 0.04
hsCRP
Median (mg/L) 0.68 1.99 4.61 9.34
hsCRP
Quartile Range (mg/L)
0.27 - 
1.21 1.22 - 3.06 3.08 - 6.45 6.59 - 143
Relative Risk of SCD
Adjusted for age, fasting 1.0
1.31 (0.65 
-2.61)
1.43 (0.72 
-2.86)
1.91 (0.97-
3.77) 0.07
Relative Risk of SCD
Multivariate Model (cardiac risk 
factors, biomarkers)
1.0 1.16 (0.50 - 2.69)
1.09 (0.45 - 
2.63)
1.29 (0.54 - 
3.11) 0.61
9:30 a.m.
1029-43 Delayed-Enhanced Magnetic Resonance Imaging in 
Non-Ischemic Cardiomyopathy: Utility for Identifying 
the Ventricular Arrhythmia Substrate
Sanjaya K. Gupta, Benoit Desjardins, Eric Good, Thomas Crawford, Hakan Oral, 
Matthew Ebinger, Frank Pelosi, Aman Chugh, Krit Jongnarangsin, Fred Morady, Frank 
Bogun, University of Michigan, Ann Arbor, MI
Background: In patients with non-ischemic cardiomyopathy, ventricular arrhythmias often 
are associated with scar tissue. Delayed-enhanced magnetic resonance imaging (DE-
MRI) can be used to precisely deﬁne scar tissue and therefore may be a useful guide to 
mapping and ablation of ventricular arrhythmias in non-ischemic cardiomyopathy.
Methods: DE-MRI was performed in 28 consecutive patients (mean age 50±15 years) 
with non-ischemic cardiomyopathy (mean ejection fraction 38±9%) referred for catheter 
ablation of ventricular tachycardia (VT) or premature ventricular complexes (PVCs). Scar 
tissue was extracted from DE-MRIs and displayed in a 3 dimensional manner. It was then 
integrated into the electroanatomic map using the CARTO Merge function. Mapping data 
were correlated with respect to the localization of scar tissue (right ventricular vs left 
ventricular and endocardial vs epicardial vs intramural).
Results: Scar tissue was identiﬁed by DE-MRI in 13/28 patients. Nine of these patients 
had VT and four had PVCs. Areas of DE identiﬁed critical sites in all patients in whom 
the ablation could be carried out successfully. In ﬁve of the patients the scar was either 
endocarial or transmural and mapping and ablation of arrhythmias was effectively 
performed from the endocardium in all 5 patients. In 2 patients scar was either intramural 
or epicardial with extension to the endocardium. In both patients with partial endocardial 
scar extension, the ablation was effective in eliminating some but not all arrhythmias. In 
2 patients most of the scar tissue was conﬁned to the epicardium; mapping identiﬁed 
and eliminated an epicardial origin in both patients. No effect on arrhythmias could be 
achieved in the other 4 patients with predominantly intramural scar.
Conclusions: DE-MRI in patients without prior infarctions can help to identify the 
arrhythmogenic substrate; furthermore it helps to plan an appropriate mapping and 
ablation strategy.
9:30 a.m.
1029-44 J Point ST Elevation Does Not Predict Arrhythmic 
Events in Dilated Cardiomyopathy
Kishan Parikh, Eugene Greenstein, Jason Ng, Haris Subacius, Alan Kadish, 
Northwestern University Feinberg School of Medicine, Chicago, IL
Background: Recent studies have suggested that J point ST elevation or notching is 
associated with idiopathic VF in patients without structural heart disease. We hypothesized 
that patients with this ECG ﬁnding who had dilated cardiomyopathy would also be at risk 
9:30 a.m.
1029-40 Mapping and Ablation of Ventricular Arrhythmia With 
Magnetic Navigation: Comparison Between 4mm and 8 
mm Catheter Tip
Luigi Di Biase, J. David Burkhardt, Dhanunjaya Lakkireddy, Esam Baryun, Jayasree 
Pillarisetti, Mazda Biria, Dimpi Patel, Rodney Horton, Javier Sanchez, Joseph G. 
Gallinghouse, Shane Bailey, Salwa Beheiry, Steven Hao, Richard Hongo, Gery 
Tomassoni, Andrea Natale, Texas Cardiac Arrhythmia Institute, Austin, TX
Introduction: Remote magnetic navigation (RMT) has been reported as an effective and 
safe tool to overcome to need for advanced operator skill in the treatment of complex 
arrhythmias.
Pts undergoing RF catheter ablation of ventricular arrhythmias (VA) using the RMT with 
either a 4 mm catheter tip or a 8 mm catheter tip were enrolled
Methods: 63 pts with clinical and symptomatic history of VA were included.
When required epicardial access was obtained. The magnetic catheter was used to 
deliver radiofrequency (RF) applications remotely along the endocardial and/or epicardial 
surfaces. Ablations were delivered either with a 4 mm or an 8 mm tip magnetic catheter.
When ablation with the RMT catheter failed, a manual irrigated catheter was used to 
eliminate the VT.
Results: 28 patients (45%) had ischemic cardiomyopathy (CAD), 14 patients (22%) non
ischemic cardiomyopathy, (IDC) and 21 pts (33%) had normal structural heart (NSH).
Of the latter group 19 patients had right ventricle outﬂow tract tachycardia (RVOT). 
Epicardial instrumentation was obtained in 18 pts (28%).
Results sorted by cardiopathy and cather tip are summarized in the table.
In 28 cases (44%), the magnetic catheter failed to eliminate VA and ablation was 
completed manually with an open irrigated catheter.
Conclusions: Using RMT there is an increased success related to the catheter tip 
utilized. However, in patients with right ventricular outﬂow origin, the standard 4 mm tip 
provided adequate lesion for successful ablation in most patients 
Cardiopathy 4 mm catheter tip 8 mm catheter tip
CAD Success 31% (5/16) Success 58% (7/12)
IDC Success 27% (3/11) Success 100% (3/3)
Normal structural heart/RVOT Success 85% (11/13) Success 87% (7 /8)
9:30 a.m.
1029-41 Change of Left Ventricular Function After Ablation of 
Chronic Frequent Premature Ventricular Beats
Yong H. Kim, Soon-Joon Hong, Sung-Mi Park, Do-Sun Lim, Hui-Nam Park, Young-
Hoon Kim, Wan-Joo Shim, Hong-Euy Lim, Cardiovascular Division, Korea Univ Medical 
Center, Seoul, South Korea
Background:Chronic ventricular tachycardia is well-known as a cause of cardiomyopathy. 
Recently, it has been reported that the pathologic remodeling and systolic dysfunction 
caused by frequent premature ventricular complexes (PVC) can be reversed by eliminating 
PVCs. This study was undertaken to investigate the impact of radiofrequency catheter 
ablation(RFCA) of PVCs on cardiac function in the patients with chronic frequent PVCs .
Methods:Thirty two patients who had received RFCA for chronic frequent PVCs were 
studied. (Mean age; 44.2±15.1 yrs, M:F=16:16). Before and more than 3 months after 
RFCA (Mean follow-up duration; 391±235days), cardiac function was evaluated with 
echocardiography. LV(left ventricle) dimension and volume, LV ejection fraction(EF), and 
other conventional variables were measured.
Results:The averaged burden of PVCs was 22.8±12.3% from the 24-hour Holter 
monitoring. Baseline left ventricular end-diastolic and end-systolic dimension (LVEDD, 
LVESD) and LV ejection fraction(LVEF) was 51±5.5mm, 35±5.9mm and 50.9±6.7% 
respectively. Before RFCA, Patients with LBBB-shape PVCs had lower ejection fraction 
than with RBBB-shape PVCs (n=22:10, 49.2±6.3 vs 54.6±6.3, p=0.037). After ablation, 
LVEDD and LVESD decreased and LVEF improved signiﬁcantly (49.3±4.7mm, p<0.01, 
31.3±4.6mm, p<0.01, 50.4±6.8%, p<0.01, respectively). Structural and functional 
improvements were observed in both groups with RBBB or LBBB-shape PVCs. Reverse 
remodeling of LV and improved LVEF were also observed in the patients with preserved 
EF more than 50%. (n=16, from 57.4±4.2 to 63.5±6.6%, p<0.01).
Conclusions:The severity of LV functional deterioration was worse in patients with 
LBBB-shape PVCs. However, the beneﬁcial effects on reverse remodeling and cardiac 
function by RFCA were observed in both groups with RBBB and LBBB-shape PVCs. The 
improved function and reverse remodeling of LV by the elimination of PVCs suggests 
that chronic repetitive PVCs can initiate pathologic process of myocardium. More active 
therapeutic approach should be considered in this subset of patients
9:30 a.m.
1029-42 Amino-Terminal Pro-B Type Natriuretic Peptide and 
hsCRP as Predictors of Sudden Cardiac Death Among 
Women
Ethan C. Korngold, James L. Januzzi, Jr., Mary Lou Gantzer, MV Moorthy, Nancy R. 
Cook, Christine M. Albert, Massachusetts General Hospital, Boston, MA, Brigham and 
Women’s Hospital, Boston, MA
Background: Plasma levels of N-terminal pro-B type natriuretic peptide (NT-proBNP) 
independently predict risk of sudden cardiac death (SCD) in patients with cardiac disease; 
C-Reactive Protein (hsCRP) levels predict risk among healthy men. Currently there are no 
JACC March 10, 2009 ABSTRACTS - Cardiac Arrhythmias  A121
C
ardiac A
rrhythm
ias
subendocardial scar size as assessed by DE-MRI correlated well with the area of low 
voltage (39±26 vs 33±25 cm2; R=0.79, p<0.001). Sites critical to ventricular arrhythmias 
were conﬁned to low voltage areas that projected on the registered scar. 
Conclusion: Selective identiﬁcation and extraction of scar, followed by registration with a 
real-time mapping system is feasible and helps to identify and display the arrhythmogenic 
substrate in post-infarction patients with ventricular arrhythmias. Scar registration 
helps to streamline and facilitate the mapping and ablation procedure of post-infarction 
arrhythmias.
9:30 a.m.
1029-47 Myocardial Infarct and Peri-Infarct Zone Volumes 
Determined by Magnetic Resonance Imaging Do Not 
Predict Inducible Ventricular Tachycardia
Brad J. Mikaelian, Erich L. Kiehl, Michael K. Atalay, Kristin E. Ellison, Peem Lorvidhaya, 
Malcolm M. Kirk, Jason T. Machan, Alfred E. Buxton, The Warren Alpert Medical School 
of Brown University, Providence, RI, Rhode Island Hospital, Providence, RI
Background: Magnetic resonance imaging (MRI) provides high-resolution anatomic 
delineation of myocardial infarction (MI). We tested the hypothesis that integration of 
structural analysis of MI by MRI with functional information from electrophysiologic testing 
(EP) would improve understanding of mechanisms of ventricular tachycardia (VT) after 
MI.
Methods: Patients with prior MI referred for EP underwent cine and gadolinium-enhanced 
MRI on a 1.5-T Siemens scanner. Infarct was delineated semi-automatically by a reviewer 
blinded to EP results using Siemens software and deﬁned on short axis images as 
signal intensity q2 standard deviations (SD) above normal myocardium. Core scar was 
deﬁned as either >3 SD or >5 SD and the peri-infarct as all scar between 2-3 or 2-5 SD, 
respectively. EP (2 right ventricular sites, 2 cycle lengths, 1-3 extrastimuli) was positive 
(EP+) if sustained monomorphic VT was induced and otherwise negative (EP-).
Results: We studied 33 patients (primary prevention: 18; spontaneous sustained VT: 10; 
cardiac arrest/syncope: 5), and 14 were EP+. EP+ did not correlate with infarct volume 
(absolute or normalized to heart size) determined by 2 SD, 3 SD, or 5 SD cutoffs. EP+ 
was not predicted by peri-infarct zone at either the 2-3 SD or 2-5 SD levels. EP+ was not 
predicted by number of discrete scars or scar location. Cycle length of induced MMVT did 
not correlate with scar volume. Sustained polymorphic VT and ventricular ﬁbrillation also 
did not correlate with infarct volume measures.
Conclusions: Multiple metrics of scar morphology deﬁned by MRI, including infarct and 
peri-infarct zone size, do not correlate with EP ﬁndings. It is possible that other features 
of scar morphology may be more predictive of EP ﬁndings. Because most monomorphic 
VT after MI likely arises from small areas of myocardium, MI size on MRI may not predict 
risk for VT.
9:30 a.m.
1029-48 Ventricular Arrhythmias Following Non-ST Segment 
Elevation ACS and the Relationship With Sudden 
Cardiac Death in the MERLIN-TIMI 36 Trial
Benjamin M. Scirica, David A. Morrow, Ewa Karwatowska-Prokopczuk, Chester M. 
Hedgepeth, III, Whedy Wang, Jie Qin, Luiz Belardinelli, Eugene Braunwald, TIMI Study 
Group, Brigham and Women’s Hospital, Boston, MA
Background: The association between ventricular tachycarida (VT) and sudden cardiad 
death (SCD) following NSTE ACS has not been well described because most studies 
were performed in STEMI and before the widespread use of revascularization and optimal 
medical therapy. Ranolazine is an anti-anginal agent with anti-arrhythmic properties.
Methods: The MERLIN-TIMI 36 trial randomized 6560 pts with NSTEACS to ranolazine 
or placebo. Seven-day Holter recordings were initiated at randomization. SCD (n=121) 
was assessed at 1yr.
Results: 6355 pts (97%) had recordings for analysis with 1603 pts (25.3%) having VT>= 
4bts, 431 (6.8%) with VT>= 8bts, and 123 (1.9%) with VT>=15bts. SCD occurred more 
frequently in patients with VT >=4 bts (3.3 v 1.3%, p<0.001), VT>=8bts (4.3 v 1.6%, 
p=0.003), and VT>=15bts (9.5 vs. 1.6%, p<0.001). In multivariable analysis high TIMI risk 
score, history of heart failure, EF<40%, CrCl, BNP >80 pg/ml and VT>=8bts (HR
adj 2.2, 
p=0.05) were independently associated with SCD The relationship between VT and SCD 
remained consistent after excluding pts who died within 24 hrs of VT (VT>=4 bts [3.1 v 
1.3%, p<0.001), VT>=8 bts (3.4 v 1.6%, p=0.097), and VT>= 15 bts (6.3 vs. 1.6%, p=0.027). 
VT>=8 bts was associated with SCD (7.1 v. 1.8%, HR 3.0, p<0.001) in patients treated with 
placebo but not in those treated with ranolazine (2.5 v. 3.3, HR 1.3, p=0.68). (Figure)
Conclusion: VT in the days following NSTEACS was associated with SCD over the 
subsequent year. Ranolazine may reduce the risk of SCD associated with VT. 
for arrhythmic events (double hit phenomenom).
Methods: We analyzed baseline ECG characteristics in all 458 patients enrolled in the 
The Deﬁbrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation - DEFINITE trial 
(NIDCM, ejection fraction < 36%, PVCs/NSVT) using MATLAB software (Mathworks™). 
ECGs showing atrial ﬁbrillation or QRS duration >120ms were excluded, and then only 
QRS <100 for a subgroup analysis. Outcomes were deﬁned as an appropriate shock or 
sudden cardiac death in the ICD cohort and sudden death in the control cohort. ST height 
was digitally measured using computer scanned magniﬁed ECGs with methodology 
previously shown to have excellent reproducibility. Arrhythmic events were deﬁned as 
sudden cardiac death that appeared to be arrhythmic or appropriate ICD shocks for VT/
VF. Evaluations were performed by an independent events committee. Since gender 
can affect ST height, we also examined gender differences in ST height and interaction 
between gender and ECG prediction of arrhythmic events.
Results: 198 patients(132 M) were included in the study, and 26 had arrhythmic events 
(19 M). In the QRS<100ms subgroup, 11(8 M) of 110 patients (64 M) had arrhythmic 
events. There was no difference in ST height (J point) between patients with and without 
arrhythmic events (I: -0.21±0.15mm vs. -0.33±0.50, p<0.1; II: -0.34±0.29 vs. -0.39±.39, 
p<0.7; v1: 0.32±0.32 vs. 0.37±0.38, p<0.07; v2: 0.04±0.38 vs. 0.22±0.47, p<0.2; v3: 
-0.33±0.74 vs. -0.04±0.49, p<0.3; v4: -0.35±0.57 vs. -0.24±0.46, p<0.6), as well as in 
QRS<120ms. ST heights were higher in men in the QRS<100ms group in V1 (0.05±0.03 
vs. 0.04±0.03, p<0.05) and V2 (0.06±0.05 vs. 0.03±0.04, p<0.01).
Conclusions: As in healthy patients, ST height is higher in male NIDCM patients. 
Although recent reports have suggested that ST height at J point is associated with 
idiopathic ventricular ﬁbrillation, this ECG ﬁnding was not predictive of arrhythmic events 
in NIDCM patients.
9:30 a.m.
1029-45 Early Repolarization Associated With Idiopathic 
Ventricular Tachycardia/Ventricular Fibrillation
Faisal M. Merchant, Peter Noseworthy, Rory Weiner, Sheldon Singh, Jeremy N. Ruskin, 
Vivek Y. Reddy, Massachusetts General Hospital, Boston, MA, University of Miami, 
Miami, FL
Background: Although early repolarization (ER) has traditionally been considered a 
benign electrocardiographic (ECG) entity, a recent multi-center series suggested that 
over 30% of idiopathic ventricular tachycardia/ventricular ﬁbrillation (VT/VF) cases may 
be associated with ER. However, the signiﬁcance of these ﬁndings among all patients 
presenting with idiopathic VT/VF is unknown. We sought to deﬁne the prevalence of ER 
associated with idiopathic VT/VF in a large, single-center experience.
Methods: We reviewed medical records for implantable-cardioverter deﬁbrillators (ICDs) 
implanted at a single institution (1988-2008) to identify cases of resuscitated idiopathic 
VT/VF. Three blinded reviewers scored twelve-lead ECGs for the presence of ER in either 
the inferior (II, III, aVF) or left precordial (V4-V6) leads. ER was deﬁned as at least 0.1mV 
elevation of the QRS-ST junction manifest as either J-point slurring or terminal QRS 
notching in 2 contiguous leads. ER was considered present only if identiﬁed independently 
by all 3 reviewers. The free-marginal kappa statistic was used to deﬁne inter-observer 
variability. Follow-up was ascertained by medical records review.
Results: Out of 1224 consecutive ICD implants, we identiﬁed 39 cases of idiopathic VT/
VF. Nine out of these 39 cases (23%) demonstrated ER. There was substantial inter-
observer agreement in identifying ER (kappa 0.79). Cases of idiopathic VT/VF associated 
with ER were younger (mean [+/- SD] years, 33.1 +/- 11.1 vs. 44.0 +/ -15.1, p=0.05) and 
tended to be more frequently male (78% vs. 50%, p=0.25). There were no signiﬁcant 
differences in other clinical parameters. Follow-up was available for 32 out of 39 patients. 
During a mean follow-up of 7.2 +/- 4.6 years, there was no signiﬁcant difference in the 
frequency of the combined endpoint of appropriate ICD shocks or all-cause mortality in 
cases with ER compared to those without (11% vs. 30%, p=0.40).
Conclusions: Our ﬁndings conﬁrm the presence of ER in a signiﬁcant percentage of 
consecutive patients presenting with idiopathic VT/VF. The impact of this ECG ﬁnding on 
prognosis and its relevance for clinical management requires further investigation.
9:30 a.m.
1029-46 Use of Scar Detected by Delayed Enhanced Magnetic 
Resonance Imaging to Guide Mapping and Ablation of 
Ventricular Arrhythmias in Post-infarction Patients
Sanjaya K. Gupta, Timir Baman, Karl Ilg, Eric Good, Thomas Crawford, Hakan Oral, 
Matthew Ebinger, Frank Pelosi, Aman Chugh, Krit Jongnarangsin, Fred Morady, Frank 
Bogun, University of Michigan, Ann Arbor, MI
Background: Post-infarction arrhythmias are most often conﬁned to scar tissue. Scar can 
be detected by delayed enhanced magnetic resonance imaging (DE-MRI).The purpose 
of this study was to assess the feasibility of pre-procedural scar identiﬁcation, extraction 
and intra-procedural image registration using the CARTO Merge software in an attempt 
to target the extracted scar during an ablation procedure.
Methods: In a consecutive series of 14 patients (11 men, age: 64±9 years, ejection fraction 
32±13) with prior infarct and ventricular arrhythmias, DE-MRIs were performed prior to 
the ablation procedure. Scar tissue was identiﬁed and registered with the electroanatomic 
map (EAM). Using landmark, surface registration as well as visual alignment, the MRI 
shell with the labeled scar was registered with the EAM that was constructed in real 
time. The mapping procedure focused on the location of the DE-MRI scar. Registration 
accuracy data, scar/low bipolar voltage (<1.0mV) correlations (size and location) were 
assessed. Furthermore critical areas for ventricular arrhythmias were correlated with the 
presence or absence of scar based on the extracted scar.
Results: Surface registration / visual alignment statistics showed a positional error of 
5±4 mm of the EAM with the registered MRI shell. Seventy-eight percent of regional 
low voltage points obtained during the EAM projected onto the registered scar. The 
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1029-51 Strategies to Prevent Phrenic Nerve Injury During 
Epicardial Ablation
Luigi Di Biase, Gemma Pelargonio, Antonio Dello Russo, David J. Burkhardt, Rodney 
Horton, Javier Sanchez, Joseph G. Gallinghouse, Shane Bailey, Amin Al-Ahmad, Paul 
Wang, Steven Hao, Salwa Beheiry, Gery Tomassoni, Robert A. Schweikert, Andrea 
Natale, , Texas Cardiac Arrhythmia Institute, Austin, TX
Introduction: The vicinity of the phrenic nerve (PN) to the cardiac tissue relevant to 
arrhythmias may prevent successful ablation.Strategies to avoid PN injury (PNI) in the 
pericardial space is limited to shielding with a balloon which requires additional access 
and could be difﬁcult to place.
Methods: 7 consecutive pts referred for epicardial ablation were enrolled. Endocardial 
and epicardial access were obtained in all pts.
A 3-D mapping system was used to guide mapping and ablation. All pts underwent 
epicardial catheter ablation. Pacing via the ablation catheher identiﬁed the left phrenic 
nerve. In order to prevent PNI, 4 new strategies were tested in each pts.
We sought to increase the distance between the epicardium and the phrenic nerve 
introducing 1) ﬂuid in steps of 60 ml, till the blood pressure drop below 70 mmHg; 2) Air 
injection; 3) ﬂuids infusion followed by air injection, respectively, to achieve a “controlled” 
progressive hydropneumopericardium; 4) Placement of a peripheral balloon between the 
nerve and the myocardium.
Results:.At each step, epicardial pacing was performed to assess phrenic nerve 
stimulation.
Differences with each strategy are in the table. The balloon could not be positioned in 3 
out of the 5 cases.
Conclusion: Controlled and progressive inﬂation of air and ﬂuids together with a careful 
monitoring of the haemodynamic parameters seems to be the best strategy to prevent PNI 
during epicardial ablation. Placement of a balloon appeared difﬁcult in most patients.
Patients Arrhythmias Strategy to prevent PNI
1 VT normal heart Fluid only Air only Air + Fluid Balloon
1 VT normal heart F F S NA
2 VT normal heart F F S F
3 VT normal heart F F S NA
4 VT normal heart F S S F
5 Inappropriate Sinus Tachycardia F F F S
6 Ischemic Cardiomyopathy VT F S S S
7 Dilated Cardiomyopathy VT F S S F
F= failure to prevent phrenic nerve capture
S= success to prevent phrenic nerve capture
NA= not attempted
9:30 a.m.
1029-52 Signiﬁcance of QRS Prolongation During Diagnostic 
Ajmaline Test in Patients With Suspected Brugada 
Syndrome
Velislav N. Batchvarov, Malini Govindan, A John Camm, Elijah R. Behr, St. George’s 
University of London, London, United Kingdom
Background: The HRS/EHRA consensus document on Brugada syndrome recommend 
the i.v. administration of a Na-channel blocker to be stopped when the QRS prolongs to 
130% or more of baseline, presumably because of increased arrhythmic risk. This risk, as 
well as the potential loss of diagnostic information due to early termination of the test in 
case of QRS prolongation have not been investigated.
Methods: We retrospectively analysed a database of digital 12-lead ECGs collected 
during diagnostic ajmaline test in 148 patients (92 men, age 36±15 years). The PR, QRS 
and QTc (Fridericia formula) intervals were measured in 3 ECGs at baseline and 2 ECGs 
during each minute from the 1st to 7th, then the 10th and 15th after initiation of ajmaline 
administration.
Results: The average QRS prolongation was 36±16% (range 9-88%) and was not 
signiﬁcantly different between positive (n=30) and negative (n=118) tests. The QRS 
prolonged to 130% or more during 16 (55%) positive and 71 (61%) negative tests (p=0.50), 
with no clinical side effects. There were no signiﬁcant differences in the incidence of all 
classes of ventricular arrhythmias between patients with and without QRS prolongation of 
130% or more. In 40% of the positive tests QRS prolongation of 130% occurred earlier by 
more than 1 minute than diagnostic Brugada ECG changes.
Conclusions: QRS prolongation to 130% or more of baseline occurs in more than half of 
all positive and negative tests, and does not appear to carry additional risk of ventricular 
arrhythmias. In 40% of all positive tests such QRS prolongation occurs before the onset of 
diagnostic Brugada ECG changes. Early termination of the test due to QRS prolongation 
may result in a false negative outcome and loss of diagnostic information.
9:30 a.m.
1029-49 Risk of Death After First Syncope in the Long QT 
Syndrome
Christian Jons, Arhur J. Moss, Judy Liu, Wojciech Zareba, Ilan Goldenberg, Scott 
McNitt, Jennifer L. Robinson, the International LQTS Registry Investigators, University of 
Rochester Medical Center, Rochester, NY
Background: Syncope is highly predictive of future aborted cardiac arrest (ACA) or death 
(SCD) in the Long QT Syndrome. However, risk stratiﬁcation within this high-risk group of 
LQTS patients experiencing syncope has not been investigated.
Methods: 1527 LQTS patients presenting with syncope as ﬁrst symptom were drawn 
from the International LQTS registry. Cox proportional hazards regression was used to 
identify risk factors for ACA/SCD, and Cox model estimated survivorship functions were 
used to construct survival graphs showing absolute risk for each group of patients with 
included covariates.
Results: The absolute rate and relative risk of ACA/SCD for patients with and without 
the included covariates are shown in the ﬁgure. The absolute rate of ACA/SCD for LQTS 
patients experiencing only one syncope off beta-blockers is about 6+2% in 10 years 
[light gray]. Experiencing two or more syncopes doubles the risk (RR=2.10, p<0.001), 
and experiencing a syncope while on beta blocker therapy increases the risk three-fold 
(RR=3.08, p<0.001) [15+5% events in 10 yrs, medium gray]. Repeated syncope on beta 
blockers increase the risk of ACA/SCD further (RR=4.24, p<0.001) [25+10% events in 10 
yrs, dark gray]. A QTc over 500 ms (RR=1.76, p<0.001) and female gender (RR=1.99, 
p<0.001) almost doubles risk in each of the risk groups.
Conclusions: Risk differs considerably among LQTS patients with a previous syncope, 
and the absolute rate of ACA/SCD can be estimated from clinical parameters and 
response to treatment. 
9:30 a.m.
1029-50 New Insights Into Effects of Verapamil on Reentrant 
Circuits During Ventricular Fibrillation in In Vivo Pigs
Qi Jin, Jack M. Rogers, Derek J. Dosdall, Raymond E. Ideker, Jian Huang, University 
of Alabama at Birmingham, Birmingham, AL, Shanghai Rui Jin Hospital, Shanghai, 
People’s Republic of China
Background: The mechanism by which verapamil reduces reentry is still not clear.
Methods: Six open-chest pigs received intravenous verapamil (0.136 mg/kg). Two 20-s 
episodes of VF were induced before and another 2 20-s episodes of VF were induced 
after verapamil injection. Recordings from a 21x24 unipolar electrode plaque (2 mm 
spacing) sutured to the lateral posterior LV epicardium were analyzed for each episode to 
calculate reentry incidence, the mean wavefront propagation speed, reentry core area and 
perimeter, the mean time required for wavefronts to circle the core. The mean wavelength 
was approximated by the product of the mean propagation speed of the wavefronts and 
activation interval. The activation intervals during VF were used to estimate the ventricular 
effective refractory period (VERP).
Results: Verapamil signiﬁcantly increased the conduction velocity by 11% and activation 
rate by 12% but did not signiﬁcantly change the core area, core perimeter or wavelength. 
After verapamil, the mean time for wavefront propagation around the core decreased 
(18%), much more than reduction in refractoriness (12%, p<0.05) (table).
Conclusions: Verapamil signiﬁcantly decreased the incidence of reentry during VF 
by accelerating the propagation speed in the reentrant pathway. When the reentrant 
wavefront propagated back to the original excited site, the tissue there might still be in its 
refractory period, causing termination of the circuit.
Baseline Verapamil %Change P value
Conduction velocity (mm/ms) 0.44±0.09 0.49±0.09 11% up <0.01
Reentry incidence (%) 3.3±2.1 1.0±0.9 70% down <0.01
Reentrant core area (mm2) 83±49 77±50 7% down NS
Reentrant core perimeter (mm) 47±15 43±17 9% down NS
Wavelength (mm) 45±14 46±17 2% up NS
Estimated VERP (ms) 104±11 93±16 12% down 0.01
Propagating time (ms) 107±14 88±13 18% down <0.01
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1029-55 Role of Magnetic Resonance Imaging in Assessing 
Reversibility of Cardiomyopathy After the Ablation 
of Frequent Premature Ventricular Complexes in the 
Absence of Prior Myocardial Infarction
Sreedhar Billakanty, Wai S. Wong, Srikar Veerareddy, Daniel Buerkel, Sanders Chae, 
Christopher Ellis, Chin P. Chan, Johan Aasbo, Satchana Pumprueg, Thomas Crawford, 
Eric Good, Matthew Ebinger, Frank Pelosi, Aman Chugh, Krit Jongnarangsin, Hakan 
Oral, Fred Morady, Frank Bogun, University of Michigan, Ann Arbor, MI
Background: Frequent premature ventricular complexes (PVCs) in the absence of 
prior myocardial infarction can cause cardiomyopathy. Effective radiofrequency 
ablation often results in reversal of this type of cardiomyopathy. Not all patients, 
however, have normalization of left ventricular ejection fraction (LVEF) after the 
ablation. We assessed whether a pre-ablation cardiac magnetic resonance imaging 
with delayed enhancement (DE-MRI) can predict who will beneﬁt from an ablation 
procedure. Scar burden was classiﬁed as focal versus signiﬁcant (>5% of left 
ventricular volume).
Methods: A cardiac DE-MRI was performed in 29 consecutive patients with non-
ischemic cardiomyopathy (15 women; age: 51±14 years; LVEF: 35±9%) and frequent 
PVCs. Echocardiography and 24 hour Holter monitoring were performed prior 
to and 3 to 6 months after the ablation. An effective ablation was deﬁned as a 
reduction of q80% of the pre-ablation PVC burden. 
Results:The ablation was effective in 22 patients (76%). This resulted in a reduction of the 
PVC burden from 29±18% to 1.9±3% (p<0.001). The LVEF improved and/or normalized 
in 15/22 patients (68%) from 34±14 to 56±7% (p<0.0001). The pre-procedural DE-MRI 
showed scar tissue in 8/29 (28%) patients (focal: 3, signiﬁcant: 5). During a follow-up of 
18±8 months, the presence of signiﬁcant scarring as deﬁned by DE-MRI was associated 
with failure to improve LVEF after ablation for frequent PVCs (p<0.01). Of the 5 patients 
(17%) with signiﬁcant scar, none had normalized LVEF post-ablation even though 4/5 
patients had effective ablation procedures.
Conclusions: The presence of signiﬁcant scar tissue on DE-MRI in patients with non-
ischemic cardiomyopathy is associated with failure to improve LVEF even after effective 
ablation of frequent PVCs. In the setting of cardiomyopathy associated with frequent 
PVCs, DE-MRI is helpful to assess whether a patient may beneﬁt from ablation of PVCs.
9:30 a.m.
1029-56 Chronic Myocardial Effects of Various Pacing Lead 
Sites on Left Ventricular Dynamics in the Young With 
Complete Congenital Heart Block: A Three-Dimensional 
Echocardiography Study
Mark V. Zilberman, Wei Du, Peter P. Karpawich, Children’s Hospital of Michigan, Detroit, 
MI, Wayne State University, Detroit, MI
Comparisons of results of chronic pacing from various lead sites on left ventricular (LV) 
size and function are very limited. As cardiac MRI is contraindicated in patients (pts) 
with pacemakers, 3-D echocardiography (3DE) becomes the best non-invasive method to 
assess these pts. We studied effects of chronic pacing from different sites on LV dynamics 
in young pts with congenital complete congenital heart block (CCB).
Methods: 23 asymptomatic pts with CCB chronically paced from either RV apex, RV 
mid-septum, RV epicardium, or LV epicardium were studied with ECG and 3DE (table). 
QRS axis and duration were measured. LV end-diastolic volumes (LV EDV) and volume 
changes throughout the cardiac cycle were recorded. 3DE LV ejection fraction (EF) and 
LV mechanical synchrony index (SI) were calculated. Statistics included analysis of 
variance and linear regression analyses. A p-value <0.05 was considered signiﬁcant.
Results: Of 23 patients, 21 had normal LVEDV, 20 had normal 3D-EF and 13 had normal 
DI. Depending on 4 pacing lead sites, groups differed in age, QRS axis and QRS duration 
but were similar in EDV (normalized to BSA), 3D-EF and SI. However, regression 
analysis demonstrated that as time from pacemaker implant increased, the EF 
decreased in all but the mid-septal group. The difference between the two slopes was 
statistically signiﬁcant (p=0.013).
Conclusion: Deterioration of paced LV dynamics is a chronic process in the young with 
CCB. Mid-septal RV pacing optimizes preservation of LV function long-term. 
RV apex RV septum LV epicardial RV epicardial P
Number of patients 5 9 4 5
Age (y) 23.01* 18.67* 8.82 10.07 0.002
Time from implant (y) 8.84 4.13 5.36 6.32 0.311
QRS axis -67* 75 35 -58* 0.012
QRS duration(msec) 152* 124 150* 140* 0.002
EDV/BSA 67.3 63.9 65.5 65.8 NS
EF (%) 54.94 50.25 54.78 55.22 NS
SI (%) 2.07 5.25 4.71 1.69 NS
* - statistically different from those without a symbol
9:30 a.m.
1029-53 Non-sustained Ventricular Tachycardia Is a Risk Factor 
for Development of Atrial Fibrillation: A CARISMA 
Substudy
Christian Jons, Uffe J. Gang, Rikke M. Jorgensen, Heikki Huikuri, Marc Messier, Poul 
Erik Bloch Thomsen, Gentofte University Hospital, Copenhagen, Denmark
Background: The purpose of the study was to test whether common arrhythmias such as 
non-sustained ventricular tachycardia (nsVT), bradycardia, advanced AV block and sinus 
arrest would predict development of atrial ﬁbrillation in patients with acute myocardial 
infarction (AMI) and left ventricular systolic dysfunction (LVSD) during a 2 year follow up 
using an implantable loop recorder (ILR).
Methods: The study included 271 patients from the CARISMA study without atrial 
ﬁbrillation at enrollment. All patients had AMI and an ejection fraction < 40 %. The ILR 
was implanted within 21 days after the MI. Patients were followed and the ILR interrogated 
every 3 months for 2 years.
Results: 95 patients (35.1%) developed AF events recorded by the ILR during the 
study. 36 patients developed nsVT, 29 developed AV block, 20 sinus bradycardia and 
16 developed sinus arrest. Patients with nsVT recorded by the ILR had an increased 
risk of atrial ﬁbrillation (HR=2.65 [1.62-4.34], p=0.001) after adjustment for age > 70 yrs 
(HR=1.62 [1.07-2.45], p=0.023). None of the other arrhythmias signiﬁcantly predicted 
development of AF.
Conclusions: In patients with recent MI and moderate to severe LVSD, patients 
with episodes of non-sustained VT is at high risk of development of AF. Episodes of 
bradycardia, sinusarrest or AV-block, were not associated with future development of AF. 
9:30 a.m.
1029-54 New-Onset Atrial Fibrillation as the First Clinical 
Manifestation of Latent Brugada Syndrome: Incidence 
and Clinical Signiﬁcance
Vincenzo Santinelli, Andrea Radinovic, Gabriele Vicedomini, Giuseppe Ciconte, 
Francesco Maria Sacco, Simone Sala, Stefania Sacchi, Massimo Saviano, Gabriele 
Paglino, Simone Gulletta, Pasquale Vergara, Cristiano Ciaccio, Marta Casamassima, 
Carlo Pappone, San Raffaele University Hospital, Milan, Italy
Background: There are no data on latent BrS incidence and signiﬁcance in patients with 
new-onset AF.
Methods: Between January 2000 and June 2008, all consecutive patients with new-
onset AF who after ﬂecainide exhibited typical Brugada ECG patterns underwent EPT, 
pharmacologic and genetic testing.
Results: Among 346 patients (mean age, 53.2±12 years), 7 (2%) showed atypical 
Brugada ECG and 11 (3.2%; mean age, 50.4±12.9, 9 males), diagnosed as lone AF, 
exhibited typical ECG pattern. SCN5A testing was negative. VT/VF was induced by 
EPT (5 patients) or during ﬂecainide infusion (1 patient). Patients with type 1 pattern 
and inducible VT/VF underwent ICD implantation. During a median follow-up of 31.5 
months (10-85) after ICD implantation, 5 patients had AF recurrences and 3 of them 
experienced life-threatening VT/VF. Patients without ICD remained asymptomatic during 
a median follow-up of 74 months. Persistent type 1 pattern occurred only in ICD patients 
with spontaneous VT/VF while patients without ICD showed transient ﬂuctuations as 
documented in 26/130 available ECGs (20%).
Conclusions: This study for the ﬁrst time demonstrates that new-onset AF can be the 
ﬁrst clinical manifestation of a latent BrS. Persistence of type 1 pattern, VT/VF inducibility, 
and AF recurrences represent a marker of electrical instability leading to sudden death.
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maintained in AF for 3 months before cardioversion. Pacing leads were then placed at 8 
biatrial sites, including pulmonary vein ostia. For single-site pacing (SSP), a drive train 
(S1) was delivered at each site individually, with a premature stimulus (S2) from the S1 
site and other leads, one at a time. Multisite pacing (MSP) was performed by pacing 
all 8 leads simultaneously and delivering S2 at each site individually. Pacing trials were 
performed with S1 of 380 msec and S2 beginning at 200 msec, decrementing by 10 
msec, to endpoints of AF or refractoriness. Results were analyzed with Fisher’s exact 
test and t-testing.
Results: AF was induced in 9.4% of MSP trials vs. 16.4% of SSP (p=.027). Left atrial S2 
sites induced more AF than right atrial sites (15.5% vs. 4.4%, p<.0001). MSP suppressed 
AF at several left-sided S2 sites (right superior pulmonary vein, p=.0135; left inferior 
pulmonary vein, p<.0001; and left atrial appendage, p=.0049) as compared to SSP. The 
average S2 coupling interval for AF was 104 msec with MSP vs. 120 msec with SSP 
(p=.024). Refractory periods were 94.4 ± 20.8 msec (mean ± standard deviation, 95% 
conﬁdence interval 75.2-113.6) for MSP and 105.7 ± 29.6 msec (78.3-133.1) for SSP.
Conclusions: The 43% reduction in AF induction with MSP vs. SSP supported the 
hypothesis. Left atrial S2 sites were more likely to induce AF, and MSP showed signiﬁcant 
AF suppression with left-sided S2 locations. There was a shorter S2 for AF with MSP, 
indicating a requirement for greater prematurity to induce AF. A possible mechanism for 
this difference is the decreased dispersion of refractoriness with MSP, as evidenced by 
the narrower refractory period interval. This is the ﬁrst study to target multisite pacing 
to the left atrial sites associated with the triggers and substrate for the induction and 
maintenance of AF.
9:30 a.m.
1029-60 Comparison of the Efﬁcacy of Two Different Surgical 
Alternatives for Cardiac Resynchronyzation Therapy: 
Transapical Versus Epicardial Left Ventricular Lead 
Implantation
Attila Mihalcz, Imre Kassai, Csaba Földesi, Attila Kardos, Tamas Szili-Török, Hungarian 
Institute of Cardiology, Budapest, Hungary
Background: When coronary sinus (CS) lead placement for transvenous left ventricular 
(LV) pacing in resynchronization therapy is failed the most frequently used surgical 
alternative is the epicardial pacing lead implantation. Recent data support endocardial 
lead implantation, because this method provides further hemodynamic advantages. For 
endocardial LV pacing we developed a fundamentally new method, the transapical lead 
implantation, which provides access to any segment of the LV. The aim of this prospective 
study was to compare the outcome of patients (pts) between transapical endocardial or 
epicardial LV pacing.
Methods: In group-A 9 end-stage heart failure pts (mean age 60,4±7.9 yrs) underwent 
transapical LV lead implantation with an active ﬁxation endocardial lead, which was 
placed into the LV cavity using standard Seldinger technique through the LV apex. 
Group-B: In 12 end-stage heart failure pts (mean age 62,9±7.9 yrs) epicardial LV leads 
were implanted. All pts were on optimal medical therapy and all pts in group-A were orally 
anticoagulated with target anticoagulation level identical to mechanical valve prostheses. 
The following parameters were compared: LV ejection fraction (LVEF), LV end diastolic 
diameter (LVEDD), NYHA functional class.
Results: After one-year follow-up period all but one pts in group-A responded favorably 
to the treatment (LVEF 29±8.2% vs. 39,2±10,3%, p=0.006 ; LVEDD 70,5±6,8 mm vs. 
65,3±7,3 mm, p=0,002; NYHA class 3,58±0,4 vs. 2,41±0,4, p=0,002). During the follow-
up period two pts died in group-B, and another patient was considered to be non-
responder (p=0.008). In group-B echocardiographic measurements showed identical 
overall improvement as compared to group A. (LVEF 28±9.7% vs. 38,3±15,1%, p= 0,001; 
LVEDD 72,2±8,3 mm vs. 65±5,2 mm, p=0,03) There was one lead dislocation in each 
group. None of the pts developed thromboembolic complications.
Conclusions: Our data suggest that LV transapical endocardial lead implantation serves 
as an alternative to epicardial LV pacing with additional advantages such as providing 
more responders to CRT therapy.
9:30 a.m.
1029-61 Impaired Renal Function Is Associated With 
Less Echocardiographic Response to Cardiac 
Resynchronization Therapy
Rutger J. van Bommel, Sjoerd A. Mollema, C. Jan Willem Borleffs, Claudia Ypenburg, 
Ernst E. van der Wall, Martin J. Schalij, Jeroen J. Bax, Leiden University Medical Center, 
Leiden, The Netherlands
Background: Renal insufﬁciency is highly prevalent in heart failure patients, including 
patients eligible for CRT, and is associated with poor prognosis. Consequently, aim of this 
study was to investigate impact of renal function on response to CRT.
Methods: This study comprised 490 patients undergoing CRT. Clinical and 
echocardiographic parameters were assessed at baseline and at 6 months. Response 
was deﬁned as a decrease in LV end-systolic volume q15%.
Results: At baseline, mean serum creatinine was 115±43 umol/L and mean glomerular 
ﬁltration rate (GFR) 70±28 mL/min. GFR<90 ml/min was observed in 81% of patients. 
At 6 months follow-up, 263 patients (54%) demonstrated response to CRT. There were 
no differences in age, sex, QRS duration, NYHA class, LV volumes and LVEF between 
responders and non-responders. However, baseline creatinine and GFR levels differed 
signiﬁcantly between the groups, with a creatinine of 104±30 umol/L in responders vs. 
127±51 in non-responders, and a GFR of 74±26 mL/min in responders vs. 64±28 in non-
responders (both p<0.001). Also, non-ischemic etiology was more frequently observed in 
responders (51% vs. 38%, p<0.001). Patients with a GFR <60 mL/min showed the lowest 
response to CRT, while no differences were noted between the groups with a GFR of 60-
90 mL/min and the group with a GFR >90 mL/min (Figure).
9:30 a.m.
1029-57 Targeting the Electrically Delayed Segment Improves 
the Mitral Regurgitant Volume in Patients Receiving 
Cardiac Resynchronization Therapy
Jagmeet P. Singh, Jorge Solis-Martin, David McCarty, Annabel Tournoux-Chen, Mary 
Orencole, Michael H. Picard, Judy H. Hung, Massachusetts General Hospital, Boston, MA
Background: Previous work has suggested that left ventricular (LV) lead placement at 
a site of maximal electrical delay can enhance response to cardiac resynchronization 
therapy (CRT). Our study examined the impact of this lead placement strategy on the 
magnitude of mitral regurgitation.
Methods: Patients referred for CRT had the LV lead implanted at an optimal anatomical 
site (lateral wall, L or postero-lateral wall, PL) with maximal left ventricular lead electrical 
delay (LVLED). LVLED was measured intra-operatively from the onset of the surface 
ECG QRS complex to the onset of sensed electrogram (EGM) on LV lead, and as a 
percentage of the baseline QRS interval (LVLED%). All patients underwent 3D and 2D 
echocardiography pre-CRT (within 24 hrs of implant) and at follow up (within 6 months). 
Dyssynchrony (max delay between segments (MTD) and standard deviation in time to 
peak velocity (Ts-SD)) and LV volumes (end-systolic, ESV) were measured. Percent 
change in mitral valve annular area (MAA) and mitral regurgitant volume (M_RV) were 
assessed using 3D Echo.
Results: 20 patients (age, 64+15, 14 men, 7 with ischemic cardiomyopathy, LVEF, 
22.2+5.3, QRS, 179+31.5 ms) were included in this study. There was a decrease in 
LV volumes (ESV: 205±103 vs. 159±96 ml, p=0.001) increase in EF (22±5 vs. 30±8%, 
p<0.001), reduction in MAA (11.9+4.3 vs. 11.2+4.1, p=0.03) and M_RV (34.7+16.3 vs. 
21.0+10.6 cc, p=0.001). Based on the impact of CRT on the mitral regurgitant volume 
patients were divided into 2 groups: Group I (% decrease in M_RV > 25%, n=12) and 
Group II (% decrease in M_RV<25%, n=8). Patients in group I had a greater LVLED 
(148.9+48.2ms vs.92.7+45.9ms, p=<0.02) and LVLED% (79.4+27.2, vs.56.7+23.2,
p=0.069), as compared to group 2. There was a signiﬁcant reduction in M_RV in Group 
I vs. Group II (58+17% vs. -28+55, p<0.001). There were no signiﬁcant difference in the 
baseline dyssynchrony or relative change in dyssynchrony, percent mitral annular area 
change and anatomical lead location between the 2 groups (group 1, 6L and 5PL vs. 
group 2, 6L and 2PL).
Conclusions: LV pacing at sites of greater electrical delay and not anatomical location 
may be a determinant of a greater reduction in mitral regurgitation post-CRT.
9:30 a.m.
1029-58 Characterization of the Suitability of Coronary Venous 
Anatomy for Targeting Left Ventricular Lead Placement 
in Patients Undergoing Cardiac Resynchronization 
Therapy
Fakhar Z. Khan, Munmohan S. Virdee, Denis O’Halloran, Pegah Salahshouri, Phil Read, 
Timothy Watson, Simon P. Fynn, David P. Dutka, Addenbrooke’s Hospital, Cambridge, 
United Kingdom, Papworth Hospital, Cambridge, United Kingdom
Background: Left ventricular (LV) lead position is an important determinant of CRT 
response. Recent studies have suggested differences in the quantity and distribution of 
coronary veins between patients with ischemic (I) and non-ischemic (N) cardiomyopathy. 
We hypothesize that these differences may affect the potential for LV lead targeting in 
patients undergoing CRT with and without ischemic heart disease.
Methods: In 133 patients who underwent CRT, the retrograde contrast venograms were 
retrospectively reviewed. The quantity and distribution of coronary veins were recorded 
for each patient as well as the ﬁnal lead position on the chest radiograph.
Results: LV lead positions were: posterior vein 14.04% (I) vs.15.79% (N) (p=1.00), 
posterolateral vein 21.05% (I) vs. 18.42% (N) (p=0.36), lateral vein 59.65% (I) vs 50.00% 
(N) (p=0.29), anterolateral vein 3.51% (I) vs. 13.16% (p=0.11) and the middle vein in 1 
patient (I). There were no major differences in the distribution of ﬁnal LV lead positions 
between the I and N patients. The proportion of patients with 1 or more vein suitable for LV 
lead placement in each territory was 26.32% (posterior), 36.84% (posterolateral), 59.40% 
(lateral) and 24.81% (anterolateral) with no signiﬁcant differences according to underlying 
aetiology. Excluding the middle and great cardiac veins only 58/133 patients had more 
than one suitable vein for LV lead placement (I - 36.8% vs N- 50.0%, p=0.16). There 
was a mean of 1.64+/-0.94 suitable veins per patient (I - 1.51 +/- 0.87 veins per patient 
vs 1.73 +/- 0.98 veins per patient p=0.18). Within the ischemic population there were no 
differences according to a history of previous CABG.
Conclusion: Underlying aetiology does not appear to affect the quantity and distribution 
of coronary veins available for LV lead placement or the ﬁnal achieved lead positions. The 
limitations of venous anatomy restrict LV lead placement to a single vein with little scope 
for site selection in almost half of all patients. Given these limitations, in many patients, 
prospective targeting of LV lead placement may require a direct surgical approach.
9:30 a.m.
1029-59 Multisite Biatrial Pacing Protects Against Atrial 
Fibrillation in the Canine Model
James C. Hansen, Rakesh Latchamsetty, Nimrod Lavi, Roger Hastings, Boaz Avitall, 
University of Illinois at Chicago, Chicago, IL, Boston Scientiﬁc Corporation, Minneapolis, MN
Background: The induction and sustainability of atrial ﬁbrillation (AF) are most commonly 
due to left atrial triggers and susceptible substrate. We hypothesized that simultaneous 
8-site pacing of tissues exhibiting high levels of fractionated electrical activity would 
reduce atrial susceptibility to AF.
Methods: Mongrel dogs underwent implantation of rapid-bursting pacemakers and were 
JACC March 10, 2009 ABSTRACTS - Cardiac Arrhythmias  A125
C
ardiac A
rrhythm
ias
sex, duration of procedure >1hour, presence of pyrexia within 48 hours prior to procedure 
or procedure type (I implant or revision) weren’t associated with the higher infection risk. 
Presence of diabetes mellitus was associated with higher infection risk in patients not 
receiving gentamicin wound irrigation, (OR 4.16, 95% CI 0.96-18.2, p=0.057).
Conclusion : Pacemaker pocket irrigation with 80 mg gentamicin solution at the time of 
wound closure has no signiﬁcant impact on pacemaker infection in patients undergoing 
PPI, except patients with diabetes mellitus, who may beneﬁt from this practice.
9:30 a.m.
1029-64 Pacing Induced Systolic Dyssynchrony Predates Long-
Term Left Ventricular Adverse Remodeling in Patients 
With Preserved Ejection Fraction Receiving Right 
Ventricular Apical Pacing
Cheuk-man Yu, Fang Fang, Joseph YS Chan, Qing Zhang, Gabriel WK Yip, Chun-yan 
Ma, The Chinese University of Hong Kong, Hong Kong SAR, Hong Kong, Prince of 
Wales Hospital, Hong Kong SAR, Hong Kong
Background: To examine long-term adverse left ventricular (LV) remodeling after right 
ventricular apical (RVA) pacing and its relation with pacing induced LV dyssynchrony.
Methods: 62 patients with preserved LV ejection fraction receiving RVA pacing were 
prospectively assessed by real-time 3D echocardiography (RT3DE) and tissue Doppler 
imaging (TDI) (iE33, Philips) at baseline, 1 month and 1 year. Pacing induced systolic 
dyssynchrony at 1 month was deﬁned by RT3DE (Tmsv16-SD q16ms) and TDI (Ts-SD 
q33ms), while LV remodeling was deﬁned as increase in LV end-systolic volume q15%
at 1 year.
Results: At 1 month, pacing induced systolic dyssynchrony was present in 30 patients 
when assessed by RT3DE and 30 patients by TDI. The concordant rate of the 2 methods 
was 80%. By using either method to deﬁne systolic dyssynchrony, increase in LV 
volume with decline in ejection fraction at 1 year was only observed in the group with 
dyssynchrony (Table). LV adverse remodeling was observed in 30 patients (49%) at 1 
year, which was more prevalent in the group with dyssynchrony (by RT3DE: 70% vs 
26%, C2=11.9, p=0.001; by TDI: 76% vs 19%, C2=19.2, p<0.001). By multiple regression 
analysis, Tmsv16-SD (B=0.45) and Ts-SD (B=0.45) at 1 month independently predicted 
LV adverse remodeling at 1 year (both p<0.001).
Conclusion: Long-term deleterious remodeling occurred in nearly half of the patients 
received RVA pacing. It mainly occurred in those who developed early evidence of LV 
systolic dyssynchrony as evident by either RT3DE or TDI. 
Patients without dyssynchrony at 1 
month by RT3DE (N=32)
Patients with dyssynchrony at 1 
month by RT3DE (N=30)
Baseline 1 year P value Baseline 1 year P value
LV end-diastolic 
volume, ml 66±16 64±15 NS 75±19 81±27† 0.025
LV end-systolic 
volume, ml 25±9 25±9 NS 32±12 43±19* <0.001
LV ejection 
fraction,% 61±6 60±7 NS 58±10 49±9* <0.001
Patients without dyssynchrony at 1 
month by TDI (N=32)
Patients with dyssynchrony at 1 
month by TDI (N=30)
Baseline 1 year P value Baseline 1 year P value
LV end-diastolic 
volume, ml 68±16 65±15 NS 74±20 80±28† 0.014
LV end-systolic 
volume, ml 27±9 25±9 NS 31±13 43±20* <0.001
LV ejection 
fraction,% 61±7 61±7 NS 58±9 48±8* <0.001
* p<0.001; † p<0.01 vs patients without dyssynchrony at 1 month
9:30 a.m.
1029-65 Cardiac Resynchronization Therapy Inﬂuences Not Only 
Cardiac Function but Endothelial Function in Patients 
With Chronic Heart Failure
Kenshiro Arao, Yoshitaka Sugawara, Chikashi Suga, Norifumi Kubo, Shin-ichi 
Momomura, Department of Integrated Medicine 1, Jichi Medical University Saitama 
Medical Center, Saitama, Japan, Division of Cardiovascular Medicine, Jichi Medical 
University Saitama Medical Center, Saitama, Japan
Background: Increase in peripheral arterial blood ﬂow augments arterial shear stress and 
consequently increases production of nitric oxide. The effects of cardiac resynchronization 
therapy (CRT) in patients with a non-ischemic cause were superior to an ischemic cause 
according to previous investigations.The purpose of this study was to evaluate acute 
effects of CRT therapy on cardiac and endothelial function in patients with chronic heart 
failure (CHF).
Methods: We enrolled 20 patients (62±11 years old, ischemia 6 non-ischemia 14, BNP 
376±80pg/ml) indicated for CRT. At steady-state, acute hemodynamic effect of CRT was 
evaluated prior to device implantation to estimate effects on maximal left ventricular dP/
dt (LVdP/dt) and cardiac output. One week before and three weeks after CRT device 
implantation, we measured post-ischemic forearm reactive hyperemia (FBF) with 
straingauge plethysmography, blood parameters including lipid, blood sugar proﬁle 
and BNP, blood pressure, body weight and left ventricular ejection fraction (LVEF) on 
echocardiogram.
Results: At baseline, FBF was correlated with systolic blood pressure (r=0.225, P=0.02) 
in multivariate regression analysis. Hemodynamic evaluation showed increase in LV dP/
dt (from 1058±69 to 1304±72 mmHg/sec, P=0.0001) and cardiac output (from 4.1±0.2 to 
4.3±0.2 L/min. P=0.023) during CRT compared to spontaneous rhythm. FBF and LVEF 
were signiﬁcantly increased (from 23.3±1.2 to 29.1±1.5 ml/min/100ml tissue, P=0.0019, 
Conclusions: Impaired renal function is common among patients with heart failure 
eligible for CRT and is associated with non-response during 6 months follow-up. 
9:30 a.m.
1029-62 Right Ventricular Pacing Improves the Right Ventricular 
Hemodynamic Response in Heart Failure With RBBB
J Lacy Sturdivant, Yinghong Yu, Robert B. Leman, Michael R. Gold, Medical University 
of South Carolina, Charleston, SC, Boston Scientiﬁc Corp., St. Paul, MN
Background: The magnitude of hemodynamic response to cardiac resynchronization 
therapy (CRT) in LBBB patients (pts) can be predicted by measures of left ventricular (LV) 
activation delay. Speciﬁcally, the QLV interval, measured from the onset of QRS to the peak 
depolarization at LV stimulation site, correlates well with the hemodynamic response, as 
measured by LV dP/dt. Since RBBB patients have delayed right ventricular (RV) activation 
(i.e. electrical dyssynchrony), we hypothesized that RV pacing should improve right sided 
hemodynamics and this should be predicted by electrical dyssynchrony measures.
Methods: 9 RBBB pts (NYHA Class III-IV with QRS duration > 150 ms) were studied. 
Stimulation was delivered at the RV apex with 4 AV delays tested in a randomized order. 
Activation delay (QRV) was measured from the onset of surface ECG to the peak of RV 
Egram. RV and LV dP/dt are measured from high-ﬁdelity pressure catheters.
Results: RV pacing improved RV dP/dt in all 9 pts compared to the baseline (14±4%, p<0.01). 
The maximum improvement in LV dP/dt was 1±3 % (p=NS). The QRV interval was 82±21 ms. A 
linear correlation was observed between QRV and %RV +dP/dt (r=0.8, p<0.001, see ﬁgure).
Conclusions: The relationship of QRV to RV dP/dt is similar to that of QLV vs. LV 
dP/dt, suggesting that delayed electrical activation is an important determinant of the 
hemodynamic response to pacing in heart failure. This may explain why CRT is beneﬁcial 
in pts with LBBB, but only right ventricular function improves in pts with RBBB. 
9:30 a.m.
1029-63 Pacemaker Pocket Irrigation With Antibiotics Has No 
Role in Infection Prevention
Sudhanshu K. Dwivedi, King George Medical College, Lucknow, India
Background: Pacemaker pocket irrigation with antiseptic/ antibiotic solution as infection 
prophylaxis, at the time of permanent (PPI), is a common practice despite lack of deﬁnite 
evidence.
Aim: Present study was done to assess impact of wound irrigation with gentamicin 
solution on the incidence of pacemaker pocket infection in a prospective blinded 
randomized fashion.
Method: Consecutive 252 patients (187 males, mean age 63.6 yrs), undergoing PPI were 
randomized to receive either 2cc (80mg) of Gentamicin solution (group A, n=133),
or normal saline (group B, n=119) for pacemaker pocket irrigation just prior to closure of 
incision. End point of the study was wound infection which was labeled as early when fever 
persisted beyond 48 hours of implant and was associated with any one of these: local 
redness, swelling, tenderness and pus discharge or late when ﬂuctuant swelling (abscess) 
or device extrusion was noted with or without fever requiring pacemaker revision. All patients 
received IV Teicoplanin 400mg, 2 hours prior to procedure & after 24 hrs.
Result: Infection was present in 10/252 (4%) of the study group. There was no difference 
in overall infection (4.5% vs 3.3%), early infection (3% vs 2.5%) or late infection (1.5% vs 
o.8%) in group A & B respectively. On multivariate logistic regression analysis, age>65yrs, 
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were monitored for at least 48 hours, and PPM was not routinely implanted. A subset of 
the latter group underwent electrophysiology study (EPS) to evaluate AV conduction.
Results: EPS was performed on 48 patients (transient CHB=13, new RBBB=27, both=8). 
There were no differences between the transient CHB group and the new RBBB group 
with regard to HV interval (60±12 ms vs. 58±10 ms, p=0.59), AV node effective refractory 
period (244±50 ms vs. 275±89 ms, p=0.27), or Wenckebach block rate (331±83 ms vs. 
367±86 ms, p=0.25). One patient in the CHB group, 2 patients in the RBBB group and 1 
patient in the “both” group had infrahisian heart block and received a PPM or ICD.
Conclusions: Transient CHB and new RBBB are common following ASA, but overall the 
degree of conduction system disease in these patients is relatively mild. However, 8.3% 
of such patients have infrahisian heart block. Further studies are needed to better risk 
stratify patients for heart block following ASA.
3:30 p.m.
1038-32 Improvements in Repolarization Following Cardiac 
Resynchronization Therapy Are Associated With 
Ejection Fraction Response and Improvements in 
Mechanical Dyssynchrony
Hideyuki Hara, Hidekazu Tanaka, Olusegun Oyenuga, Han-Na Kim, David 
Schwartzman, John Gorcsan, III, University of Pittsburgh, Pittsburgh, PA
Background: Although cardiac resynchronization therapy (CRT) has been shown to 
beneﬁt patients with mechanical dyssynchrony by altering depolarization, the relationship 
of CRT to changes in repolarization are not clear.
Methods: We studied 117 consecutive heart failure patients for CRT with ejection fraction 
(EF) 24±6% and QRS 150±35ms. Echocardiograms and 12-lead electrocardiograms 
(ECG) were examined before (PRE), the day after, and 7±5months after CRT. 
Repolarization was determined from the ECG as QTp (QRS to T-wave peak) and the 
maximum QTp dispersion (difference between maximum and minimum QTp in 12 leads). 
Intraventricular dyssynchrony was assessed by speckle tracking peak radial strain delay. 
Interventricular mechanical delay (IVMD) was assessed as the difference between right 
and left ventricular ejection. Response to CRT was deﬁned as an improvement in EF 
>15% at chronic follow-up.
Results: Signiﬁcant changes in repolarization by QTp dispersion were observed in 
EF responders following CRT, but not in non-responders. Similarly, intraventricular and 
interventricular dyssynchrony only improved signiﬁcantly in EF responders (p<0.02). 
Improvements in QTp dispersion were associated with improvements in dyssynchrony 
(r=0.60, p<0.01).
Conclusions: Improvements in repolarization occur in patients who are EF responders 
following CRT. Changes in repolarization appear related to improvements in mechanical 
dyssynchrony, and may have clinical implications. 
3:30 p.m.
1038-33 Comparison of Epicardial and Endocardial 
Left Ventricular Pacing in a Canine Model of 
Dyssynchronous Heart Failure
Christine Tompkins, Robert Helm, Kerry Phillips, Richard Tunin, David D. Spragg, Henry 
Halperin, Ronald D. Berger, David A. Kass, Albert C. Lardo, Johns Hopkins Hospital, 
Baltimore, MD
Background: Dyssynchronous heart failure (DHF) induces changes in the electrophysiologic 
substrate that may predispose the development of fatal ventricular arrhythmias. The 
electrophysiologic consequence of reversing the normal endocardial (ENDO) to epicardial 
(EPI) activation sequence, as occurs during clinical cardiac resynchronization therapy 
(CRT), is unknown. Accordingly, we compared the acute effect of EPI and ENDO CRT on 
myocardial activation and repolarization in a canine of model DHF.
Methods: DHF was induced in adult anesthetized mongrel dogs by radiofrequency 
ablation of the left bundle branch followed by 3-4 weeks of rapid right atrial pacing at 180 
bpm (N=4). Bipolar ENDO and EPI stimulation was performed using multi-polar plunge 
electrode arrays in the lateral wall. Pacing was performed in DDO mode with pacing 
rate of 150 msec (20-30 msec above intrinsic) and AV delay of 70 msec. A customized 
3-D ENDO and EPI recording system was used to obtain simultaneous activation and 
repolarization sequences during baseline right atrial pacing (RAP) and biventricular 
pacing varying ENDO versus EPI stimulation.
Results: There was no difference in EPI activation time when pacing either the ENDO or 
EPI lateral wall (69.25 + 1.63 ms vs. 83.5 + 1.9 ms; p=0.16). ENDO activation time was 
reduced for EPI pacing compared with ENDO (29.3 + 2.1 ms vs. 42.75 + 1.81 ms; p=.04). 
There was no difference in repolarization time when pacing either the lateral ENDO or 
lateral EPI (522.3 + 28.2 ms vs. 540.6 + 8.4, p=0.59).
Conclusions: EPI and ENDO pacing of the lateral wall reduces activation and 
from 27.6±2.0 to 32.3±3.4 %, P=0.025) and BNP tended to be decreased (P=0.08) after 
CRT despite no signiﬁcant changes of medical treatment, body weight, lipid and blood 
sugar proﬁles and blood pressure during this study. Improvement of FBF after CRT was 
higher in patients with non-ischemic CHF than that in ischemic CHF (7.6±1.4 vs 1.1±2.5 
ml/min/100ml tissue, P=0.025).
Conclusion: CRT has a potential effect to improve endothelial function partially due to 
hemodynamic increase especially in patients with non-ischemic CHF.
9:30 a.m.
1029-66 Inpatient Versus Elective Outpatient Cardiac 
Resynchronization Therapy Device Implantation and 
Long Term Clinical Outcome
Olujimi A. Ajijola, II, David McCarty, Conor D. Barrett, Melanie Barantke, E. Kevin Heist, 
Lindsay R. Riedl, Gaurav Upadhyay, Mary Orencole, Michael Picard, G. William Dec, 
Jeremy N. Ruskin, Jagmeet P. Singh, Massachusetts General Hospital, Boston, MA, 
Harvard Medical School, Boston, MA
Background: Outside of standard indications for cardiac resynchronization therapy 
(CRT), strategies for optimal patient selection are lacking. We hypothesized that patients 
undergoing CRT device implantation during inpatient hospitalization may not derive the 
same beneﬁt as elective outpatient admits.
Methods: We retrospectively separated patients undergoing CRT at Massachusetts 
General Hospital over a 3-year period into inpatient (IP, n=65) and outpatient (OP, 
n=112) implants. Long-term response, measured as a combined endpoint of heart failure 
hospitalization, all-cause mortality, or heart transplant over a 2-year follow up period, was 
estimated by the Kaplan-Meier method, with comparisons made using the log-rank test.
Results: Baseline measures were comparable between IP and OP (64±11 vs 66±12 
years; 84% vs 76% males, 59% vs 53% ischemic; and NYHA Class 3±0.4 vs 3±0.4). IP 
admissions included HF (57%), Ventricular Tachycardia (18%), and atrial ﬁbrillation (5%). 
Inpatient device implantation was associated with worse clinical outcomes within the entire 
cohort (HR: 1.8, 95% CI: 1.06 to 3.06, p=0.027) compared to elective outpatient implants. 
Elective OP implants had a longer event free survival compared to the IP group (Figure).
Conclusion: Compared to outpatient CRT implants, patients receiving implants as 
inpatients during hospitalization are at increased risk for worse long-term outcomes, with 
a shorter time to ﬁrst heart failure hospitalization, mortality or cardiac transplant.
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3:30 p.m.
1038-31 Electrophysiology Studies for Conduction System 
Disease Following Alcohol Septal Ablation
Anil Rajendra, Matthew Forcina, Matthew Klein, E. Matthew Quin, J. Lacy Sturdivant, 
Robert B. Leman, J. Marcus Wharton, Valerian L. Fernandes, Christopher D. Nielsen, 
William H. Spencer, III, Michael R. Gold, Medical University of South Carolina, 
Charleston, SC
Background: Alcohol septal ablation (ASA) is an effective treatment for symptomatic 
hypertrophic obstructive cardiomyopathy. Early studies reported that the risk of procedural 
complete heart block (CHB) requiring a permanent pacemaker (PPM) is 14 - 25%. Newer 
techniques have allowed reduction in the size of the iatrogenic infarct with a resultant 
reduction of PPM implants. However, most patients still develop a new right bundle branch 
block (RBBB) or transient CHB post-procedure. The extent of AV node and infrahisian 
conduction abnormalities in these patients are not known.
Methods: We analyzed 302 consecutive patients undergoing ASA at a single center who 
did not have a preexisting PPM or implantable cardiac deﬁbrillator (ICD). A PPM was 
implanted for persistent CHB in <7%. For CHB lasting < 1 hours or new RBBB, patients 
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1038-36 Improvement of Left Ventricular Ejection Fraction 
Following Biventricular Pacing Device Implantation 
Predicts Improved Survival
Mahesh Manne, Mina Chung, David Martin, Patrick Tchou, Cleveland Clinic, Cleveland, OH
Background: Patients (Pts) who undergo implantation of a biventricular (BiV) pacing 
device have varying degrees of improvement in their Left ventricular ejection fraction 
(LVEF) at follow up. We examined the degree to which this response correlated with 
survival in a large cohort of patients (N=750) undergoing BiV device implantation at the 
Cleveland Clinic from 1999 to 2008.
Methods: Pts were divided into three groups based on the response of their LVEF 
following BiV implantation: Group 1 (good responders, N=88, LVEFq50%), Group 2 
(modest responders, N=82, LVEF 40-49%), and Group 3 (poor responders, N=580, LVEF 
<40%). Survival outcomes were evaluated using Kaplan-Meier survival analysis
Results:.The Figure shows the survival outcomes of the 3 groups. Group 3 had 
statistically signiﬁcant lower survival when compared to Groups 1 and 2 (P<0.001). 
While Group 2 had somewhat lower survival than Group 1, this difference did not reach 
statistical signiﬁcance (P= 0.17).
Conclusions: Pts with modest to good improvements in their LVEF after BiV implantation 
had better survival compared to those with poor response. Improvement of LVEF appears 
to play an important role in improved survival associated with BiV device implantation. 
3:30 p.m.
1038-37 Left Ventricular Noncontact Mapping In Humans With 
Cardiomyopathy: Mechanistic Insights for Cardiac 
Resynchronization Therapy
Matthew Ginks, Pier Lambiase, Phani Chinchapatnam, Kawal Rhode, Julian Bostock, 
Maretha Navue, Stephen Sinclair, Cliff Bucknall, Reza Razavi, C. Aldo Rinaldi, St 
Thomas’ Hospital, London, United Kingdom, King’s College, London, United Kingdom
Introduction
Left ventricular (LV) endocardial (EN) pacing may be more effective than conventional 
biventricular (BIV) pacing alone with one mechanism being direct activation of the His-
Purkinje system. This may constitute an alternative therapeutic strategy in heart failure.
Methods: 6 patients (4 with non-ischemic dilated cardiomyopathy & 2 with ischemic 
cardiomyopathy) and indications for Cardiac Resynchronization Therapy (CRT) underwent 
invasive electrophysiological (EP) study using NCM of the LV with a multi-electrode array. EP 
electrodes were positioned in the high right atrium, his bundle, right ventricular apex & coronary 
sinus. The NCM array, a bipolar pacing lead and a pressure wire were passed via femoral 
arterial access to the LV endocardium. The pressure wire provided real-time mean peak dP/dt. 
A pacing protocol was performed as described below. The LV endocardial activation pattern was 
repolarization times compared to RAP. However, there is no difference in activation or 
repolarization times when comparing EPI and ENDO pacing sites. These data suggest 
limited acute electrophysiologic consequences associated with reversing the natural 
direction of transmural conduction. Long-term pacing studies are required to assess 
possible electrical remodeling resulting from chronic CRT.
3:30 p.m.
1038-34 Vibration Systolic Dyssynchrony Index Is Increased and 
Related to QRS Width in Patients With Right Ventricular 
Pacing
Dawod Sharif, Naira Radzievsky, Amin Hassan, Nimer Samnieh, Uri Rosenschein, Bnai 
Zion Medical Center, Haifa, Israel
Background: Prediction of response to biventricular pacing is limited. Right ventricular 
pacing alters sequence of contraction and may reduce systolic function. We developed 
a new transthoracic method for mapping cardiac mechanical vibrations. Aim: Evaluation 
of cardiac synchrony in subjects with right ventricular pacing and in normals using a new 
tarnsthoracic vibration systolic dyssynchrony index(VSDI).
Methods:Thirty four subjects were examined, 24 were normal controls and 10 subjects 
with right ventricular apical pacing. A matrix of 5x5 transducers was applied to the chest 
and the vibrations were mapped and recorded digitally. The interval between the onset 
of q-wave and the peak of the amplitude of vibration for each transducer was measured 
and a colored three dimensional map for the whole matrix of transducers was generated 
(ﬁgures). VSDI for each subject was determined as the standard deviation of the difference 
between the median value and each transducer interval.
Results:VSDI for normal controls (12.6±6.2msec) was lower than for patients with right 
ventricular pacing (30.3±9.9msec), p<0.05. VSDI correlated with QRS width, however 
with various degrees of dyssynchrony.
Conclusions:A simple new transthrocic dyssynchrony index can differentiate between 
various degrees of cardiac dyssynchrony related to QRS width in patients with right 
ventricular pacing. 
3:30 p.m.
1038-35 Beyond PROSPECT: 3D Echo Comes of Age in CRT 
Selection
Stamatis Kapetanakis, Amit Bhan, Nicholas Gall, Julia DeCourcey, Francis Murgatroyd, 
Mark J. Monaghan, King’s College Hospital, London, United Kingdom
Background: ECG based selection criteria for cardiac resynchronisation therapy (CRT) 
confer a non-responder rate of 20-30%. 3D Echo has been proposed as an alternative 
but evidence is limited to small cohorts. We examine evidence from the largest cohort in 
3D echo so far.
Methods: 186 patients under went implant of biventricular devices over the last 4 years. 
All patients underwent functional assessment and 3D echo pre-implant and at follow up. 
3D echo quantiﬁcation was used to derive the Systolic Dyssynchrony Index (SDI). Positive 
response was considered reduction in NYHA by q 1 class and q20% relative increase in 
LVEF. Receiver operator characteristics were calculated for QRS duration (QRSd) and 
SDI as predictors of response.
Results: Complete data were available for 147 patients. QRSd did not predict improvement 
in NYHA (AUC 0.48) or LVEF (AUC 0.56). SDI had excellent predictive value (AUC 0.80 
and 0.86 for NYHA and LVEF).
Adherence to standard ECG criteria would have slightly increased the response rate at the 
cost of excluding 38% of patients due to AF or narrow QRS. Stricter ECG criteria (QRSd 
q 150 ms) would have excluded 2/3 of patients with no signiﬁcant increase in response 
rate. Had 3D SDI alone been used for selection, 106 (72%) of implants would have been 
included with signiﬁcantly better response (94.8% for NYHA and 85.1% for LVEF).
Conclusions: 3D echo selection of patients would have led to fewer patients being 
implanted but with a much higher response rate. Multicentre studies are awaited to 
conﬁrm this. 
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time integral was 19+5% and of MPI was 26+8% from baseline. RA IVCT data and echo 
ED data is shown in the Figure. Baseline and ﬁnal atrioventricular delay were 136+48 to 
134+56 and baseline and ﬁnal interventricular delays were -2+11 to -8+11 ms.
Conclusions:Biv PM Opt improves LV velocity time integral and shortens IVCT. RA 
tonometry may be a useful method for Biv PM Opt. Ratio of IVCT and ED obtained (a 
parameter comparable to MPI) simultaneously from RA pulse wave may be a useful non 
invasive method of Biv PM Opt and should be evaluated against echo and other invasvie 
methods of Biv PM Opt.
3:30 p.m.
1038-40 Effects of Right Ventricular Pacing Site on Left 
Ventricular Regional Timing and Magnitude of 
Deformation and Global Torsion and Dyssynchrony 
Demonstrated by Two-Dimensional Speckle Tracking 
Echocardiography
Haruhiko Abe, Yoshinori Yasuoka, Keiko Katsuki, Susumu Hattori, Takahiro Imanaka, 
Ryo Araki, Ryo Matsutera, Daisuke Morisawa, Hirokazu Kitada, Yoshiki Noda, Hidenori 
Adachi, Hiroaki Irino, Tatsuya Sasaki, Kunio Miyatake, Osaka Minami Medical Center, 
Osaka, Japan
Background: Right ventricular septal pacing (RVS-P) has advantages on electrical 
conduction and mechanical function of the left ventricle (LV) compared to right ventricular 
apical pacing (RVA-P). However, the effects of right ventricular pacing site on LV regional 
timing and magnitude of deformation, LV global torsion, and dyssynchrony remain 
unclear.
Methods: We studied 16 patients (age 72±10 years) with DDD pacemaker, normal LV 
function, and no structural heart disease. 7 of these studied subjects were RVA-P and 9 
were RVS-P. All patients were paced 60 beats per minute and underwent conventional 
and 2-D speckle tracking echocardiographies. 2-D speckle tracking was applied to 
measure timing and magnitude of regional longitudinal, radial, and circumferential strains 
from base to apex and global torsion. The timing of regional strain was measured as the 
time difference from the onset of Q-wave to peak strain. The extent of LV dyssynchrony 
was calculated as the standard deviation of time to peak strains among 18 LV segments 
(6 basal, mid, and apical segments).
Results: There were no signiﬁcant differences in LV size and ejection fraction. Most 
of left ventricular regional timing and magnitude of deformation were similar between 
the RVA-P and RVS-P, however, apical radial strain was signiﬁcantly reduced in RVA-P 
when compared to RVS-P (9.0±8.1 vs. 27.1±12.8%, p=0.006). Both LV global torsion 
and systolic torsion rate were signiﬁcantly reduced in RVA-P when compared to RVS-P 
(9.0±5.5 vs. 18.3±9.5 degree, p=0.03; 72.9±32.9 vs. 114.4±19.4 degree/sec, p=0.007). 
The extent of LV longitudianl and circumferential dyssynchrony were not signiﬁcantly 
different between RVA-P and RVS-P (76.2±35.1 vs. 75.9±21.9 msec, p=NS; 78.4±32.3 vs. 
83.0±20.5 msec, p=NS), however, the extent of LV radial dyssynchrony was signiﬁcantly 
greater in RVA-P than in RVS-P (105.9±49.0 vs. 67.0±14.8 msec, p=0.03).
Conclusions: Although global LV function was similar between the RVA-P and RVS-P, 
our ﬁndings suggest that RVS-P has advantages on LV regional radial function, LV global 
torsion, and radial dyssynchrony compared to RVA-P.
3:30 p.m.
1038-41 Regional Conduction Velocity Reversal in a Canine 
Model of Dyssynchrony With and Without Heart Failure
Christine Tompkins, Robert Helm, Kerry Phillips, Richard Tunin, David D. Spragg, Henry 
Halperin, Ronald D. Berger, David A. Kass, Albert C. Lardo, Johns Hopkins Hospital, 
Baltimore, MD
Background: Optical mapping studies of tissue samples have identiﬁed electrical 
changes that occur in dyssynchronous heart failure (DHF) that may predispose to fatal 
ventricular arrhythmias. Whether such changes occur in the intact heart is unknown.
Methods: Dyssynchrony without failure (n=3) and DHF (n=4) were induced in adult 
anesthetized dogs by ablation of the left bundle branch. After ablation, DHF animals 
received 3-4 weeks of rapid right atrial pacing at 180 bpm. Acute pacing studies were 
performed to assess regional conduction velocity (CV) during endocardial (ENDO) and 
epicardial (EPI) ventricular pacing. Bipolar ENDO and EPI stimulation was performed 
using a multipolar plunge electrodes in the anterior and lateral walls. A custom 3-D 
acquired by NCM and the LVTAT was calculated. Statistical analysis used ANOVA.
Results: Mean baseline dP/dt max was 811+/-163 mmHg/s in sinus rhythm (SR). Results 
for other pacing modes were calculated as % change from baseline. Corresponding 
LVTATs were calculated & expressed as % reduction compared with SR.
Conclusions: 1. CRT pacing signiﬁcantly improves hemodynamics compared with sinus 
rhythm, AAI & RV pacing, associated with a signiﬁcant reduction in LVTAT.
2. Additional endocardial TRIV pacing results in additional acute hemodynamic beneﬁt 
and may improve hemodynamics in non-responders to CRT.
3:30 p.m.
1038-38 Closed Loop Stimulation Sensor Allows Early Detection 
of a Blood Pressure Drop in Patients Undergoing Head 
up Tilt Testing: Role of Permanent Pacing Utilizing 
the Closed Loop Stimulation Sensor in Patients With 
Bradycardia and Neurocardiogenic Syncope
Atul Prakash, Pranesh Thirukkonda, Hannes Kraetschmer, St Mary’s Hospital, Passaic, 
NJ, St. Joseph’s Regional Center, Paterson, NJ
Neurocardiogenic syncope can be associated with hypotension and bradycardia. The 
ineffectiveness of permanent pacing can be due to a vasodepressor response with the 
bradycardia. A sensor facilitating early rate intervention during a blood pressure drop may 
attenuate this response.
Methods: Patients with syncope and bradycardia underwent implantation with a Biotronik 
permanent pacemaker with a Closed Loop stimulation (CLS) sensor. The CLS sensor 
responds to a change in cardiac contractility, by measuring localized cardiac impedance. 
Then, using a complex algorithm, translates this to an appropriate rate response. Pts. 
who continued with syncopal symptoms underwent Tilt table testing (HUT). HUT utilized 
a standard protocol. The pacemaker was programmed to nominal settings. Impedance 
data was collected from the pacemaker which would reﬂect changes in contractility. Blood 
pressure and heart rates were recorded every minute for 25 minutes.
Results: 13 pts. with a bradycardia indication for pacing, h/o persistence syncope despite 
pacing underwent Tilt testing. In 8 pts., a transient or sustained drop in BP was associated 
with a corresponding increase in the CLS rate. BP drop ranged from 10 to 40 mm of Hg. The 
increase in CLS was near simultaneous. In 4 additional pts., this response occurred with 
Isopril infusion. One pt showed no change. The timing of this BP reponse occurred from 2 to 
14 minutes after commencement of Tilt. Response of CLS was uniform regardless of the time, 
but correlated with the degree of drop in blood pressure. Frank syncope occurred in only one 
patient in which the patient had a junctional rhythm greater than the programmed lower rate.
Conclusions: 1. Persistence of syncopal symptoms in patients with permanent 
pacemakers may be as a result of a drop in blood pressure which can manifest during 
HUT 2. Increase in myocardial contractility occurs even with the smallest and transient 
reduction in blood pressure. 3. The CLS sensor is very sensitive to these blood pressure 
reductions, with corresponding changes in contractility 4. This can increase the pacing 
rate in accordance with the aggressiveness of programming and has the potential to 
attenuate a syncopal episode.
3:30 p.m.
1038-39 Effect of Biventricular Pacemaker Optimization on 
Isovolumic Contraction Time Measured by Radial 
Artery Tonometry
Jing Zhang, Asim M. Raﬁque, Tasneem Z. Naqvi, Cardiovascular and Thoracic Institute, 
Keck School of Medicine, University of Southern California, Los Angeles, CA, Cedars 
Sinai Medical Ctr, Los Angeles, CA
Background:Biventricular pacemaker (Biv PM) shortens isovolumic contraction time 
(IVCT) and lenghthens ejection duration (ED). Tailored PM optimization (Opt) can further 
reduce IVCT and increase ED. Echo guided Opt is however time, resource and labor 
intensive. We report on the utility of IVCT measured by radial artery (RA) tonometry during 
Biv PM Opt. Methods: Simultaneous echo Doppler and RA tonometry was performed at 
baseline and after determination of optimal atrioventricular and interventricular delays 
guided by echo Doppler in 11 symptomatic patients post Biv PM. Age was 71+13 yrs, 
NYHA 2.5+0.6 and left ventricular (LV) ejection fraction 0.32+0.1. Results: IVCT was 
measured from the onset of Q wave to the onset of ejection on RA waveform. LV time 
velocity integral improved from 16+5.4 to 19+5.8 cm (p<0.01) and myocardial performance 
index (MPI) rom 0.58+0.09 to 0.43+0.06, (p<0.01). Improvement in echo Doppler velocity 
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(LVESV) at follow-up had decreased by q 15%.
Results: Responders (69.7%) and non-responders (30.3%) had similar baseline 
characteristics. In responders, CRT increased BRS by 30% (P=0.03); this differed 
signiﬁcantly (P=0.02) from the average BRS change (-2%) in the non-responders. 
Also, CRT increased HRV by 30% in responders (P=0.02), but there was no signiﬁcant 
difference found compared to change in HRV (8%) in the non-responders. ROC analysis 
revealed that the percentual BRS increase had predictive value for the discrimination 
of responders and non-responders (area-under-the-curve 0.69; 95% conﬁdence interval 
0.51-0.87; maximal accuracy 0.70).
Conclusions: We demonstrated that a CRT-induced acute BRS increase has predictive 
value for the echocardiographic response to cardiac resynchronization therapy. This 
ﬁnding suggests that the autonomic nervous system is actively involved in reverse 
remodelling.
3:30 p.m.
1038-44 Electrocardiographic Characteristics in Right 
Ventricular Versus Biventricular Pacing in Patients With 
a Right Bundle Branch Block QRS Pattern
Marwan Refaat, E. Kevin Heist, Daniel Dindy, Jeremy Ruskin, Moussa Mansour, 
University of Pittsburgh Medical Center, Pittsburgh, PA, Massachusetts General 
Hospital, Boston, MA
Background: A right bundle branch block (RBBB) QRS morphology is present in most 
of patients with biventricular pacing (BiVP) but is also present in some patients with 
right ventricular pacing (RVP). The aim of this study is to determine if there are EKG 
characteristics which distinguish BiVP from RVP in patients with a RBBB QRS pattern.
Methods: 12-lead paced EKGs were analyzed from 356 consecutive patients (302 
RVP and 54 BiVP). Results: 50 of 302 RVP EKGs (16.6%) and 50 of 54 (92.6%) BiVP 
EKGs had RBBB morphology. EKG characteristics identiﬁed in this study with a paced 
RBBB QRS morphology that are associated with RVP but not BiVP (p<0.05) include 
positive concordance in the precordial leads, qR conﬁguration in lead V1 and a late QRS 
transition beyond lead V3. BiVP had shorter QRS duration and was associated with right 
superior quadrant QRS axis (p<0.05). RVP was associated with a mean QRS axis in 
the left superior quadrant (p<0.05). In regard to LV pacing site, LBBB pattern during BiV 
pacing was only found with the LV pacing lead in the middle cardiac vein, and a late 
precordial transition (especially beyond lead V2) was signiﬁcantly associated with a more 
posterior LV lead location (p<0.05).Conclusions: Even among patients with a paced 
RBBB pattern, the 12-lead EKG can help to distinguish RVP from BiVP and to determine 
LV lead location during BiVP. This information may be useful in evaluating non-response 
to BiVP resulting either from LV non-capture (with consequent RVP) or from sub-optimal 
LV lead location during BiVP.
Patient Characteristics with RBBB EKG pattern
Variable RVP(N=50)
BiVP
(N=50)
Age (years) 67.8 + 9.7 69.1+ 10.6
Gender (% Male) 80 78
Mean frontal paced QRS axis (degrees) 291.8+ 9.4 243.3 +11.4
Quadrant of mean paced QRS axis:
Left Superior (%)/Right Superior (%)/Right Inferior (%)/
Left Inferior (%)
70/20/4/6 32/58/6/4
Mean paced QRS duration (ms) 174.6+ 4.4 157.4 + 3.8
QRS conﬁguration in lead V1:
Rs pattern (%)/qR pattern (%)/monophasic R pattern 
(%)/Twin Peaks pattern (%)/Triphasic pattern (%)
46/32/8/8/6 64/0/22/8/6
Mean R/S ratio in lead V1 2.3+ 0.3 2.5+ 0.8
Discordance (%) 86 100
Transition lead:
V1 (%)/V2(%)/V3(%)/V4(%)/V5(%) 7/51/26/9/7 46/42/12/0/0
3:30 p.m.
1038-45 Lead Extraction Practice in the United States
Charles A. Henrikson, Karl Zhang, Jeffrey A. Brinker, Johns Hopkins Medical 
Institutions, Baltimore, MD
Background: Endovascular lead extraction is an infrequently performed procedure, with 
wide variation in practice. We sought to assess differences in perception of risk and to 
determine the variation in degree of surgical support. 
Methods: We surveyed 1400 physician members of the Heart Rhythm Society via email 
solicitation. “Extraction” was deﬁned as the endovascular removal of chronic (in place > 
1 year) leads.
Results: Of the 252 respondents (18%), 221 (88%) reported either performing 
extractions themselves (71%) or having privileges at a hospital where extractions are 
performed (29%). The vast majority reported that extractionists at their center were 
electrophysiologists (83% of sites), although cardiac surgeons also perform endovascular 
lead extraction in signiﬁcant numbers (20% of sites). Most respondents report infrequent 
performance of the procedure at their site: 42% reported 10-25 procedures/year, 22% 
26-50 procedure/year, and only 18% reported performance of >50 procedures/year. 36% 
of respondents reported that extractions were done in the operating room (OR) with the 
surgeon present or immediately available, 39% done in EP lab with surgeon and OR 
identiﬁed and available, and 25% in EP lab without a surgeon or OR identiﬁed. A single 
site reported the performance of lead extraction at a hospital without onsite cardiac 
surgery. For all respondents, 87% felt that active ventricular leads were “easier” or “much 
easier” to extract than passive leads, and similar numbers (66%) felt that extraction of 
recording system was used to obtain simultaneous local activation at baseline and with 
CRT.
Results: In both dyssynchronous and DHF models, CV patterns seen in normal hearts 
(ENDO more rapid than EPI) were reversed in the lateral wall, with a signiﬁcant reduction 
in ENDO CV relative to EPI (FIG, 0.43 + 0.03 m/s vs 0.67 + 0.04 m/s; p=0.008). The 
anterior wall retained a normal CV pattern in both models. In neither model were 
ventricular arrhythmias inducible by programmed stimulation.
Conclusions: Reversal of the normal conduction velocity proﬁle of the lateral wall was 
observed in an animal model of dyssynchrony and DHF. The mechanism of this reversal, 
impact on arrhythmogenesis and response to chronic CRT warrant further investigation. 
3:30 p.m.
1038-42 Evaluation of Negative Response to Cardiac 
Resynchronization Therapy by Multivariate Regression
Xuedong Shen, Mark J. Holmberg, Aryan N. Mooss, Tom Hee, Stephanie Maciejewski, 
Dennis J. Esterbrooks, The Cardiac Center of Crieighton University, Omaha, NE
Background: PROSPECT trial pointed out that no single echocardiographic measurement 
of ventricular dyssynchrony may be recommended to improve patient selection for cardiac 
resynchronization therapy (CRT). We hypothesized that combined echocardiographic, 
electrocardiogram (ECG) and clinical factors may predict CRT response.
Methods: We retrospectively studied 100 patients with CRT (male 73, age 69.9± 9.6 years). 
Follow-up duration was 17± 11 months. Patients with atrial ﬁbrillation and mitral stenosis 
were excluded. Variables in the analysis included 1) age; 2) gender; 3) QRS duration; 
4) intrinsic or right ventricular pacing-induced left bundle branch block (LBBB); 5) left 
ventricular (LV) mechanical dyssynchrony (LVMD) evaluated by tissue Doppler imaging; 6) 
LV restrictive ﬁlling; 7) Wall motion score index (WMSI); 8) LV end-diastolic and end-systolic 
dimensions; 9) Left ventricular ejection fraction; 10) Left atrial volume; 11) Degree of mitral 
regurgitation; 12) Medications for heart failure. Positive response to CRT was deﬁned as LV 
end systolic volume decrease of q15% after CRT. Multivariate regression was used if the 
variables achieved a signiﬁcance level of p< 0.20 by univariate regression.
Results: Intrinsic LBBB (p=0.003), absence of LVMD (p<0.0001) and WMSI (p= 
0.009) were related to negative response to CRT by both univariate and multivariate 
regression. A 3-point score was generated. We assigned 1 point for intrinsic LBBB, 1 
point for absence of LVMD and 1 point for WMSI> cutoff value (>1.59). Higher scores 
represent a poorer response to CRT. Overall mean response score was 1.7 ± 1.0 (0-3). 
The cutoff point for response score to predict negative response to CRT was > 1 by 
ROC analysis. The area under the ROC curve was 0.92 (p= 0.0001). Sensitivity and 
speciﬁcity at response score>1 were 91.2 and 83.7%, respectively. CRT non-responders 
in patients with response score a 1 and > 1 were 5/41 (12%) and 52/59 (88%, p< 0.001), 
respectively. After adjusting for age and gender, the response score remains related to 
CRT non-response (p< 0.0001).
Conclusions: A response score generated from clinical, ECG and echocardiographic 
factors is a useful predictor for CRT response.
3:30 p.m.
1038-43 Acute Increase in Baroreﬂex Sensitivity After 
Institution of Biventricular Pacing Has Predictive 
Value for the Echocardiographic Response to Cardiac 
Resynchronization Therapy
Maaike GJ Gademan, Rutger J. van Bommel, Jan Willem Borleffs, Sum-Che Man, Joris 
CW Haest, Martin J. Schalij, Ernst E. van der Wall, Jeroen J. Bax, Cees A. Swenne, 
Leiden University Medical Center, Leiden, The Netherlands
Background: In a previous study we demonstrated that institution of biventricular pacing 
in chronic heart failure (CHF) acutely facilitates the arterial baroreﬂex. The arterial 
baroreﬂex is known to have important prognostic value in CHF. We hypothesized that 
the acute response in baroreﬂex sensitivity (BRS) has predictive value for the clinical 
response to cardiac resynchronization therapy (CRT).
Methods: One day after implantation of a CRT device in 33 CHF patients (27 male / 6 
female, age 66.5 ± 9.5 years , left ventricular ejection fraction 28 ± 7%) we measured 
noninvasive baroreﬂex sensitivity (BRS) and heart rate variability (HRV) in two conditions: 
CRT device switched-on and switched-off (on/off order randomized). Echocardiography 
was performed prior to implantation (baseline) and six months after implantation (follow-
up). CRT responders were the patients in whom left ventricular end systolic volume 
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1038-48 Disparities in the Use of Implantable Cardioverter-
Deﬁbrillators for Primary Prevention of Sudden Cardiac 
Arrest
Umashankar Lakshmanadoss, Ashim Aggarwal, Kavitha Manne, Vinod Jeevanandham, 
David H. Hsi, Saadia Sherazi, Abrar H. Shah, Unity Health System, Rochester, NY, 
University of Rochester, Rochester, NY
Background: Cardiovascular disease continues to be the leading cause of death, 
with sudden cardiac arrest (SCA) accounting for approximately 50% of all deaths from 
cardiovascular causes. Several randomized trials of implantable cardioverter deﬁbrillator 
(ICD) therapy for the prevention of SCA have been reported, and ICD therapy has been 
consistently efﬁcacious. Most recent literate shows under-utilization of ICD among eligible 
patient population. Furthermore, disparities by gender, race and age exist in the use of an 
ICD. We report utilization of ICD in an ambulatory cardiology practice.
Methods: In this retrospective study, we reviewed data from an ambulatory cardiology 
practice in Rochester NY from December 2007 to May 2008. Patients eligible for 
primary prevention of SCA were included; left ventricular ejection fraction less than 35% 
and NYHA Class II-III. The review of records included age, gender, race and etiology 
of cardiomyopathy (ischemic or non-ischemic). The information regarding an ICD 
implantation included any prior device implantation, referral to the electrophysiologists for 
implant in the future and any contraindication for the procedure. Institutional review board 
of Unity Health system approved the study.
Results: We identiﬁed 10,254 patient records and 275 were eligible for an ICD for 
primary prevention of SCA. Despite meeting the criteria only 116 (42.2%) received an 
ICD. Overall, a signiﬁcantly higher number of men received ICD (50.6% men vs. 30.7% 
women, p 0.001). When compared by race, 39.0% of white subjects vs. 57.9% of non-
white subjects received ICD (p 0.029). The ICD placement was signiﬁcantly less among 
patients > 80 years of age (50.8% vs. 26.7%; p <0.001). Forty six percent of patients 
with ischemic cardiomyopathy received ICD compared to 26.1% of patient’s non-ischemic 
cardiomyopathy (p 0.009).
Conclusion: This study identiﬁes under-utilization of cardiac deﬁbrillator for primary 
prevention of SCA. It also highlights inequality among gender, race and age. Interesting 
ﬁnding is a relatively higher utilization of ICD among non-whites patients. Future research 
should focus on understanding potential barriers for this disparity.
3:30 p.m.
1038-49 Implantable Cardioverter Deﬁbrillator Lead Malfunction 
Most Commonly Occurs Greater Than One Year 
Following Implant
Anastasios P. Saliaris, Larisa Tereshchenko, Charles A. Henrikson, Johns Hopkins 
Hospital, Baltimore, MD
Background: There is little literature describing the overall incidence of implantable 
cardioverter-deﬁbrillator (ICD) lead malfunction. We determined the incidence and time 
course of ICD lead malfunction resulting in inappropriate therapy or necessitating invasive 
therapy.
Methods: We retrospectively reviewed medical records from 372 patients (74% male; 
26% female) who underwent ICD implantation for primary (79%) or secondary (21%) 
prevention of sudden cardiac death. Mean follow-up was 18.7 ± 22.7 months. Signiﬁcant 
lead malfunction was deﬁned as any lead problem leading to surgical intervention.
Results: Single chamber ICDs were implanted in 50% of patients, dual chamber in 
40%, and biventricular in 10%. A total of 13 (3.5%) lead malfunctions were noted. Early 
malfunctions, occurring <7 days following implant, accounted for 8% of malfunctions, while 
delayed malfunctions, occurring >7days but <1 year following implant, accounted for 38%. 
The majority of malfunctions (54%) were noted > 1 year following implant and occurred 
mostly in the right ventricular lead (77%). Patients with right ventricular lead malfunction 
presented with an inappropriate shock in 5 (45%) cases. Malfunctions included insulation 
breaks (31%), dislodgements (31%), and conductor fractures (23%). One patient required 
intervention for a loose set screw and one required lead revision after a right ventricular 
infarct that resulted in poor sensing.
Conclusions: ICD lead malfunction most commonly occurs greater than one year 
following implant and is an important cause of morbidity. Patients receiving ICDs must be 
counseled regarding the potential need for future surgical interventions and the likelihood 
of inappropriate shocks.
active ventricular leads were “less risky” or “much less risky” than passive leads. Similar 
results were found for active atrial leads (86% thought they were easier, and 67% less 
risky than passive). Lastly, the overall risks of lead extraction were felt to be 1-5% of major 
complication and 0.5-1% of mortality, roughly in line with published data.
Conclusions: Extraction is relatively infrequently performed. While there is agreement 
as to the risk of major complication and death, the degree of surgical availability varies 
considerably, suggesting the need for standardization of practice.
3:30 p.m.
1038-46 Left Ventricular Pacing and Biventricular Pacing 
Improve Left Anterior Descending Coronary Artery 
Flow in Patients With Advanced Heart Failure
Luca Rossi, Vincenzo Turco, Edoardo Casali, Vincenzo Malavasi, Maria Grazia Modena, 
Division of Cardiology, Modena, Italy
Background: Asynchronous ventricular activation, induced by left bundle branch 
block (LBBB), is known to have deleterious effects on left ventricle function. Cardiac 
resynchronization therapy (CRT) is an useful method to restore a synchronized contraction 
pattern in patient with reduced ejection fraction and LBBB.
Methods: 37 patient with biventricular pacing implanted for advanced heart failure 
and LBBB underwent transthoracic Doppler echocardiography (TTE) to measure left 
anterior descending coronary ﬂow velocity. Coronary ﬂow velocity was measured during 
biventricular pacing, during left ventricular stimulation and during right ventricular 
stimulation. A correct LAD doppler pattern was obtained in 28 patient, in 9 cases it wasn’t 
possible to have a LAD doppler pattern
Results: Coronary ﬂow velocity resulted signiﬁcantly higher during left ventricular stimulation 
(25.72±6.69 cm/s) or biventricular stimulation (23.82±64.1 cm/s) when compared with the 
values found out during right ventricular stimulation (20.68±54.12 cm/s).
Conclusions: Left ventricular pacing and biventricular pacing improve coronary blood 
ﬂow velocities of the distal LAD in patient with advanced heart failure and LBBB. Our 
ﬁndings suggest that the physiological mechanisms involved in a
successful CRT may be more complex thanthe bare mechanical resynchronization.
3:30 p.m.
1038-47 Regional Variations of Primary Prevention Implantable 
Cardioverter-Deﬁbrillators: Results From the National 
Cardiovascular Data Registry
Dan D. Matlock, Pamela N. Peterson, Paul A. Heidenreich, F. Lee Lucas, David J. 
Malenka, Jeptha P. Curtis, Yongfei Wang, Jean S. Kutner, Elliott S. Fisher, Frederick A. 
Masoudi, University of Colorado Denver Health Sciences Center, Aurora, CO
Background: Use of implantable cardioverter-deﬁbrillators (ICDs) for the primary 
prevention of sudden cardiac death varies by sex and race. Geographic variation in ICD 
use remains unexplored.
Methods: To examine regional variations, we used the NCDR-ICD registry to identify the 
64,220 registered Medicare patients who underwent primary prevention ICD placement in 
2006 and 2007. Using hospital referral regions (HRR) as the unit of regional analysis, we 
calculated age, sex, and race adjusted ICD rates for the entire Medicare population per 
HRR. Regional rate ratios were determined by comparison to the national average rate. 
Next, we evaluated the relationship between these ratios and the supply of cardiologists, 
electrophysiologists (both determined by the American Medical Association Masterﬁle), and 
the proportion of patients meeting the criteria of the major primary prevention trials per HRR.
Results: Substantial variation was found across quintiles of rate ratios of ICD implantation 
(Figure). The variation in rates was not explained by either the supply of cardiologists (R2
=0.01) or electrophysiologists (R2 =0.01) or with the proportion meeting the criteria of the 
major primary prevention trials (R2 <0.01).
Conclusions: There is marked geographic variation in the use of primary prevention 
ICDs in the US which is not explained by the supply of cardiologists, electrophysiologists, 
or adherence to criteria. Whether this variation represents underuse, misuse, or overuse 
needs further study. 
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1038-52 Implantable Cardiac Deﬁbrillator Shocks Do Not Predict 
Death in a Secondary Prevention Population
Apurva Badheka, Ankit Rathod, Mohammad A. Kizilbash, Zongshan Lai, Neha Garg, 
Samrat Bhat, Luis Afonso, Sony Jacob, Wayne State University, Detroit, MI
Background: ICD implantation is standard of care for patients who have survived life 
threatening ventricular tachyarrhythmias (LTVA). ICD shocks predict future adverse events 
in patients with ICD implantation for primary prevention. However role of ICD shocks to 
predict adverse events in a secondary prevention population is unknown.
Methods: The Antiarrhythmics Versus ICDs (AVID) Trial (n=1016) was a randomized 
controlled trial comparing ICD (n=507) and antiarrhythmic drugs (n=509) in the treatment 
of patients with LTVA. Mean follow-up duration was 916 ± 471 days. Data of ICD evaluation 
and event adjudication carried out by primary investigators in the NHLBI AVID Limited 
Access Dataset was used for this analysis. ICD shocks were categorized as appropriate if 
underlying rhythm triggering the shock was ventricular tachycardia or ventricular ﬁbrillation 
and inappropriate if it was due to atrial ﬁbrillation, any supraventricular tachycardia or 
other inappropriate sensing.
Results: Data on ICD therapy was available for 420 patients. Any shock (n=380), any 
appropriate (n=296) or any inappropriate (n=72) shock was not associated with increased 
all cause, cardiac or arrhythmic mortality. However any appropriate shock was associated 
with increased rLTVA.
Conclusion
In LTVA survivors, ICD shocks do not confer increased risk of arrhythmias or death on 
follow up. Use of ICD shocks as surrogate marker for adverse outcomes is not viable in 
secondary prevention patients. 
3:30 p.m.
1038-53 Mortality in Dialysis Patients With a Deﬁbrillator: A 
Quantitative Meta-Analysis
Rahul Sakhuja, Mary Keebler, Tai-Shaun Lai, Cara McLaughlin Gavin, Ranjan Thakur, 
Deepak L. Bhatt, Massachusetts General Hospital, Boston, MA, Brigham and Women’s 
Hospital, Boston, MA
Background: Patients on dialysis are at high risk for sudden cardiac death. Although 
clinical trials have shown that implantable cardiac deﬁbrillators (ICD) are effective 
in improving survival in a variety of populations, dialysis patients have been routinely 
excluded from these analyses. The purpose of this meta-analysis was to synthesize 
the available evidence regarding the effectiveness of ICD therapy in patients receiving 
dialysis.
Methods: We searched MEDLINE, EMBASE, Web of Science, and Google Scholar for 
pertinent studies published from 1999 - 2008. In addition, we performed hand searches 
of the relevant annual scientiﬁc sessions and major scientiﬁc meetings in North America 
and Europe from 2000 - 2008. All clinical reports describing outcomes of ICD therapy in 
relation to renal function were eligible. Four investigators independently extracted the data 
in a standardized manner.
Results: We identiﬁed 7 studies with a total of 2516 patients and 89 patients receiving 
dialysis. Despite having an ICD, there was still a 2.67-fold increase in mortality in patients 
undergoing dialysis compared with patients not undergoing dialysis. Results were similar 
in both ﬁxed and random effects models. When comparing patients on dialysis and those 
with chronic kidney disease but not on dialysis, there was no signiﬁcant difference in 
mortality (RR 1.62, 95% CI 0.84-3.14). We found no evidence of publication bias. 
Compared with trials with <75% patients on beta-blockers, trials with >75% patients on 
beta-blockers found a higher mortality among patients on dialysis and a lower mortality 
rate for patients not on dialysis. Despite signiﬁcant heterogeneity in studies included 
(Q 25.4 (p<0.001), I2 76.4), other trial-level variables, such as mean follow-up time and 
sample size, did not signiﬁcantly affect the results in a meta-regression. We found no 
evidence of publication bias.
Conclusions: This meta-analysis suggests that even among those with ICDs, there is 
still a 2.67-fold increased mortality risk in patients who receive dialysis compared with 
those who do not. Beta-blockers may be less cardioprotective among patients with ICDs 
who are on dialysis.
3:30 p.m.
1038-50 Increased Intracardiac Variability of the QRST Integral 
Ratio Predicts Fast Ventricular Tachyarrhythmias
Larisa G. Tereshchenko, Johns Hopkins University, Baltimore, MD
Background: Novel marker for prediction of the fast ventricular tachycardia (FVT)/ 
ventricular ﬁbrillation (VF), named QRST integral ratio (QRSTIR) variability index, was 
proposed and tested in this study.
Methods: Far-ﬁeld (FF) intracardiac electrogram (EGM) was recorded at rest (mean 
heart rate 65 ± 15 bpm) for 4.5 ± 1.3 minutes in 448 patients (mean age 58 ± 14; 329 
male [74%]) with ischemic (268 patients, 60%) and non-ischemic (180 patients, 40%) 
cardiomyopathy and implanted single- or dual-chamber Medtronic ICD for primary (339 
patients, 76%) or secondary (109 patients, 24%) prevention of sudden cardiac death. 
Patients were followed prospectively at least 18 months; sustained FVT/VF events (cycle 
length less than 240 msec) with appropriate ICD shocks served as endpoints for analysis. 
The QRSTIR variability index was calculated as the logarithm of the variance of the 
ratio of positive to negative areas under the QRST curve normalized by the heart rate 
variance.
Results: During mean follow-up of 16 ± 7 months, 28 (6.2%) patients sustained FVT/VF 
events and received appropriate ICD shocks. The Kaplan-Meier survival analysis showed 
that the highest quartile of FF EGM QRSTIR variability index predicts FVT/VF event-free 
rate (88% vs. 97%, Log Rank test p = 0.015; Figure 1A). In ROC curve analysis (Figure 
1B) area under the curve = 0.655, p=0.045. Conclusion: In this prospective study, 
QRSTIR variability index measured from FF intracardiac electrograms is associated with 
increased risk of FVT/VF events. 
3:30 p.m.
1038-51 Clinical Characteristics and In-Hospital Outcome of 
Patients With End-Stage Renal Disease on Dialysis 
Referred for Implantable Cardioverter Deﬁbrillator 
Implantation
Atul Aggarwal, Yongfei Wang, John S. Rumsfeld, Jeptha Curtis, Paul A. Heidenreich, on 
behalf of National Cardiovascular Data Registry, Nebraska Heart Institute, Hastings, NE, 
Yale University, New Haven, CT
Background: Little is known about clinical proﬁle and in-hospital outcome of patients 
with End Stage Renal Disease (ESRD) who undergo implantable converter deﬁbrillator 
(ICD) implantation.
Methods: Patients undergoing ﬁrst time device implantation in NCDR ICD registry from 
01/01/06-12/31/07 were analyzed (n=164,069). ESRD patients receiving dialysis were 
compared with patients without ESRD. Primary outcome was in-hospital complications. 
Because length of stay of ESRD patients was signiﬁcantly longer (8 days vs 4 days), 
complications rates within 2 days of implantation were also examined.
Results: Overall, 6,851 patients (4.4%) were receiving dialysis. ESRD patients had 
higher rates of comorbid conditions, major and total complications (Table), and were less 
likely to receive an ICD for primary prevention. Despite comparable appropriateness of 
ICD implantation (SCD-HeFT/MUSTT/MADIT II criteria), ESRD patients were less likely 
to receive B-blockers and ACE inhibitors (P<0.0001 for both). Multivariable analysis 
conﬁrmed that ESRD was independently associated with total in-hospital complications 
(odds ratio OR = 1.37, 95% CI=1.22-1.53), and total complications at 2 days (OR=1.12, 
95% CI=0.1.05-1.35).
Conclusions: ESRD patients who present for ICD implantation have multiple 
comorbidities, and higher rates of in-hospital complications even when accounting 
for overall longer length of hospital stay. Strategies to decrease complications among 
patients with ESRD need exploration.
ESRD Patients 
(n=6,851)
Patients without ESRD 
(N=156,218) P-value
Diabetes mellitus 59% 36% <0.0001
Hypertension 83% 74% <0.0001
Atrial ﬁbrillation 34% 31% <0.0001
Ventricular tachycardia 40% 34% <0.0001
Cardiac arrest 17% 9% <0.0001
Major complications in-hospital 2.2% 1.3% <0.0001
Total complications in-hospital 5.1% 3.5% <0.0001
Major complications within 2 days 1.4% 1.1% 0.08
Total complications within 2 days 3.7% 3.0% 0.002
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1038-56 Implantable Cardioverter Deﬁbrillator Recipients: 
Comparison of Primary and Secondary Indicated 
Patients During Long-Term Follow-up
C. Jan Willem Borleffs, Guido H. van Welsenes, Lieselot van Erven, Rutger J. van 
Bommel, Enno T. van der Velde, Frits R. Rosendaal, Ernst E. van der Wall, Jeroen J. 
Bax, Martin J. Schalij, Leiden University Medical Center, Leiden, The Netherlands
Background: Large trials have shown the beneﬁcial effect of an implantable cardioverter 
deﬁbrillator (ICD) for secondary, as well as primary prevention of sudden death. The aim 
of this study was to assess the long-term follow-up of ICD recipients and to compare 
patients with a primary to those with a secondary indication.
Methods: A total of 1870 consecutive patients (1519 male, age 63±12 years) were 
evaluated at ICD implantation. Seven-hundred-eighty-seven patients (42%) received 
an ICD for secondary prevention: after a ventricular arrhythmia lasting longer than 
30 seconds or with hemodynamic consequences. The remaining 1083 had a primary 
indication. During follow-up, all events triggering appropriate device therapy and death 
were noted.
Results: During a mean follow-up of 39±31 months, a total of 323 (17%) patients died. 
Appropriate device therapy was noted in 590 (32%) patients, consisting of 2.3±5.3 shocks 
and 24.8±148.0 ATP. Cumulative event rate (Figure) for death after six years was 28% for 
primary prevention and 26% for secondary prevention (p=0.13). Calculated cumulative 
rate of appropriate therapy at six years was 34% for primary prevention and 52% for 
secondary prevention (p<0.001).
Conclusions: In a large cohort of ICD-recipients, comparison of the long-term follow-
up in patients with a primary or a secondary indication shows major differences in the 
occurrence of ventricular arrhythmias, causing ICD therapy. Survival is not signiﬁcantly 
different between the two groups.
3:30 p.m.
1038-57 Subcutaneous Only Implantable Cardioverter 
Deﬁbrillators
Gust H. Bardy, Warren Smith, Margaret Hood, Andrew Grace, Ian Crozier, Iain Melton, 
Seattle Institute for Cardiac Research, Seattle, WA
Background: Transvenous (TV) implantable cardioverter deﬁbrillators (ICDs) prevent 
sudden death but also cause serious surgical complications. Further, device recalls from 
TV lead failure can threaten large patient populations and result in enormous costs. This 
report describes the ﬁrst human experience with a subcutaneous-only ICD speciﬁcally 
engineered to avoid TV leads.
Methods and Results: Six patients with standard ICD indications received a 
subcutaneous-only ICD system, S-ICDTM, (Cameron Health, Inc., San Clemente, CA). All 
patients were provided full disclosure about relative risks and provided informed consent. 
No patient required anti-bradycardia or anti-tachycardia pacing.
The S-ICD consists of a single left parasternal tripolar electrode and an electrically active 
pulse generator positioned in the left anterior axillary line between the 5th and 6th ribs. Only 
anatomic landmarks were used for the surgical procedure (i.e., no ﬂuoroscopy). VF was 
induced and terminated twice using 65J shocks to ensure an adequate safety margin; 
the S-ICD delivers 80J shocks for spontaneous VT/VF. A discrimination zone that uses a 
waveform analysis and rate detection algorithm can be programmed between 170 - 250 
bpm to avoid inappropriate shocks for supraventricular tachycardia, non-sustained VT and 
double detection. The device has only 4 programmable parameters: post-shock pacing 
off/on, discrimination zone off/on, and lower and upper rate limits for the discrimination 
zone. Over 2.5 months of follow-up no spontaneous VF/VT events occurred. Importantly, 
no false positive shocks occurred after a total of 35 million (M) detected heart beats.
Conclusion: This is the ﬁrst report of a fully subcutaneous-only ICD that can be inserted 
without ﬂuoroscopy using only anatomic landmarks. In this early clinical experience, the 
S-ICD has detected and terminated induced VF without difﬁculty. Equally importantly, it 
has avoided inappropriate therapies after monitoring more than 35M heartbeats. In this 
early experience, the S-ICD appears to offer a viable alternative to traditional transvenous 
ICD systems where protection from cardiac arrest is indicated.
3:30 p.m.
1038-58 Effect of Renal Disease on Recurrent Arrhythmia and 
Death in Survivors of Life Threatening Ventricular 
Tachyarrhythmias
Apurva Badheka, Ankit Rathod, Mohammad A. Kizilbash, Zongshan Lai, Neha Garg, 
Samrat Bhat, Ashok Kondur, Luis Afonso, Sony Jacob, Wayne State University, Detroit, MI
Background: Renal disease (RD) is associated with increased cardiac and non cardiac 
mortality. However role of RD in recurrence of life threatening ventricular tachyarrythmias 
(rLTVA) has not been well studied.
Methods: The Antiarrhythmics Versus ICDs (AVID) Trial (n=1016) was a multicenter 
3:30 p.m.
1038-54 Clinical Course and Six-Month Mortality of Patients 
With Malignant Ventricular Tachyarrhythmia Within 48 
Hours of Acute Myocardial Infarction in the Setting of 
Individually Optimized Therapy: Results From the CAMI 
Multicenter Regsitry
Torsten Becker, Thomas Kleemann, Margit Strauss, Ralf Zahn, Claus Schmitt, 
Ulrich Tebbe, Matthias Pauschinger, Hugo Katus, Wolfgang von Scheidt, Georg 
Sabin, Johannes Brachmann, Karlheinz Kuck, Karlheinz Seidl, Arrhythmia Center 
Ludwigshafen, Ludwigshafen, Germany, Asklepios Klinik St. Georg, Kardiologie, 
Hamburg, Germany
Background: Newer data support the hypothesis that VT/VF in the setting of acute 
myocardial infarction (AMI) is a predictor for mortality even in pts with preserved EF. 
Therefore, a randomized trial of ICD implantation vs. coventional therapy in these pts 
may be reasonable.
Methods: German multicenter prospective registry with the inclusion criteria: VF/VT 
within the 48 hour interval of AMI, individually optimized therapy applied. The observed 
rate of sudden cardiac death (SCD) and ICD implantation for secondary prophylaxis 
during a follow-up of 6 months was used to calculate the propability for a factual event 
rate of 5% for SCD in a future randomized trial, giving reference if it would be relevant 
and feasible.
Results: Over 2.5 years 129 pts with VF/VT within 48 hours of AMI were included from 9 
German centers. Tbl.1 shows clinical characteristics.
Tbl. 1
Age [y] 59 (50-68)
Female gender 33 (26%)
Diabetes 14 (11%)
Median duration of resuscitation [min] 10 (3-20)
ST elevation AMI 105 (82%)
Performed PCI/Thrombolysis 123 (95%)
Median ejection fraction [%] 55 (45-65)
Time on intensive care unit [d] 4 (2-8)
During index stay 1 pt had VF > 48 hours after AMI and received an ICD, 4 pts (3%) 
died intrahospital. During follow-up 3 pts died (2.4%) with SCD in 2 pts (1.6%) and 3 
pts (2.4%) received an ICD for secondary prophylaxis. As 6 pts (4.6%) suffered of the 
predeﬁned events the calculated propability for the factual event rate to be at least 5% 
exceeds 80 %.
Conclusions: 1. During 6 months after AMI complicated by VT/VF 5% of pts died. 2. 
The observed event rate of SCD and ICD for secondary propyhlaxis during follow-up 
was 4.6% 3. A propability of > 80% for a factual event rate of 5% in 6 months for a future 
randomized trial can be calculated, therefore it would be relevant and feasible.
3:30 p.m.
1038-55 Low Penetration of Device Therapy in CRT/ICD 
Indicated Patients and Related Long-Term Outcome: 
Final Results of the CRediT Heart Failure Registry
Christoph Stellbrink, Ernst G. Vester, Medical Center Bielefeld, Bielefeld, Germany, 
Evangelic Hospital Duesseldorf, Duesseldorf, Germany
Background: Based on the COMPANION study the CRediT registry evaluated data on 
the prevalence and perspectives of high risk heart failure patients (pts) in daily practice. 
The chosen therapeutic options - e.g. conventional, CRT or ICD therapy - and the long 
term outcomes were documented.
Methods: From Feb. 04 to Sep. 06 3,148 pts with heart failure NYHA III or IV and/or a low 
ejection fraction (EF a.35) were screened in 101 German centers - primary care hospitals 
and private practitioners - using online data entry. Source data veriﬁcation was performed 
by clinical monitors. Follow up (FU) data was received primarily from the patient. In cases 
of cardiac events, interventions or death, physicians´ reports were requested. As in 
COMPANION the primary endpoint of CRediT was all cause mortality or hospitalization. 
Secondary endpoints were mortality and cardiac morbidity. FU was done after 2 months, 
then semi-annually up to 4 years. The registry was closed in Dec. 2007.
Results: Utilization of device therapy: Analysis of 2,560 pts with FU (71.8% men, 
67.7±10.7 years) revealed 22.3% had characteristics similar to COMPANION (NYHA III/
IV, EFa.35, QRSq120ms). The MADIT II/SCD-HeFT criteria were met in 18.0 / 71.9%, 
respectively. After two months only 11.9% of the COMPANION- like pts received a CRT 
device and 6.4 / 5.5% of the MADIT II/SCD-HeFT pts got an ICD (“timely”). Another 7.9% 
/ 10.5% / 7.5% got a device later during the course of the registry.
Long term outcome: In the COMPANION-like group of the CRediT registry, device therapy 
(by CRT-D, CRT-P or ICD) was associated with a signiﬁcant reduction of all cause mortality 
by 46.9% (p=.009). Subanalysis revealed a mortality decrease of 59.9%/28.8%/51.8%, 
with p<.05 for CRT-D only.
Conclusion: In the CRediT registry the prevalence of high risk patients in a heart failure 
population with a class I indication for CRT or ICD - based on the results of COMPANION, 
MADIT II and SCD-HeFT - is high. There was a clear discrepancy between the number 
of patients eligible for CRT or ICD therapy and the actual frequency of device implants. 
In this registry, device therapy was associated with a signiﬁcant decrease of all cause 
mortality in heart failure patients also in a real-world environment.
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Black ICD candidates were younger than White or Hispanic candidates (mean age 
66.0 vs. 71.4 and 70.4 years, P<0.05), and had fewer comorbid conditions than White 
candidates (mean 4.15 vs. 4.27, P <0.05). In-hospital mortality for Black ICD candidates 
was lower than for Whites or Hispanics (2.2% vs. 3.2% and 2.9%, P<0.0001). Within one 
year of diagnosis of ICM, 6.0% of Blacks received an ICD as compared to 7.0% for Whites 
and 6.1% for Hispanics (P=0.0002; Black vs. White). In multivariable models Blacks were 
signiﬁcantly less likely to receive an ICD than Whites (OR: 0.793, 95% CI 0.722-0.870, 
P=<0.0001) while Hispanics were not less likely than Whites (OR: 0.847, 95% CI: 0.673-
1.064, P=0.154).
Conclusion: Black veterans with ICM are signiﬁcantly less likely to receive ICDs as 
compared to Whites. Given that all veterans theoretically have similar access to ICDs, our 
ﬁndings suggest that differences in patient preferences or provider decision making may 
play a role in racial disparities in ICD use.
3:30 p.m.
1038-61 Deﬁbrillation Threshold Testing Should Not Be 
Abandoned in Patients Receiving an Implantable 
Cardioverter Deﬁbrillator for Primary Prevention.
Tanyanan Tanawuttiwat, Adarsh Bhan, Tasma Harindhanavudhi, Manoj Duggal, Marc A. 
Silver, Department of Internal Medicine, Advocate Christ Medical Center/University of 
Illinois at Chicago, Oak Lawn, IL
Background: While routine deﬁbrillation threshold (DFT) testing in patients receiving 
implantable cardioverter deﬁbrillator (ICD) for primary prevention is being challenged, the 
debate is far from over. With improving technology, DFTs have been lower but patients 
with high DFTs are still encountered. Accurately predicting patients with high DFTs 
remains difﬁcult.
Methods: Single center retrospective study included 186 patients who underwent 
ICD implantation for primary prevention from January 2007 to August 2008. Baseline 
characteristics including age, gender, body mass index (BMI) and medications were 
recorded. DFT estimation was performed with shock on T wave protocol with initial 
therapy of 10-20 J based on a modiﬁed upper limit of vulnerability assessment. A 10 J 
safety margin was considered necessary. If DFT was greater than 25 J or with less than 
10 J safety margin, lead repositioning, altering vectors or additional subcutaneous coils 
were placed to achieve a 10 J safety margin.
Results: Baseline DFT data were available for 177 patients (95.16%) (Mean age 
64.61±13.79). 65.5% were male and 59.2% had ischemic cardiomyopathy. All patients 
were on optimized medications and had ejection fraction (EF) < 35% (Mean 26.90±6.83). 
The DFT was a 20 J in 146 patients (82.48%). Thirteen patients (7.34%) had DFT q 25J. 
Eleven of those underwent lead revision and two were implanted subcutaneous coils. 
There were no major complications due to ICD placement or DFT testing. Interestingly, 
the patients in the high DFT group (> 20J) had higher proportion of non-ischemic 
cardiomyopathy than those with low DFT(a 20J) (p< 0.002). There were no signiﬁcant 
differences in age, BMI, EF, blood pressure, heart rate and medications.
Conclusion: A signiﬁcant percentage of High DFTs are still encountered, 7.34% in our 
patient population. This may lead to lead revision or placement of additional subcutaneous 
coils. Predicting this has not been reliable. Being implanted for primary prevention it is 
not justiﬁable to abandon routine DFT testing. Till a prospective trial is undertaken, this 
controversy will continue.
3:30 p.m.
1038-62 Deﬁning the True ICD Utilization Treatment Gap
Shaw R. Natan, Muzzamal Habib, Ganesh Athappan, Laura Immordino, Michael 
Orlov, David Whellan, St. Elizabeth’s Medical Center, Boston, MA, Thomas Jefferson 
University, Philadelphia, PA
Background: ICD therapy is life saving in patients with EF<35% after appropriate 
medical therapy and/or revascularization. Multicenter observational registries estimate 
that ICD utilization rates range from 25-42% in primary prevention pts. We attempted to 
better deﬁne this population. 
Methods: Patients with EF<35% were randomly selected from an echo database at two 
institutions from 2005-2007 and followed. All available electronic inpatient and outpatient 
medical records were reviewed. Patient’s ICD candidacy was based on 2006 ACC/AHA 
guidelines. Patients without an ICD were categorized as either ineligible or missed. 
Missed patients were characterized as a patient miss if they refused an ICD or were lost 
to scheduled cardiology/EP follow up, or a physician miss if there was no documented 
assessment for ICD candidacy. 
Results: N= 450 pts, mean age = 69 (range 28-96), M= 307 F= 147. See table. Physician 
misses occurred more frequently on a non-cardiology service vs. cardiology service (22% 
vs. 7% p<0.05) . 
randomized controlled trial comparing ICD (n=507) and antiarrhythmic drugs (AAD) 
(n=509) for secondary prevention in patients with LTVA. Mean follow up duration is 916 
± 471 days. End point was rLTVA. Cox proportional analysis of NHLBI AVID Limited 
Access Dataset was carried out while controlling for medication use, ejection fraction, 
hypertension, smoking, atrial ﬁbrillation, age and history of myocardial infarction at 
baseline.
Results: 41 patients had RD in both the ICD and AAD arms. RD was an independent 
predictor of rLTVA, cardiac death and all cause mortality in the AAD arm. RD was also 
a predictor of all cause mortality in the ICD arm. RD did not inﬂuence occurrence of 
appropriate, inappropriate or total shocks. (p=NS)
Conclusion: No prior study has investigated the effect of renal dysfunction on secondary 
prevention of LTVA. ICD implantation is protective against recurrent arrhythmias and 
cardiac death in renal patients when compared to AAD. 
3:30 p.m.
1038-59 End-Stage Renal Disease Predicts Complications in 
Device Implants
Christine Tompkins, Alan Cheng, Darshan Dalal, Jeffrey A. Brinker, Charles T. Leng, 
Joseph E. Marine, Saman Nazarian, David D. Spragg, Sunil Sinha, Henry Halperin, 
Gordon F. Tomaselli, Ronald D. Berger, Hugh Calkins, Charles A. Henrikson, Johns 
Hopkins Hospital, Baltimore, MD
Background: Little information is available assessing relative complication rates at the 
time of device implantation in patients with end-stage renal disease (ESRD).
Methods: We reviewed the medical records of patients undergoing ICD or pacemaker 
implantation from August 2004 - August 2007. Within this cohort, we assessed the 
association between ESRD and the development of procedure-related complications. 
Bleeding complications were deﬁned as: need for pocket exploration or blood transfusion; 
hematoma requiring pressure dressing or change in medical therapy; or prolonged 
hospitalization. Infection was deﬁned as deﬁnite infection of the pocket or lead system 
identiﬁed within 60 days of implantation.
Results: Of the 1388 patients reviewed, 38 patients had ESRD requiring hemodialysis. 
Overall, there were 73 bleeding complications (5.3%) and a total of 3 procedure-related 
infections (0.22% of cases). Infection rates were signiﬁcantly higher in patients with 
ESRD requiring hemodialysis when compared to patients without ESRD (5.3% vs. 0.07%; 
p<0.0001). Similarly, a signiﬁcant increase in bleeding complications was observed in 
those with ESRD when compared to the study population (21.1% vs. 5.3%, respectively; 
p<0.001). The incidence of signiﬁcant bleeding complications in those with a creatinine > 2 
was considerably greater than those with a creatinine < 1.0 (14.9% vs. 3.5%, respectively; 
p<0.0001) and creatinine 1.0-2.0 (14.9% vs. 5.9%; p=0.002) for the study population.
Conclusions: End-stage renal disease signiﬁcantly increases the risk of device-
related infections in our study population. Similarly, bleeding complications occur at a 
markedly elevated rate in this patient population. Progressive renal dysfunction shows 
a corresponding rise in the risk of bleeding complications that increases in parallel with 
the severity of renal dysfunction. Further research is needed to determine how to make 
device implantation safer in this patient population.
3:30 p.m.
1038-60 Racial Variation in Implantable Cardioverter Deﬁbrillator 
Placement for the Primary Prevention of Sudden 
Cardiac Death in Veterans
James N. Mohn, Kelly K. Richardson, Mary S. Vaughan-Sarrazin, Peter M. Cram, 
University of Iowa Hospitals and Clinics, Iowa City, IA, Center for Research in the 
Implementation of Innovative Strategies in Practice, VA Medical Center, Iowa City, IA
Background: Implantable cardioverter-deﬁbrillator (ICD) placement for the primary 
prevention of sudden cardiac death (SCD) has expanded in the last decade as evidence of 
beneﬁt has evolved and reimbursement formalized. Our goal is to evaluate racial variation 
in the use of ICDs among Veterans with newly diagnosed ischemic cardiomyopathy 
(ICM).
Methods: We used 2003-2007 Veterans Health Administration patient treatment ﬁles 
to identify beneﬁciaries with newly diagnosed ICM and no history of ICD implantation 
using ICD9-CM codes. Comorbid conditions were identiﬁed using the method of Quan 
et al. The principal outcome was receipt of an ICD within one-year of initial diagnosis of 
ICM. We compared demographics, rates of comorbid illness, and receipt of ICDs among 
Blacks, Hispanics and Whites with newly diagnosed ICM. We used multivariable models 
to examine odds of ICD implantation for Blacks as compared to Whites after adjusting for 
patient demographics and comorbidity.
Results: Between 2003 and 2007, we identiﬁed 56,272 veterans (mean age 70.2 years) 
with newly diagnosed ICM who we considered candidates for ICD; 98.2% were male, 
70.2% were White, 20.6% Black, 2.5% Hispanic, 1.3% Other and 5.3% Missing race. 
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worsening outcomes with advancing stages of CKD. The current ACC guidelines for ICD 
implantation give a class III recommendation for those with an expected survival of 12 
months or less. In our study, patients with Stage 5 CKD had only marginally better survival 
of 21 months. The impact of CKD should be carefully evaluated by patients and physicians 
as an important prognostic marker when considering ICD implantation.
3:30 p.m.
1038-65 Post-Operative Renal Dysfunction in Patients 
With Pacemaker or Deﬁbrillator Related Infection 
Undergoing Lead Extraction
Parijat Saurav Joy, Hari P. Joshi, Mark Mascarenhas, Mohammad H. Pirastehfar, 
Michelle Vrabel, John M. Fontaine, Steven P. Kutalek, Mohammed Al-Bataineh, Drexel 
University College of Medicine, Philadelphia, PA
Background: Patients with infected pacemaker or deﬁbrillator (device) undergoing 
therapy with lead extraction and antibiotic therapy, have often been observed to develop 
post operative renal dysfunction.
Methods: We prospectively reviewed hospital records of 118 patients with documented 
device associated infection that underwent device extraction at our institution. Incidence of 
post-operative (post-op) renal dysfunction, baseline co-morbidities and choice of antibiotic 
therapy were studied. Post-op renal dysfunction was deﬁned as a relative (>50%) or 
absolute (>0.5 mg/dL) increase in serum creatinine from the pre-operative baseline.
Results: In the studied population, the mean age was 68 years, 73% were male, and 
41% had infections with Staphylococcus (aureus or epidermis). Comorbidities present were: 
baseline chronic kidney disease (26%), diabetes mellitus (38%), coronary disease (57%) 
and congestive heart failure(57%). Post-op renal dysfunction occurred in 32(27%). Culture 
proven bloodstream infection and/or intracardiac vegetation was present in 22/32(69%) 
who developed acute renal insufﬁciency (ARI) but only in 34/86(40%) who did not develop 
ARI (p= .007). Among patients with positive pocket wound culture, incidence of ARI was 
13/32(41%) with a non-signiﬁcant p=0.27. ARI occurred in 6/13(46%) of patients on nafcillin-
based regimen versus 26/105(25%) of patients on a non-nafcillin based regimen (p=0.02).
Conclusions: Compared to commonly known risk factors for renal insufﬁciency, only the 
presence of positive blood culture and/or intracardiac vegetation was associated with 
post-op renal dysfunction, in patients undergoing lead extraction for therapy of device 
related infections. Further research is needed to evaluate a causal relationship.
3:30 p.m.
1038-66 Changing Patterns of Deﬁbrillation Testing at the Time 
of Implantable Cardioverter Deﬁbrillator Insertion Over 
the Past Eight Years
Andrea M. Russo, Edward P. Gerstenfeld, Sanjay Dixit, Peter Leong-Sit, Mathew 
Hutchinson, Michael Riley, Rupa Bala, Fermin Garcia, David Lin, Ralph J. Verdino, 
Joshua Cooper, Vickas Patel, David J. Callans, Francis E. Marchlinski, University of 
Pennsylvania, Philadelphia, PA
Background: With high output devices, active cans, and biphasic waveforms, the need 
for deﬁbrillation (DEFIB) testing at the time of implantable cardioverter deﬁbrillator (ICD) 
implantation has been questioned. However, clinical trials demonstrating efﬁcacy of ICDs 
in primary and secondary prevention of sudden cardiac death have all involved induction 
of VF to document effective arrhythmia termination. We investigated changing patterns 
of ICD implant testing.
Methods: A retrospective review of ICD records was performed at our center to determine 
the frequency of DEFIB testing over the past 8 years in 2407 consecutive patients (pts) at 
implant, excluding routine generator replacements.
Results: Pts were divided into 3 groups, based on year of ICD implant (group 1 = 2000 
to 2002, group 2 = 2003 to 2005, group 3 = 2006 to 2008). Comparisons were made 
using ANOVA and chi square analysis. In pts who underwent testing, mean DEFIB was 
18.1 ± 5.5 J. In more recent years, pts were younger, more likely to be female, and 
less likely to undergo DEFIB testing (p<0.01). (Table) Common reasons for no testing 
include LA thrombus, LV thrombus, recent CVA or TIA, atrial ﬁbrillation without adequate 
anticoagulation, hemodynamic instability, severe aortic stenosis, and severe CAD.
Conclusions: An increasing number of pts do not have DEFIB testing performed at ICD 
implant. A prospective trial evaluating efﬁcacy of arrhythmia termination and mortality 
during follow-up is needed to support or refute current practice trends.
Group#: 1 2 3 p =
N= 786 995 626
Mean age (years) 64.6
±13.9
62.9
±14.7
58.9
±16.6 <0.01
Sex (% women) 23% 26% 34% <0.01
LVEF (%) 30.6
±14.9
26.1
±12.8
28.7
±15.1 <0.01
No DEFIB testing (%) 10.4% 18.6% 29.6% <0.01
Conclusions: The ICD utilization rate of 42% in this two center study was similar to 
larger multicenter studies. However, after correcting for contraindications and pt 
refusal, the physician miss rate was only 10% of screened pts. Multicenter registries 
likely overestimate missed patients because they do not capture pt refusal and patient 
contraindications may only be evident in the medical record. Educational efforts targeting 
non-cardiology providers may improve ICD utilization.
3:30 p.m.
1038-63 Does ICD Implantation Improve Survival After 
Septal Myectomy for Hypertrophic Obstructive 
Cardiomyopathy?
Alaeddin M. Ayyad, Kenneth Mayuga, Omar Batal, Sara Mekuria, Harry M. Lever, 
Nicholas Smedira, Mina K. Chung, Cleveland Clinic, Cleveland, OH
Background: While implantable cardioverter-deﬁbrillators (ICDs) have prevented sudden 
death in selected patients with hypertrophic cardiomyopathy (HCM), studies showing 
improved mortality after septal myectomy suggest that ICDs may be unnecessary after 
myectomy. We aimed to determine whether ICDs are associated with better survival after 
septal myectomy in patients with HCM.
Methods: Patients with HCM who had septal myectomy (without aortic valve repair/
replacement) were identiﬁed from prospectively collected databases of HCM patients 
and ICD procedures and their medical records reviewed. Mortality rates were determined 
from the Social Security Death Index. Kaplan-Meyer and Cox regression analyses were 
performed.
Results: In 663 HCM patients with septal myectomy, mean age was 60.2 ± 15.4 yrs, and 
39 patients received ICD implants post-myectomy. Of 15 patients with regular follow up, 3 
(20%) received appropriate ICD therapy for ventricular arrhythmias. Over a mean follow up 
of 6.5 years, 73 patients died. No patient with an ICD died; all 73 deaths occurred in patients 
without an ICD (11.6%, Kaplan-Meier log rank p = 0.02, Figure) Patients with ICD implants 
were younger on average and age was an independent predictor of increased mortality.
Conclusion: In septal myectomy patients, there remains a trend toward survival beneﬁts 
associated with ICDs. However, ICDs tended to be implanted in younger patients. Long 
term survival beneﬁts among these patients should continue to be studied. 
3:30 p.m.
1038-64 The Effect of Renal Function on Survival After 
Implantable Cardioverter Deﬁbrillator Placement
Casey S. Hager, Jeffrey Blackwell, Sunil Jain, Benjamin Culp, Elaine Davis, Charin 
Hanlon, Christopher D. Chiles, Texas A+M University Health Science Center at Scott 
and White Hospital, Temple, TX, West Virginia University at Charleston Area Medical 
Center, Charleston, WV
Background: Despite optimal medical therapy, congestive heart failure is associated with 
annual mortality rates as high as 10%. Numerous studies have demonstrated the efﬁcacy 
of ICDs in reducing arrhythmic death in patients with systolic heart failure. However, few 
studies have investigated outcomes after ICD implantation in patients with chronic kidney 
disease (CKD).
Methods: We conducted a multicenter retrospective study of 958 patients who had 
undergone ICD placement for primary prevention of sudden death between 2000 and 
2006. Patients were stratiﬁed into ﬁve groups based on chronic kidney disease stage. Data 
was collected by manual chart review, and Social Security Death Index was referenced 
for survival status and date of death. Cox Proportional Hazards Model was performed for 
multivariate analysis and Kaplan Meier was performed to assess mortality.
Results: Of 958 patients included in the analysis, 73 (7.6%) had died within 1 yr. Mortality 
at one year increased with worsening CKD (1.75%, 5.32%, 9%, 22.2%, and 38.46% for 
stage 1-5, respectively, p < 0.0001). After multivariate analysis, CKD was found to be an 
independent predictor of mortality; HRs 1.0, 1.075 (95% conﬁdence interval [CI] 0.578-
2.0), 1.372 (CI 0.736-2.556), 3.092 (CI 1.52-6.29), and 10.15 (CI 4.25-24.23) for stages 
1-5, respectively( p <0.0001 for group). Patients with stage 5 CKD were much more likely 
to die during the study than patients with stage 1 CKD (OR 35.0, CI 5.85- 209.6, p < 
0.0001), with a median survival of 21 months.
Conclusions: CKD is an independent predictor of mortality in patients undergoing ICD 
implantation for primary prevention of sudden death. Our study, which is the largest 
analysis of the impact of CKD in patients undergoing ICD implantation, demonstrates 
JACC March 10, 2009 ABSTRACTS - Cardiac Arrhythmias  A135
C
ardiac A
rrhythm
ias
The % of CRT ON pts with a decrease of a15% in LVESVi ranged from 75% (170-230 ms 
group) to 31% (120-129 ms group), the % of CRT OFF pts improving was relatively constant 
across the QRS widths. Similar results were observed for LVEDVi.
Conclusion: QRS width is an independent and strong predictor of reverse remodeling 
in pts receiving CRT, indicating that electrical dyssynchrony is an important predictor of 
response to CRT in mild HF. 
2:30 p.m.
0909-5 Cardiac Resynchronization Therapy in Patients With 
Heart Failure and Non-Left Bundle Branch Block 
Morphologies
Jack Rickard, Dharam Kumbhani, Christopher Ingelmo, Bryan Baranowski, Oussama 
Wazni, Richard Grimm, Bruce Wilkoff, Cleveland Clinic, Cleveland, OH
Background: In select patients with heart failure, cardiac resynchronization therapy 
(CRT) has been shown to improve quality of life, exercise capacity, ejection fraction 
(EF) and survival. Currently, 20-30% of patients fail to demonstrate a clinical response 
to CRT despite meeting current selection criteria. The vast majority of patients enrolled 
in clinical trials involving CRT have had a native left bundle branch block pattern prior to 
implantation of the biventricular device. As such, far less is known about the response to 
CRT in patients with a right bundle branch block (RBBB) or a non-speciﬁc intraventricular 
conduction delay (IVCD). Methods: We reviewed the ECG prior to original biventricular 
pacemaker implantation in 304 consecutive patients presenting to the Cleveland Clinic, 
Cleveland, OH between 2/2006 and 7/2007. Patients were placed into one of three groups 
based on this ECG: LBBB, RBBB, and IVCD. Patients with a narrow QRS or a paced 
ventricular rhythm were excluded. The primary endpoint was time to death, placement of 
a left ventricular assist device (LVAD), or heart transplant. Results: Of 304 consecutive 
patients undergoing CRT at the Cleveland Clinic, 122 patients were identiﬁed as having 
LBBB, 19 RBBB, and 52 IVCD. There were a total of 23 deaths, 1 LVAD implantation, 
and 1 transplant. The incidence of the composite endpoint was 8.2% in the LBBB group, 
26.3% in the RBBB group, and 21.2% in the IVCD group (p=0.017). On multivariate 
analysis, there was a higher incidence of the composite outcome in patients with RBBB 
(Hazard Ratio [HR] = 3.76 (95% Conﬁdence Interval [CI]1.19-11.88, p= 0.024), but not 
in patients with IVCD (HR = 1.57 (95% CI 0.56-4.42, p=0.40), compared with those with 
LBBB. There was a signiﬁcant difference in the EF pre- and post CRT between the LBBB 
(9.7±10.7%), RBBB (0.3±7.7%) and IVCD (2.4± 6.2%) groups (p=0.002). There was no 
difference in the end-systolic (-0.65± 1.14, 0.46±.77, -0.32±0.95, p=0.10), or end-diastolic 
diameters (in cm) (-0.47±0.94, 0.03±0.46, -0.12±0.65, p=0.053) between the three 
groups, respectively. Conclusion: Patients with HF and a RBBB have poorer outcomes 
and less improvement in EF with CRT than patients with a native LBBB morphology.
2:45 p.m.
0909-6 Deﬁbrillation Thresholds in Hypertrophic 
Cardiomyopathy
Ernest Matthew Quin, Thad Tuten, Matthew Forcina, Matthew Klein, Anbukarasi Maran, 
J Lacy Sturdivant, Robert B. Leman, J Marcus Wharton, Michael R. Gold, Medical 
University of South Carolina, Charleston, SC
Background Left ventricular (LV) mass is a predictor of implantable deﬁbrillator (ICD) 
deﬁbrillation thresholds (DFTs). Patients with hypertrophic cardiomyopathy (HCM) have 
massive LV hypertrophy and are believed to have high DFTs. However, limited data 
are available comparing DFT in this group with more typical patients undergoing ICD 
implantation.
Methods As part of a prospective evaluation of DFTs, patients underwent initial 
implantation with a dual coil lead and a left pectoral active pulse generator and a 
standardized modiﬁed step-down DFT protocol. There were 73 patients with HCM and 
600 controls with dilated cardiomyopathy (ischemic or nonischemic).
Results There were marked clinical differences between groups. HCM patients were 
younger than controls (53 ± 15 vs. 64 ± 12 years, respectively; p < 0.001). Within 
the control group, 65% had an ischemic cardiomyopathy, the mean New York Heart 
Association class was 2.65± 0.64), and left ventricular ejection fraction was 29 ± 11%. 
All patients in the HCM group had normal or supernormal ejection fractions. The mean 
left ventricular (LV) mass in the HCM group was 401 ± 139 gm vs. 335 ± 113 gm in the 
control group (p = 0.001). Despite these differences, DFTs were similar between groups. 
The mean DFT in the HCM group was 11.7 ± 5.6 J vs. 10.4 ± 5.8 J in the control group; 
p = 0.09. However, 17 patients (24%) in the HCM group vs. 60 patients (12%) in the 
control group had an elevated DFT (> 15 J, p = 0.01). Within the HCM group there were 
no predictors of high DFTs. Speciﬁcally, interventricular septal thickness, LV mass, or 
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0909-3 Comparison of Dyssynchrony and Response to 
Resynchronization Therapy in Patients With Intrinsic 
Left Bundle Branch Block to Those With Chronic Right 
Ventricular Pacing
Hidekazu Tanaka, Hideyuki Hara, Olusegun Oyenuga, Han-Na Kim, Saba Samir, John 
Gorcsan, III, University of Pittsburgh, Pittsburgh, PA
Background: Most cardiac resynchronization therapy (CRT) trials have enrolled heart 
failure (HF) patients with intrinsic wide QRS. However, differences in dyssynchrony and 
response to CRT may exist in patients with right ventricular (RV) pacing induced QRS 
widening compared to those with intrinsic left bundle brunch block (LBBB).
Methods: We studied 207 HF patients, 151 with intrinsic LBBB and 56 with chronic 
RV pacing. All had Class III-VI HF, QRS>130ms, and ejection fraction (EF)< 35%. 
Dyssynchrony was assessed by tissue Doppler (TDI) longitudinal velocity, speckle tracking 
radial strain and pulsed Doppler interventricular mechanical delay (IVMD). Follow-up on 
130 patients (8±4 mo.) for EF response was available.
Results: The prevalence and degree of intraventricular dyssynchrony was similar in both 
LBBB and RV paced groups: TDIq65ms (72% vs. 68% and 84±39 vs. 84±41ms), radial 
strainq130ms (73% vs. 69% and 217±123 vs. 220±133ms). However, RV paced patients 
had a higher incidence and degree of IVMD dyssynchrony q40ms than those with LBBB: 
55%* vs. 40% and 43±22* vs. 35±22ms (*p<0.05). Both RV Paced and LBBB groups 
had similar EF responses: 24±8 to 32±11* and 24±7 to 31±12*, respectively (*p<0.05 
vs. baseline).
Conclusions: Chronically RV paced HF patients had greater degrees of IVMD but similar 
intraventricular dyssynchrony as those with intrinsic LBBB. Importantly, RV paced patients 
had a similar EF response to CRT as those with LBBB. These observations could have 
clinical implications. 
2:15 p.m.
0909-4 Relationship of QRS Duration to Reverse Remodeling 
With Cardiac Resynchronization Therapy in Mild Heart 
Failure: Results From the REsynchronization reVErses 
Remodeling in Systolic left vEntricular Dysfunction 
(REVERSE) Trial
Michael Robert Gold, Cecilia Linde, Ignacio Fernandez Lozano, Claude Daubert, 
William T. Abraham, Medical University of South Carolina, Charleston, SC
Background: CRT is an accepted therapy for advanced systolic heart failure (HF) patients 
(pts) with wide QRS. Controversy exists about the role of mechanical dyssynchrony to 
predict reverse remodeling with CRT. Less is known about the inﬂuence of electrical 
dyssynchrony on remodeling. We evaluated the relationship between QRS width and 
changes in left ventricular (LV) dimensions in pts with mild HF over 12 months.
Methods: Pts in the REVERSE trial have NYHA I or II HF, QRS-duration q120 ms and 
LVEF a40%. LV end systolic volume index (LVESVi) and LV end diastolic volume index 
(LVEDVi) were measured by core labs. Baseline QRS width was a continuous variable in 
the ANOVA model.
Results: 610 pts were randomized, 419 to CRT ON and 191 to CRT OFF. Post-hoc analysis 
showed that LVESVi decreased more among CRT ON than CRT OFF pts (-18.4±29.1 vs 
-1.3±23.4 ml/m2, p<0.0001). This change was related to QRS width (see graph). An ANOVA 
model with LVESVi change as the dependent variable shows, QRS width (p<0.0001), 
randomization group (p=0.009), and their interaction (p=0.0002) were statistically signiﬁcant. 
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to inﬂuence oxidative stress (age, diabetes, hypertension, and cigarette smoking). In 
these matched patients women had higher levels of DROM (452 ± 86 vs. 401 ± 83 Carr, 
p=0.007), but no signiﬁcant differences in IL-6 or CRP.
Conclusion: Appropriate ICD shocks were higher in women, as were levels of 
inﬂammatory and oxidative stress markers. This was observed despite younger age and 
lower incidence of ischemic cardiomyopathy. When matched to men for clinical factors 
known to affect oxidative stress, women had higher levels of DROM.
9:30 a.m.
1047-32 Implantable Cardioverter-Deﬁbrillators for Primary and 
Secondary Prevention in Patients With Noncompaction 
Cardiomyopathy
Kadir Caliskan, Dominic A.M.J. Theuns, Yvonne M. Hoedemaekers, Folkert J. Ten Cate, 
Luc J. Jordaens, Tamas Szili-Torok, Erasmus MC, Rotterdam, The Netherlands
Background. Noncompaction cardiomyopathy (NCCM) is a yet rare, recently classiﬁed 
primary cardiomyopathy. Initial presentation includes congestive heart failure, embolic 
events and (potentially lethal) arrhythmias, including sudden death. Implantable 
cardioverter-deﬁbrillators (ICDs) are frequently used for primary and secondary prevention 
in patients with different cardiomyopathies. The aim of this study was to investigate the 
ICD indications and outcome in NCCM patients.
Methods. We used the prospective data from our NCCM cohort registry from 2005 to 
present (n=67 pts, mean age: 40 ± 14 years, range [17 - 73]).
Results. The ICD was implanted in 28 (42 %) patients with NCCM (15 males (68%); 
mean age: 41 ± 14 years, range [13-63]). A secondary prevention indication was present 
in seven patients (3 pts with sudden deaths, 4 pts with sustained VT / syncope; 3 males 
median age 33, range [17-50]) and primary prevention in 21, because of severe LV 
dysfunction / heart failure, with or without non-sustained VTs (12 males, mean age 43 ± 
14 years, range [18-63]), in which of six of them combined with a biventricular pacemaker. 
During a median follow-up of 20 months range [7 - 66], three patients presented with 
appropriate ICD therapy (median 6 months, range [1-16], all of them in the secondary 
prevention group. Seven patients presented with inappropriate ICD therapy (5 in primary 
group and 2 in secondary group), after a median follow-up of 4 months, range [2-23]. 
Atrial arrhythmias triggered inappropriate ICD therapy in 4 patients, and oversensing 
problems in 3 patients.
Conclusions. In our cohort of NCCM patients, an ICD was frequently indicated for primary 
or secondary prevention of sudden death. After long-term FU, frequent appropriate ICD 
therapy occurred in patients with secondary prevention. However, frequent inappropriate 
ICD therapy was occurred more frequently in patients with primary prevention, which 
suggests the need of further research for appropriate risk stratiﬁcation of sudden death 
in patients with NCCM.
9:30 a.m.
1047-33 Pragmatic Upper Limit of Vulnerability Determination 
for the Assessment of Deﬁbrillation Efﬁcacy at the Time 
of Device Implantation
Mehul Patel, Ashok Shah, Khyati Pandya, Jay Thaker, Mark Castellani, Ranjan Thakur, 
Sparrow Hospital. Michigan State University, Lansing, MI
Background: Upper limit of vulnerability(ULV) is the lowest energy above which a T-wave 
shock fails to induce ventricular ﬁbrillation(VF). Despite good correlation with deﬁbrillation 
threshold(DFT), traditional ULV has found little place in clinical practice as it requires 
multiple shocks and VF inductions. We integrated ULV with DFT while minimizing VF 
inductions during device check(Pragmatic Upper Limit of Vulnerability-PULV).
Methods: Patients receiving implantable cardioverter deﬁbrillator(ICD) underwent PULV 
assesment, standardized with a drive cycle length of 400ms for 8 beats, coupled to a 
T-wave shock either at 20msec before the peak of T-wave, at the peak of T-wave, 20msec 
after the peak of T-wave or at 310msec ﬁxed coupling-interval.Study patients were thus 
divided into four groups. Initial energy of 9 joules was used for inducing VF. If VF was 
induced, shock strength was raised by increments of 2J until VF could no longer be 
induced. If VF was not induced, shock strength was reduced in decrements of 2J until 
VF was induced. Rescue shocks for deﬁbrillation were programmed at ULV and ULV+2J. 
If internal deﬁbrillation failed, an external shock was used for rescue. If ULV+2J failed to 
terminate VF, ULV+4 and ULV+6J were tested.
Results: Table 1 shows the summary of results.
Conclusion 
ULV is tightly coupled with DFT at the peak of the T wave.Assesment of ULV at the peak 
of T-wave provides useful information of PULV and DFT along with VF sensing while 
minimizing VF inductions.
Table 1 
LV mass index did not differ between high and normal DFT patients (p’s = 0.93, 0.74, 
and 0.93 respectively). Moreover, no patient needed additional leads or thoracotomy to 
achieve an adequate safety margin.
Conclusions Overall DFTs are only marginally higher among patients with HCM and an 
adequate safety margin can be achieved routinely. However, this group is twice as likely 
to have an elevated DFT compared with patients with dilated cardiomyopathies, so the 
standard use of high output generators is appropriate in this cohort.
3:00 p.m.
0909-7 The Relationship Between Renal Function and All-
Cause Mortality Among Veterans Receiving Implantable 
Cardioverter Deﬁbrillators
Cara McLaughlin Gavin, Ranjan Thakur, J. Michael Gaziano, James Kaufman, Deepak 
Bhatt, Boston VA Healthcare System, Boston, MA, Harvard Medical School, Boston, MA
BACKGROUND: Individuals with chronic kidney disease (CKD) and end-stage renal 
disease (ESRD) are at increased risk for sudden cardiac death. Implantable cardioverter-
deﬁbrillators (ICDs) have been shown to decrease mortality in patients with poor cardiac 
function. As previous ICD clinical trials excluded patients with CKD and ESRD, there are 
limited data on the relationship between impaired renal function and mortality in patients 
with ICDs.
METHODS: We assembled a nationally representative retrospective cohort of 9791 US 
veterans who had ICDs implanted as inpatients in the Veterans Affairs Healthcare System 
between September 1997 and April 2008 and classiﬁed them according to their calculated 
glomerular ﬁltration rates (GFRs). We used Cox proportional hazards analysis to calculate 
crude and multivariate adjusted hazard ratios (HRs) and 95% conﬁdence intervals (CIs) 
for mortality. We compared individuals with CKD stage IIIA (GFR 45-59 ml/min/1.73m2),
IIIB (GFR 30-44), IV (GFR 15-29), V(GFR 60) kidney function. The multivariate analysis 
adjusts for age, race, cardiac and non-cardiac co-morbidities, and cardiac medications.
RESULTS: In this cohort of veterans receiving ICDs, 50% had documented CKD, 80% 
had documented heart failure, 50% had a history of ventricular tachycardia/ﬁbrillation and 
90% had known coronary artery disease. The mean age for ICD implantation was 67.21 
(SD, 10.37). During a median follow-up of 2.6 years, there were 3765 deaths. Compared 
to those with stage I and II kidney function, the mortality risk increased with increasing 
CKD stages (IIIA; HR 1.13, 95% CI (1.02-1.24), IIIB; HR 1.65, 95% CI (1.50-1.81), IV; HR 
2.96, 95% CI (2.69-3.27), V; HR 3.91, 95% CI (3.41-4.49). The mortality risk for patients 
on dialysis fell between the risks for stage IV and V CKD [HR 3.50, 95% CI (2.74-4.46)].
CONCLUSIONS: Despite the presence of an ICD, renal function is independently 
associated with mortality. The increase in risk appears to be directly related to the 
degree of renal impairment. Further study is needed to investigate the non-arrhythmic 
mechanisms of death in patients with marked renal insufﬁciency.
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1047-31 Effect of Gender on Patients With Systolic Heart Failure: 
Women Have More Ventricular Arrhythmias Than Men 
and Have Higher Levels of Inﬂammatory and Oxidative 
Stress Markers
Richard N. Vest, III, Raul R. Blanco, Ravinder R. Valadri, Rebecca Gutmann, Barry 
London, Samuel C. Dudley, Maziar Zafari, Heather L. Bloom, Emory University School of 
Medicine, Atlanta, GA, University of Pittsburgh Medical Center, Pittsburgh, PA
Background: Recent studies emphasize the need for better understanding of ventricular 
arrhythmias in patients with heart failure but are inconclusive in evaluating the effect of 
gender on the incidence and mechanisms of ventricular arrhythmias. We examined a 
database of patients with heart failure and implantable cardioverter-deﬁbrillators (ICDs) 
to compare incidence of ICD shocks and levels of inﬂammatory and oxidative stress 
markers between women and men.
Methods: Demographic data, biomarkers, and appropriate ICD shocks were examined 
in 232 heart failure subjects (LVEF a35%) with ICDs enrolled in the Genetic Risk 
Assessment of Deﬁbrillator Events study. Blood was analyzed for derivatives of reactive 
oxygen metabolites (DROM), high sensitivity C-reactive protein (CRP), and interleukin-6 
(IL-6).
Results: Subjects were 20% (46) female and 80% (186) male. Mean follow-up time was 
17 months. LVEF did not signiﬁcantly differ (19% ± 7% vs. 20% ± 7%, p=0.74) nor did 
incidence of diabetes, hypertension, or heart failure classiﬁcation. Women were younger 
than men (58 ± 10 vs. 62 ± 12 years, p<0.001) and had lower incidence of ischemic 
cardiomyopathy (37% [17] vs. 67% [125], p<0.001). Women had higher levels of DROM 
(452 ± 102 vs. 365 ± 95 Carr, p<0.001) and CRP (7.7 ± 5.3 vs. 5.6 ± 5.0 ng/dl, p=0.015). 
IL-6 levels did not signiﬁcantly differ. Appropriate ICD shocks occurred more frequently in 
women (24% [11] vs. 12% [23], p=0.015), while event rates of appropriate ICD therapies 
over time were signiﬁcantly higher in women (0.84 vs. 0.21 events/year, p=0.011). Of 
the 46 women in this study, 32 were matched to male patients for clinical factors known 
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infection temporally related to the device implantation procedure. Infection was deﬁned 
as deﬁnite infection of the pocket or lead system identiﬁed within 60 days of implantation. 
Pre- and post-procedure WBC were obtained within 48 hours of the procedure. Signiﬁcant 
leukocytosis was deﬁned as greater than 50% increase in WBC.
Results: 1388 device implantation procedures met inclusion criteria and were used for 
analysis. Of these cases, 3 procedures resulted in device-related infections (0.22%). Two 
patients required device extraction for pocket infection, while one developed mitral valve 
endocarditis 4 days following device implantation and subsequently died due to overwhelming 
sepsis. A modest 17.4 + 29.6% mean increase in WBC was observed for the entire study 
population. Surprisingly, cases resulting in infection demonstrated a mean decrease in WBC 
of 11.4 + 24% following device implantation (p=0.33). No infections were noted in patients with 
> 50% rise in WBC (n=146, 10.5%) following device implantation. Compared to the overall 
study population, patients with post-procedure leukocytosis were more like to be African-
American (32.9% vs. 23.1%; p=0.01), to receive an ICD (72.7% vs. 60.3%; p=0.004), and to 
have longer total procedure time (119 + 100 min vs. 114 + 78 min; p<0.001).
Conclusions: Following device implantation, a > 50% increase in WBC count is uncommon 
and occurs in ~ 10% of patients. Race, type of device and procedure time inﬂuence the 
development of leukocytosis. Infection was extremely rare (<0.3%) in our study population, 
not heralded by a rise in WBC count, and if present, associated with dire consequences.
9:30 a.m.
1047-36 Both Shorter Baseline QRS Duration and Failure 
to Increase QRS Duration During Antihypertensive 
Therapy Are Associated With A Decreased Risk of New-
Onset Heart Failure: The LIFE Study
Peter M. Okin, Richard B. Devereux, Sverre E. Kjeldsen, Jonathan M. Edelman, Björn 
Dahlöf, Weill Cornell Medical College, New York, NY
Background: Prolonged QRS duration (QRS) has been associated with left ventricular 
(LV) dyssynchrony and dysfunction and the development of heart failure (HF). However, 
whether failure to increase QRS during treatment is associated with decreased HF 
incidence in hypertensive patients, independent of blood pressure lowering and regression 
of ECG left ventricular hypertrophy (LVH), has not been examined.
Methods: The relation of baseline QRS (QRS_BL) and change in QRS between baseline 
and year 1 (QRS_DY1) to incident HF was examined in 8527 hypertensive patients 
without HF randomly assigned to losartan- or atenolol-based treatment.
Results: During 3.9±0.8 years follow-up after year-1, HF hospitalization occurred in 204 
patients (2.4%). In Cox analyses in which both QRS_BL and QRS_DY1 were entered 
together, both QRS_BL <110 ms (HR 0.46, 95% CI 0.31-0.68) and QRS_DY1 a0 ms (HR 
0.60, 95% CI 0.45-0.80) were independently associated with a decreased risk of new HF 
after adjustment for treatment, baseline risk factors for heart failure, and for baseline and 
in-treatment ECG LVH and blood pressure. The combination of QRS_BL and QRS_DY1 
improved risk stratiﬁcation compared with either alone, with QRS_BL <110 and QRS_
DY1 a0 associated with the lowest incidence and risk of HF (Table). 
QRS_BL
q110
QRS_DY1 
>0
(n=566)
QRS_BL
q110
QRS_DY1 
a0
(n=1264)
QRS_BL
<110
QRS_DY1 
>0
(n=2478)
QRS_BL
<110
QRS_DY1 
a0
(n=4219)
p value
4-Year HF Incidence (%) 6.4 3.4 2.6 1.8 <0.0001
Univariate Cox Model 
(HR, 95% CI) 1
0.53 (0.33-
0.84)
0.42 (0.27-
0.64)
0.27 (0.18-
0.41) <0.001
Multivariate Cox Model 
(HR, 95% CI) 1
0.50 (0.30-
0.83)
0.40 (0.24-
0.66)
0.26 (0.16-
0.44) <0.001
Conclusion: Both shorter baseline QRS and failure to increase QRS over 1 year during 
antihypertensive therapy are associated with a decreased likelihood of subsequent new-
onset HF in patients with essential hypertension.
9:30 a.m.
1047-37 Deceleration Capacity Predicts All-Cause Mortality and 
Sudden Death in Patients From MADIT II Trial
Iwona Cygankiewicz, Wojciech Zareba, Przemyslaw Guzik, Slava Polonsky, Mark 
Andrews, Arthur J. Moss, Heart Research Follow- up Program, University of Rochester 
Medical Center, Rochester, NY
Background: Recent years have seen an ongoing debate on the further risk stratiﬁcation 
of patients who will beneﬁt the most from implantable cardioverter deﬁbrillators (ICD). The 
aim of this study was to evaluate deceleration capacity (DC), providing insight in vagal 
cardiac modulation, as a risk marker of all-cause mortality and sudden death in patients 
from Multicenter Automatic Deﬁbrillator Implantation Trial (MADIT) II Trial.
Methods: The study involved 867 postinfarction patients (719 men), mean age 63±10 
years, with LVEF<=30% from MADIT II Trial randomized to conventional or ICD arm. 
Deceleration capacity was assessed from 10-minutes ECG recording and evaluated both 
as continuous as well as categorized values. According to the original method patients 
were categorized into three groups: low risk (DC category 0 >4.5ms); intermediate risk 
(DC category 1= 2.6-4.5ms) and high risk (DC category 2 <=2.5ms). All-cause mortality 
was considered as primary endpoint and VT/VF therapy as secondary endpoint in ICD 
arm. Multivariate Cox regression analysis was performed to determine the prognostic 
value of DC in predicting endpoints.
Results: During a mean of 20 months follow-up there were 120 deaths. Patients who 
died had signiﬁcantly lower DC values than survivors (median 1.97 vs 3.33 ms, p<0.001). 
Patients with DC category 2 were characterized by 23% 2-year mortality as compared 
to 14% in DC1 and 7% in DC0 group. High risk DC category (DC2) was an independent 
predictor of all-cause mortality and sudden death after adjustment for signiﬁcant clinical 
PULV and DFT at various portions of T wave
Shock on T wave at p value
Fixed at 
310 msec
(A)
n=41
20 msec 
before the 
peak of T
(B)
n=42
Peak of T 
wave
(C)
n=45
20 msec 
after the 
peak of T 
wave
(D)
n=47
A
vs B
A
vs C A vs D
B vs 
C
C
vs D
B vs 
D
No of VF 
induced/
patient
1.27± 0.45 1.35 ± .57 1.26 ± .57 1.31 ± .66 0.480 0.92 0.74 .046 0.69 0.76
ULV 6.41± 2.69 6.54± 3.53 7.81± 3.65 8.92± 3.24 0.851 0.047 0.0002 0.10 0.12 0.001
DFT 8.34± 2.80 7.92± 3.65 8.47± 3.04 9.11± 2.80 0.558 0.83 0.2 0.44 0.29 0.08
$ULV DFT 1.92± 2.65 1.66± 1.73 0.64± 1.84 1.23±2.21 0.59 0.010 0.186 0.009 0.168 0.31
ICM (%) 79 71 70 64
EF 28.15±7.58 28.9± 10.33 27.15± 6.42 27.89± 8.14 0.707 0.50 0.87 0.341 0.63 0.60
NYHA (%)
Class 1 7.5 12.5 7.5 4.5
Class 2 70 67.5 85 80.5
Class 3 22.5 20 7.5 15
Class 4 0 0 0 0
9:30 a.m.
1047-34 Occurrence of Ventricular Arrhythmias in Ischemic 
Primary Prevention ICD Recipients: Incidence and Risk 
Stratiﬁcation During Long-Term Follow-up
C. Jan Willem Borleffs, Guido H. van Welsenes, Lieselot van Erven, Rutger J. van 
Bommel, Enno T. van der Velde, Frits R. Rosendaal, Ernst E. van der Wall, Jeroen J. 
Bax, Martin J. Schalij, Leiden University Medical Center, Leiden, The Netherlands
Background: Large trials have shown a beneﬁcial effect of an implantable cardioverter 
deﬁbrillator (ICD) in the primary prevention of sudden death. The aim of the current study 
was to determine the actual occurrence of ventricular arrhythmia (VA) during long-term 
follow-up and to identify baseline predictors in a large cohort of patients with an ICD for 
primary prevention.
Methods: A total of 704 primary prevention ICD recipients (615 male, 64±11 years) 
with ischemic cardiomyopathy were evaluated. All patients received an ICD (48% 
biventricular) for primary prevention. All patients were evaluated at baseline and during 
periodical three-six months follow-up. Events triggering appropriate device therapy and 
death were noted.
Results: During a mean follow-up of 28±22 months (range 0 to 126 months), 143 patients 
(23%) received appropriate ICD therapy with a mean time to ﬁrst therapy of 16±18 
months. Cumulative incidence of appropriate therapy during six years follow-up was 
39%. A multivariate model (Figure) demonstrated a history of non-sustained ventricular 
tachycardia, a history of atrial ﬁbrillation or ﬂutter, current smoking, and a long QRS 
duration as independent predictors of appropriate therapy during long-term follow-up.
Conclusions: The majority of ischemic primary prevention ICD recipients do not receive 
appropriate therapy during long-term follow-up. At baseline, patients at high risk for 
potentially lethal VAs, can be stratiﬁed.
9:30 a.m.
1047-35 Leukocytosis Following Device Implantation Is Not an 
Indicator of Infection
Christine Tompkins, Alan Cheng, Darshan Dalal, Jeffrey A. Brinker, Charles T. Leng, 
Joseph E. Marine, Saman Nazarian, David D. Spragg, Sunil Sinha, Henry Halperin, 
Gordon F. Tomaselli, Ronald D. Berger, Hugh Calkins, Charles A. Henrikson, Johns 
Hopkins Hospital, Baltimore, MD
Background: Infection remains one of the most feared complications following device 
implantation. Leukocytosis is a recognized marker of infection. Whether early post-
procedure leukocytosis is a warning sign of impending infection or merely a systemic 
inﬂammatory response is unclear and was the focus of this study.
Methods: We performed a retrospective chart review of patients undergoing ICD or 
pacemaker implantation from August 2004 - August 2007. Within this cohort, we assessed 
the association between change in white blood cell (WBC) count and the development of 
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9:30 a.m.
1047-40 Diagnostic Utility of Signal Averaged Electrocardiogram 
in Arrhythmogenic Right Ventricular Dysplasia
Palaniappan G. Muthappan, Raoul Manalac, Amy Daly, Rahul Jain, Cynthia James, 
Crystal Tichnell, Theodore Abraham, Harikrishna Tandri, Stuart D. Russell, Hugh 
Calkins, Darshan Dalal, Division of Cardiology, Johns Hopkins Department of Internal 
Medicine, Baltimore, MD
Background: Late potentials on signal averaged electrocardiogram (SAECG) are a minor 
criterion for the diagnosis of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy 
(ARVD/C). The true diagnostic utility of SAECG has not yet been validated in a large 
series of patients evaluated for ARVD/C.
Methods: SAECGs from 251 patients (68 ARVD/C, age 30±15 years) were evaluated 
using a 40-250 Hz ﬁlter to achieve a noise level <1μV. Receiver operating characteristic 
curves were used to assess the discriminatory ability of ﬁltered QRS duration (fQRS), 
low amplitude signal duration below 40 μV (LAS), and root mean square voltage in last 
40 ms of the QRS (RMS), comparing against a diagnosis made using task force criteria 
excluding SAECG variables.
Results: The area under the curve statistic for fQRS, RMS, and LAS was 0.74, 0.77, 
and 0.74 respectively (P<0.001). At a sensitivity of 85%, the speciﬁcity for fQRS, RMS, 
LAS was 51, 47, and 34% and at a speciﬁcity of 85%, the sensitivity was 47, 58, and 
53% respectively. The sensitivity/speciﬁcity using for fQRS>114ms, RMS<20μV, and 
LAS>38ms were 65/71, 60/79, and 60/75%. Overall, the sensitivity/speciﬁcity were 73/59, 
62/78, and 51/89% for presence of 1+, 2+, and 3 SAECG abnormalities respectively.
Conclusions: SAECG has fair diagnostic utility for ARVD/C, with all SAECG parameters 
having a similar discriminatory ability. This justiﬁes continued use of SAECG in the 
diagnostic algorithm for ARVD/C. 
9:30 a.m.
1047-41 Intraventricular Conduction Delays on a 12-Lead ECG 
Is Associated With Signiﬁcantly Higher Mortality Rate 
Than Bundle Branch Block in Patients With Congestive 
Heart Failure
Waddah Maskoun, Bilal Safadi, Mithilesh K. Das, Indiana University, Indianapolis, IN
Background: Wide QRS (wQRS, QRS >120ms) on a 12-lead ECG occurs due to typical 
bundle branch block (BBB) or intraventricular conduction delays (IVCD). IVCD most likely 
represents myocardial disease; however BBB is primarily due to conduction system 
disease and may or may not be associated with signiﬁcant myocardial scar. We postulate 
that IVCD in patients with congestive heart failure (CHF) is associated with signiﬁcantly 
higher mortality rate than patients with BBB.
Methods: We reviewed the ECGs of 238 CHF patients; these ECGs were performed at the 
time a CHF diagnosis was ﬁrst made. Mortality was the endpoint of follow-up, which was 
deﬁned as death or cardiac transplant. BBB group included right and left BBB. IVCD group 
included patients with QRS > 120 ms who did not meet the standard criteria for a BBB. 
Results: 81 patients had wQRS (mean age: 62.3 + 10.5 years, male: 98.8%, ejection 
fraction: 24% + 15, QRS duration: 146 + 20, mean follow-up: 5.2 + 2.8 years) and 58% of 
the patients (n = 47) had BBB (LBBB: 64%). The IVCD patients had signiﬁcantly higher 
mortality rate than the BBB patients (76.5% versus 37.3%, p = 0.001). Multivariate 
predictors of death were age (p = 0.006, HR 1.04), and IVCD (p = 0.002, HR 2.79). 
Kaplan Meier survival analysis (ﬁgure) revealed a signiﬁcantly decreased survival in the 
IVCD group versus the BBB group (p < 0.001).
Conclusions: IVCD on a 12-lead ECG is associated with signiﬁcantly increased mortality 
in CHF patients as compared to BBB.
covariates in the entire studied population (HR=2.31, CI=1.45-3.69, p<0.001 and 
HR=2.65, CI=1.25-5.61, p=0.011 for all cause death and sudden death, respectively). 
High risk DC values were also predictive for VT/VF therapy in patients randomized to 
ICD arm.
Conclusions: Our study documented that patients after myocardial infarction with 
signiﬁcantly impaired ejection fraction can be stratiﬁed using deceleration capacity. 
Deceleration capacity assessed in a short-term 10 minute ECG recording can differentiate 
patients at high risk of all- cause mortality and sudden death.
9:30 a.m.
1047-38 Repolarization instability in the GISSI-HF Trial
Craig P. Dobson, Cara Olsen, Maria Teresa LaRovere, Marino Berardinangeli, Marco 
Veniani, Paolo Midi, Luigi Tavazzi, Mark Haigney, Uniformed Services University, Bethesda, 
MD, Fondazione Salvatore Maugeri, Istituto Scientiﬁco di Montescano, Pavia, Italy
Background: Increased temporal variability of repolarization, as reﬂected by QT interval 
variability measured over 10 minutes, predicted spontaneous ventricular arrhythmias in 
ICD patients, but it is unclear how these measures perform in 24 hour recordings.
Methods: 24-hour digital Holter recordings from 314 subjects with heart failure enrolled 
in GISSI-HF were analyzed using a template-matching, semi-automatic algorithm to 
measure QT and heart rate time series in sequential 5 minute epochs over 24 hours. QT 
variability was expressed as normalized QT variance (QTVN) or as the log ratio of the 
normalized QT variance over normalized heart rate variance (QTVI).
Results: A pronounced diurnal variation was seen in both QTVI and QTVN. Both were 
lowest in the midnight-6AM time frame and increased throughout the day, peaking at 
noon-6PM, then decreasing 6PM-midnight. For QTVI, all four time points were signiﬁcantly 
different (p <0.001). QTVI correlated with heart rate (r=0.38, p<0.001), and was signiﬁcantly 
higher for those in NYHA class 3-4 compared with 2. QTVN did not correlate with heart 
rate or NYHA but correlated negatively with serum potassium (r=-0.24, p=0.0001), and 
manifested the greatest increase during mid morning hours (ﬁgure).
Conclusions: Repolarization lability as reﬂected in QT variability has a pronounced 
diurnal variation and increases signiﬁcantly after 6 AM, the time of greatest arrhythmic 
risk. Measuring QT variability over 24 hours may signiﬁcantly improve risk prediction. 
9:30 a.m.
1047-39 Atypical Electrocardiographic Features of 
Cavotricuspid Isthmus-Dependent Atrial Flutter 
Occurring During Left Atrial Fibrillation Ablation
Janice Chyou, Kathleen Hickey, Laurence Diamond, William Whang, Jose Dizon, Hasan 
Garan, Angelo Biviano, NewYork-Presbyterian Hospital, Columbia University Medical 
Center, New York, NY
Background: Patients who undergo percutaneous catheter ablation for atrial ﬁbrillation 
(AF) may develop cavotricuspid isthmus-dependent atrial ﬂutter (AFL), which can 
occur either spontaneously or via induction during left atrial ablation for AF. The ECG 
characteristics of cavotricuspid isthmus-dependent AFL occurring during left atrial 
ablation have not been described. The purpose of this study was to describe the ECG 
features of cavotricuspid isthmus-dependent AFL occurring during percutaneous left 
atrial catheter ablation for AF.
Methods: ECGs of those patients who developed cavotricuspid isthmus-dependent atrial 
ﬂutter during the AF ablation procedure were analyzed in order to characterize ECG 
patterns of the atrial ﬂutters.
Results: Of 223 patients presenting for ﬁrst AF ablation at our institution between May 
2004 and February 2008, 20 patients (9%) developed cavotricuspid isthmus-dependent 
AFL during left atrial ablation for AF. Cavotricuspid isthmus-dependent atrial ﬂutter 
developed spontaneously in 4 patients (20%) and was induced in 16 patients (80%). 
Among these 20 patients, 8 (40%) had typical ECG patterns and 12 (60%) had atypical 
ECG patterns. Flutter waves in the inferior leads were biphasic in 10 patients (50%), 
downward in 3 patients (15%), positive in 3 patients (15%), and not ﬁtting the above 
classiﬁcations in 4 patients (20%). There was no statistically signiﬁcant association 
between AFL pattern and left atrial size, left ventricular ejection fraction, total ablation 
time, duration of prior AF, or type of prior AF.
Conclusions: The majority of patients with cavotricuspid isthmus-dependent AFL 
occurring during left atrial ablation have atypical ECG patterns. Biphasic ﬂutter waves in 
the inferior leads are common ECG features, occurring in one-half of patients. Right atrial 
cavotricuspid isthmus-dependent AFl should be suspected even if the ECG appearance 
is atypical.
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9:30 a.m.
1047-44 Increased Wedensky Modulation Index Predicts Time 
to Ventricular Arrhythmia Occurrence in Patients With 
Implantable Cardioverter Deﬁbrillators
Peter A. Brady, Paul Erne, Jesus E. Val-Mejias, Joerg O. Schwab, Rainer Schimpf, 
Michael Orlov, Tom Mattioni, Marek Malik, Jan Amlie, Mayo Clinic, Rochester, MN
Background. Wedensky modulation (WM) comprised subthreshold transthoracic electrical 
stimulation delivered to every other QRS complex. A WM index was computed from 
electrocardiographic differences between stimulated and non-stimulated complexes and 
has been shown to accurately predict ventricular arrhythmic (VA) events. We hypothesized 
that an increased index might predict early VA occurrence.
Methods. R-wave WM index (WMIR) and combined RT-wave WM index (WMIRT) were 
prospectively evaluated from a prospective observational study at 8 international centers. 
The time from WM testing to VA occurrence, along with rate of the VA, were compared 
to the WM indices.
Results. Low-group WMIRT days to event (D2E) was 183±107 days, compared to the 
high-group WMIRT D2E of 148±108 days (p=0.01). Strong positive correlation between 
WMIR (p=0.03) and WMIRT (p=0.003) and the time from WM testing to initial VA event was 
determined. Patients with a positive index value (WMq0.5) were more likely to have a VA 
event sooner than patients with a negative index value (WM<0.5). There was a strong positive 
correlation between WMIRT and the VA rate (p = 0.014). Spontaneous VA rates were predicted 
as 172+(124*WMIRT) days from WM testing for VA events in the ﬁrst year (p = 0.008).
Conclusions. The time from Wedensky modulation testing to VA event, and associated VT 
rate, for post-myocardial infarction patients, were strongly, positively correlated with WM 
index values for predicting future arrhythmia events. 
9:30 a.m.
1047-45 Baroreﬂex Sensitivity Assessed by Multivariate Phase-
Rectiﬁed Signal Averaging as Risk Predictor After 
Myocardial Infarction
Axel Bauer, Petra Barthel, Alexander Müller, Georg Schmidt, Deutsches Herzzentrum 
und Technische Universität München, Munich, Germany
Background: Multivariate phase-rectiﬁed signal averaging (MPRSA) is a novel method 
for quantiﬁcation of cross-correlations between multiple non-stationary signals. Here we 
propose a MPRSA-based measure of baroreﬂex sensitivity (BRS) as risk predictor after 
acute MI.
Methods: 938 survivors of AMI (sinus rhythm, age a80y) were included. One week after 
AMI, non-invasive 30-min high resolution ECGs (1600Hz) and arterial pressure curves 
(Finapress) were recorded. The new method identiﬁes normal-to-normal intervals (RRI) 
observed at simultaneous increases of systolic pressure (,,anchor RRIs“). RRI segments 
with anchors are aligned and averaged. Deviations from zero of the average signal 
(Figure) can be attributed to changes of arterial pressure. The maximum amplitude of 
the central deviation is quantiﬁed by Haar-wavelet analysis and serves as measure of 
baroreﬂex sensitivity (M-BRS). Endpoint was total mortality at two years. Multivariate Cox-
regression analysis included M-BRS, LVEF a30%, and major clinical risk predictors.
Results: During follow, 36 patients died. M-BRS was signiﬁcantly lower in non-survivors than 
in survivors (0.8±2.4ms vs. 3.3±2.8ms, p<0.0001). Univariately, M-BRS a1.0ms yielded a 
relative risk of 6.4 (31.1-13.3). Multivariately, M-BRS a1.0ms was the most signiﬁcant predictor 
of death with a relative risk of 3.7 (1.7-8.0) followed by LVEF a30% (RR 3.4 (1.5-7.3)).
Conclusions: M-BRS is a strong and independent predictor of mortality in post-infarction 
patients. 
9:30 a.m.
1047-42 Incremental Value of Inferior Lead T Wave Inversion 
in Diagnosis of Arrhythmogenic Right Ventricular 
Dysplasia/Cardiomyopathy
Rahul Jain, Darshan Dalal, Heide Hullsiek, Rohit Jain, P. G. Muthappan, Crystal Tichnell, 
Cynthia James, Amy Daly, Hari Tandri, Stuart Russell, Theodore Abraham, Hugh 
Calkins, Johns Hopkins School of Medicine, Baltimore, MD
Background: Right precordial T-wave inversion (TWI) on a 12-lead ECG contributes to the 
Task Force diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). 
Although TWI in inferior leads has been reported in ARVD/C patients, it is unclear whether its 
presence is of incremental utility in the Task Force diagnosis of ARVD/C.
Methods: TWI in inferior leads (TWI in 2 out of 3 inferior leads was considered positive) 
and precordial leads on a standard 12-lead ECG was studied in 68 ARVD/C patients 
without right bundle branch block (RBBB) (51% male; age 36 ± 12 years), 32 ARVD/C 
patients with RBBB (75% male; age 41 + 13 years), 27 normal controls (35% male; age 
35 ± 14 years), and 30 normal controls with RBBB (37 % male; age 46 ±14 years).
Results: The prevalence of TWI in > V3 was seen in 75% of ARVD/C patients without 
RBBB, 4% of controls, 82% of ARVD/C patients with RBBB, and 10% of controls with 
RBBB. TWI in > V3 and/or inferior leads was seen in 79% of patients with ARVD without 
RBBB, 7% of normal controls, 91% of patients with ARVD with RBBB, 0.10% of normal 
controls with RBBB (Figure).
Conclusions: Addition of TWI in inferior leads to TWI in right precordial leads marginally 
improves the sensitivity and speciﬁcity in the diagnosis of ARVD/C in individuals with 
RBBB and also improves the sensitivity in diagnosing ARVD/C patients without RBBB. 
9:30 a.m.
1047-43 Rates of Abnormal Screening Electrocardiograms Differ 
Greatly Between US Collegiate Cohorts
J Jason West, John P. Higgins, David D. McPherson, Danny J. Mistry, John M. 
MacKnight, Ethan N. Saliba, Rahul Damani, Benjamin Rose, Srijoy Mahapatra, 
University of Texas Houston, Houston, TX, University of Virginia, Charlottesville, VA
Background: The European Society of Cardiology (ESC) guidelines are based upon 
a screening ECG, and and their implementation have reduced young athlete mortality. 
Little comparative data exists regarding the electrocardiographic abnormalities found 
in cohorts of US collegiate athletes. This confounds the interpretation of screening 
electrocardiograms (ECGs) in US athletes and limits the generalization of ECG ﬁndings.
\Methods: We compared ECGs obtained during preparticipation screening of collegiate 
athletes at two major collegiate programs (A & B). These ECGs were analyzed according 
to ESC guidelines.
Results: Cohorts consisting of 925 (A) and 384 (B) athletes were characterized from 
two major universities. Cohort A had 195/925 abnormal ECGs (21.2%). Cohort B had 
signiﬁcantly more (143/384) abnormal screening ECGs (37.2%, P<0.05). LVH was the most 
common abnormality in both cohorts (A=12%, B=28%), but was signiﬁcantly more common 
in cohort B (P<0.05). Gender was a signiﬁcant predictor of both LVH and all abnormal ECGs 
in cohort A (both P<0.05), and for cohort B (P<0.05 and 0.05, respectively). There was a 
signiﬁcantly greater proportion of LVH and all abnormal ECGs for both genders in cohort B 
(P<0.05 for all). Race was a signiﬁcant predictor of LVH and all abnormal ECGs in cohort A 
but not B (P<0.05 vs P=0.16, P=0.30 respectively). The proportion of LVH and all abnormal 
ECGs for Black athletes did not differ between the cohorts (P=NS). However, the proportion 
of LVH and all abnormal ECGs was signiﬁcantly greater for White athletes (39.0 vs 12.0% 
and 30.7 vs 14.9%, respectively) in cohort B (P<0.05).
Conclusions: Abnormalities are present in 21-37% of screening ECGs in collegiate 
athletes. We found a signiﬁcant difference in the proportion of abnormal ECGs between 
these two cohorts. With an abnormal screening rate of 37%, the ESC screening criteria 
may not be valid when applied to US collegiate populations. The differing results between 
these two cohorts calls into question the sensitivity and speciﬁcity of the ESC guidelines. 
More work is needed to deﬁne the best ECG criteria for the identiﬁcation of latent cardiac 
abnormalities in US collegiate athletes.
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9:30 a.m.
1047-48 Fragmented QRS Complexes on a 12-lead ECG as 
a Marker of Noncoronary Artery Disease-Related 
Myocardial Disease by Gadolinium Delayed 
Enhancement Cardiac Magnetic Resonance Imaging
Mohamed Homsi, Lamaan Alsayed, Anas Safadi, Mithilesh K. Das, Jo Mahenthiran, 
Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN
Background: We have demonstrated that fragmented QRS complexes (fQRS) on a 12-lead 
ECG correlate with the presence of myocardial scar in coronary artery disease (CAD). However, 
the extent of fQRS as a marker of non-CAD related myocardial pathology as seen on delayed 
gadolinium enhancement (GDE) cardiac magnetic resonance imaging (CMR) is unknown.
Method: The fQRS on 12-lead ECG was deﬁned as the presence of fragmented QRS, 
notched R or S wave, or RSR` pattern in at least 2 contiguous leads corresponding to an 
individual coronary artery region (anterior:V1 to V6 leads, lateral: I, aVL and V5,V6 leads, 
and inferior: II, III and aVF leads, respectively) in absence of a typical bundle branch block 
pattern. CMR studies of 91 patients (pts) with GDE (0.1 mmol/kg Gadolinium) and ECG 
were studied. Presence of non-subendocardial and patchy or diffuse mid to subepicardial 
GDE patterns was considered abnormal. Pts with CAD, prior myocardial infarction, and 
transmural/subendocardial GDE were excluded (n=34).
Results: Of 57 pts (mean age 41 ± 15 years, 41% male), 17 (30%) pts had fQRS on 
their 12-lead ECG and 8(14%) pts had abnormal non-CAD-related GDE. Sensitivity and 
speciﬁcity of detecting non-CAD related myocardial pathology by fQRS on ECG were 
88% and 80% respectively p<0.001. Results are summarized in the table.
Conclusion: Fragmented QRS complexes on a 12-lead ECG is reliable marker of both 
CAD and non-CAD related myocardial disease with a high degree of speciﬁcity to localize 
the region of the involved myocardium. 
Indication for CMR Number of 
cases
fQRS noFQRS
dilated cardiomyopthy 9 3 6
rule out myocarditis 5 1 4
constrictive pericarditis 6 2 4
Arrhythmia 14 2 12
intracardiac mass 7 2 5
inﬁltrative disease (sarcoidosis, amyloidosis 
and hemochromatosis) 18 7 11
. . . .
Sensitivity Speciﬁcity P value
fQRS 88% 80% <0.001
Anterior fQRS 50% 94% 0.01
Lateral fQRS 67% 98% <0.001
Inferior fQRS 80% 81% 0.01
9:30 a.m.
1047-49 Abnormal Heart Rate Turbulence Predicts 
Cardiovascular Mortality in High-Risk Post-MI Patients 
With Left Ventricular Dysfunction in the EPHESUS 
Study
Phyllis K. Stein, Stephanie Q. Mistretta, Prakash Deedwania, Washington University 
School of Medicine, St. Louis, MO
Background: Heart rate turbulence (HRT) is a promising marker for risk of mortality 
post-MI. We investigated the optimal HRT cutpoint for prediction of cardiovascular (CV) 
mortality in high-risk post-MI patients.
Methods: HRT was calculated from Holters from 481 hospitalized post-MI patients with 
heart failure and/or diabetes with left ventricular dysfunction before randomization in the 
Eplerenone Post-Acute Myocardial Infarction Heart Failure Efﬁcacy and Survival Study 
(EPHESUS). During 1 year follow up, 55 died, 49 of CV causes. HRT onset (TO) and 
slope (TS) were categorized using cohort-optimized cutpoints and their independent 
contribution to risk of CV death determined. Models were tested with <5 VPCs categorized 
as normal (N=452) and <5 VPCs excluded (N=342).
Results: In EPHESUS, optimal cutpoints were TS a3.0 ms/beat and TO q0.0 %. The 
strongest model for predicting cardiovascular mortality excluded subjects with <5 VPCs. 
On multivariate analysis, using a 3-category HRT model (TS and TO normal, either 
abnormal, both abnormal), having both abnormal (RR=3.6 [95% CI 1.6-8.6], p=0.003) and 
left ventricular ejection fraction a30% (RR=2.0 [95% CI 1.04-3.8], p=0.037) independently 
predicted CV death. The ﬁgure shows survival curves for HRT and for LVEF cut at 30%. 
Abnormal HRT identiﬁed a subgroup at much higher risk of CV mortality than did LVEF.
Conclusions: Abnormal HRT measured as both TS and TO abnormal is a powerful 
independent predictor of CV death in a high-risk post-acute MI population. 
9:30 a.m.
1047-46 AVR ST-Elevation: An Important but Neglected Sign in 
ST-Elevation Acute Myocardial Infarction
Cheuk-Kit Wong, Harvey D. White, HERO-2 investigators, Dunedin School of Medicine, 
Otago university, Dunedin, New Zealand, Greenlane cardiovascular unit, Auckland 
hosptial, Auckland, New Zealand
Background: Lead aVR is non-adjacent to other leads and traditionally neglected, but 
aVR ST elevation may be prognostically important during ST elevation acute myocardial 
infarction (AMI).
Methods: Lead aVR ST elevation was measured to the nearest 0.5mm on both 
randomization and 60-minutes ECG in 15,825 patients from the HERO-2 trial, with 30-
day mortality as the end-point.
Results: aVR ST elevation >1mm was associated with higher mortality in patients with 
normal conduction regardless of AMI location (14.7% vs 11.2% for anterior, P=0.0045 
and 16.0% vs 6.4% for inferior AMI, P<0.0001). After adjusting for summed ST elevation 
and summed ST depression in the other 11 leads, associations with higher mortality were 
found with aVR ST elevation of > 1.5mm for anterior (odds ratio 1.69 [95% CI 1.16 to 
2.45]) and of > 1mm for inferior AMI (odds ratio 2.41 [95% CI 1.76 to 3.30]). Mortality was 
similar between anterior and inferior AMI (11.5% vs 13.2% respectively, P=0.51) with aVR 
ST level =1mm (7.5% and 3.1% of patients respectively), and with level >1.5mm (2.7% 
and 1.4% of patients respectively, mortality 23.5% vs 22.5% respectively, P=0.84). At 60 
minutes after ﬁbrinolytic therapy, resolution of ST elevation to <1mm was associated with 
lower mortality (11.0% vs 20.6%, P=0.0003; and 11.1% vs 21.5%, P=0.0067 respectively 
for anterior and inferior AMI), while new ST elevation >1mm was associated with higher 
mortality (18.5% vs 10.4%, P<0.0001; and 12.6% vs 6.0%, P=0.0006 respectively).
Conclusions: aVR ST elevation is an important adverse prognostic sign in AMI with 
both infarct locations. When present with inferior AMI, mortality is as high as presence 
with anterior AMI.
9:30 a.m.
1047-47 Prognostic Signiﬁcance of ST-T-Wave Abnormalities on 
Baseline Electrocardiogram in Patients Without History 
of Coronary Artery Disease Referred for Dobutamine 
Stress Echocardiography 
Abdou A. Elhendy, Chiara Pedone, Jeroen Bax, Ron van Domburg, Don Poldermans, 
Marshﬁeld Clinic, Marshﬁeld, WI, Thoraxcenter, Rotterdam, The Netherlands
Background: The aim of this study was to determine the prognostic signiﬁcance of resting 
ST-T wave abnormalities in patients (pts) referred for dobutamine stress echocardiography 
(DSE) who have no history of coronary artery disease.
Methods: We evaluated 1308 pts without previous myocardial infarction or 
revascularization who underwent DSE (up to 40μg/kg/min of dobutamine-atropine up to 
2 mg). End points during follow up were hard cardiac events (cardiac death and non fatal 
myocardial infarction). An abnormal DSE was deﬁned as new or worsened wall motion 
abnormalities.
Results: ST-T wave abnormalities were detected on resting EKG in 162 (12%) pts. Pts 
with baseline ST-T abnormalities had a higher incidence of ischemia (46% vs 28%, 
p<0.0001). Mean follow up was 4.6±3 y. Pts with resting ST-T abnormalities had a higher 
annual event rate compared to pts without (5.3% vs 3%, p <0.01 in pts with abnormal 
DSE and 3.1% vs. 1.4%, p<0.01 in pts with normal DSE, ﬁgure). In a Cox proportional 
modelling, resting ST-T abnormalities added incremental information over clinical and 
DSE data (global C2 increased from 79 to 100 p<0.05). The incremental value of ST-T 
abnormalities was also observed in pts with normal DSE (global C2 increased from 21 
to 28; p<0.05).
Conclusion: Baseline ST-T wave abnormalities are associated with increased the risk of 
cardiac events, incremental to clinical and DSE data. The increased risk is observed in pts 
with normal as well as abnormal DSE. 
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invasive criteria for that challenging location.
Methods: We included 65 consecutive patients (24 females; mean age: 24±11 years) 
with an ECG pattern compatible with preexcitation (QRS duration >110 ms) through an 
anteroseptal AP following established ECG criteria. A parahissian AP was deﬁned when 
the location of its successful catheter ablation coincided with either the largest recordable 
His bundle electrogram or a His bundle potential of >0.1 mV. Patients without that deﬁnition 
were included in the control group. Cryoablation was performed in 37 patients.
Results: A parahissian location of the AP was found in 32 patients (mean His bundle 
potential amplitude: 0.15±0.08 mV). In 3 of these patients the largest obtainable His bundle 
electrogram was <0.1 mV. AP location of the remaining 33 patients (control group) were: 
anteroseptal (31 patients), fasciculoventricular (1 patient) or nodoventricular (1 patient). 
A negative delta wave in leads V1 and V2 was observed in only 7 of the patients with 
parahissian APs (sensitivity, 22%; speciﬁcity, 100%). However, the sum of initial r waves 
amplitudes in those leads was <0.45 mV in 26 of the latter patients and in 6 patients of the 
control group (sensitivity, 81%; speciﬁcity, 82%; area under ROC curve: 0.896, p=0.0005).
Conclusions: The presence of negative delta waves in leads V1 and V2 shows a poor 
sensitivity and high speciﬁcity to detect APs with a strict deﬁnition of parahissian location. 
The sum of initial r waves amplitudes in those ECG leads could be a useful, adjuntive 
marker in the non-invasive identiﬁcation of these APs.
9:30 a.m.
1047-53 Risk Stratiﬁcation of Mortality in Congestive Heart 
Failure Patients With Ejection Fraction >35%
Iwona Cygankiewicz, Wojciech Zareba, Rafael Vazquez, Antoni Bayes-Genis, 
Domingo Pascual, Jesus Almendral, Miquel Fiol, Alfredo Bardaji, Jose R. Gonzalez-
Juanatey, Vicente Nieto, Mariano Valdes, Juan Cinca, Antoni Bayes de Luna, MUSIC 
Investigators, Catalan Institute of Cardiovascular Sciences, Barcelona, Spain, Heart 
Research Follow-up Program, University of Rochester Medical Center, Rochester, NY
Background. The population of patients with CHF and mild to moderate left ventricular 
dysfunction is growing, and mortality remains high. There is a need for better risk 
stratiﬁcation of patients who might beneﬁt from primary prevention of mortality. This study 
aimed to evaluate the prognostic value of Holter-based parameters for predicting mortality in 
congestive heart failure (CHF) patients with left ventricular ejection fraction (LVEF) >35%.
Methods. The study involved 294 patients (199 men, mean age 66 years) with CHF of 
ischemic and nonischemic etiology, NYHA class II-III, and LVEF>35%. Surface ECG and 
24-hour Holter monitoring were performed at enrollment to assess traditional ECG variables 
as well as heart rate variability, heart rate turbulence (HRT), and repolarization dynamics 
(QT/RR). Total mortality and sudden death were the primary and secondary endpoints.
Results. During a median 44-month follow up there were 43 (15%) deaths. None of the 
traditional ECG risk parameters predicted mortality. SDNN a 86ms, TS a 2.5ms/RR, and 
QTe/RR>0.21 at daytime were found to be independent risk predictors of mortality in 
multivariate analyses. The predictive score based on these three variables showed that 
patients having q 2 risk markers abnormal were at risk of death (30% 3-year mortality) and 
sudden death (12%), comparable to death rates observed in patients with LVEF a 35%.
Conclusions. Increased risk of mortality and sudden death could be predicted in 
CHF patients with LVEF>35% by evaluating the combination of SDNN, TS, and QT/
RR, parameters reﬂecting autonomic control of the heart, baroreﬂex sensitivity, and 
repolarization dynamics.
9:30 a.m.
1047-54 Poor Sensitivity of the Fragmented QRS Complex in 
Detecting Myocardial Scar
Dee Dee Wang, Daniel Buerkel, Stanley J. Chetcuti, Hitinder S. Gurm, University of 
Michigan, Ann Arbor, MI
Background: A single Circulation study (113:2495) has suggested that the fragmented 
QRS complex on an ECG is a highly sensitive and speciﬁc marker of myocardial scar as 
detected by regional perfusion abnormalities. There is no external validation of this data. It 
is unknown if the fragmented QRS complex can be used to deﬁne myocardial viability.
Methods: We correlated the ECG and nuclear perfusion images of 462 consecutive 
patients with known or suspected coronary artery disease. The presence of fragmented 
QRS or Q waves in two contiguous ECG leads was correlated with major coronary artery 
distribution on nuclear perfusion imaging.
Results: Of the 1842 evaluated territories, 1397 (75.8%) were normal, 152 (8.3%) had 
a reversible perfusion defect, 50 (2.7%) had a ﬁxed defect, and 152 (8.3%) had mixed 
reversible and ﬁxed defect. Among patients with normal perfusion, Q waves were seen in 17 
(1.4%) versus fragmented QRS in 221 (15.8%). Among patients with reversible perfusion 
defects, Q waves were seen in 2 (1.3%), while fragmented QRS were seen in 28 (18.4%). 
Among patients with ﬁxed defects, Q waves were seen in 11 (18.3%), while fragmented 
QRS was seen in 24 (40%). Among patients with mixed defects, Q waves were seen in 
14 (5.8%), while fragmented QRS was seen in 48 (19.8%). Sensitivity, speciﬁcity, positive 
predictive value, and negative predictive value for myocardial scar as detected by nuclear 
perfusion imaging analysis were 18.3%, 98.1%, 25%, and 97.3%, respectively, for the Q 
wave alone; 31.7%, 83.6%, 6.1%, and 97.3% , respectively, for the fragmented QRS; 1.7%, 
98.9%, 5%, and 96.8%, respectively for the Q wave and or fragmented QRS. Both Q waves 
and fragmented QRS performed poorly in detecting ﬁxed or mixed defects.
Conclusions: In our study population, both the fragmented QRS and Q wave had poor 
sensitivity in detecting ﬁxed or mixed myocardial scar. Larger studies are needed to 
evaluate fragmented QRS as a surrogate of myocardial scar before it can be incorporated 
into clinical practice.
9:30 a.m.
1047-50 The Prognostic Signiﬁcance of QRS Axis Deviation in 
Patients With Bundle Branch Blocks
Amir Kaykha, Kenneth B. Desser, Kathleen M. Benson, Akil Loli, Frank Cardello, 
Jonathan Myers, Victor F. Froelicher, Banner Good Samaritan Medical Center, Phoenix, 
AZ, VA Palo Alto Health Care System, Palo Alto, CA
Background: Although right (RBBB) and left bundle branch block (LBBB) have been 
reported to be signiﬁcant predictors of cardiovascular (CV) mortality, it is unclear if patients 
with BBB and different QRS axes might have worse outcomes. Methods: Computerized 
12-lead electrocardiograms (ECGs) obtained on 42,301 male veterans at the Palo Alto 
Veterans Affairs Medical Center since 1987 were evaluated. Several ECG interpretations 
deﬁned by standardized computer criteria in the MUSE® ECG system were extracted. 
Subgroup analysis was performed on 2,182 subjects with LBBB and RBBB, and patients 
were stratiﬁed according to QRS axis into three categories of normal axis, left (LAD) and 
right axis deviation (RAD). Only 9 patients with LBBB had RAD and were excluded from 
analysis along with ECGs exhibiting Wolff-Parkinson-White pattern and electronic pacing, 
leaving 41,955 patients with a mean age of 57 years. LAD was deﬁned as an axis deviation 
between -30 to -90 degrees, RAD as 90 to 180 degrees and normal axis as -30 to 90 
degrees. The main outcome measure was CV mortality with a mean follow-up of 6 years.
Results: LBBB and RBBB were present in 556 (1.3%) and 1,615 (3.8%) patients, 
respectively. After adjusting for age and heart rate in a multivariate Cox regression model, 
LBBB and RBBB were signiﬁcant and independent predictors of CV mortality but LBBB 
(HR 1.9, p<0.0001) was a stronger predictor than RBBB (HR 1.4, p<0.0001). When further 
subdivided using QRS axis, RBBB with RAD (HR 2.6, p<0.0001) was a stronger predictor 
of CV mortality in a multivariate Cox model, followed by LBBB with LAD (HR 2.2, p<0.0001), 
LBBB with normal axis (HR 1.8, p<0.0001) and RBBB with LAD (HR 1.5, p<0.0001).
Conclusions: Abnormal QRS axis in patients with BBB was associated with increased CV 
mortality. Although LBBB is more predictive of CV mortality compared to RBBB, patients 
with RBBB and RAD have increased mortality compared to patients with LBBB. Patients with 
BBB and QRS axis deviations might beneﬁt from more aggressive risk factor modiﬁcation 
and more frequent follow-up with special consideration to those with RBBB and RAD.
9:30 a.m.
1047-51 Terminal QRS Notching Distinguishes Between Benign 
and Malignant Variants of Early Repolarization
Faisal M. Merchant, Peter Noseworthy, Rory Weiner, Sheldon Singh, Jeremy N. Ruskin, 
Vivek Y. Reddy, Massachusetts General Hospital, Boston, MA, University of Miami, 
Miami, FL
Background: Recent data suggest that a malignant variant of early repolarization (ER) 
may be associated with idiopathic ventricular tachycardia/ventricular ﬁbrillation (VT/VF). 
We sought to distinguish between electrocardiographic (ECG) features of benign and 
malignant ER variants.
Methods: We reviewed a database of implantable-cardioverter deﬁbrillators (ICDs) to 
identify cases of idiopathic VT/VF. Three blinded reviewers scored the ECGs for the 
presence of ER deﬁned as q0.1mV elevation of the QRS-ST junction manifest as J-point 
slurring or terminal QRS notching in 2 contiguous leads. We also identiﬁed 200 healthy 
age and gender matched controls with ECG ﬁndings identiﬁed as benign ER.
Results: We identiﬁed 9 cases of malignant ER associated with idiopathic VT/VF. 
Comparison of ECG patterns between cases and controls demonstrated that QRS 
notching was signiﬁcantly more prevalent among cases when present in leads V4 (44% 
vs 7%, p<0.01), V5 (44% vs 8%, p=0.02) and V6 (33% vs. 6%, p=0.01). The sensitivity, 
speciﬁcity, PPV and NPV of left precordial QRS notching for identifying malignant variants 
of ER was 56%, 90%, 19% and 98%. J-point slurring did not distinguish between benign 
and malignant variants in any lead.
Conclusions: Terminal QRS notching in the left precordial leads may serve as a marker 
of malignant early repolarization. These ﬁndings have important implications for the 
identiﬁcation and risk stratiﬁcation of patients at risk for life-threatening arrhythmias.
9:30 a.m.
1047-52 A Negative Delta Wave in V1-2 Shows a High Speciﬁcity 
but Low Sensitivity for the Detection of Parahissian 
Accessory Pathways
Esteban Gonzalez-Torrecilla, Jesús Almendral, Angel Arenal, Felipe Atienza, Francisco 
Javier García-Fernández, Rafael Peinado, Leonardo Atea, Francisco Fernández-Avilés, 
Hospital General Universitario Gregorio Marañon, Madrid, Spain
Background: Identiﬁcation of electrocardiographic (ECG) criteria for parahissian 
accessory pathways (APs) are based on small series of patients. The presence of a 
negative delta wave in V1-V2 has been suggested as an ECG marker of this AP location. 
Our purpose is to validate these ECG ﬁndings in a large series of patients with strict 
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9:30 a.m.
1047-57 Interpretation of the Spatial QRS-T Angle: Normal 
Limits in Healthy Subjects in Relation to Values in 
Ischemic Cardiomyopathy
Roderick W.C. Scherptong, C. Jan Willem Borleffs, Sum Che Man, Ivo R. Henkens, Arie 
C. Maan, Saskia Le Cessie, Hubert W. Vliegen, Martin J. Schalij, Cornelis A. Swenne, 
Leiden University Medical Center, Leiden, The Netherlands
Background: In healthy subjects, the QRS and T axes have a similar orientation, 
resulting in a small spatial QRS-T angle (spatial angle). A spatial angle wider than 105° is 
associated with the presence of cardiac disease and increased cardiac mortality. Normal 
variations of the spatial angle are largely unknown. We derived normal limits of the spatial 
angle from healthy subjects and compared those to the spatial angle of patients with 
ischemic cardiomyopathy.
Methods: The ECGs of 660 healthy subjects and 412 patients with ischemic cardiomyopathy 
(ejection fraction <40%) were included. The spatial angle was calculated from the standard 
ECG with a computer program. Normal limits were deﬁned as the 2nd to 98th percentiles of 
the values of normal subjects and these were compared to values of patients.
Results: Normal limits ranged from 20°-130°. The mean spatial angle was 71 ± 25° in normal 
subjects and 139 ± 32° (range 31°-179°) in patients with ischemic cardiomyopathy, (p<0.0001). 
Interestingly, important overlap existed between the spatial angle in healthy subjects and 
patients. Furthermore, 6.3% of normal subjects had a spatial angle within normal limits, but 
wider than 105°, which is currently considered a high risk category (ﬁgure).
Conclusions: Although the spatial angle is signiﬁcantly wider in patients with ischemic 
cardiomyopathy, there is important overlap with normal subjects. Furthermore, the current 
cut-off of 105° is probably too strict to identify cardiac disease.
9:30 a.m.
1047-58 Electrocardiographic Screening in Competitive 
Collegiate Athletes
Anthony Magalski, Marcia McCoy, Michael Zabel, Lawrence McGee, Joseph 
Goeke, Linda Bunten, Michelle Dew, Michael Hajdu, Kimberly Reid, Brian Ramza, 
Cardiovascular Consultants, Mid America Heart Institute, Kansas City, MO, University of 
Kansas, Lawrence, KS
Background: Pre participation screening for cardiac abnormalities in high school and 
college athletes is controversial and not well established. We sought to identify a cardiac 
proﬁle of competitive collegiate athletes participating in multiple sports.
Methods: Prospective registry of male and female college athletes age 18-21 undergoing 
pre participation evaluation at a National Collegiate Athletic Association institution from 
2004-2008. All subjects underwent standard 12-lead electrocardiography (ECG), medical 
history, physical examination and brief (5 min) comprehensive 2D echocardiogram. ECGs 
were classiﬁed as normal, mildly or distinctly abnormal (Table 1).
Results: A total of 781 athletes (52% female) from 14 sports were screened. ECGs were 
classiﬁed as abnormal in 31.6% (9.5% distinctly abnormal). Distinct abnormalities were 
more common in males than females (14.7 vs 4.7%, P<0.001) as were repolarization 
changes and increased R/S wave voltage (Table 1). Major echo abnormalities were 
uncommon. Three athletes (0.4%) were disqualiﬁed from competition: dilated ascending 
aorta (2) and long QT (1). No athlete with hypertrophic cardiomyopathy was identiﬁed and 
no cardiac events have occurred since registry initiation.
Conclusions: ECG abnormalities were present in one-third of college athletes, and 1 
in 10 had characteristics most suggestive of cardiac disease. Major echo abnormalities 
were uncommon.
9:30 a.m.
1047-55 The Prediction of the Presence of True Signiﬁcant 
Coronary Stenosis in Patients With Severe (q
2.0 mm) ST-Segment Depression on Exercise 
Electrocardiography Test
Jong Seong Park, Kwang Soo Cha, Young Hee Nam, Jae Hoon Lee, Tae Ho Park, Moo 
Hyun Kim, Young Dae Kim, Dong-A University Medical Center, Busan, South Korea
Background: Severe ST-segment depression on exercise electrocardiography(ECG) test 
is regarded as a parameter associated with adverse prognosis and multivessel diseases. 
However, it is not always associated with signiﬁcant coronary stenosis. Therefore, we 
determined the predictors of the presence of true signiﬁcant stenosis in patients with 
severe ST-segment depression on exercise ECG test.
Methods: The consecutive 139 patients who showed severe (q 2.0 mm), horizontal or 
downward sloping, ST-segment depression on exercise ECG test were derived from 
the 10,694 patients for 6 years. Clinical factors and electrocardiographic parameters 
were compared between the two groups with or without signiﬁcant coronary stenosis. 
Multivariate logistic regression analysis was performed.
Results: Signiﬁcant coronary stenosis was present in 82 patients (59%) out of 139. 
Logistic regression analysis for its predictors was as follows. 
Multivariate analysis Hazard Ratio 95% CI p value
Maximum ST depression during recovery 11.1 2.4 ~ 51.7 0.002
Maximum ST depression at stage II 10.3 2.0 ~ 54.1 0.006
ST depression in V1~3, I, and aVL 10.5 1.3 ~ 81.8 0.025
Hypertension 4.2 1.3 ~ 13.5 0.007
Typical chest pain 4.1 1.3 ~ 14.6 0.023
Male gender 3.6 0.9 ~ 14.6 0.068
Conclusions: The incidence of signiﬁcant coronary stenosis in patients with severe 
ST-segment depression on exercise ECG test was 59% in our series of patients. The 
clinical and ECG predictors were ST-segment depression during recovery and at stage 
II, ST-segment depression in V1~3, I, and aVL, hypertension, typical chest pain, and male 
gender. It is more reasonable to do the second noninvasive stress test than to move 
quickly into invasive test in patients without above-mentioned predictors who showed 
severe ST-segment depression on exercise ECG test.
9:30 a.m.
1047-56 Prognostic Value of Reduced Heart Rate Variability in 
the GISSI-HF Trial
Maria Teresa La Rovere, Gian Domenico Pinna, Roberto Maestri, Simona Barlera, 
Marino Berardinangeli, Marco Veniani, Roberto Latini, Luigi Tavazzi, GISSI-HF 
Investigators, Fondazione Salvatore Maugeri, IRCCS, Montescano (Pavia), Italy
Background: Reduced heart rate variability (HRV) is a marker of impaired autonomic 
nervous system activity and is associated with increased mortality in patients with heart 
failure (HF). However, its ability to predict survival in the current setting of treatment, 
(including large scale use of beta-blockers (BB) which partially restores autonomic 
balance), has not been reassessed. The aim of the present study was to evaluate the 
predictive value of HRV among patients enrolled in the GISSI-HF Trial.
Methods: We analyzed 24-hour time (SDNN) and frequency domain (Low Frequency 
Power, LFP, 0.04-0.15 Hz) HRV in 314 HF patients in sinus rhythm enrolled in a Holter 
substudy (82% males, 36% with age >70 yrs, NYHA III-IV 20%, 93% with LVEF < 0.40 
and 68% under BB treatment). After categorization into quartiles the predictive value of 
SDNN and LFP was tested in a multivariate model (Cox analysis) adjusting for all clinical 
and functional parameters signiﬁcantly associated with the outcome.
Results: During a median of 3.9 years (IQR 3.0-4.5) the two co-primary endpoints: time 
to death and time to death or admission to hospital for cardiovascular reasons were 
experienced in 56 and 153 patients respectively. Both reduced SDNN (< 81 ms) and 
LFP (< 67 ms2) showed signiﬁcant univariate association with the two endpoints and 
remained signiﬁcantly associated with mortality after adjustment for age (< 70 vs > 70 
yrs), NYHA cl (I-II vs III-IV), ischemic etiology, LVEF (as a continuos variable), presence of 
NSVT, treatment with beta-blocker and n-3 PUFA with a relative risk of 2.3 (95% CI 1.27-
4.28) and 3.2 (95% CI 1.66-6.36) respectively. LFP but not SDNN remained of borderline 
signiﬁcance (RR 1.52, 95% CI 1.03-2.25) in the multivariate model testing the association 
with the combined end-point of death or hospitalization.
Conclusions: These results indicate that HRV remains an independent predictor of poor 
survival even in the presence of beta-blocker treatment and signiﬁcantly adds to currently 
used risk predictors in HF.
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ECG Classiﬁcation Criteria by Gender
Male
(n=374)
Female
(n=407) P-Value
Normal
(Patterns Commonly Associated With Athlete’s Heart Syndrome)
Increased PR interval duration >0.2 s 5 (1.3) 2 (0.5) 0.27
Mild increase in R or S wave voltage (25-29 mm) 12 (3.2) 2 (0.5) 0.004
Sinus bradycardia <60 beats/minute 30 (8.0) 42 (10.3) 0.27
Early repolarization (ST elevation >2 mm in >2 leads 
exclusive of V2 and V3) 38 (10.2) 8 (2.0) <0.001
Incomplete RBBB (Rsr’’ in V1 <0.12 s) 22 (5.9) 20 (4.9) 0.55
Mildly Abnormal
(Patterns Suggestive of Cardiac Disease)
Increased R or S wave voltage (30-34 mm) in any lead 23 (6.1) 1 (0.2) <0.001
Q-waves (2-3 mm) in depth and present in >2 leads 5 (1.3) 2 (0.5) 0.27
Repolarization patterns with ﬂat, minimally inverted, 
or particularly tall (i.e. >15 mm) T-waves in >2 leads 
exclusive of AVR
28 (7.5) 63 (15.5) <0.001
Abnormal precordial R-wave progression with R>S wave 
only in V5-V6 2 (0.5) 7 (1.7) 0.18
Right bundle branch block (RBBB) (rsR’’ >0.12 s in lead 
V1 or V2) 3 (0.8) 1 (0.2) 0.35
Short PR interval <0.12 s. 0 (0.0) 5 (1.2) 0.06
Left atrial enlargement (prolonged positive P-wave in 
lead II and/or deep prolonged negative P-wave in V1) 26 (7.0) 9 (2.2) 0.001
Distinctly Abnormal
(Patterns Strongly Suggestive of Cardiac Disease)
Increased R or S wave voltage >35 mm in any lead 28 (7.5) 2 (0.5) <0.001
Repolarization pattern with inverted T-wave >2 mm in >2 
leads exclusive of AVR 10 (2.7) 4 (1.0) 0.08
Q-waves >4 mm in depth and present in >2 leads 4 (1.1) 4 (1.0) 1.0
Marked left (<-30º) or right (>110º) QRS axis deviation 13 (3.5) 8 (2.0) 0.19
Wolff-Parkinson-White pattern 3 (0.8) 2 (0.5) 0.68
Corrected QT interval >470 msec for males; >480 msec 
for females 0 (0.0) 1 (0.2) 1.0
Data are N (%)
